0001493152-20-015837.txt : 20200814 0001493152-20-015837.hdr.sgml : 20200814 20200814160559 ACCESSION NUMBER: 0001493152-20-015837 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200814 DATE AS OF CHANGE: 20200814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OZOP SURGICAL CORP. CENTRAL INDEX KEY: 0001679817 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 352540672 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55976 FILM NUMBER: 201105006 BUSINESS ADDRESS: STREET 1: 31 SANDFORT LN. CITY: WARWICK STATE: NY ZIP: 10990 BUSINESS PHONE: (845) 544-5112 MAIL ADDRESS: STREET 1: 31 SANDFORT LN. CITY: WARWICK STATE: NY ZIP: 10990 FORMER COMPANY: FORMER CONFORMED NAME: Newmarkt Corp. DATE OF NAME CHANGE: 20160715 10-Q 1 form10-q.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarter ended: June 30, 2020

 

OR

 

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Transition Period from ___________ to____________

 

Commission File Number: 000-55976

 

OZOP SURGICAL CORP.

(Exact name of registrant as specified in its charter)

 

Nevada   35-2540672

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

 

31Sandfort Lane

Warwick, NY 10990

(Address of principal executive offices) (zip code)

 

(845) 544-5112

(Registrant’s telephone number, including area code)

 

Not applicable.

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. [X] Yes [  ] No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). [X] Yes [  ] No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer [  ] Accelerated filer [  ]
  Non-accelerated filer [  ] Smaller reporting company [X]
  (Do not check if a smaller reporting company) Emerging growth company [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). [  ] Yes [X] No

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
None   N/A   N/A

 

As of August 10, 2020, there were 2,904,963,462 shares outstanding of the registrant’s common stock, $0.001 par value per share.

 

 

 

 
 

 

Ozop Surgical Corp.

 

INDEX
       
PART I. FINANCIAL INFORMATION  
       
  ITEM 1 Financial Statements (Unaudited)  
    Condensed Consolidated Balance Sheets as of June 30, 2020 and December 31, 2019 (Unaudited) 1
    Condensed Consolidated Statement of Comprehensive Loss for the three and six months ended June 30, 2020 and 2019 (Unaudited) 2
    Condensed Consolidated Statement of Changes in Stockholders’ Deficit for the three and six months ended June 30, 2020 and 2019 (Unaudited) 3
    Condensed Consolidated Statement of Cash Flows for the six months ended June 30, 2020 and 2019 (Unaudited) 4
    Notes to Interim Unaudited Condensed Consolidated Financial Statements 5
  ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 35
  ITEM 3. Quantitative and Qualitative Disclosures About Market Risk 41
  ITEM 4. Controls and Procedures 42
       
PART II. OTHER INFORMATION
     
  ITEM 1. Legal Proceedings 43
  ITEM 1A. Risk Factors 43
  ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 43
  ITEM 3. Defaults Upon Senior Securities 43
  ITEM 4. Mine Safety Disclosures 43
  ITEM 5. Other Information 43
  ITEM 6. Exhibits 43
       
  SIGNATURES 46

 

   

 

 

OZOP SURGICAL CORP

CONDENSED CONSOLIDATED BALANCE SHEET

(Unaudited)

 

    June 30,     December 31,  
    2020     2019  
ASSETS                
Current Assets                
Cash   $ 304,676     $ 10,877  
Advance for acquisition     400,000       -  
Prepaid expenses     2,167       5,417  
Assets of discontinued operations     -       5,462,195  
Total Current Assets     706,843       5,478,489  
                 
Property and equipment, net     10,910       4,001  
Goodwill     194,951       194,951  
License Rights, net of accumulated amortization     151,041       171,875  
TOTAL ASSETS   $ 1,063,745     $ 5,849,316  
                 
LIABILITIES AND STOCKHOLDERS’ DEFICIT                
Liabilities                
Current Liabilities                
Accounts payable and accrued expenses   $ 419,355     $ 370,640  
Accounts payable and accrued expenses, related parties     419,692       470,886  
Convertible notes payable, net of discounts     1,767,505       1,694,227  
Current portion of notes payable     270,030       425,033  
Derivative liabilities     9,471,445       2,462,940  
Liabilities of discontinued operations     75,270       5,592,706  
Total Current Liabilities     12,423,299       11,016,432  
Long Term Liabilities                
Note payable, net of discount     176,365       -  
TOTAL LIABILITIES     12,599,663       11,016,432  
                 
Stockholders’ Deficit                
Preferred stock (10,000,000 shares authorized, par value  $0.001, 50,000 shares issued and outstanding)                

Series C Preferred Stock (50,000 shares authorized and 50,000 issued and outstanding, par value $0.001)

     50       50  
Common stock (4,990,000,000 shares authorized par value $0.001; 1,549,176,877 and 219,035 shares issued and outstanding June 30, 2020, and December 31, 2019, respectively)     1,549,177       219  
Deferred stock compensation     -       (49,033 )
Treasury stock, Series C Preferred Stock (47,500 shares, par value $0.001)     (100,000 )     -  
Common stock to be issued (1,350 shares issuable)     1       1  
Additional paid in capital     28,452,220       5,090,936  
Accumulated Deficit     (41,436,232 )     (10,208,905 )
Stock subscription receivable     (7,600 )     (7,600 )
Accumulated comprehensive gain     6,466       7,216  
Total Stockholders’ Deficit     (11,535,918 )     (5,167,116 )
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT   $ 1,063,745     $ 5,849,316  

 

 

See notes to condensed consolidated financial statements.

 

 1 

 

 

OZOP SURGICAL CORP

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS

(Unaudited)

 

   For the Three Months Ended June 30,   For the Six Months Ended June 30, 
   2020   2019   2020   2019 
Revenue  $-   $1,521   $-   $49,123 
                     
Operating expenses:                    
General and administrative, related parties   30,000    163,000    87,505    283,000 
General and administrative, other   170,006    453,454    291,241    1,048,819 
Research and development   -    10,400    -    63,604 
Impairment   -    44,200    -    44,200 
Total operating expenses   200,006    671,054    378,746    1,439,623 
                     
Operating loss   (200,006)   (669,533)   (378,746)   (1,390,500)
                     
Other (income) expenses:                    
Interest expense   11,390,835    572,229    15,212,160    939,703 
Loss (Gain) on change in fair value of derivatives   2,148,349    (20,762)   3,682,522    (68,372)
Loss on extinguishment of debt   11,816,065    696,241    12,011,607    559,566 
Total Other Expenses   25,355,250    1,247,708    30,906,290    1,430,897 
                     
Loss from continuing operations before income taxes   (25,555,256)   (1,917,241)   (31,285,036)   (2,821,397)
Income tax provision   -    -    -    - 
Loss from continuing operations  $(25,555,256)  $(1,917,241)   (31,285,036)   (2,821,397)
Discontinued operations:                    
Loss from discontinued operations, net of income taxes   -    -    (29,147)   - 
Gain from license termination, net of income taxes   -    -    86,856    - 
Net loss  $(25,555,256)  $(1,917,241)  $(31,227,327)  $(2,821,397)
Other comprehensive income (loss):                    
Foreign currency translation adjustment   (9)   (717)   (750)   (530)
Comprehensive loss  $(25,555,265)  $(1,917,958)  $(31,228,077)  $(2,821,927)
                     
Loss per share basic and fully diluted  $(0.06)  $(59.54)  $(0.14)   (91.87)
                     
Weighted average shares outstanding                    
Basic and diluted   432,058,100    32,203    217,814,987    30,711 

 

See notes to condensed consolidated financial statements.

 

 2 

 

 

OZOP SURGICAL CORP

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ DEFICIT

THREE AND SIX MONTHS ENDED JUNE 30, 2020

(Unaudited)

 

   Common stock   Common stock to be issued   Series C Preferred Stock   Treasury   Deferred Stock   Stock
Subscription		   Accumulated
comprehensive		   Additional
Paid-in		   Accumulated   Stockholders’ Equity 
   Shares   Amount   Shares   Amount   Shares   Amount   Stock   Compensation   Receivable   income   Capital   Deficit   (Deficit) 
Balances January 1, 2020   219,035   $219    1,350   $1    50,000   $50   $-   $(49,033)  $(7,600)  $7,216   $5,090,936   $(10,208,905)   (5,167,116)
                                                                  
Shares issued for conversions of note and interest payable   4,939,400    4,939    -    -    -    -    -    -    -    -    1,127,959    -    1,132,899 
                                                                  
Adjustment for rounding of reverse split   58    -    -    -    -    -    -    -    -    -    -    -    - 
                                                                  
Redemption Series C Preferred stock   -    -    -    -    (2,500)   -   (50,000)    -    -    -    -   -    (50,000)
                                                                  
Issuance Series C Preferred stock as compensation   -    -    -    -    2,500    -    -    -    -    -    4,998    -    5,000 
                                                                  
Amortization of deferred stock compensation   -    -    -    -    -    -    -    49,033    -    -    -    -    49,033 
                                                                  
Foreign currency translation adjustment   -    -    -    -    -    -    -    -    -    (741)   -    -    (741)
                                                                  
Net loss   -    -    -    -    -    -    -    -    -    -    -    (5,672,071)   (5,672,071)
                                                                  
Balances March 31, 2020   5,158,493    5,158    1,350    1    50,000    50    (50,000)    -    (7,600)   6,475    6,223,895    (15,880,976)   (9,702,997)
                                                                  
Shares issued for conversions of note and interest payable   1,439,298,485    1,439,298    -    -    -    -    -    -    -    -    21,620,570    -    23,059,868 
                                                                  
Redemption Series C Preferred stock   -    -    -    -    -   -   (50,000)   -    -    -    -    -    (50,000)
                                                                  
Shares issued upon cashless exercise of warrants   104,719,899    104,720    -    -    -    -    -    -    -    -    607,755    -    712,475 
                                                                  
Foreign currency translation adjustment   -    -    -    -    -    -    -    -    -    (9)   -    -    (9)
                                                                  
Net loss   -    -    -    -    -    -    -    -    -    -    -    (25,555,256)   (25,555,256)
                                                                  
Balances June 30, 2020   1,549,176,877   $1,549,177    1,350   $1    50,000   $50   $(100,000)  $-   $(7,600)  $6,466   $28,452,220   $(41,436,232)  $(11,535,917)

 

OZOP SURGICAL CORP

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ DEFICIT

THREE AND SIX MONTHS ENDED JUNE 30, 2019

(Unaudited)

 

   Common stock   Common stock to be issued   Series B Preferred Stock   Treasury   Series C Preferred Stock   Deferred Stock   Stock Subscription   Accumulated comprehensive  

Additional

Paid-in

   Accumulated  

Total

Stockholders’ Equity

 
   Shares   Amount   Shares   Amount   Shares   Amount   Stock   Shares   Amount   Compensation   Receivable   income   Capital   Deficit   (Deficit) 
Balances January 1, 2019   29,068   $29    -   $-    -   $-   $-        $        $(269,167)  $(7,600)  $8,228   $1,988,897   $(4,068,747)  $(2,348,360)
                                                                            
Shares issued for conversions of note and interest payable   231    -    -    -                   -    -    -    -    -    51,750    -    51,750 
                                                                            
Shares issued in private placement   160    -    -    -                   -    -    -    -    -    80,000    -    80,000 
                                                                            
Share issued and to be issued for services   171    -    450    1                   -    -    (422,100)   -    -    422,099    -    - 
                                                                            
Reclassification of derivatives for payments of convertible notes   -    -    -    -                   -    -    -    -    -    18,479    -    18,479 
                                                                            
Amortization of deferred stock compensation   -    -    -    -                   -    -    395,720    -    -    -    -    395,720 
                                                                            
Unrealized gain on foreign translation   -    -    -    -                   -    -    -    -    187    -    -    187 
                                                                            
Net loss   -    -    -    -                   -    -    -    -    -    -    (904,156)   (904,156)
                                                                            
Balances March 31, 2019   29,630    29    450    1    -    -    -    -    -    (295,547)   (7,600)   8,415    2,561,225    (4,972,903)   (2,706,380)
                                                                            
Shares issued for conversions of note and interest payable   5,597    6    -    -                   -    -    -    -    -    995,809    -    995,815 
                                                                            
Shares issued and to be issued for services   200    -    450    0                   -    -    (55,500)   -    -    87,500    -    32,000 
                                                                            
Amortization of deferred stock compensation   -    -    -    -                   -    -    235,982    -    -    -    -    235,982 
                                                                            
Shares issued in private placement   40    -    -    -                   -    -    -    -    -    20,000    -    20,000 
                                                                            
Shares of Series B Preferred Stock issued   -    -    -    -    1,000    1         -    -    -    -    -    67,999    -    68,000 
                                                                            
Unrealized gain on foreign translation   -    -    -    -                   -    -    -    -    (717)   -    -    (717)
                                                                            
Net loss for the three months ended June 30, 2019   -    -    -    -                   -    -    -    -    -    -    (1,917,241)   (1,917,241)
                                                                            
Balances June 30, 2019   35,467   $35    900   $1    1,000   $1   $-    -   $-   $(115,065)  $(7,600)  $7,698   $3,732,533   $(6,890,144)  $(3,272,541)

 

See notes to condensed consolidated financial statements.

 

 3 

 

 

OZOP SURGICAL, CORP

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Unaudited)

 

   For the Six Months Ended June 30, 
   2020   2019 
Cash flows from operating activities:          
Net loss from continuing operations  $(31,285,036)  $(2,821,397)
Net gain from discontinued operations   57,709    - 
Adjustments to reconcile net loss to net cash used in operations          
Non-cash interest expense   14,727,584    860,561 
Amortization and depreciation   22,313    22,433 
Loss (Gain) on fair value change of derivatives   3,682,522    (68,372)
Loss on extinguishment of debt   12,011,607    559,567 
Stock compensation expense   54,033    706,702 
Gain on termination of license   (86,856)   - 
Impairment   -    44,200 
Changes in operating assets and liabilities:          
Accounts receivable   -    42,590 
Prepaid expenses   3,249    7,359 
Accounts payable and accrued expenses   481,140    137,501 
Accounts payable and accrued expenses, related parties   (51,193)   (28,924)
Net cash used in operating activities-continuing operations   (440,638)   (537,780)
Net cash provided by operating activities-discontinued operations   89,326    - 
Net cash used in operating activities   (351,312)   (537,780)
           
Cash flows from investing activities:          
Purchase of office and computer equipment   (8,389)   - 
Advance for acquisition   (400,000)   - 
Net cash used in investing activities   (408,389)   - 
           
Cash flows from financing activities:          
Redemption of preferred stock   (100,000)   - 
Proceeds from sale of common stock   -    100,000 
Proceeds from issuances of convertible notes payable   803,250    494,950 
Proceeds from issuances of notes payable   351,000    - 
Payments of principal of convertible note payable and notes payable   -    (102,805)
Net cash provided by financing activities   1,054,250    492,145 
           
Effects of exchange rate on cash  $(750)  $(530)
           
Net increase (decrease) in cash   293,799    (46,165)
           
Cash, Beginning of period   10,877    50,903 
           
Cash, End of period  $304,676   $4,738 
           
Supplemental disclosure of cash flow information:          
Cash paid for interest  $47,737   $3,135 
Cash paid for income taxes  $-   $- 
           
Schedule of non-cash Investing or Financing Activity:          
Original issue discount included in convertible notes payable  $202,500   $66,050 
Default penalties added to convertible notes payable  $1,680,544   $- 
Issuance of common stock upon convertible note and accrued interest conversion  $3,207,320   $155,440 
Reclassification of notes payable to convertible notes payable  $330,000   $- 
           
Carrying value of assets and liabilities at termination of license with Spinal Resources, Inc.          
Inventory  $374,500   $- 
Implant instruments, net   350,825    - 
Patent rights, net   2,714,204    - 
Goodwill   2,002,314    - 
License fee payable   (1,234,089)   - 
Present value of option to buy SRI   (2,899,420)   - 
Common stock payable   (245,000)     
Iberia Note   (447,153)   - 
Equity line payable   (45,359)   - 
Note issued for inventory and instruments   (640,699)   - 
Accrued interest   (16,979)   - 
Gain on termination  $86,856   $- 

 

See notes to condensed consolidated financial statements.

 

 4 

 

 

OZOP SURGICAL CORP

Notes to Condensed Consolidated Financial Statements

June 30, 2020

 

NOTE 1 - ORGANIZATION

 

Business

 

Ozop Surgical Corp. (the” Company,” “we,” “us” or “our”) was originally incorporated as Newmarkt Corp. on July 17, 2015, under the laws of the State of Nevada. Following the acquisition of OZOP Surgical, Inc. (“Ozop”) as discussed below, we have been engaged in the business of inventing, designing, developing, manufacturing and distributing innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies, focused on spine, neurological and pain management procedures and specialties.

 

Stock Purchase Agreement

 

On February 28, 2020, the Company entered into a Binding Letter of Intent (the “LOI”) with Power Conversion Technologies, Inc., a Pennsylvania corporation (“PCTI”), and Catherine Chis (“Chis”), PCTI’s Chief Executive Officer (“CEO”) and its sole shareholder. On June 26, 2020, the Company, PCTI and Chis signed a Stock Purchase Agreement (the “SPA”) and on July 10, 2020, the Company closed the SPA with PCTI and Chis, the sole shareholder of PCTI. Under the terms of the SPA, the Company acquired one thousand (1,000) shares of PCTI, which represents all of the outstanding shares of PCTI, from Chis in exchange for a cash payment of $400,000 (of which $100,000 was paid May 26, 2020, and $300,000 was paid June 26,2020) and is presented as advance for acquisition on the accompanying balance sheet, and the issuance of 47,500 shares of the Company’s Series C Preferred Stock, 18,667 shares of the Company’s Series D Preferred Stock, and 500 shares of the Company’s Series E Preferred Stock to Chis. PCTI operates in the very high-power niche of the power electronics market, designing and manufacturing leading edge equipment for use in power conversion applications. PCTI serves clients in several industries including energy storage, shore power, DEWs, microgrid, telecommunications, military, transportation, renewable energy, aerospace and mission critical defense systems. PCTI’s clients include Fortune 500 companies, all branches of the US Department of Defense including the US Army and the US Air Force, NASA as well as other global military organizations

 

Acquisition and Termination of Exclusive License Agreement

 

On August 23, 2019, the Company entered into an Exclusive License Agreement (the “Agreement”) with Spinal Resources, Inc. (“SRI”). Pursuant to the Agreement, SRI granted to the Company an exclusive license, for products, as defined in the Agreement, and utilized in spine and related surgical procedures. In accordance with ASC 805, the Company has determined to account for the Agreement as a business combination. As consideration for the Agreement, the Company agreed to pay license fees equal to $1,500,000, over the eighteen- month term of the Agreement. The Company recorded the liability at its present value of $1,234,089. Additionally, the Company has agreed to issue 6,000 shares of restricted common stock on a quarterly basis, pursuant to the terms of the Agreement, of which 1,000 shares were issued on August 23, 2019. The Company valued the shares issued at $49,000 (based on the market price of the common stock) and included the $49,000 as part of the consideration of the transaction. The remaining 5,000 shares to be issued has been recorded as a $245,000 liability to be paid in common stock and was included in the total consideration issued in the transaction. The Company also issued a Promissory Note (the “Note”) to SRI for $723,524 for the purchase of the inventory of the Products (as defined in the Agreement). This note has a stated interest rate of six percent (6%) and payment terms of this note are in eighteen equal instalments, beginning on October 1, 2019. Either party may terminate the Agreement upon written notice if the other party has failed to remedy a material breach within 30 days (or 15 days in the case of a breach of a payment obligation). SRI also granted the Company an option to purchase the Company on or before the termination date of the license for a minimum of $5,500,000 which could have been increased based on the revenue rate at the time the option would be exercised. If the Company did not elect to exercise their option to purchase SRI, SRI can “put” the Acquisition to the Company. Any payments made for the license, this note and other liabilities assumed by the Company can be net against the option to buy price. The Company calculated the net minimum purchase price to be $3,093,604 and recorded the liability at its present value of $2,834,692. The difference of $258,912 was charged to interest expense over the option period.

 

 5 

 

 

The following table summarizes the preliminary value of the consideration issued and the preliminary purchase price allocation of the fair value of assets acquired and liabilities assumed in the transaction:

 

   Purchase Price Allocation 
Fair value of consideration issued  $5,286,305 
Liabilities assumed   524,387 
Total purchase price  $5,810,692 
Assets acquired  $723,524 
Intellectual Property/Technology   2,810,000 
Goodwill   2,277,168 
   $5,810,692 

 

The total purchase price of $5,810,692 has been allocated on a preliminary basis to the tangible and intangible assets acquired and liabilities assumed based on preliminary estimated fair values as of the completion of the transaction. These allocations reflect various preliminary estimates that are currently available and are subject to change upon the valuation being finalized within the measurement period.

 

On January 16, 2020, the Company received from SRI notice that the Agreement dated August 23, 2019, between SRI and the Company has been revoked, as the Company did not make the required January 6, 2020, license payment nor cure the default. Based on the termination of the Agreement, the Company recorded an impairment charge to goodwill of $274,854 as of December 31, 2019. The impairment charge was calculated as the difference of the carrying values of the assets acquired compared to the consideration and liabilities assumed in the transaction.

 

The Company recorded a gain of $86,856 for the six months ended June 30, 2020 based on the difference of the carrying values of the assets acquired and liabilities that were assumed in the transaction as follows:

 

Assets    
Inventory  $374,500 
Instruments, net   350,825 
Patent rights, net   2,714,204 
Goodwill   2,002,314 
Total assets as of January 16, 2020  $5,441,843 

 

Consideration issued and liabilities assumed    
Common Stock payable  $245,000 
License fee payable   1,234,089 
Equity Line payable   45,359 
Iberia Note   447,153 
Inventory and Instrument note   640,699 
Accrued interest   16,979 
Option to buy   2,899,420 
Total consideration and liabilities assumed balances  $5,528,699 
Gain on termination of license  $86,856 

 

See Note 12 for further discussion on discontinued operations.

 

 6 

 

 

Corporate Matters

 

OZOP was originally incorporated in Switzerland on November 28, 1998 under the name Perma Consultants Holding AG (“Perma”). On July 19, 2016, Mr. Eric Siu (“Siu”), a former director purchased 100% of the outstanding capital stock of Perma and changed the name from Perma to Ozop Surgical AG (“Ozop AG”). On February 1, 2018, Ozop AG was re-domiciled as a Delaware corporation and changed its name to Ozop Surgical, Inc. On July 28, 2016, Ozop formed as the sole member, Ozop Surgical, LLC (“Ozop LLC”), a Wyoming limited liability company. On October 28, 2016, Ozop acquired 100% of Ozop Surgical Limited (“Ozop HK”), from Siu, the sole shareholder of Ozop HK. Ozop HK, is a private limited company incorporated in Hong Kong.

 

NOTE 2 – GOING CONCERN AND MANAGEMENT’S PLANS

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. On January 16, 2020, the Company received from SRI notice that the Agreement dated August 23, 2019, between SRI and the Company has been revoked, as the Company did not cure a payment default within the cure period. As of June 30, 2020, the Company had a stockholders’ deficit of $11,535,918 and a working capital deficit of $11,716,456. In addition, the Company has generated losses since inception. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern.

 

In December 2019, a novel strain of coronavirus (COVID-19) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to most other countries and infections have been reported globally. Because COVID-19 infections have been reported throughout the United States, certain federal, state and local governmental authorities have issued stay-at-home orders, proclamations and/or directives aimed at minimizing the spread of COVID-19. The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but it may have a material adverse impact on our business, financial condition and results of operations. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which it may have an impact cannot be determined at this time.

 

Management’s Plans

 

As a public company, management believes it will be able to access the public equities market for fund raising for product development and regulatory approvals, sales and marketing and as we expand our distribution in the US market, we will need to meet increasing inventory requirements.

 

On July 10, 2020, the Company entered into the SPA with PCTI, and Chis, PCTI’s CEO and its sole shareholder (see Note 1).

 

The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING PRONOUNCEMENTS

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June 30, 2020, and the results of operations and cash flows for the periods presented. The results of operations for the three and six months ended June 30, 2020, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Current Report on Form 10-K filed on May 14, 2020.

 

 7 

 

 

The unaudited condensed consolidated financial statements include the accounts of the Company and Ozop and its wholly owned subsidiaries Ozop LLC, Ozop HK and Spinus, LLC (“Spinus”). All intercompany accounts and transactions have been eliminated in consolidation.

 

Emerging Growth Companies

 

The Company qualifies as an “emerging growth company” under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging growth company, the Company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company has elected to take advantage of the benefits of this extended transition period.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits

 

Sales Concentration and credit risk

 

Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the three and six months ended June 30, 2020, and 2019, and their accounts receivable balance as of June 30, 2020:

 

   Sales % Three Months Ended June 30, 2020   Sales % Three Months Ended June 30, 2019   Sales % Six Months Ended June 30, 2020   Sales % Six
Months Ended
June 30, 2019		   Accounts receivable balance June 30, 2020 
Customer A   N/A    100%   N/A    100%  $      - 

 

Accounts Receivable

 

The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.

 

 8 

 

 

Inventory

 

Inventory, if any, which consists of finished goods, is valued at the lower of cost or net realizable value. Cost is determined using the first in first out (FIFO) method. Provision for potentially obsolete or slow-moving inventory is made based on management analysis or inventory levels and future sales forecasts.

 

Purchase concentration

 

The principal purchases by the Company is comprised of finished goods that the Company sells to its customers. Following is a summary of suppliers who accounted for more than ten percent (10%) of the Company’s purchases for the three and six months ended June 30, 2020, and 2019:

 

   Purchase % Three Months Ended June 30, 2020   Purchase % Three Months Ended June 30, 2019   Purchase % Six Months Ended June 30, 2020   Purchase % Six
Months Ended
June 30, 2019		 
Supplier A   N/A    100%   N/A    100%

 

Property, plant and equipment

 

Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets.

 

The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows:

 

   June 30, 2020   December 31, 2019 
Office equipment  $17,979   $9.590 
Less: Accumulated Depreciation   (7,069)   (5,589)
Property and Equipment, Net  $10,910   $4,001 

 

Depreciation expense was $816 and $1,480 for the three and six months ended June 30, 2020, respectively, and $800 and $1,599 for the three and six months ended June 30, 2019, respectively.

 

Intangible Assets

 

Intangible assets primarily represent purchased patent and license rights. The Company amortizes these costs over the shorter of the legal life of the patent or its estimated economic life using the straight-line method. The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to future undiscounted cash flows to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. For the year ended December 31, 2019, the Company impaired $44,200 of tradenames as management has decided not to go forward with the use of the trade name Spinus. For the three and six months ended June 30, 2020, the Company recorded amortization expense of $10,415 and $20,833, respectively and the three and six months ended June 30, 2019, $10,417 and $20,834, respectively. In accordance with ASC 350, “Intangibles—Goodwill and Other,” goodwill and other intangible assets with indefinite lives are no longer subject to amortization but are tested for impairment annually or whenever events or changes in circumstances indicate that the asset might be impaired.

 

 9 

 

 

Goodwill

 

Goodwill is measured as the excess of consideration transferred and the net of the acquisition date fair value of assets acquired, and liabilities assumed in a business acquisition. During the year ended December 31, 2019, the Company recorded goodwill of $2,277,168, included in assets of discontinued operations in the accompanying balance sheet at December 31, 2019, related to the SRI transaction. The Company reviews the goodwill allocated to each of our reporting units for possible impairment annually and whenever events or changes in circumstances indicate carrying amount may not be recoverable. When assessing goodwill for impairment, the Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its’ carrying amount. If, after assessing the totality of events or circumstances, the Company determines it is more likely than not that the fair value of a reporting unit is less than its’ carrying amount, then the Company performs a two-step impairment test. If the Company concludes otherwise, then no further action is taken. The Company also has the option to bypass the qualitative assessment and only perform a quantitative assessment, which is the first step of the two-step impairment test. In the two-step impairment test, the Company measures the recoverability of goodwill by comparing a reporting unit’s carrying amount, including goodwill, to the estimated fair value of the reporting unit. During the year ended December 31, 2019. the Company recorded an impairment of goodwill of $274,854, for the termination of the SRI License Agreement due to no known future cash flows being provided by the assets, and as of January 16, 2020, the Company wrote off the remaining Goodwill balance associated with SRI transaction of $2,002,314.

 

In assessing the qualitative factors, the Company assesses relevant events and circumstances that may impact the fair value and the carrying amount of the reporting unit. The identification of relevant events and circumstances, and how these may impact a reporting unit’s fair value or carrying amount involve significant judgments and assumptions. The judgment and assumptions include the identification of macroeconomic conditions, industry, and market considerations, cost factors, overall financial performance and share price trends, and making the assessment as to whether each relevant factor will impact the impairment test positively or negatively and the magnitude of any such impact.

 

The carrying amount of each reporting unit is determined based upon the assignment of our assets and liabilities, including existing goodwill and other intangible assets, to the identified reporting units. Where an acquisition benefits only one reporting unit, the Company allocates, as of the acquisition date, all goodwill for that acquisition to the reporting unit that will benefit. Where the Company has had an acquisition that benefited more than one reporting unit, The Company has assigned the goodwill to our reporting units as of the acquisition date such that the goodwill assigned to a reporting unit is the excess of the fair value of the acquired business, or portion thereof, to be included in that reporting unit over the fair value of the individual assets acquired and liabilities assumed that are assigned to the reporting unit.

 

If the carrying amount of a reporting unit is in excess of its fair value, an impairment may exist, and the Company must perform the second step of the impairment analysis to measure the amount of the impairment loss, by allocating the reporting unit’s fair value to its assets and liabilities other than goodwill, comparing the carrying amount of the goodwill to the resulting implied fair value of the goodwill, and recording an impairment charge for any excess.

 

Discontinued Operations

 

In accordance with ASC 205-20 Presentation of Financial Statements: Discontinued Operations, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when the components of an entity meets the criteria in paragraph 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations. .

 

 10 

 

 

On January 16, 2020, the Company pursuant to the termination of the SRI transaction Agreement (see Note 1) which meets the definition of a discontinued operation. For additional information, see Note 12- Discontinued Operations.

 

Revenue Recognition

 

Effective January 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. Under ASC 606, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The Company has no outstanding contracts with any of its’ customers. Revenues from Spinus were $1,521 and $47,602 for the three and six months ended June 30, 2019, and are recognized as an agent and are recorded at net. There was no impact on the Company’s financial statements as a result of adopting Topic 606 for the three and six months ended June 30, 2020, and 2019.

 

Advertising and Marketing Expenses

 

The Company expenses advertising and marketing costs as incurred. For the six months ended June 30, 2020, and 2019, the Company recorded $1,226 and $59,422, respectively, of advertising and marketing expenses.

 

Research and Development

 

Costs and expenses that can be clearly identified as research and development are charged to expense as incurred. For the six months ended June 30, 2020, and 2019, the Company recorded $-0- and $63,604 of research and development expenses, respectively.

 

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

 

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

 

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of this note transaction and the effective conversion price embedded in this note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.

 

The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.

 

 11 

 

 

Fair Value of Financial Instruments

 

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

 

The following are the hierarchical levels of inputs to measure fair value:

 

  ● Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
  ● Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
  ● Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.

 

The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of June 30, 2020, and December 31, 2019, for each fair value hierarchy level:

 

June 30, 2020  Derivative
Liabilities		   Total 
Level I  $-   $- 
Level II  $-   $- 
Level III  $9,471,445   $9,471,445 

 

December 31, 2019  Derivative
Liabilities		   Total 
Level I  $-   $- 
Level II  $-   $- 
Level III  $2,462,940   $2,462,940 

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the deferred tax assets will not be realized.

 

Tax benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting periods presented.

 

 12 

 

 

Foreign Currency Translation

 

The accounts of the Company’s Hong Kong subsidiary are maintained in Hong Kong dollars and the accounts of the U.S. companies are maintained in USD. The accounts of the Hong Kong subsidiary were translated into USD in accordance with Accounting Standards Codification (“ASC”) Topic 830, Foreign Currency Matters. According to Topic 830, all assets and liabilities were translated at the exchange rate on the balance sheet date; stockholders’ equity is translated at historical rates and statement of comprehensive income items are translated at the weighted average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with ASC Topic 220, Comprehensive Income. Gains and losses resulting from the foreign currency transactions are reflected in the statements of comprehensive income.

 

Relevant exchange rates used in the preparation of the consolidated financial statements are as follows for the periods ended June 30, 2020 and December 31, 2019, (Hong Kong dollar per one U.S. dollar):

 

   June 30, 2020   December 31, 2019 
Balance sheet date   .1290    .1284 
Average rate for statements of operations and comprehensive loss   .1288    .1276 

 

Earnings (Loss) Per Share

 

The Company reports earnings (loss) per share in accordance with ASC 260, “Earnings per Share.” Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net loss by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. As of June 30, 2020, and 2019, the Company’s dilutive securities are convertible into approximately 923,181,023 and 138,402,792 shares of common stock, respectively. This amount is not included in the computation of dilutive loss per share because their impact is antidilutive. The following table represents the classes of dilutive securities as of June 30, 2020, and 2019:

 

   June 30, 2020   June 30, 2019 
Common stock to be issued   1,350    750 
Convertible preferred stock   50,000    - 
Convertible notes payable   923,129,673    138,402,042 
    923,181,023    138,402,792 

 

Recent Accounting Pronouncements

 

There have no recent accounting pronouncements or changes in accounting pronouncements during the period ended June 30, 2020, that are of significance or potential significance to the Company.

 

NOTE 4 – INTANGIBLE ASSETS

 

Patents as of June 30, 2020, and December 31, 2019, consist of the following:

 

   June 30, 2020   December 31, 2019 
Patents and license rights  $250,000   $250,000 
Accumulated amortization   (98,959)   (78,125)
Net carrying amount  $151,041   $171,875 

 

Amortization expense for the six months ended June 30, 2020, and 2019, was $20,834 respectively.

 

 13 

 

 

NOTE 5 - CONVERTIBLE NOTES PAYABLE

 

During the year ended December 31, 2017, OZOP issued 19 convertible promissory notes (the “2017 Notes”), in amounts of $10,000 to $50,000. OZOP received proceeds of $710,000 in the aggregate. The 2017 Notes matured on their one- year anniversary and bear interest at ten percent (10%). The initial conversion feature allowed the holders to convert this note and any unpaid interest due, into shares of the Company’s common stock on the 15th business day that the Company becomes listed, at conversion prices equal to discounts of 35%-50% of the average of the three lowest closing prices of the common stock. In August 2018, the Company offered any noteholder to convert their principal and interest into shares of common stock at $0.50 per share. OZOP also issued $25,500 of convertible notes for consulting fees. During the year ended December 31, 2018, the Company issued a $50,000 convertible promissory note (the “March 2018 Note”) and received proceeds of $50,000. The Company determined that the conversion feature of the 2017 Notes and the March 2018 Note (together, the “Notes”) did not meet the criteria of an embedded derivative and therefore the conversion feature was not bi-furcated and accounted for as a derivative because the Company was a private company, there was no quoted price and no active market for the Company’s common stock.

 

On April 13, 2018, the Company determined the conversion feature of the Notes represented an embedded derivative since the Notes were convertible into a variable number of shares upon conversion. Accordingly, on April 13, 2018, the Notes were not considered to be conventional debt under ASC 815 and the embedded conversion feature was bifurcated from the debt host and accounted for as a derivative liability. Accordingly, the fair value of the derivative instruments of the Notes that occurred prior to April 13, 2018, were recorded as a liability on April 13, 2018, with the corresponding amount recorded as a discount to the notes. Such discount was amortized from the date of issuance to the maturity dates of the Notes. The change in the fair value of the liability for derivative contracts are recorded in other income or expenses in the reporting period, with the offset to the derivative liability on the balance sheet. The embedded feature included in the Notes resulted in the recognition of a derivative liability. On August 29, 2019, pursuant to a Debt Purchase Agreement, one investor sold the principal balance of $15,000, accrued and unpaid interest of $2,624 and a repayment balance of $5,250 to third party investor, for a total purchase price of $22,874 (see below). Also, on August 29, 2019, pursuant to a Debt Purchase Agreement, a second investor sold the principal balance of $25,000, accrued and unpaid interest of $4,248 and a repayment balance of $8,750 to third party investor, for a total purchase price of $37,998 (see below). On February 18, 2020, an investor purchased two $50,000 convertible notes from investors (see below). On June 23, 2020, pursuant to a Debt Purchase Agreement, one investor sold the principal balance of $50,000 and a repayment balance of $10,000 to third party investor, for a total purchase price of $60,000 (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of the 2017 Notes was $25,000 and $175,000, respectively.

 

On April 13, 2018, we issued a convertible promissory note in the principal amount of $442,175, pursuant to a Securities Purchase Agreement we entered into with an investor dated April 1, 2018. This note bears interest at the rate of 12% per annum and was due and payable on April 13, 2019. This note is convertible at any time following the funding of this note into a variable number of the Company’s common stock, based on a conversion ratio of 55% of the average of the lowest trading price for the 25 days prior to conversion. This note was funded on April 13, 2018, when the Company received proceeds of $350,000, after OID of $57,675, and disbursements for the lender’s transaction costs, fees and expenses of $34,500, of which $25,000 were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. During the year ended December 31, 2019, the investor sold $30,000 of this note to another investor. This note was in default and during the year ended December 31, 2019, the Company recorded additional interest expense of $26,188 and added that amount to the principal amount outstanding. For the six months ended June 30, 2020, the investor converted a total of $52,375 of the face value and $39,670 of accrued interest into 35,813,035 shares of common stock, at an average conversion price of $0.00257. During the six months ended June 30, 2020, the Company wrote off the remaining principal balance of $26,188 and recognized a gain on debt extinguishment of $26,188. As of June 30, 2020, and December 31, 2019, the outstanding principal balance and carrying value of this note was $-0- and $78,563, respectively. 

 

 14 

 

 

On August 29, 2018, we issued a convertible promissory note in the principal amount of $339,250, pursuant to a Securities Purchase Agreement we entered into with the investor. This note bears interest at the rate of 12% per annum and is due and payable on August 29, 2019. This note is convertible at any time following the funding of this note into a variable number of the Company’s common stock, based on a conversion ratio of 55% of the average of the lowest trading price for the 25 days prior to conversion. This note was funded on August 29, 2018, when the Company received proceeds of $280,000, after OID of $44,250, and disbursements for the lender’s transaction costs, fees and expenses of $15,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. Periodic payments are due by us on this note at the rate of $1,000 per day (the “Repayment Amount”) via direct withdrawal from our bank account, beginning on August 30, 2018, until this note is satisfied in full. From time to time the investor waives any Repayment Amount for a period of time as agreed upon. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. This note was in default and during the year ended December 31, 2019, the Company recorded additional interest expense of $87,390 and added that amount to the principal amount outstanding. For the six months ended June 30, 2020, the investor converted a total of $112,141 of the face value and $4,630 of accrued interest into 23,237,756 shares of common stock at an average conversion price of $0.0053. During the six months ended June 30, 2020, the Company wrote off the remining principal balance of $74,990 and recognized $74,990 as a gain on debt extinguishment. As of June 30, 2020, and December 31, 2019, the outstanding principal balance and carrying value of this note was $-0- and $187,130, respectively. 

 

On November 15, 2018, the Company issued a 12% convertible promissory note, in the principal amount of $500,000, pursuant to a Securities Purchase Agreement we entered into with the investor. This note matures November 15, 2019. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of this note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company’s common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. Pursuant to this note, the Company agreed to include on its next registration statement filed with the Securities and Exchange Commission, all shares issuable upon conversion of this note. Pursuant to the Security Agreement, all of the obligations under this note are secured by a first security interest in and to all of the Company’s rights, title and interests in, to and under all assets and all personal property of the Company. The Security Agreement includes customary representations, warranties and covenants by the Company. This note was funded on November 19, 2018, when the Company received proceeds of $458,500 after OID of $37,500, and disbursements for the lender’s transaction costs, fees and expenses of $4,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, the investor converted a total of $445,360 of the face value and $39,570 of accrued interest and fees into 150,631,924 shares of common stock at an average conversion price of $0.0032. As of June 30, 2020, and December 31, 2019, the outstanding principal balance and carrying value of this note was $-0- and $445,360, respectively. In connection with the issuance of this note, during the six months ended June 30, 2020, the Company issued 43,500,000 shares upon the cashless exercise of warrants issued.

 

On January 7, 2019, the Company issued an 8% convertible promissory note, in the principal amount of $150,000, pursuant to a Securities Purchase Agreement we entered into with the investor. This note matured January 7, 2020. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of this note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company’s common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. This note was funded on January 9, 2019, when the Company received proceeds of $133,250 after OID of $14,000, and disbursements for the lender’s transaction costs, fees and expenses of $2,750, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $2,416 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $150,000 of the face value and $28,664 of accrued interest and fees into 96,727,034 shares of common stock at an average conversion price of $0.00185. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $150,000 with a carrying value of $147,584, as of December 31, 2019, net of unamortized discounts of $2,416.

 

 15 

 

 

On February 5, 2019, the Company issued an 8% convertible promissory note (the “Master Note”) in the aggregate principal amount of up to $165,000 in exchange for an aggregate purchase price of up to $148,500 with an original issue discount of $16,500 to cover the Investor’s accounting fees, due diligence fees, monitoring and other transactional costs incurred in connection with the purchase and sale of the Master Note, which is included in the principal balance of this note. On February 8, 2019, the Investor funded the first tranche under the Master Note, with a maturity date of February 8, 2020, and the Company received $49,500 ($47,500 after payment of $2,000 of the Investor’s legal fees) for this first tranche of $55,000 under the Master Note and on the same date, the Company issued this note to the Investor. This note is convertible into shares of the Company’s common stock, beginning on the date which is 180 days from the issuance date of the Master Note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of conversion of the Master Note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company’s common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of the Master Note. The embedded conversion feature included in the Master Note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $12,102 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $22,105 of the face value and $4,400 of fees into 6,017,711 shares of common stock at an average conversion price of $0.0044. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of the Master Note was $-0- and $11,640, respectively, with a carrying value as of December 31, 2019, of $7,144, net of unamortized discounts of $4,496. In connection with the issuance of this Note, during the six months ended June 30, 2020, the Company issued 20,138,746 shares upon the cashless exercise of warrants issued.

 

On March 7, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $85,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock, at a conversion price equal to 58% of the average of the two lowest trading prices of the Company’s common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company. This note was funded on March 11, 2019, when the Company received proceeds of $77,900 after OID of $3,000, and disbursements for the lender’s transaction costs, fees and expenses of $4,100, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $15,714 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $31,800 of the face value and $3,427 of accrued interest into 446,416 shares of common stock at an average conversion price of $0.07891. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $31,800, respectively, with a carrying value as of December 31, 2019, of $16,086, net of unamortized discounts of $15,714.

 

On May 29, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $80,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock, at a conversion price equal to 58% of the average of the two lowest trading prices of the Company’s common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company. This note was funded on March 29, 2019, when the Company received proceeds of $73,300 after OID of $2,800, and disbursements for the lender’s transaction costs, fees and expenses of $3,900, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $32,021 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $19,300 of the face value and $2,058 of accrued interest into 3,784,352 shares of common stock at an average conversion price of $0.00564. On May 28, 2020, pursuant to a Debt Purchase Agreement, the investor sold the principal balance of $60,700 and accrued and unpaid interest of $6,665 to third party investor, for a total purchase price of 67,365 (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $80,000, respectively, with a carrying value on December 31, 2019, of $47,979, net of unamortized discounts of $32,021.

 

On June 5, 2019, an investor (the “Purchaser”) pursuant to an Assignment Agreement, purchased a convertible note issued by the Company on December 5, 2018, with a maturity date of December 5, 2019. The Purchaser paid $93,391 to acquire this note. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 65% multiplied by the average of the lowest two trading prices during the 15- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. The embedded conversion feature pursuant to the Assignment Agreement resulted in the recognition of a derivative liability. On April 17, 2020, the Purchaser sold the note to another third- party investor (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of assigned note was $-0- and $93,391, respectively.

 

 16 

 

 

On June 7, 2019, an investor (the “Purchaser”) pursuant to an Assignment Agreement, purchased a convertible note issued by the Company on October 19, 2018, with a maturity date of October 19, 2019. The Purchaser paid $77,000 to acquire this note. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 65% multiplied by the average of the lowest two trading prices during the 15- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. The embedded conversion feature pursuant to the Assignment Agreement resulted in the recognition of a derivative liability. On April 24, 2020, the Purchaser sold the note to another third- party investor (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of assigned note was $-0- and $77,000, respectively.

 

On July 22, 2019, the Company issued a 10% convertible promissory note, in the principal amount of $38,900, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock, at a conversion price equal to 60% of the lowest closing bid price of the Company’s common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company. This note was funded on July 24, 2019, when the Company received proceeds of $30,000 after OID of $3,900, and disbursements for the lender’s transaction costs, fees and expenses of $5,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $22,587 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $38,900 of the face value and $2,714 of accrued interest into 6,379,036 shares of common stock at an average conversion price of $0.00652. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $38,900, respectively, with a carrying value as of December 31, 2019, of $16,313, net of unamortized discounts of $22,587.

 

On August 2, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $157,500, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 60% multiplied by the average of the lowest two trading prices during the 20 trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note was funded on August 2, 2019, when the Company received proceeds of $150,000 after disbursements for the lender’s transaction costs, fees and expenses of $7,500, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $77,844 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $157,500 of the face value and $13,523 of accrued interest into 23,114,263 shares of common stock at an average conversion price of $0.0074. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $157,500, respectively, with a carrying value as of December 31, 2019, of $79,656, net of unamortized discounts of $77,844.

 

On August 21, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $55,125, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 58% multiplied by the average of the lowest two trading prices during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note was funded on August 21, 2019, when the Company received proceeds of $50,000 after OID of $2,625, and disbursements for the lender’s transaction costs, fees and expenses of $2,500, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability . For the six months ended June 30, 2020, amortization of the debt discounts of $33,479 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $3,825 of the face value and $247 of accrued interest into 77,144 shares of common stock at an average conversion price of $0.05278, and on March 9, 2020, sold the remining portion of this note to a third part investor (see below) for $76,000. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $55,125, respectively, with a carrying value of $21,646, as of December 31, 2019, net of unamortized discounts of $33,479. On March 9, 2020, the Company also issued a warrant for $25,000 to the investor in consideration of the sale of this note. The exercise price of the warrant is equal to a 42% discount of the average of the two lowest trading prices of the Company’s common stock for the twenty days preceding the exercise and the warrant expires September 9, 2020. For the six months ended June 30, 2020, the Company issued 3,967,740 shares of common stock upon the cashless exercises of the warrant.

 

 17 

 

 

On August 19, 2019, the Company issued an 8% convertible promissory note, in the principal amount of $85,000, pursuant to a Securities Purchase Agreement we entered into with the investor. This note matures May 19, 2020. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of this note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company’s common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. This note was funded on August 22, 2019, when the Company received proceeds of $75,000 after OID of $7,250, and disbursements for the lender’s transaction costs, fees and expenses of $2,750, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $33,656 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $85,000 of the face value and $7,121 of accrued interest into 39,658,500 shares of common stock at an average conversion price of $0.00232. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $85,000, respectively, with a carrying value as of December 31, 2019, of $51,344, net of unamortized discounts of $33,656. The Company also issued a five- year warrant to purchase 28,333 shares of common stock at an exercise price of $1.50, subject to adjustments.

 

On August 23, 2019, the Company issued to a third-party investor a convertible redeemable promissory note with a face value of $37,800, including an original issue discount of $1,800. This note matures on May 23, 2020, has a stated interest of 10% and is convertible into a variable number of the Company’s common stock, based on a conversion ratio of 58% of the average of the two lowest trading prices for the 20 days prior to conversion. This note was funded on August 26, 2019, when the Company received proceeds of $33,500, after disbursements for the lender’s transaction costs, fees and expenses of $2,500, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $19,239 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $24,317 of the face value and $2,980 of accrued interest into 4,336,000 shares of common stock at an average conversion price of $0.0063, and on April 28, 2020, sold the remining portion of $13,483 of this note to a third- party investor (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $0-0 and $37,800, respectively, with a carrying value as of December 31, 2019, of $18,561, net of unamortized discounts of $19,239.

 

On August 29, 2019, the Company issued a 10% convertible promissory note, in the principal amount of $45,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 60% multiplied by the average of the lowest two trading prices during the 20 trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note was funded on September 4, 2019, when the Company received proceeds of $40,000 after disbursements for the lender’s transaction costs, fees and expenses of $5,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $26,567 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $45,000 of the face value and $2,838 of accrued interest into 7,933,325 shares of common stock at an average conversion price of $0.00603. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $45,000, respectively, with a carrying value as of December 31, 2019, of $18,434, net of unamortized discounts of $26,566.

 

On August 29, 2019, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note issued by the Company on September 1, 2017 (see above). The Purchaser paid $22,874 to acquire this note. This note, as amended, is convertible into common stock at a conversion price equal to a 35% discount to the average of the 3 lowest closing prices of the common stock for fifteen prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, the investor converted a total of $15,874 of the face value and $968 of accrued interest into 217,331 shares of common stock at an average conversion price of $0.0775. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of assigned note was $-0- and $15,874, respectively.

 

 18 

 

 

On August 29, 2019, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note issued by the Company on October 2, 2017 (see above). The Purchaser paid $37,998 to acquire this note. This note, as amended, is convertible into common stock at a conversion price equal to a 35% discount to the average of the 3 lowest closing prices of the common stock for fifteen prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, the investor converted a total of $37,998 of the face value and $2,331 of accrued interest into 3,781,509 shares of common stock at an average conversion price of $0.01066. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of assigned note was $-0- and $37,998, respectively.

 

On October 1, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $68,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 61% multiplied by the lowest closing bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note was funded on October 2, 2019, when the Company received proceeds of $65,000 after disbursements for the lender’s transaction costs, fees and expenses of $3,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $41,584 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $68,000 of the face value and $4,080 of accrued interest into 9.186,036 shares of common stock at an average conversion price of $0.00785. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $68,000, respectively, with a carrying value as of December 31, 2019, of $26,416, net of unamortized discounts of $41,584.

 

On October 8, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $66,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock, at a conversion price equal to 60% of the average of the two lowest trading prices of the Company’s common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company. This note was funded on October 10, 2019, when the Company received proceeds of $57,000 after OID of $6,000, and disbursements for the lender’s transaction costs, fees and expenses of $2,300, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $83,398 was charged to interest expense. For the six months ended June 30, 2020, the investor added $37,750 od defaults to the principal balance of the note. For the six months ended June 30, 2020, the investor converted a total of $103,750 of principal and $2,640 of accrued interest into 24,394,666 shares of common stock at an average conversion price of $0.00436. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $66,000, respectively, with a carrying value as of December 31, 2019, of $18,452, net of unamortized discounts of $47,548.

 

On October 24, 2019, the Company issued a convertible promissory note in the principal amount of $248,400, pursuant to a Securities Purchase Agreement we entered into with the investor. This note bears interest at the rate of 12% per annum and matures 12 months after the date of issuance. This note is convertible at any time following the funding of this note into a variable number of the Company’s common stock, based on a conversion ratio of 60% of the lowest trading price for the 25 days prior to conversion. This note was funded on October 28, 2019, when the Company received proceeds of $200,000, after OID of $32,400, and disbursements for the lender’s transaction costs, fees and expenses of $16,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months June 30, 2020, amortization of the debt discounts of $221,683 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $48,400 of principal and $16,796 of accrued interest into 26,288,995 shares of common stock at an average conversion price of $0.00248, and on May 7, 2020, sold the remining portion of $200,000 of this note to a third- party investor (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $248,400, respectively, with a carrying value as of December 31, 2019, of $26,717, net of unamortized discounts of $221,683.

 

 19 

 

 

On October 24, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $225,000, pursuant to a Securities Purchase Agreement we entered into with the investor. This note matures October 24, 2020. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) $0.05 and (2) 58% multiplied by the average of the 2 lowest trading prices of the Company’s common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. This note was funded on October 31, 2019, when the Company received proceeds of $202,250 after OID of $20,000, and disbursements for the lender’s transaction costs, fees and expenses of $2,750, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $147,689 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $225,000 of principal and $16,858 of accrued interest into 125,613,294 shares of common stock at an average conversion price of $0.00193. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $225,000, respectively, with a carrying value as of December 31, 2019, of $77,311, net of unamortized discounts of $147,689.

 

On October 25, 2019, the Company issued a convertible promissory note in the principal amount of $36,750, pursuant to a Securities Purchase Agreement we entered into with the investor. This note bears interest at the rate of 12% per annum and matures 12 months after the date of issuance. This note is convertible at any time following the funding of this note into a variable number of the Company’s common stock, based on a conversion ratio of 58% of the average of the two lowest closing bid prices for the 20 days prior to conversion. This note was funded on October 25, 2019, when the Company received proceeds of $33,000, after OID of $1,750, and disbursements for the lender’s transaction costs, fees and expenses of $2,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months June 30, 2020, amortization of the debt discounts of $31,106 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $36,750 of principal and $2,219 of accrued interest into 7,881,267 shares of common stock at an average conversion price of $0.00494. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $36,750, respectively, with a carrying value as of December 31, 2019, of $5,644, net of unamortized discounts of $31,106.

 

On November 27, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $53,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 56% multiplied by the lowest closing bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note was funded on December 2, 2019, when the Company received proceeds of $50,000 after disbursements for the lender’s transaction costs, fees and expenses of $3,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the three months ended March 31, 2020, amortization of the debt discounts of $48,2742 was charged to interest expense. On May 15, 2020, pursuant to a Debt Purchase Agreement, the investor sold the principal balance of $53,000, accrued and unpaid interest of $2,997 and a prepayment of $19,003, which was recognized as interest expense, to a third- party investor, for a total purchase price of $75,000 (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $53,000, respectively, with a carrying value as of December 31, 2019, of $4,626, net of unamortized discounts of $48,374.

 

On January 8, 2020, the Company entered into a securities purchase agreement (the “SPA”) with an investor (the “Investor”), pursuant to which the Company agreed to issue to the Investor a 12% Convertible Promissory Note, in the principal amount of $38,000 in exchange for a purchase price of $35,000. This note was funded by the Investor on January 13, 2020, and on such date pursuant to the SPA, the Company reimbursed the Investor for expenses for legal fees and due diligence of $3,000. This note proceeds will be used by the Company for general working capital purposes. The SPA includes customary representations, warranties and covenants by the Company and customary closing conditions. The embedded conversion feature included in this note resulted in an initial debt discount and derivative liability of $29,063. For the six months ended June 30, 2020, amortization of the debt discounts of $32,063 was charged to interest expense. On May 15, 2020, pursuant to a Debt Purchase Agreement, the investor sold the principal balance of $38,000, accrued and unpaid interest of $1,624 and a prepayment of $12,276, which was recognized as interest expense, to a third- party investor, for a total purchase price of $52,000 (see below). As of June 30, 2020, the outstanding principal balance of this note was $-0-.

 

 20 

 

 

On February 18, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note issued by the Company on August 18, 2017 (see above). The Purchaser agreed to pay $50,000 to acquire this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for the thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended March 31, 2020, the Company recorded additional interest expense of $154,627 due to various defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in interest expense of $607,950 (since the purchased note was past its’ maturity date and was in default) with the offset recorded to derivative liabilities. For the six months ended June 30, 2020, the investor converted a total of $202,541 of principal and $64,650 accrued interest and fees into 90,191,785 shares of common stock at an average conversion price of $0.00257. As of June 30, 2020, the outstanding principal balance of assigned note was $2,086.

 

Also, on February 18, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note issued by the Company on August 18, 2017 (see above). The Purchaser agreed to pay $50,000 to acquire this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for the thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended June 30, 2020, the Company recorded additional interest expense of $192,025 due to various defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in interest expense of $607,950 (since the purchased note was past its’ maturity date and was in default) with the offset recorded to derivative liabilities. For the six months ended June 30, 2020, the investor converted a total of $242,025 of principal and $84,849 accrued interest and fees into 241,489,074 shares of common stock at an average conversion price of $0.00123. As of June 30, 2020, the outstanding principal balance of assigned note was $-0-.

 

On February 26, 2020, the Company entered into a securities purchase agreement (the “SPA”) with an investor (the “Investor”), pursuant to which the Company agreed to issue to the Investor a 12% secured convertible promissory note in the aggregate principal amount of $132,750 in exchange for a purchase price of $117,750. Pursuant to the SPA, the Company agreed to pay the Investor $15,000 to cover the Investor’s due diligence expenses incurred in connection with the SPA and Note, which is to be offset against the proceeds of this note. This note was funded by the Investor on February 26, 2020, and on such date pursuant to the SPA, the Company reimbursed the Investor for expenses for legal fees and due diligence of $2,750. This note proceeds will be used by the Company for general working capital purposes. The SPA includes customary representations, warranties and covenants by the Company and customary closing conditions. In conjunction with this note, the Company issued a warrant to purchase 2,212,500 shares of common stock at an exercise price of $0.03, subject to adjustments and expiring on the five-year anniversary of the Issuance Date. The embedded conversion feature included in this note resulted in an initial debt discount and derivative liability of $86,001. For the six months ended June 30, 2020, amortization of the debt discounts of $34,584 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $132,750 with a carrying value of $63,583, net of unamortized discounts of $69,167.

 

On February 26, 2020, the Company and an investor (the “Investor”) agreed to exchange $330,000 of notes payable into a 12% convertible note with a face value of $330,000. This note is convertible into common stock at a conversion price equal to a 44% discount to the lowest trading price of the common stock for the 20 prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature included in this note resulted in interest expense of $365,757 with the offset to derivative liabilities. On March 3, 2020, a third-party investor (the “Purchaser”), pursuant to a Debt Purchase Agreement, purchased this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended June 30, 2020, the Company recorded additional interest expense of $468,750 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in interest expense of $1,321,618 with the offset recorded to derivative liabilities. As of June 30, 2020, the outstanding principal balance of assigned note was $798,750. This note was fully converted as of August 13, 2020.

 

On March 9, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a convertible note issued by the Company on August 19, 2019, with a maturity date of May 19, 2020 (see above). The Purchaser paid $76,000 to acquire this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount and derivative liability of $76,000. For the six months ended June 30, 2020, the Company recorded additional interest expense of $83,263 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. For the six months ended June 30, 2020, amortization of the debt discounts of $76,000 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $3,603 of the face value and $81,521 of accrued interest and fees into 52,946,489 shares of common stock at an average conversion price of $0.0014. As of June 30, 2020, the outstanding principal balance of assigned note was $155,632. This note was fully converted as of August 13, 2020.

 

 21 

 

 

On March 9, 2020, (the “Issuance Date”) the Company issued a 12% convertible promissory note, in the principal amount of $80,000, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $.25 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.25 or 50% of the lowest trading price for the thirty trading days prior to the conversion. The embedded conversion feature included in this note resulted in an initial debt discount of $57,000, interest expense of $64,067 and an initial derivative liability of $121,067. For the six months ended June 30, 2020, amortization of the debt discounts of $48,933 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $80,000 with a carrying value of $48,933, net of unamortized discounts of $31,067.

 

On April 17, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note initially issued by the Company on December 5, 2018, and thereafter was acquired on June 5, 2019 (see above). The Purchaser acquired the note balance of $93,391. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in interest expense of $1,476,436 (since the purchased note was past its’ maturity date and was in default) with the offset recorded to derivative liabilities. For the six months ended June 30, 2020, the Company recorded additional interest expense of $259,305 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. As of June 30, 2020, the outstanding principal balance of assigned note was $352,695. This note was fully converted as of August 13, 2020. 

 

On April 24, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note initially issued by the Company on October 19, 2018, and thereafter was acquired on June 7, 2019 (see above). The Purchaser acquired the note balance of $77,000. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in interest expense of $881,058 (since the purchased note was past its’ maturity date and was in default) with the offset recorded to derivative liabilities. For the six months ended June 30, 2020, the Company recorded additional interest expense of $121,250 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. For the six months ended June 30, 2020, the investor converted a total of $198,183 of the face value and $44,396 of accrued interest and fees into 179,688,215 shares of common stock at an average conversion price of $0.00131. As of June 30, 2020, the outstanding principal balance of assigned note was $67.

 

On April 27, 2020, the Company issued a 15% convertible redeemable note in the principal amount of $60,000. This note matures on April 27,2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company. This note was funded on April 27, 2020, when the Company received proceeds of $50,000, after OID of $10,000, which was recorded as a discount against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in an initial debt discount of $50,000, interest expense of $36,274 and an initial derivative liability of $86,274. For the six months June 30, 2020, amortization of the debt discounts of $10,000 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $60,000 with a carrying value of $10,000, net of unamortized discounts of $50,000.

 

On April 28, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a convertible note issued by the Company on August 23, 2019 with a maturity date of May 23, 2020 (see above). The Purchaser acquired $13,483 of this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount of $13,483, interest expense of $42,261 and an initial derivative liability of $55,744. For the six months ended June 30, 2020, the Company recorded additional interest expense of $1,348 due to a default of this note and the amount was added to the principal balance owed the Purchaser. For the six months ended June 30, 2020, amortization of the debt discounts of $13,483 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of assigned note was $14,831.

 

 22 

 

 

On April 28, 2020, the Company issued a 12% convertible promissory note, (the “Note”) in the principal amount of $53,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 58% multiplied by the lowest closing bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. The Company received proceeds of $50,000 (including direct payments from the lender to certain Company vendors) on May 4, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $3,000. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $50,000, interest expense of $1,539 and an initial derivative liability of $51,539. For the six months June 30, 2020, amortization of the debt discounts of $8,833 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $53,000 with a carrying value of $8,833, net of unamortized discounts of $44,167.

 

On May 4, 2020, the Company issued a 12% convertible promissory note, (the “Note”) in the principal amount of $110,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lower of $0.50 or 58% multiplied by the average of the two lowest closing trading price or bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. The Company received proceeds of $96,250 on May 6, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $13,750. This note proceeds will be used by the Company for general working capital purposes. In conjunction with this note, the Company issued a warrant to purchase 3,666,666 shares of common stock at an exercise price of $0.015, subject to adjustments and expiring on the five-year anniversary of the Issuance Date. The embedded conversion feature included in this note resulted in an initial debt discount of $100,000, interest expense of $5,526 and an initial derivative liability of $105,526. For the six months ended June 30, 2020, amortization of the debt discounts of $18,792 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $110,000 with a carrying value of $16,042, net of unamortized discounts of $93,958.

 

On May 5, 2020, (the “Issuance Date”) the Company issued a 12% convertible promissory note, (the “Note”) in the principal amount of $162,000, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $03 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.03 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $100,000 on May 13, 2020, and this note included an original issue discount of $62,000. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $100,000, interest expense of $151,512 and an initial derivative liability of $251,512. For the six months ended June 30, 2020, amortization of the debt discounts of $54,000 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $162,000 with a carrying value of $54,000, net of unamortized discounts of $108,000. In conjunction with this note, the Company issued a warrant to purchase 4,325,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.

 

On May 7, 2020, the Company issued a 15% convertible redeemable note in the principal amount of $30,000. This note matures on May 7,2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company. The Company received proceeds of $25,000 on May 7, 2020, and this note included an original issue discount of $5,000, which was recorded as a discount against the debt to be amortized into interest expense through maturity This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $25,000, interest expense of $17,828 and an initial derivative liability of $42,828. For the six months June 30, 2020, amortization of the debt discounts of $4,375 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $30,000 with a carrying value of $4,375, net of unamortized discounts of $25,625.

 

 23 

 

 

On May 7, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a convertible note issued by the Company on October 24, 2019, with a maturity date of October 24, 2020 (see above). The Purchaser acquired $200,000 of this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount of $200,000, interest expense of $111,128 and an initial derivative liability of $311,128. For the six months ended June 30, 2020, amortization of the debt discounts of $200,000 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $200,000 of the face value and $16,922 of accrued interest and fees into 92,332,507 shares of common stock at an average conversion price of $0.00218. As of June 30, 2020, the outstanding principal balance of assigned note was $-0-.

 

On May 15, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a convertible note initially issued by the Company on January 8, 2020, with a maturity date of January 8, 2021 (see above). The Purchaser paid $52,000 for the note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended June 30, 2020, the Company recorded additional interest expense of $63,500 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount of $100,000, interest expense of $526,507 and an initial derivative liability of $626,507. For the six months ended June 30, 2020, amortization of the debt discounts of $25,000 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $66,454 of the face value and $5,246 of accrued interest and fees into 53,110,926 shares of common stock at an average conversion price of $0.00129. As of June 30, 2020, the outstanding principal balance of assigned note was $83,546, with a carrying value of $8,546, net of unamortized discounts of $75,000. This note was fully converted as of August 13, 2020.

 

On May 15, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a convertible note initially issued by the Company on November 27, 2019, with a maturity date of November 27, 2020 (see above). The Purchaser paid $75,000 for the note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended June 30, 2020, the Company recorded additional interest expense of $75,000 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount of $77,000, interest expense of $388,385 and an initial derivative liability of $465,385. As of June 30, 2020, the outstanding principal balance of assigned note was $115,500, with a carrying value of $52,398, net of unamortized discounts of $62,563. This note was fully converted as of August 13, 2020.

 

On May 28, 2020, the Company issued a 15% convertible redeemable note in the principal amount of $30,000. This note matures on May 28, 2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company. The Company received proceeds of $25,000 on May 28, 2020, and this note included an original issue discount of $5,000. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $25,000, interest expense of $19,346 and an initial derivative liability of $44,346. For the six months June 30, 2020, amortization of the debt discounts of $2,500 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $30,000 with a carrying value of $2,500, net of unamortized discounts of $27,500.

 

On May 28, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a convertible note issued by the Company on May 29, 2019 (see above). The Purchaser acquired $67,365 of this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount of $67,365, interest expense of $443,420 and an initial derivative liability of $510,785. For the six months ended June 30, 2020, the Company recorded additional interest expense of $83,395 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. For the six months ended June 30, 2020, amortization of the debt discounts of $67,365 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $47,090 of the face value and $3,000 of accrued interest and fees into 39,959,295 shares of common stock at an average conversion price of $0.00118. As of June 30, 2020, the outstanding principal balance of assigned note was $103,671. This note was fully converted as of August 13, 2020.

 

 24 

 

 

On June 1, 2020, (the “Issuance Date”) the Company issued a 12% convertible promissory note, (the “Note”) in the principal amount of $127,500, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $100,000 on June 1, 2020, and this note included an original issue discount of $27,500. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $100,000, interest expense of $103,250 and an initial derivative liability of $203,250. For the six months ended June 30, 2020, amortization of the debt discounts of $21,250 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $127,500 with a carrying value of $21,250, net of unamortized discounts of $106,250. In conjunction with this note, the Company issued a warrant to purchase 6,375,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.

 

On June 11, 2020, the Company issued a 12% convertible promissory note, (the “Note”) in the principal amount of $53,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 58% multiplied by the lowest closing bid price during the twenty trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. The Company received proceeds of $50,000 on June 12, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $3,000. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $50,000, interest expense of $2,218 and an initial derivative liability of $52,218. For the six months June 30, 2020, amortization of the debt discounts of $2,849 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $53,000 with a carrying value of $2,849, net of unamortized discounts of $50,151.

 

On June 23, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note initially issued by the Company on October 6, 2017 (see above). The Purchaser paid $60,000 for the note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended June 30, 2020, the Company recorded additional interest expense of $52,500 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in interest expense of $658.093 (since the purchased note was past its’ maturity date and was in default) with the offset recorded to derivative liabilities. For the six months ended June 30, 2020, the investor converted a total of $91,579 of the face value and $42,071 of accrued interest and fees into 99,000,000 shares of common stock at an average conversion price of $0.00133. As of June 30, 2020, the outstanding principal balance of assigned note was $20,921. This note was fully converted as of August 13, 2020.

 

On June 30, 2020, (the “Issuance Date”) the Company issued a 15% convertible promissory note, (the “Note”) in the principal amount of $129,500, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $102,000 on July 1, 2020, and this note included an original issue discount of $27,500 and lender costs of $2,000. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $100,000, interest expense of $107,122 and an initial derivative liability of $207,122. As of June 30, 2020, the outstanding principal balance of this note was $129,500 with a carrying value of $-0-, net of unamortized discounts of $129,500. In conjunction with this note, the Company issued a warrant to purchase 6,375,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.

 

 25 

 

 

A summary of the convertible note balance as of June 30, 2020, and December 31, 2019, is as follows:

 

   June 30, 2020   December 31, 2019 
         
Principal balance  $2,640,450   $2,500,230 
Unamortized discount   (872,945)   (806,003)
Ending balance, net  $1,767,505   $1,694,227 

 

NOTE 6 – DERIVATIVE LIABILITIES

 

The Company determined the conversion feature of these notes, which all contain variable conversion rates, represented an embedded derivative since the notes were convertible into a variable number of shares upon conversion. Accordingly, the notes are not considered to be conventional debt under ASC 815 and the embedded conversion feature was bifurcated from the debt host and accounted for as a derivative liability.

 

The Company valued the derivative liabilities at June 30, 2020, and December 31, 2019, at $9,471,445 and $2,462,490, respectively. The Company used the Monte Carlo simulation valuation model with the following assumptions as of June 30, 2020, risk free interest rates from 0.16% to 0.18%, and volatility of 81% to 105% and as of December 31, 2019, risk-free interest rates from 1.57% to 1.77% and volatility of 31% to 36%. The initial derivative liabilities for convertible notes issued during the six months ended June 30, 2020, used the following assumptions; risk-free interest rates from 0.12% to .24% and volatility of 74% to 105%.

 

A summary of the activity related to derivative liabilities for the six months ended June 30, 2020, and the year ended December 31, 2019, is as follows:

 

Balance- January 1, 2019  $1,199,514 
Issued during period   1,460,123 
Converted or paid   (850,248)
Change in fair value recognized in operations   653,551 
Balance- December 31, 2019   2,462,940 
Issued during the period   11,953,787 
Converted or paid   (8,627,804)
Change in fair value recognized in operations   3,682,522 
Balance June 30, 2020  $9,471,445 

 

NOTE 7 – NOTES PAYABLE

 

The Company has the following note payables outstanding:

 

   June 30, 2020   December 31, 2019 
Note payable, interest at 8%, matured September 6, 2018, in default  $-   $330,033 
Notes payable, interest at 8%, matured January 5, 2020, currently in default   45,000    45,000 
Other, due on demand, interest at 6%   50,000    50,000 
Note payable, interest at 18%, matures June 23, 2022, net of discount of $34,635   175,365    - 
Note payable, interest at 12%, matures June 25, 2021, net of discount of $26,970   176,030    - 

Sub- total notes payable

   446,395    425,033 
Less long-term portion, net of discount   176,365    - 
Current portion of notes payable, net of discount  $270,030   $425,033 

 

 26 

 

 

On February 26, 2020, the Company and the noteholder agreed to convert $330,033 of principal note balances to a 12% convertible note with a face value of $330,000 (see Note 5).

 

On June 23, 2020 (the “Execution Date”), the Company entered into a Loan and Securities Purchase Agreement with a third- party (the “Lender”). Pursuant to the agreement in exchange for a $210,000 Promissory Note, inclusive of an original issue discount of $35,000 the Company received proceeds of $175,000 from the Lender. The note carries an interest rate of 18% and matures and is due in one lump sum on the 24- month anniversary (the “Maturity Date”) of the Execution Date. For the first nine months interest may accrue on a monthly basis, and the Company has the option to pay the monthly interest or add such interest to the principal balance of the note. Commencing on the tenth month of the note, all accrued interest, if any, shall be added to the principal amount of the note, and interest on the new principal amount shall become due and payable on a monthly basis. Should the Company default on making any interest payments following the initial nine-months, or paying the note by the Maturity Date, the note shall automatically be converted into an 18% convertible debenture.

 

On June 25 (the “Issue Date”), 2020, the Company entered into a 12%, $203,000 face value promissory note with a third-party (the “Holder”) due June 25, 2021 (the “Maturity Date”). Principal payments shall be made in six instalments of $33,333 commencing 180 days from the Issue Date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the Maturity Date. The Holder shall have the right from time to time, and at any time following an event of default, as defined on the agreement, to convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company, at the lower of i) the Trading Price (as defined in the agreement) during the previous five trading days prior to the Issuance Date or ii) the volume weighted average price during the five trading days ending on the day preceding the conversion date. The Company received proceeds of $176,000 on June 26, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $27,000. In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 10,000,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expires on the five-year anniversary of the Issue Date.

 

NOTE 8 – RELATED PARTY TRANSACTIONS

 

Employment Agreement

 

On February 28, 2020, the Company and Mr. Conway entered into an employment agreement (the “Employment Agreement”). Pursuant to the terms of the Employment Agreement, Mr. Conway is to receive an annual salary of $120,000, for his position of CEO of the Company, payable monthly. Mr. Conway was also issued 2,500 shares of Series C Preferred Stock. The Company valued the shares at $5,000.

 

Management Fees and related party payables

 

For the three and six months ended June 30, 2020, and 2019, the Company recorded expenses to its officers in the following amounts:

 

   Three months ended
June 30,		   Six months ended
June 30,		 
   2020   2019   2020   2019 
CEO, parent (includes $5,000 stock-based compensation six months ended June 30, 2020)  $30,000   $-   $45,000   $- 
CEO, former   -    88,000    22,505    133,000 
COO, former   -    45,000    -    90,000 
CFO, former   -    30,000    20,000    60,000 
Total  $30,000   $163,000   $87,505   $283,000 

 

 27 

 

 

As of June 30, 2020, and December 31, 2019, included in accounts payable and accrued expenses, related party is $456,185 and $470,886, respectively, for the following amounts owed the Company’s former officers for accrued fees, accounts payable and loans made. The loans have no terms of repayment.

 

   June 30, 2020   December 31, 2019 
Former CEO, former (1)  $200   $125 
Former CEO, subsidiary (2)   144,087    144,639 
Former COO and CCO (3)   162,085    162,085 
Former COO (4)   112,500    112,500 
Former CFO (5)   -    51,537 
CEO   100    - 
Total  $419,692   $470,866 

 

(1)The former CEO, parent resigned February 28, 2020.

(2) The former CEO, subsidiary resigned on March 4, 2019.

(3) The Former COO and CCO resigned from those positions on October 1, 2018, and March 4, 2019, respectively.

(4) The former COO resigned on October 23, 2019.

(5) The former CFO resigned effective February 28, 2020.

 

Other

 

On February 9, 2018, the Company recorded a stock subscription receivable from its officers and directors of $7,600 related to the issuance of 7,600,000 shares of common stock.

 

NOTE 9 – COMMITMENTS AND CONTINGENCIES

 

Licenses

 

On February 1, 2018, Spinus entered into an Intellectual Property Licensing Agreement (the “Licensing Agreement”). The Company assumed the obligations under the Licensing Agreement and pledged the assets of Spinus as security. Pursuant to the terms of the Licensing Agreement, in consideration of $250,000 Spinus has the exclusive rights to certain patents and the non-exclusive rights to other patents. The patents surround mechanical or inflatable expandable interbody implant products. The Company paid the $250,000 on November 20, 2018. The Company also will pay a royalty of 7% of net sales on any product sold utilizing any of the patents. There have not been any sales of the licensed products and accordingly, no royalties have been incurred.

 

Consulting Agreements

 

On March 4, 2019, the Company entered into a Separation Agreement (the “Separation Agreement”) with Salman J. Chaudhry, pursuant to which Mr. Chaudry resigned immediately from his positions as the CCO and Secretary of the Company and as a member of the Board and from all positions with the Company effective immediately and pursuant to which the Company agreed to pay Mr. Chaudry $227,200 (the “Outstanding Fees”) in certain increments as set forth in the Separation Agreement. Mr. Chaudry’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. As of June 30, 2020, and December 31, 2019, the balance owed Mr. Chaudhry is $162,085.

 

On March 24, 2019, the Company and Newbridge Securities Corporation (“Newbridge”) entered into an Investment Banking Engagement Agreement (the “Agreement”). Under the terms of the Agreement, Newbridge will provide investment banking and financial advisory services to the Company, including, but not limited to assisting the Company with an up-listing process to a national exchange in the United States, introducing the Company to other investment banking firms focused on servicing emerging growth companies; rendering advice related to capital structures, capital market opportunities, evaluating potential capital raise transactions and assisting the Company to develop growth optimization strategies. The term of the Agreement is 12 months from the date of the Agreement, however either party may terminate the Agreement anytime upon 15 days written notice. As compensation for its services under the Agreement, Newbridge and its assignees received 172 shares of the Company’s common stock. The Agreement contains customary terms relating to payment of expenses, indemnification and other matters. The Agreement also includes customary representations, warranties and covenants by the Company. The Company valued the shares at $77,130, based on the market price of the common stock on the date of the agreement, to be amortized over the one-year term of the contract. For the six months ended June 30, 2020, the Company amortized $17,783 as stock-based compensation expense. As of June 30, 2020, the expense has been fully recognized.

 

 28 

 

 

On September 2, 2019, the Company entered Consulting Agreement (the “Agreement”) with a consultant to act as the Company’s Executive Vice President, Sales and Marketing (the “EVP”) through December 31, 2019, and to provide the Company with customary services of an EVP. The Company has agreed to compensate the consultant $10,000 per month. Either party may terminate the Agreement in its sole and absolute discretion. The parties have agreed that they will negotiate follow up agreement with terms and conditions to include salary, commission, bonuses and stock and or option grants or awards, to be consistent with industry standards for like size companies prior to the termination of the Agreement. For the year ended December 31, 2019, the Company has expensed $30,000. As of June 30, 2020, and December 31, 2019, the Company owes the EVP $10,000, included in liabilities of discontinued operations.

 

On September 3, 2019, the Company entered into an Investor Relations Agreement (the “Agreement”) with a consultant. Under the terms of the Agreement, the consultant will provide consulting services to the Company, including, but not limited to assisting the Company in the conception and implementation of the Company’s corporate and business development plan. The term of the Agreement is 6 months from the date of the Agreement. As compensation for its services under the Agreement, the consultant received 1,250 shares of the Company’s common stock. The Agreement contains customary terms relating to payment of expenses, indemnification and other matters. The Agreement also includes customary representations, warranties and covenants by the Company. The Company valued the shares at $46,875, based on the market price of the common stock on the date of the agreement, to be amortized over the term of the contract. For the six months ended June 30, 2020, the Company amortized $15,625 as stock-based compensation expense. As of June 30, 2020, the expense has been fully recognized.

 

On September 3, 2019, the Company entered into a Consulting Agreement (the “Agreement”) with a consultant. Under the terms of the Agreement, the consultant will provide consulting services to the Company, including, but not limited to assisting the Company in its general strategy for corporate communications. The term of the Agreement is 6 months from the date of the Agreement. As compensation for its services under the Agreement, the consultant received 1,250 shares of the Company’s common stock. The Agreement contains customary terms relating to payment of expenses, indemnification and other matters. The Agreement also includes customary representations, warranties and covenants by the Company. The Company valued the shares at $46,875, based on the market price of the common stock on the date of the agreement, to be amortized over the term of the contract. For the six months ended June 30, 2020, the Company amortized $15,625 as stock-based compensation expense. As of June 30, 2020, the expense has been fully recognized.

 

On June 5, 2020, the Company entered into a one-year agreement for media relations services with a third-party. Pursuant to the Agreement, the Company will pay the consultants $10,000 per month for the development and execution of a comprehensive media relations plan.

 

NOTE 10 - INCOME TAXES

 

The Company was incorporated in the United States and has operations in two tax jurisdictions - the United States and Hong Kong. The Company’s HK subsidiary is subject to a 16.5% profit tax based on its taxable net profit. The Company’s U.S. operations are subject to income tax according to U.S. tax law.

 

A reconciliation of the provision for income taxes determined at the U.S. statutory rate to the Company’s effective income tax rate is as follows:

 

   Six Months Ended 
   June 30, 
   2020   2019 
Pre-tax loss  $(31,227,327)  $(2,823,397)
U.S. federal corporate income tax rate   21%   21%
Expected U.S. income tax benefit   (6,557,739)   (592,493)
Tax rate difference between U.S. and foreign operations   -    289 
Permanent differences   6,198,791    417,713 
Change of valuation allowance   358,948    174,491 
Effective tax expense  $—   $— 

 

 29 

 

 

The Company had deferred tax assets as follows:

 

   June 30, 2020   December 31, 2019 
Net operating losses carried forward  $1,381,018   $1,022,071 
Less: Valuation allowance   (1,381,018)   (1,022,071)
Net deferred tax assets  $—   $— 

 

As of June 30, 2020, the Company has approximately $6,108,000 and $595,000 net operating loss carryforwards available in the United States and Hong Kong, respectively, to reduce future taxable income. The net operating loss from Hong Kong operations can be carried forward with no time limit from the year of the initial loss pursuant to relevant Hong Kong tax laws and regulations. For U.S. purposes the NOL deduction for a tax year is equal to the lesser of (1) the aggregate of the NOL carryovers to such year, plus the NOL carry-backs to such year, or (2) 80% of taxable income (determined without regard to the deduction). Generally, NOLs can no longer be carried back but are allowed to be carried forward indefinitely. The special extended carryback provisions are generally repealed, except for certain farming and insurance company losses. The amendments incorporating the 80% limitation apply to losses arising in tax years beginning after Dec. 31, 2017. It is more likely than not that the deferred tax assets cannot be utilized in the future because there will not be significant future earnings from the entity which generated the net operating loss. Therefore, the Company recorded a full valuation allowance on its deferred tax assets.

 

As of June 30, 2020, and December 31, 2019, the Company has no material unrecognized tax benefits which would favourably affect the effective income tax rate in future periods, and does not believe that there will be any significant increases or decreases of unrecognized tax benefits within the next twelve months. No interest or penalties relating to income tax matters have been imposed on the Company during the three and six months ended June 30, 2020, and 2019, and no provision for interest and penalties is deemed necessary as of June 30, 2020, and 2019.

 

Since the Company’s foreign subsidiaries have not generated income since inception, the Company believes that Tax Act will not have significant impact on the Company’s consolidated financial statements.

 

NOTE 11 – STOCKHOLDERS’ EQUITY

 

On January 21, 2020, the Company filed an amendment to its Certificate of Incorporation, with the Nevada Secretary of State, for 1-for-1,000 reverse stock split of our common stock (the “Reverse Stock Split”) effective February 10, 2020. The number of shares of common stock subject to outstanding options, warrants and convertible securities were also reduced by a factor of one- thousand and no fractional shares were issued. All historical share in this report have been adjusted to reflect the Reverse Stock Split. There were no changes to the authorized number of shares and the par value of our common stock.

 

Common stock

 

On July 5, 2019, the Company entered into an Equity Financing Agreement (the “Equity Agreement”) with GHS Investments, LLC, a Nevada limited liability company (the “Investor”), with the Investor committing to purchase up to $7,000,000 of the Company’s common stock in tranches of up to $400,000, following an effective registration of the shares and subject to restrictions regarding the timing of each sale and total percentage stock ownership held by the Investor. The purchase price for the shares will be 85% of the lowest closing price during the 10-day period prior to each sale, and with each sale, the Investor will receive an issuance premium of 5% to cover the Investor’s transaction costs associated with selling the shares and payable by the Company to the Investor in registered shares. The obligation of the Investor to purchase shares pursuant to the Equity Agreement is subject to several conditions, including (i) that the Company has filed a registration statement (the “Registration Statement”) with the United States Securities and Exchange Commission (the “SEC”) registering the shares to be sold to the Investor within 30 calendar days from the date of the Equity Agreement, with the Registration Statement being declared effective prior to sale of any shares to the Investor; and (ii) that the purchase of shares by the Investor pursuant to the Equity Agreement shall not cause the Investor to own more than 4.99% of the outstanding shares of the Company’s common stock.

 

 30 

 

 

In connection with the Equity Agreement, on July 5, 2019, the Company also entered into a Registration Rights Agreement with the Investor (the “Registration Rights Agreement”). On October 1, 2019, the SEC issued a Notice of Effectiveness of the Company’s Registration Statement.

 

During the six months ended June 30, 2020, holders of an aggregate of $2,774,896 in principal and $636,466 of accrued interest and fees of convertible notes issued by the Company, converted their debt into 1,444,237,885 shares of our common stock at an average conversion price of $0.00236 per share. The Company also issued 104,719,899 shares of common stock upon the cashless exercise of common stock purchase warrants.

 

As of June 30, 2020, the Company has 4,990,000,000 shares of $0.001 par value common stock authorized and there are 1,549,176,877 shares of common stock issued and outstanding.

 

Common stock to be issued

 

For the year ended December 31, 2019, the Company recorded 1,350 shares (post reverse stock split) of common stock to be issued, and valued the shares at $410,370, based on the market price of the common stock on the date of the shares being earned. For the year ended December 31, 2019, the company amortized $410,370 as stock-based compensation expense. As of June 30, 2020, and December 31, 2019, there are 1,350 shares of common stock to be issued.

 

Preferred stock

 

As of June 30, 2020, 10,000,000 shares have been authorized as preferred stock, par value $0.001 (the “Preferred Stock”), which such Preferred Stock shall be issuable in such series, and with such designations, rights and preferences as the Board of Directors may determine from time to time.

 

On March 28, 2019, the Company filed a Certificate of Designation with the Secretary of State of Nevada to designate 1,000,000 shares as Series B Preferred Stock. The Series B Preferred Stock is not convertible into common stock, nor does the Series B Preferred Stock have any right to dividends and any liquidation preference. The Series B Preferred Stock entitles its holder to a number of votes per share equal to 50 votes. On April 1, 2019, the Company issued 1,000,000 shares of Series B Preferred Stock to the Company’s CEO at the time. This resulted in a change in control of the Company.

 

On September 18, 2019, the Company filed a Certificate of Designation with the Secretary of State of Nevada to designate 50,000 shares as Series C Preferred Stock. Each share of Series C Preferred Stock shall be convertible, at the option of the holder thereof, at any time after the date of issuance, into one share of fully paid and non-assessable share of common stock. Each share of Series C Preferred Stock shall entitle the holder thereof to ten thousand (10,000) votes on all matters submitted to a vote of the stockholders of the Company.

 

On September 19, 2019, the Company issued 50,000 shares of its Series C Preferred Stock to the Company’s CEO and Director, at the time, in consideration of the cancellation and return of 1,000,000 shares of the Company’s Series B Preferred Stock. On September 20, 2019, the Company filed a Certificate of Withdrawal of Certificate of Designation (the “Certificate of Withdrawal”) for the Company’s Series B Preferred Stock, pursuant to which the prior designation of the Company’s Series B Stock was cancelled. On February 28, 2020, pursuant to a share redemption agreement between the Company and Mr. Chermak pursuant to which, the Company agreed to redeem his 50,000 shares of Series C Preferred Stock for $100,000, ($2 per share), the Company redeemed 2,500 shares of series C Preferred Stock from Mr. Chermak, and issued 2,500 shares of Series C Preferred Stock to Mr. Conway, pursuant to Mr. Conway’s employment agreement. The Company valued the 2,500 shares issued to Mr. Conway at $5,000 ($2 per share). On April 28, 2020, the Company redeemed the remaining 47,500 shares of Series C Preferred Stock from the former CEO. As of June 30, 2020, and December 31, 2019, there are 50,000 shares of Series C Preferred Stock outstanding, respectively, and no shares of Series B Preferred Stock outstanding.

 

 31 

 

 

On February 4, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company’s Series C Preferred Stock. The voting rights associated with the Series C Preferred Stock were amended whereby each share of Series C Preferred Stock shall entitle the holder thereof to have voting rights equal to two times the sum of all the number of shares of other classes of Company capital stock eligible to vote on all matters submitted to a vote of the stockholders of the Company, divided by the number of shares of Preferred Stock issued and outstanding at the time of voting.

 

Stock subscription receivable

 

On February 9, 2018, the Company recorded a stock subscription receivable from its officers and directors of $7,600 related to the issuance of 7,600 shares of common stock.

 

NOTE 12 – DISCONTINUED OPERATIONS

 

ASC 205-20 “Discontinued Operations” establishes that the disposal or abandonment of a component of an entity or a group of components of an entity should be reported in discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results. As a result, the component’s results of operations have been reclassified as discontinued operations on a retrospective basis for all periods presented. Accordingly, the assets and liabilities of this component are separately reported as “assets and liabilities held for disposal” as of December 31, 2019. The results of operations of this component, for all periods, are separately reported as “discontinued operations”. There have been no transactions between the Company and SRI since the termination.

 

A reconciliation of the major classes of line items constituting the gain from discontinued operations, net of income taxes as is presented in the Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2020, are summarized below; there was no activity of the SRI business for the three and six months ended June 30, 2019.

 

Cost of goods sold  $4,326 
Operating expenses:     
Depreciation expense   13,805 
Rent expense   2,222 
Interest expense   8.794 
Total operating expenses   24,821 
Loss from discontinued operations  $(29,147)
      
Gain from license termination  $86,856 

 

Liabilities of discontinued operations at June 30, 2020, of $75,270 consist of accounts payable and accrued expenses related to SRI.

 

The following table presents the reconciliation of carrying amounts of major classes of assets and liabilities of the Company classified as discontinued operations in the condensed consolidated balance sheet at December 31, 2019:

 

Carrying amounts of major classes of assets

included as part of assets held for discontinued operations

    
Inventory  $378,061 
Prepaid expenses   2,987 
Property and equipment, net   353,985 
License rights, net   2,724,848 
Goodwill   2,002,314 
Total assets included in the assets of discontinued operations  $5,462,195 

 

Carrying amounts of major classes of liabilities

included as part of liabilities of discontinued operations

    
Accounts payable and accrued expenses  $88,178 
Liability for common stock payable   245,000 
Current portion of notes payable   1,131,771 
Current portion of license fee payable   984,089 
Long term portion of notes payable   1,440 
Long term portion of license fee payable   250,000 
Put option payable   2,892,228 
Total liabilities included in the liabilities of discontinued operations  $5,592,706 

 

 32 

 

 

NOTE 13 – SUBSEQUENT EVENTS

 

From July 1, 2020, through August 10, 2020, the Company has issued 1,205,966,108 shares of common stock upon the conversion of $1,883,096 of principal, accrued interest and fees of convertible notes. The Company also issued 149,820,477 shares of common stock upon the cashless exercise of warrants.

 

On July 8, 2020, (the “Issuance Date”) the Company issued a 15% convertible promissory note, in the principal amount of $250,000, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $200,000 on July 9, 2020, and this note included an original issue discount of $50,000. This note proceeds will be used by the Company for general working capital purposes. In conjunction with this note, the Company issued a warrant to purchase 12,500,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.

 

On July 7, 2020, the Company filed with the Secretary of State of the State of Nevada an Amendment to Certificate of Designation of Series C Preferred Stock, a Certificate of Designation of Series D Preferred Stock, and a Certificate of Designation of Series E Preferred Stock (collectively, the “Certificates of Designation”).

 

Under the terms of the Amendment to Certificate of Designation of Series C Preferred Stock, 50,000 shares of the Company’s preferred remain designated as Series C Preferred Stock. The holders of Series C Preferred Stock have no dividend rights. For so long as any shares of the Series C Preferred Stock remain issued and outstanding, the Holder thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to sixty-seven (67%) percent of the total vote.

 

Under the terms of the Certificate of Designation of Series D Preferred Stock, 20,000 shares of the Company’s preferred stock have been designated as Series D Convertible Preferred Stock. The holders of the Series D Convertible Preferred Stock shall not be entitled to receive dividends. The holders as a group may, at any time convert all of the shares of Series D Convertible Preferred Stock into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion, by 3. Except as provided in the Certificate of Designation or as otherwise required by law, no holder of the Series D Convertible Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Company for their vote, waiver, release or other action. The Series D Convertible Preferred Stock shall not bear any liquidation rights.

 

Under the terms of the Certificate of Designation of Series E Preferred Stock, 3,000 shares of the Company’s preferred stock have been designated as Series E Preferred Stock. The holders of the Series E Convertible Preferred Stock shall not be entitled to receive dividends. No holder of the Series E Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Corporation for their vote, waiver, release or other action, except as may be otherwise expressly required by law. At any time, the Corporation may redeem for cash out of funds legally available therefor, any or all of the outstanding Preferred Stock (“Optional Redemption”) at $1,000 (one thousand dollars) per share. The shares of Series E Preferred Stock have not been registered under the Securities Act of 1933 or the laws of any state of the United States and may not be transferred without such registration or an exemption from registration.

 

On July 10, 2020, the Company closed the SPA with (“PCTI”) and Chis, the sole shareholder of PCTI. Under the terms of the SPA, the Company acquired one thousand (1,000) shares of PCTI, which represents all of the outstanding shares of PCTI, from Catherine Chis in exchange for a cash payment of $400,000 (paid as of June 30, 2020) and the issuance of 47,500 shares of the Company’s Series C Preferred Stock, 18,667 shares of the Company’s Series D Preferred Stock, and 500 shares of the Company’s Series E Preferred Stock to Chis.

 

 33 

 

 

On July 15, 2020, (the “Issuance Date”) the Company issued a 15% convertible promissory note, in the principal amount of $127,500, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.011 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $102,000 on July 22, 2020, and this note included an original issue discount of $27,500. This note proceeds will be used by the Company for general working capital purposes. In conjunction with this note, the Company issued a warrant to purchase 6,375,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.

 

On July 24, 2020, PCTI, the Company’s wholly owned subsidiary, entered into a three- month consulting agreement with a third-party. Pursuant to the agreement, the Company will pay the consultant $10,000 per month and the consultant will provide services, including, but not limited to, identifying PCTI’s best path forward into the renewable energy and energy storage industries as well as advance their presence in the maritime/transportation industry.

 

On July 29, 2020, (the “Issuance Date”) the Company issued a 15% convertible promissory note, in the principal amount of $127,500, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.011 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $100,000 on August 3, 2020, and this note included an original issue discount of $27,500. This note proceeds will be used by the Company for general working capital purposes. In conjunction with this note, the Company issued a warrant to purchase 12,750,000 shares of common stock at an exercise price of $0.01, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.

 

The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements, except as stated herein.

 

 34 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

This quarterly report and other reports filed by Ozop Surgical Corp. (“we,” “us,” “our,” or the “Company”), from time to time contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company’s management as well as estimates and assumptions made by Company’s management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used in the filings, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan” or the negative of these terms and similar expressions as they relate to the Company or the Company’s management identify forward-looking statements. Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions, and other factors. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.

 

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

 

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us to make certain estimates, judgments, and assumptions. We believe that the estimates, judgments, and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments, and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates.

 

The following discussion should be read in conjunction with our unaudited financial statements and the related notes that appear elsewhere in this Quarterly Report on Form 10-Q.

 

THE COMPANY

 

Ozop Surgical Corp. (the “Company,” “we,” “us” or “our”) was originally incorporated as Newmarkt Corp. on July 17, 2015, under the laws of the State of Nevada. Following the acquisition of OZOP Surgical, Inc., we have been engaged in the business of inventing, designing, developing, manufacturing and globally distributing innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies, focused on spine, neurological and pain management procedures and specialties. On May 8, 2018, we amended our Articles of Incorporation (the “Amendment”) to change our name from Newmarkt Corp. to Ozop Surgical Corp. in order to reflect more accurately the name of our core service offering and operations.

 

On January 21, 2020, the Company filed an amendment to its Certificate of Incorporation, with the Nevada Secretary of State, for 1-for-1,000 reverse stock split of our common stock (the “Reverse Stock Split”) effective February 10, 2020. The number of shares of common stock subject to outstanding options, warrants and convertible securities were also reduced by a factor of one- thousand and no fractional shares were issued. All historical share in this report have been adjusted to reflect the Reverse Stock Split. There were no changes to the authorized number of shares and the par value of our common stock.

 

On February 4, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company’s Series C Preferred Stock (the “Preferred Stock”). The voting rights associated with the Preferred Stock were amended whereby each share of Preferred Stock shall entitle the holder thereof to have voting rights equal to two times the sum of all the number of shares of other classes of Company capital stock eligible to vote on all matters submitted to a vote of the stockholders of the Company, divided by the number of shares of Preferred Stock issued and outstanding at the time of voting.

 

 35 

 

 

OZOP

 

OZOP was originally incorporated in Switzerland on November 28, 1998 under the name Perma Consultants Holding AG (“Perma”). On July 19, 2016, Mr. Eric Siu (“Siu”), one of our directors purchased 100% of the outstanding capital stock of Perma and changed the name from Perma to Ozop Surgical AG (“Ozop AG”). On February 1, 2018, Ozop AG was re-domiciled as a Delaware corporation and changed its name to Ozop Surgical, Inc. On July 28, 2016, Ozop formed as the sole member, Ozop Surgical, LLC (“Ozop LLC”), a Wyoming limited liability company. On October 28, 2016, Ozop acquired 100% of Ozop Surgical Limited (“Ozop HK”), from Siu, the sole shareholder of Ozop HK. Ozop HK, is a private limited company incorporated in Hong Kong.

 

On February 16, 2018, OZOP acquired the 100% membership interest (the “Membership Interest”) in Spinus, LLC, a Texas limited liability company (“Spinus”), from RWO Medical Consulting LLC (“RWO”), a Texas limited liability company (the “Acquisition”). OZOP purchased the Membership Interest from RWO in exchange for; (i) 5,000,000 shares OZOP’s common stock and ii) the assumption of all liabilities of Spinus, including an obligation of $250,000 pursuant to a license agreement by and between Spinus and a third party (the “Assumed Debt”). The Assumed Debt was paid in November 2018.

 

On August 23, 2019, the Company entered into the License Agreement (see note 1) with SRI. Pursuant to the License Agreement, SRI granted to the Company an exclusive license, for products, as defined in the License Agreement, and utilized in spine and related surgical procedures. Under the License Agreement, SRI will continue to market the Swedge platform along with the existing portfolio to existing US and International customers. Ozop purchased all existing inventory of SRI instruments and implants and will utilize SRI as a distributor. On January 16, 2020, the Company received via email from SRI notice that the Agreement dated August 23, 2019, between SRI and the Company has been revoked, as the Company did not cure a payment default within the cure period.

 

On February 28, 2020, the Company entered into a Binding Letter of Intent (the “LOI”) with Power Conversion Technologies, Inc., a Pennsylvania corporation (“PCTI”), and Catherine Chis (“Chis”), PCTI’s Chief Executive Officer (“CEO”) and its sole shareholder. On June 26, 2020, the Company, PCTI and Chis signed a Stock Purchase Agreement (the “SPA”) and transaction was closed on July 10, 2020. Pursuant to the terms of the SPA, the Company acquired 100% of the issued and outstanding shares of PCTI (the “PCTI Shares”) from Chis in consideration of (a) the issuance by the Company to Chis of (i) 47,500 shares of the Company’s Series C Preferred Stock, (ii) 18,667 shares of the Company’s Series D Preferred Stock, (iii) 500 shares of the Company’s Series E Preferred Stock; and (b) the Company paying $400,000 to PCTI (the “Acquisition”). The Company paid $100,000 on May 26, 2020, and $300,000 on June 26, 2020). PCTI operates in the very high-power niche of the power electronics market, designing and manufacturing leading edge equipment for use in power conversion applications. PCTI serves clients in several industries including energy storage, shore power, DEWs, microgrid, telecommunications, military, transportation, renewable energy, aerospace and mission critical defense systems. PCTI’s clients include Fortune 500 companies, all branches of the US Department of Defense including the US Army and the US Air Force, NASA as well as other global military organizations.

 

Results of Operations for the three and six months ended June 30, 2020 and 2019:

 

Revenue

 

For the three and six months ended June 30, 2020, the Company did not recognize any revenues due to the termination of the agreements with SRI (see above). For the three and six months ended June 30, 2019, the Company generated total revenue of $1,521 and $ 49,123, respectively. The revenues are from the sale of spine surgery products. The decrease in revenues is a result of Spinus deciding to not to continue to supply its’ spine surgery products to the surgeon who previously performed surgeries with Spinus product. Revenues from Spinus are recognized as an agent and are recorded at net.

 

 36 

 

 

Operating expenses

 

Total operating expenses for the three and six months ended June 30, 2020, were $200,006 and $378,746, respectively, compared to $671,054 and $1,439.623 for the three and six months ended June 30, 2019, respectively. The operating expenses were comprised of:

 

   Three months ended
June 30,		   Six months ended
June 30,		 
   2020   2019   2020   2019 
Management fees- related parties  $30,000   $120,000   $87,505   $240,000 
Stock-based compensation   -    310,982    49,033    706,702 
Professional and consulting fees   72,500    101,414    97,925    148,670 
Research and development   -    10,400    -    63,604 
Impairment of intangible asset   -    44,200    -    44,200 
General and administrative   97,506    84,058    144,283    236,447 
Total  $200,006   $671,054   $378,746   $1,439,623 

 

On February 28, 2020, pursuant to the LOI with PCTI (see above) our CEO and CFO at the time resigned and Mr. Brian Conway was named CEO. Through that date the former CEO and CFO were compensated $22,205 and $20,000, respectively. The Company entered into an employment agreement with Mr. Conway, which includes a monthly salary of $10,000 and the immediate issuance of 2,500 shares of Series C Preferred Stock. The Company valued the Series C Preferred stock at $5,000 and is included in management fees for the six months ended June 30, 2020, along with his monthly compensation of $30,000 and $40,000 for the three and six months ended June 30, 2020, respectively. For the three and six months ended June 30, 2019, management fees consisted of monthly fees to our CEO, COO and CFO of $15,000, $15,000 and $10,000, respectively.

 

Stock based compensation for the six months ended June 30, 2020 is comprised of:

 

  ● On March 24, 2019, the Company signed a one-year consulting agreement with a consultant. As compensation for its services under the agreement, the consultant and its assignees received 171 shares of the Company’s common stock. The Company valued the shares at $77,130, based on the market price of the common stock on the date of the agreement, to be amortized over the one-year term of the contract. For the six months ended June 30, 2020, the Company amortized $17,783 as stock-based compensation expense.
     
  ● On September 3, 2019, the Company signed a six- month consulting agreement with a consultant. As compensation for its services under the agreement, the consultant received 1,250 shares of the Company’s common stock. The Company valued the shares at $46,875, based on the market price of the common stock on the date of the agreement, to be amortized over the term of the contract. For the six months ended June 30, 2020, the Company amortized $15,625 as stock-based compensation expense.
     
  ● On September 3, 2019, the Company signed a six- month consulting agreement with a consultant. As compensation for its services under the agreement, the consultant received 1,250 shares of the Company’s common stock. The Company valued the shares at $46,875, based on the market price of the common stock on the date of the agreement, to be amortized over the term of the contract. For the six months ended June 30, 2020, the Company amortized $15,625 as stock-based compensation expense.

 

Stock based compensation for the three and six months ended June 30, 2019 is comprised of:

 

  ● Amortization of $162,500 related to a one-year consulting agreement effective on August 31, 2018, pursuant to the issuance of 650 shares of common stock. The Company valued the shares at $500 per share (the price the Company was selling shares of common stock on the date of the agreement). The Company recorded $325,000 as deferred stock compensation to be amortized over the term of the agreement, and accordingly has included $81,250 and $162,500 in stock-based compensation for the three and six months ended June 30, 2019, respectively.

 

 37 

 

 

  ● On October 19, 2018, the company recorded the issuance of 450 shares of common stock, as the first tranche of a one- year consulting agreement requiring a total of 1,800 shares. The Company valued the shares issued at $500 per share (the price the Company was selling shares of common stock on the date of the agreement). The Company recorded $225,000 as deferred stock compensation to be amortized over the first three months of the agreement, and accordingly has included $52,500 in stock-based compensation for the six months ended June 30, 2019.
     
  ● For the six months ended June 30, 2019, the Company recorded 900 shares of common stock to be issued pursuant to the one-year agreement above to issue 1,800 shares. The 900 shares were valued at $400,470, based on the market price of the common stock on their respective date of issuances, and the Company expensed $135,450 and $395,290 as stock-based compensation for the three and six months ended June 30, 2019, respectively.
     
  ● On March 24, 2019, the Company signed a one-year consulting agreement with Newbridge. As compensation for its services under the Agreement, Newbridge and its assignees received 172 shares of the Company’s common stock. The Company valued the shares at $77,130, based on the market price of the common stock on the date of the agreement, to be amortized over the one-year term of the contract. For the three and six months ended June 30, 2019, the Company amortized $19,282 and $20,782 as stock-based compensation expense, respectively.
     
  ● On April 1, 2019, the Company issued 1,000,000 shares of Series B Preferred Stock to the Company’s CEO. The shares were valued at $68,000 of which $25,000 was applied to accrued liabilities-related and $43,000 was recorded as stock-based compensation expense for the three and six months ended June 30, 2019.
     
  ● On April 29, 2019, the Company issued 100 shares of common stock for consulting services. The shares were valued at $275 per share (the market price on the date of the agreement) and $27,500 was recorded as stock-based compensation expense for the six and months ended June 30, 2019.
     
  ● On May 20, 2019, the Company issued 100 shares of common stock for consulting services. The shares were valued at $120 per share (the market price on the date of the agreement) and $4,500 was recorded as stock-based compensation expense for the three and six months ended June 30, 2019.

 

Research and development costs of $10,400 and $63,604 for the three and six months ended June 30, 2019, respectively, were all costs related to development of new product.

 

General and administrative expenses, other

 

Total general and administrative expenses, other, were $97,506 and $144,283 for the three and six months ended June 30, 2020, respectively, compared to $84,058 and $236,447 for the three and six months ended June 30, 2019, respectively, and were comprised of:

 

   Three months ended
June 30,		   Six months ended
June 30,		 
   2020   2019   2020   2019 
Travel expenses  $212   $7,095   $321   $33,118 
Advertising and marketing   1,226    33,663    1,226    59,442 
Meals and entertainment   451    2,319    451    6,141 
Investor relations   21,517    16,740    34,022    79,496 
Transfer agent fees   21,475    4,442    34,209    6,692 
Depreciation and amortization   11,232    11,216    22,313    22,432 
Other   41,393    8,583    51,741    29,126 
Total  $97,506   $84,058   $144,283   $236,447 

 

 38 

 

 

Other Income (Expenses)

 

Other expenses, net, for the three and six months ended June 30, 2020, was $25,355,250 and $30,906,290, respectively, compared to other expenses, net of $1,247,708 and $1,430,897 for the three and six months ended June 30, 2019, respectively, and were as follows.

 

   Three months ended
June 30,		   Six months ended
June 30,		 
   2020   2019   2020   2019 
Interest expense  $10,256,626   $99,701   $13,727,840   $148,493 
Amortization of debt discount   1,134,210    472,528    1,484,321    791,210 
Loss (gain) on change in fair value of derivatives   2,148,349    (20,762)   3,682,522    (68,372)
Loss on extinguishment of debt   11,816,065    696,241    12,011,607    559,566 
Total other expense, net  $25,355,250   $1,247,708   $30,906,290   $1,430,897 

 

The increase in other expense is primarily a result of increases in losses on changes in fair values of derivatives, interest expense and amortization of debt discounts and losses on extinguishment of debt for the three and six months ended June 30, 2020.

 

Net loss

 

The net loss for the three and six months ended June 30, 2020, was $25,555,256 and $31,227,327 respectively, compared to $1,917,241 and $2,821,397 for the three and six months ended June 30, 2019, respectively. The increases are a result of the changes discussed above.

 

Liquidity and Capital Resources

 

Currently, we have limited operating capital. The Company anticipates that it will require a minimum of $1,000,000 of working capital to complete substantially all of its desired business activity for the next twelve months, including PCTI. The Company currently is not generating any revenues from its business operations. Our current capital and our other existing resources will be sufficient only to provide a limited amount of working capital, and, to date, the revenues generated from our business operations have not been sufficient to fund our operations or planned growth. As noted above, we will require additional capital to continue to operate PCTI, and to further expand our business. We may be unable to obtain the additional capital required. Our inability to generate capital or raise additional funds when required will have a negative impact on our operations, business development and financial results.

 

For the six months ended June 30, 2020, we primarily funded our business operations with $803,250 of proceeds from the issuances of convertible note financings as well as $351,000 from the issuances of promissory notes. Of the proceeds, $400,000 was used for the payment to PCTI per the SPA, $100,000 was used to redeem 50,000 shares of Series C Preferred Stock from the Company’s former CEO and for working capital. We may continue to rely on the issuance of convertible notes and promissory notes to fund our business operations.

 

As of June 30, 2020, we had cash of $304,676 as compared to $10,877 at December 31, 2019. As of June 30, 2020, we had current liabilities of $12,423.299 (including $9,471,445 of non-cash derivative liabilities), compared to current assets of $706,843, which resulted in a working capital deficit of $11,716,456. The current liabilities are comprised of accounts payable, accrued expenses, convertible debt, derivative liabilities, liabilities of discontinued operations and notes payable.

 

In December 2019, a novel strain of coronavirus (COVID-19) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to most other countries and infections have been reported globally. Because COVID-19 infections have been reported throughout the United States, certain federal, state and local governmental authorities have issued stay-at-home orders, proclamations and/or directives aimed at minimizing the spread of COVID-19. The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but it may have a material adverse impact on our business, financial condition and results of operations. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which it may have an impact cannot be determined at this time.

 

 39 

 

 

Operating Activities

 

For the six months ended June 30, 2020, net cash used in operating activities from continuing operations was $440,638 compared to $537,780 for the six months ended June 30, 2019. For the six months ended June 30, 2020, our net cash used in operating activities from continuing operations was primarily attributable to the net loss from continuing operations of $31,285,036, adjusted by the non-cash expenses of interest and amortization and depreciation of $14,749,897, losses on the fair value changes in derivatives and on extinguishment of debt of $3,682,522 and $12,011,607, respectively and stock-based compensation of $54,033, partially offset by the gain on the license termination of $86,856. Net changes of $433,196 in operating assets and liabilities reduced the cash used in operating activities.

 

For the six months ended June 30, 2019, net cash used in operating activities of $537,780 was primarily attributable to the net loss of $2,821,397, a gain of $68,372 on the change in fair value of derivative liabilities, adjusted for the loss of $559,567 in extinguishment of debt, non-cash expenses of interest and amortization and depreciation of $882,994, stock-based compensation of $706,702 and an impairment charge of $44,200. Net changes of $158,525 in operating assets and liabilities reduced the cash used in operating activities.

 

Investing Activities

 

For the six months ended June 30, 2020, the Company acquired office furniture and equipment of $8,389 and advanced $400,000 to PCTI, pursuant to the SPA. There were no investing activities for the six months ended June 30, 2019.

 

Financing Activities

 

For the six months ended June 30, 2020, the net cash provided by financing activities was $1,054,250, compared to $492,145 for the six months ended June 30, 2019. During the six months ended June 30, 2020, we received $803,250 of proceeds from the issuances of convertible note financings and $351,000 from the issuances of promissory notes. During the six months ended June 30, 2020, the Company purchased 50,000 shares of Series C Preferred Stock for $100,000 from the Company’s former CEO.

 

For the six months ended June 30, 2019, the net cash provided by financing activities was $492,145, as we received $494,950 of proceeds from the issuances of convertible note financings, as well as $100,000 from the sale of 200,000 shares of common stock at $0.50 per share. The Company made payments on convertible debt of $100,000.

 

OFF BALANCE SHEET ARRANGEMENTS

 

We have no off-balance sheet arrangements including arrangements that would affect our liquidity, capital resources, market risk support and credit risk support or other benefits.

 

Critical Accounting Policies

 

Our significant accounting policies are described in more details in the notes to our financial statements appearing elsewhere in this Quarterly Report on Form 10-Q. We believe the following accounting policies to be most critical to the judgement and estimates used in the preparation of our unaudited financial statements:

 

 40 

 

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June 30, 2020, and the results of operations and cash flows for the periods presented. The results of operations for the three and six months ended June 30, 2020, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K filed on May 14, 2020.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

 

Revenue Recognition

 

Effective January 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The Company has no outstanding contracts with any of is’ customers. Revenues from Spinus of $1,521 and $49,123 for the three and six months ended June 30, 2020, respectively, are recognized as an agent and are recorded at net. There was no impact on the Company’s financial statements as a result of adopting Topic 606 for the three and six months ended June 30, 2020 and 2019.

 

Research and Development

 

Costs and expenses that can be clearly identified as research and development are charged to expense as incurred. For the six months ended June 30, 2020, and 2019, the Company recorded $-0- and $63,604 of research and development expenses.

 

Earnings (Loss) Per Share

 

The Company computes net loss per share in accordance with FASB ASC 260, “Earnings per Share.” ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the statement of operations. Basic EPS is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible notes and stock warrants, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and conversion of convertible notes. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

Not Applicable.

 

 41 

 

 

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

 

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of June 30, 2020. Based on the evaluation of these disclosure controls and procedures, and in light of the material weaknesses found in our internal controls over financial reporting, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective for the reasons discussed below.

 

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of June 30, 2020, the Company determined that there were control deficiencies that constituted material weaknesses, as described below.

 

  1. We do not have an Audit Committee – While not being legally obligated to have an audit committee, it is the management’s view that such a committee, including a financial expert member, is an utmost important entity level control over the Company’s financial statement. Currently the Board of Directors acts in the capacity of the Audit Committee, and does not include a member that is considered to be independent of management to provide the necessary oversight over management’s activities.
     
  2. We did not maintain appropriate cash controls – As of June 30, 2020, the Company has not maintained sufficient internal controls over financial reporting for cash, including failure to segregate cash handling and accounting functions, and did not require dual signatures on the Company’s bank accounts.

 

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.

 

Our management, including our Chief Executive Officer and our Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

 

Changes in Internal Controls over Financial Reporting

 

There has been no change in our internal control over financial reporting occurred during the three months ended June 30, 2020, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 42 

 

 

PART II. OTHER INFORMATION

 

Item 1. LEGAL PROCEEDINGS

 

We know of no material, existing or pending legal proceedings against our Company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

 

Item 1A. RISK FACTORS

 

Not applicable for smaller reporting companies.

 

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

During the three months ended June 30, 2020, holders of an aggregate of $2,668,959 in principal and $561,093 of accrued interest and fees of convertible notes issued by the Company, converted their debt into 1,439,298,485 shares of our common stock at an average conversion price of $0.0022 per share. The Company also issued 104,719,899 shares of common stock upon the cashless exercises of warrants.

 

The shares described above were issued pursuant to the exemption from registration requirements relying on Section 4(a)(2) of the Securities Act.

 

Item 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

Item 4. MINE SAFETY DISCLOSURE

 

Not applicable.

 

Item 5. OTHER INFORMATION

 

  (a) None.
  (b) During the quarter ended June 30, 2020, there have not been any material changes to the procedures by which security holders may recommend nominees to the Board of Directors.

 

 

Item 6. EXHIBITS

 

The following documents are filed as part of this report:

 

Exhibit

No.

   Description
     
2.1   Share Exchange Agreement dated April 5, 2018 by and among Newmarkt Corp., the shareholders of Ozop Surgical, Inc., Ozop Surgical, Inc. and Denis Razvodovskij (Incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed on April 19, 2018).
     
2.2   Stock Purchase Agreement dated June 26, 2020, by and among Ozop Surgical Corp., Power Conversion Technologies, Inc. and Catherine Chis (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on June 29, 2020).
     
3.1   Articles of Incorporation (Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016)

 

 43 

 

 

3.2   Bylaws (Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016)
     
3.3   Certificate of Amendment of Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on May 8, 2018 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on May 14, 2018).
     
3.4   Certificate of Designations for Series B Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on April 2, 2019).
     
3.5   Amended and Restated Bylaws of Ozop Surgical Corp. adopted on May 22, 2019. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on May 22, 2019).
     
3.6   Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on July 25, 2019. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on July 30, 2019).
     
3.7   Certificate of Designation of Series C Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on September 24, 2019).
     
3.8   Certificate of Withdrawal of Series B Preferred Stock. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on September 24, 2019).
     
3.9   Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on October 29, 2019. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on October 31, 2019).
     
3.10   Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on December 30, 2020, (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on December 31, 2019).
     
3.11   Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on January 21, 2020. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on February 7, 2020).
     
3.12   Amended and Restated Certificate of Designation of Series C Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on February 5, 2020).
     
3.13   Amendment to Certificate of Designation of Series C Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on July 10, 2020).
     
3.14   Certificate of Designation of Series D Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on July 10, 2020).
     
3.15   Certificate of Designation of Series E Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.3 of the Current Report on Form 8-K filed on July 10, 2020).
     
10.1   Share Redemption Agreement dated April 13, 2018, by and between Newmarkt Corp. and Denis Razvodovskij (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on April 19, 2018).
     
10.2   Equity Transfer Agreement entered into among Zhao Zhen Rong, Sun Gui Ying and OZOP (Guangdong) Medical Technology Co., Ltd. dated July 23, 2018 (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on July 25, 2018).

 

 44 

 

 

10.3   Intellectual Property Portfolio License Agreement dated February 1, 2018 by and between Loubert S. Suddaby, MD and Spinus, LLC. (Incorporated by reference to Exhibit 10.8 to the Company’s Quarterly Report on Form 10-Q filed on August 20, 2018).
     
10.4   Amended and Restated Equity Transfer Agreement entered into among Zhao Zhen Rong, Sun Gui Ying and OZOP (Guangdong) Medical Technology Co., Ltd. dated September 27, 2018. (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on September 28, 2018).
     
10.5+   Consulting Agreement entered into between Ozop Surgical Corp and Thomas J. McLeer dated October 1, 2018. (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on October 3, 2018).
     
10.6   Consulting Agreement entered into between Ozop Surgical Corp. and Draper Inc. dated October 19, 2018. (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on October 24, 2018).
     
10.7   October 24, 2018, consulting agreement with Jeffrey Patchen. (Incorporated by reference to Exhibit 10.12 of the Quarterly Report on Form 10-Q for the period ended September 30, 2018, filed on November 14, 2018).
     
10.8   Agreement of Understanding between Ozop Surgical Corp. and Eric Sui dated February 27, 2019. (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on March 6, 2019).
     
10.9   Separation Agreement between Ozop Surgical Corp. and Salman J. Chaudhry dated March 4, 2019. (Incorporated by reference to Exhibit 10.2 of the Current Report on Form 8-K filed on March 6, 2019).
     
10.10   Investment Banking Engagement Agreement between Ozop Surgical Corp. and Newbridge Securities Corporation dated March 24, 2019. (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on March 28, 2019).
     
10.11   Binding Letter of Intent dated February 28, 2020, by and between Ozop Surgical Corp. and Power Conversion Technologies, Inc, and Catherine Chis, (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on February 28, 2020).
     
10.12   Redemption Agreement dated February 28, 2020, by and between Ozop Surgical Corp. and Michael Chermak, (Incorporated by reference to Exhibit 10.2 of the Current Report on Form 8-K filed on February 28, 2020).
     
10.13+   Employment Agreement dated February 28, 2020, by and between Ozop Surgical Corp. and Brian Conway, (Incorporated by reference to Exhibit 10.3 of the Current Report on Form 8-K filed on February 28, 2020).
     
31.1*   Certification of Chief Executive Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2*   Certification of Chief Financial Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1*   Certification of Chief Executive Officer and the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63

(d)

101.INS*   XBRL Instance Document
101.SCH*   XBRL Taxonomy Extension Schema Document
101.CAL*   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   XBRL Taxonomy Extension Label Linkbase Document
101.PRE*   XBRL Taxonomy Extension Presentation Linkbase Document

 

* Filed herewith.

+ Management contract or compensatory plan or arrangement.

 

 45 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Dated: August 14, 2020

 

 /s/ Brian P Conway  
Brian P. Conway  
Chief Executive Officer  
(principal executive officer)  
(principal financial and accounting officer)  

 

 46 

 

 EX-31.1 2 ex31-1.htm

 

EXHIBIT 31.1

 

Certification of Chief Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

and Rules 13a-14 and 15d-14 under the Securities Exchange Act of 1934

 

I, Brian P Conway, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020 of OZOP SURGICAL CORP. (the “registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
  (b) Designed such internal control over financing reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 14, 2020 /s/ Brian P. Conway
 

Brian P. Conway, Chief Executive Officer

(Principal Executive Officer)

 

 

 

 EX-31.2 3 ex31-2.htm

 

EXHIBIT 31.2

 

Certification of Chief Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

and Rules 13a-14 and 15d-14 under the Securities Exchange Act of 1934

 

I, Brian P. Conway, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020 of OZOP SURGICAL CORP. (the “registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
  (b) Designed such internal control over financing reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 14, 2020 /s/ Brian P. Conway
  Brian P. Conway
  Interim Chief Financial Officer (principal financial and accounting officer)

 

 

 

 EX-32.1 4 ex32-1.htm

 

EXHIBIT 32.1

 

Certification of Periodic Financial Report by the Chief Executive Officer and

Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

Each of the undersigned hereby certifies, in his capacity as an officer of OZOP SURGICAL CORP. (the “Company”), for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 

(1) The Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: August 14, 2020

 

 /s/ Brian P Conway  
Brian P. Conway  
Chief Executive Officer  
(principal executive officer)  
(principal financial and accounting officer)  

 

 

 

 EX-101.INS 5 ozsc-20200630.xml XBRL INSTANCE FILE 0001679817 2020-01-01 2020-06-30 0001679817 2019-06-30 0001679817 2019-12-31 0001679817 2020-06-30 0001679817 us-gaap:SeriesCPreferredStockMember 2019-12-31 0001679817 us-gaap:SeriesCPreferredStockMember 2020-06-30 0001679817 us-gaap:CommonStockMember 2018-12-31 0001679817 us-gaap:CommonStockMember 2019-12-31 0001679817 OZSC:CommonStockToBeIssuedMember 2018-12-31 0001679817 OZSC:CommonStockToBeIssuedMember 2019-12-31 0001679817 us-gaap:DeferredCompensationShareBasedPaymentsMember 2018-12-31 0001679817 us-gaap:DeferredCompensationShareBasedPaymentsMember 2019-12-31 0001679817 OZSC:StockSubscriptionReceivableMember 2018-12-31 0001679817 OZSC:StockSubscriptionReceivableMember 2019-12-31 0001679817 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001679817 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001679817 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001679817 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001679817 us-gaap:RetainedEarningsMember 2018-12-31 0001679817 us-gaap:RetainedEarningsMember 2019-12-31 0001679817 us-gaap:SeriesBPreferredStockMember 2019-12-31 0001679817 OZSC:TwoThousandSeventeenNotesMember 2017-01-01 2017-12-31 0001679817 OZSC:TwoThousandSeventeenNotesMember srt:MinimumMember 2017-12-31 0001679817 OZSC:TwoThousandSeventeenNotesMember srt:MaximumMember 2017-12-31 0001679817 OZSC:TwoThousandSeventeenNotesMember 2017-12-31 0001679817 OZSC:TwoThousandEighteenNotesMember 2018-01-01 2018-12-31 0001679817 OZSC:TwoThousandEighteenNotesMember 2018-12-31 0001679817 2018-04-12 2018-04-13 0001679817 2018-04-13 0001679817 OZSC:DebtPurchaseAgreementMember OZSC:OneInvestorMember 2019-08-28 2019-08-29 0001679817 OZSC:DebtPurchaseAgreementMember OZSC:OneInvestorMember 2019-08-29 0001679817 OZSC:DebtPurchaseAgreementMember OZSC:SecondInvestorMember 2019-08-29 0001679817 OZSC:DebtPurchaseAgreementMember OZSC:SecondInvestorMember 2019-08-28 2019-08-29 0001679817 OZSC:TwoThousandSeventeenNotesMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember 2018-04-13 0001679817 OZSC:ConvertiblePromissoryNoteMember 2018-04-12 2018-04-13 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:AfterOIDMember 2018-04-12 2018-04-13 0001679817 OZSC:ConvertiblePromissoryNoteMember us-gaap:InvestorMember 2019-01-01 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteOneMember 2018-04-12 2018-04-13 0001679817 OZSC:ConvertiblePromissoryNoteOneMember 2018-04-29 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:AfterOIDMember 2018-04-28 2018-04-29 0001679817 OZSC:ConvertiblePromissoryNoteOneMember OZSC:InvestorTwoMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteOneMember 2018-11-15 0001679817 OZSC:ConvertiblePromissoryNoteOneMember 2018-11-14 2018-11-15 0001679817 OZSC:ConvertiblePromissoryNoteOneMember 2018-11-18 2018-11-19 0001679817 OZSC:ConvertiblePromissoryNoteOneMember OZSC:AfterOIDMember 2018-11-18 2018-11-19 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:InvestorSixMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-01-07 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-01-06 2019-01-07 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AfterOIDMember 2019-01-06 2019-01-07 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-01-01 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember 2019-02-05 0001679817 OZSC:ConvertiblePromissoryNoteMember 2019-02-04 2019-02-05 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:FirstTrancheMember 2019-02-07 2019-02-08 0001679817 OZSC:MasterNoteMember 2019-02-05 0001679817 OZSC:MasterNoteMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-03-07 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-03-06 2019-03-07 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AfterOIDMember 2019-03-06 2019-03-07 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:MarchSevenTwoThousandNinteenMember us-gaap:InvestorMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-05-29 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-05-28 2019-05-29 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AfterOIDMember 2019-05-28 2019-05-29 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:MayTwentyNineThousandNinteenMember 2019-12-31 0001679817 OZSC:PurchaserMember OZSC:AssignmentAgreementMember 2019-06-07 0001679817 OZSC:PurchaserMember OZSC:AssignmentAgreementMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-06-21 2019-06-22 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-06-22 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:JuneTwentyTwoThousandNinteenMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-08-19 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-08-18 2019-08-19 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AfterOIDMember 2019-08-18 2019-08-19 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-08-29 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-08-28 2019-08-29 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustTwentyNineThousandNinteenMember 2019-12-31 0001679817 OZSC:PurchaserMember OZSC:DebtPurchaseAgreementMember 2019-08-28 2019-08-29 0001679817 OZSC:PurchaserMember OZSC:DebtPurchaseAgreementMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-10-07 2019-10-08 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-10-08 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AfterOIDMember 2019-10-07 2019-10-08 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-10-24 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-10-22 2019-10-24 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AfterOIDMember 2019-10-22 2019-10-24 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:OctoberTwentyFourThousandNinteenMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-10-25 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-10-23 2019-10-25 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AfterOIDMember 2019-10-23 2019-10-25 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:OctoberTwentyFiveThousandNinteenMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-11-27 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-11-26 2019-11-27 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:NovemberTwentySevenThousandNinteenMember 2019-12-31 0001679817 OZSC:ExclusiveLicenseAgreementMember OZSC:SpinalResourcesIncMeberMember 2019-08-20 2019-08-23 0001679817 OZSC:ExclusiveLicenseAgreementMember OZSC:SpinalResourcesIncMeberMember 2019-08-23 0001679817 OZSC:SpinalResourcesIncMember 2019-08-23 0001679817 OZSC:SpinalResourcesIncMeberMember 2019-01-01 2019-12-31 0001679817 OZSC:PermaConsultantsHoldingAGMember 2016-07-19 0001679817 2016-10-28 0001679817 OZSC:SpinalResourcesIncMeberMember 2019-12-31 0001679817 us-gaap:OfficeEquipmentMember 2019-12-31 0001679817 us-gaap:FairValueInputsLevel1Member 2019-12-31 0001679817 us-gaap:FairValueInputsLevel2Member 2019-12-31 0001679817 us-gaap:FairValueInputsLevel3Member 2019-12-31 0001679817 OZSC:BalanceSheetDateMember OZSC:HKDMember 2019-12-31 0001679817 OZSC:AverageRateForStatementsOfpperationsAndComprehensiveLossMember OZSC:HKDMember 2019-12-31 0001679817 OZSC:PatentsAndLicenseRightsMember 2019-12-31 0001679817 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember 2020-06-30 0001679817 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember 2020-06-30 0001679817 us-gaap:MeasurementInputPriceVolatilityMember srt:MinimumMember 2020-06-30 0001679817 us-gaap:MeasurementInputPriceVolatilityMember srt:MaximumMember 2020-06-30 0001679817 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember 2019-12-31 0001679817 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember 2019-12-31 0001679817 us-gaap:MeasurementInputPriceVolatilityMember srt:MinimumMember 2019-12-31 0001679817 us-gaap:MeasurementInputPriceVolatilityMember srt:MaximumMember 2019-12-31 0001679817 us-gaap:DerivativeMember us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember 2020-06-30 0001679817 us-gaap:DerivativeMember us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember 2020-06-30 0001679817 us-gaap:DerivativeMember us-gaap:MeasurementInputPriceVolatilityMember srt:MinimumMember 2020-06-30 0001679817 us-gaap:DerivativeMember us-gaap:MeasurementInputPriceVolatilityMember srt:MaximumMember 2020-06-30 0001679817 OZSC:NotePayableMember 2020-06-30 0001679817 OZSC:NotePayableOneMember 2020-06-30 0001679817 OZSC:NotePayableTwoMember 2019-12-31 0001679817 OZSC:OtherMember 2020-06-30 0001679817 OZSC:NotePayableOneMember 2019-12-31 0001679817 OZSC:NotePayableMember 2019-12-31 0001679817 OZSC:OtherMember 2019-12-31 0001679817 OZSC:NotePayableMember 2019-01-01 2019-12-31 0001679817 OZSC:NotePayableMember 2020-01-01 2020-06-30 0001679817 OZSC:NotePayableOneMember 2019-01-01 2019-12-31 0001679817 OZSC:NotePayableOneMember 2020-01-01 2020-06-30 0001679817 OZSC:NotePayableTwoMember 2019-01-01 2019-12-31 0001679817 2018-02-05 2018-02-09 0001679817 us-gaap:SeriesCPreferredStockMember srt:ChiefExecutiveOfficerMember 2020-02-25 2020-02-28 0001679817 us-gaap:SeriesBPreferredStockMember 2019-09-15 2019-09-19 0001679817 srt:ChiefExecutiveOfficerMember 2020-01-01 2020-06-30 0001679817 srt:AffiliatedEntityMember 2020-01-01 2020-06-30 0001679817 srt:ChiefOperatingOfficerMember 2020-01-01 2020-06-30 0001679817 srt:ChiefFinancialOfficerMember 2020-01-01 2020-06-30 0001679817 OZSC:StockholderMember 2019-12-31 0001679817 OZSC:StockholderMember 2020-06-30 0001679817 OZSC:LicensingAgreementMember 2018-01-30 2018-02-01 0001679817 OZSC:LicensingAgreementMember 2018-11-17 2018-11-20 0001679817 OZSC:SeparationAgreementMember OZSC:SalmanJChaudhryMember 2019-03-04 0001679817 OZSC:NewbridgeSecuritiesCorporationMember OZSC:InvestmentBankingEngagementAgreementMember 2019-03-23 2019-03-24 0001679817 OZSC:NewbridgeSecuritiesCorporationMember OZSC:InvestmentBankingEngagementAgreementMember 2020-01-01 2020-06-30 0001679817 OZSC:ConsultingAgreementMember srt:ExecutiveVicePresidentMember 2019-09-01 2019-09-02 0001679817 OZSC:ConsultingAgreementMember srt:ExecutiveVicePresidentMember 2019-01-01 2019-12-31 0001679817 OZSC:ConsultingAgreementMember srt:ExecutiveVicePresidentMember 2019-12-31 0001679817 OZSC:InvestorRelationsAgreementMember 2019-08-30 2019-09-03 0001679817 OZSC:InvestorRelationsAgreementMember 2020-01-01 2020-06-30 0001679817 OZSC:ConsultingAgreementMember 2019-08-30 2019-09-03 0001679817 us-gaap:InternalRevenueServiceIRSMember 2020-06-30 0001679817 us-gaap:InlandRevenueHongKongMember 2020-06-30 0001679817 2020-01-20 2020-01-21 0001679817 2019-07-04 2019-07-05 0001679817 us-gaap:UnitrancheDebtMember 2019-07-04 2019-07-05 0001679817 us-gaap:SeriesBPreferredStockMember 2019-03-27 2019-03-28 0001679817 us-gaap:SeriesBPreferredStockMember srt:ChiefExecutiveOfficerMember 2019-03-29 2019-04-02 0001679817 us-gaap:SeriesCPreferredStockMember 2019-09-17 2019-09-18 0001679817 us-gaap:SeriesCPreferredStockMember OZSC:CEOAndDirectorMember 2019-09-15 2019-09-19 0001679817 us-gaap:SubsequentEventMember 2020-07-01 2020-08-10 0001679817 us-gaap:SubsequentEventMember OZSC:FifteenPercentConvertibleRedeemableNoteMember us-gaap:InvestorMember 2020-07-08 0001679817 2020-08-10 0001679817 us-gaap:CommonStockMember 2019-06-30 0001679817 us-gaap:CommonStockMember 2020-06-30 0001679817 OZSC:CommonStockToBeIssuedMember 2019-06-30 0001679817 OZSC:CommonStockToBeIssuedMember 2020-06-30 0001679817 us-gaap:SeriesBPreferredStockMember 2020-06-30 0001679817 us-gaap:DeferredCompensationShareBasedPaymentsMember 2019-06-30 0001679817 us-gaap:DeferredCompensationShareBasedPaymentsMember 2020-06-30 0001679817 OZSC:StockSubscriptionReceivableMember 2019-06-30 0001679817 OZSC:StockSubscriptionReceivableMember 2020-06-30 0001679817 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001679817 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001679817 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001679817 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001679817 us-gaap:RetainedEarningsMember 2019-06-30 0001679817 us-gaap:RetainedEarningsMember 2020-06-30 0001679817 2018-12-31 0001679817 2019-03-31 0001679817 2020-02-26 0001679817 2019-01-01 2019-12-31 0001679817 2020-02-25 2020-02-28 0001679817 OZSC:EmploymentAgreementMember OZSC:MrConwayMember 2020-02-25 2020-02-28 0001679817 OZSC:ExclusiveLicenseAgreementMember OZSC:SpinalResourcesIncMeberMember 2020-01-01 2020-06-30 0001679817 OZSC:SalesRevenueMember OZSC:CustomerMember 2020-01-01 2020-06-30 0001679817 OZSC:SalesRevenueMember OZSC:CustomerMember 2019-01-01 2019-06-30 0001679817 OZSC:ProductRevenueMember OZSC:SuppliersMember 2020-01-01 2020-06-30 0001679817 OZSC:ProductRevenueMember OZSC:SuppliersMember 2019-01-01 2019-06-30 0001679817 2019-01-01 2019-06-30 0001679817 OZSC:SpinalResourcesIncMeberMember 2020-01-16 0001679817 OZSC:SalesRevenueMember OZSC:CustomeAMember 2020-04-01 2020-06-30 0001679817 OZSC:SalesRevenueMember OZSC:CustomeAMember 2019-04-01 2019-06-30 0001679817 OZSC:CustomeAMember 2020-06-30 0001679817 OZSC:ProductRevenueMember OZSC:SuppliersAMember 2020-01-01 2020-06-30 0001679817 OZSC:ProductRevenueMember OZSC:SuppliersAMember 2019-01-01 2019-06-30 0001679817 us-gaap:OfficeEquipmentMember 2020-06-30 0001679817 us-gaap:FairValueInputsLevel1Member 2020-06-30 0001679817 us-gaap:FairValueInputsLevel2Member 2020-06-30 0001679817 us-gaap:FairValueInputsLevel3Member 2020-06-30 0001679817 OZSC:BalanceSheetDateMember OZSC:HKDMember 2020-06-30 0001679817 OZSC:AverageRateForStatementsOfpperationsAndComprehensiveLossMember OZSC:HKDMember 2020-06-30 0001679817 OZSC:CommonStockToBeIssuedMember 2020-01-01 2020-06-30 0001679817 us-gaap:ConvertiblePreferredStockMember 2020-01-01 2020-06-30 0001679817 us-gaap:ConvertibleNotesPayableMember 2020-01-01 2020-06-30 0001679817 OZSC:CommonStockToBeIssuedMember 2019-01-01 2019-06-30 0001679817 us-gaap:ConvertiblePreferredStockMember 2019-01-01 2019-06-30 0001679817 us-gaap:ConvertibleNotesPayableMember 2019-01-01 2019-06-30 0001679817 OZSC:PatentsAndLicenseRightsMember 2020-06-30 0001679817 OZSC:TwoThousandSeventeenNotesMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember us-gaap:InvestorMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember us-gaap:InvestorMember 2019-06-30 0001679817 OZSC:ConvertiblePromissoryNoteOneMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteOneMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteOneMember OZSC:InvestorTwoMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteOneMember OZSC:InvestorTwoMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:InvestorSixMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:InvestorSixMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2020-06-30 0001679817 OZSC:MasterNoteMember 2020-01-01 2020-06-30 0001679817 OZSC:MasterNoteMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:MarchSevenTwoThousandNinteenMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:MarchSevenTwoThousandNinteenMember us-gaap:InvestorMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:MarchSevenTwoThousandNinteenMember us-gaap:InvestorMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:MayTwentyNineThousandNinteenMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:MayTwentyNineThousandNinteenMember 2020-06-30 0001679817 OZSC:PurchaserMember OZSC:AssignmentAgreementMember 2019-06-04 2019-06-05 0001679817 OZSC:PurchaserMember OZSC:AssignmentAgreementMember 2019-06-05 0001679817 OZSC:PurchaserMember OZSC:AssignmentAgreementMember 2020-06-30 0001679817 OZSC:PurchaserMember OZSC:AssignmentAgreementMember 2019-06-04 2019-06-07 0001679817 OZSC:PurchaserMember OZSC:AssignmentAgreementMember OZSC:JuneSevenTwoThousandNinteenMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:JuneTwentyTwoThousandNinteenMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:JuneTwentyTwoThousandNinteenMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-08-02 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-08-01 2019-08-02 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AfterOIDMember 2019-08-01 2019-08-02 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustTwoThousandNinteenMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustTwoThousandNinteenMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustTwoThousandNinteenMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-08-21 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-08-20 2019-08-21 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AfterOIDMember 2019-08-20 2019-08-21 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustTwentyOneThousandNinteenMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustTwentyOneThousandNinteenMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustTwentyOneThousandNinteenMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustNineteenThousandNinteenMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustNineteenThousandNinteenMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustNineteenThousandNinteenMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-08-23 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-08-18 2019-08-23 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustTwentyThreeThousandNinteenMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustTwentyThreeThousandNinteenMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustTwentyThreeThousandNinteenMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustTwentyNineThousandNinteenMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustTwentyNineThousandNinteenMember 2020-06-30 0001679817 OZSC:PurchaserMember OZSC:DebtPurchaseAgreementMember 2020-01-01 2020-06-30 0001679817 OZSC:PurchaserMember OZSC:DebtPurchaseAgreementMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-10-01 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-09-29 2019-10-01 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:OctoberOneThousandNinteenMember 2019-01-01 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:OctoberOneThousandNinteenMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:OctoberOneThousandNinteenMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:OctoberEightThousandNinteenMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:OctoberEightThousandNinteenMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementOneMember 2019-10-24 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementOneMember 2019-10-22 2019-10-24 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementOneMember OZSC:AfterOIDMember 2019-10-22 2019-10-24 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementOneMember OZSC:OctoberTwentyFourThousandNinteenMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementOneMember OZSC:OctoberTwentyFourThousandNinteenMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementOneMember OZSC:OctoberTwentyFourThousandNinteenMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:OctoberTwentyFourThousandNinteenMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:OctoberTwentyFourThousandNinteenMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:OctoberTwentyFiveThousandNinteenMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:OctoberTwentyFiveThousandNinteenMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:NovemberTwentySevenThousandNinteenMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:NovemberTwentySevenThousandNinteenMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2020-01-08 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2020-01-07 2020-01-08 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:JanuaryEightThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:JanuaryEightThousandAndTwentyMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember 2020-02-18 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember 2020-02-17 2020-02-18 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember OZSC:FebruaryEighteenThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember OZSC:FebruaryEighteenThousandAndTwentyMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementOneMember 2020-02-18 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementOneMember OZSC:FebruaryEighteenThousandAndTwentyMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-02-26 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-02-25 2019-02-26 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:FebruaryTwentySixThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:FebruaryTwentySixThousandAndTwentyMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementOneMember 2019-02-26 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:AssignmentAgreementMember 2019-02-26 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementOneMember 2019-02-25 2019-02-26 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementOneMember OZSC:FebruaryTwentySixThousandAndTwentyMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember 2020-03-09 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember 2020-03-08 2020-03-09 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember OZSC:MarchNineThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember OZSC:MarchNineThousandAndTwentyMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementOneMember 2020-03-09 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementOneMember 2020-03-08 2020-03-09 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementOneMember OZSC:MarchNineThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementOneMember OZSC:MarchNineThousandAndTwentyMember 2020-06-30 0001679817 OZSC:SeparationAgreementMember OZSC:SalmanJChaudhryMember 2020-06-30 0001679817 OZSC:SeparationAgreementMember OZSC:SalmanJChaudhryMember 2019-12-31 0001679817 OZSC:ConsultingAgreementMember srt:ExecutiveVicePresidentMember 2020-06-30 0001679817 us-gaap:SeriesCPreferredStockMember OZSC:MrChermakMember 2020-02-27 2020-02-28 0001679817 us-gaap:SeriesCPreferredStockMember OZSC:MrChermakMember 2020-02-28 0001679817 us-gaap:SeriesCPreferredStockMember 2020-02-27 2020-02-28 0001679817 us-gaap:SeriesCPreferredStockMember OZSC:MrConwayMember 2020-02-27 2020-02-28 0001679817 us-gaap:SeriesCPreferredStockMember OZSC:MrConwayMember 2020-02-28 0001679817 OZSC:OfficersAndDirectorsMember 2018-02-05 2018-02-09 0001679817 OZSC:SpinalResourcesIncMember 2020-06-30 0001679817 OZSC:SpinalResourcesIncMember 2020-01-01 2020-06-30 0001679817 OZSC:PurchaserMember OZSC:AssignmentAgreementMember OZSC:JuneSevenTwoThousandNinteenMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember 2019-07-23 2019-07-24 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AfterOIDMember 2019-07-23 2019-07-24 0001679817 srt:ChiefExecutiveOfficerMember 2019-01-01 2019-06-30 0001679817 srt:AffiliatedEntityMember 2019-01-01 2019-06-30 0001679817 srt:ChiefOperatingOfficerMember 2019-01-01 2019-06-30 0001679817 srt:ChiefFinancialOfficerMember 2019-01-01 2019-06-30 0001679817 OZSC:FormerCEOFormerMember 2020-06-30 0001679817 OZSC:FormerCEOFormerMember 2019-12-31 0001679817 OZSC:FormerCEOSubsidiaryMember 2020-06-30 0001679817 OZSC:FormerCEOSubsidiaryMember 2019-12-31 0001679817 OZSC:FormerCOOAndCCOMember 2020-06-30 0001679817 OZSC:FormerCOOAndCCOMember 2019-12-31 0001679817 OZSC:FormerCOOMember 2020-06-30 0001679817 OZSC:FormerCOOMember 2019-12-31 0001679817 OZSC:FormerCFOMember 2020-06-30 0001679817 OZSC:FormerCFOMember 2019-12-31 0001679817 OZSC:ConsultingAgreementMember 2020-01-01 2020-06-30 0001679817 OZSC:BindingLetterOfIntentMember OZSC:SecuritiesPurchaseAgreementMember us-gaap:SeriesCPreferredStockMember 2020-02-27 2020-02-28 0001679817 OZSC:BindingLetterOfIntentMember OZSC:SecuritiesPurchaseAgreementMember us-gaap:SeriesDPreferredStockMember 2020-02-27 2020-02-28 0001679817 OZSC:BindingLetterOfIntentMember OZSC:SecuritiesPurchaseAgreementMember us-gaap:SeriesEPreferredStockMember 2020-02-27 2020-02-28 0001679817 2020-04-01 2020-06-30 0001679817 2019-04-01 2019-06-30 0001679817 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001679817 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001679817 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001679817 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001679817 us-gaap:CommonStockMember 2020-03-31 0001679817 us-gaap:CommonStockMember 2019-03-31 0001679817 OZSC:CommonStockToBeIssuedMember 2020-01-01 2020-03-31 0001679817 OZSC:CommonStockToBeIssuedMember 2019-01-01 2019-03-31 0001679817 OZSC:CommonStockToBeIssuedMember 2020-04-01 2020-06-30 0001679817 OZSC:CommonStockToBeIssuedMember 2019-04-01 2019-06-30 0001679817 OZSC:CommonStockToBeIssuedMember 2020-03-31 0001679817 OZSC:CommonStockToBeIssuedMember 2019-03-31 0001679817 us-gaap:DeferredCompensationShareBasedPaymentsMember 2020-01-01 2020-03-31 0001679817 us-gaap:DeferredCompensationShareBasedPaymentsMember 2019-01-01 2019-03-31 0001679817 us-gaap:DeferredCompensationShareBasedPaymentsMember 2020-04-01 2020-06-30 0001679817 us-gaap:DeferredCompensationShareBasedPaymentsMember 2019-04-01 2019-06-30 0001679817 us-gaap:DeferredCompensationShareBasedPaymentsMember 2020-03-31 0001679817 us-gaap:DeferredCompensationShareBasedPaymentsMember 2019-03-31 0001679817 OZSC:StockSubscriptionReceivableMember 2020-01-01 2020-03-31 0001679817 OZSC:StockSubscriptionReceivableMember 2019-01-01 2019-03-31 0001679817 OZSC:StockSubscriptionReceivableMember 2020-04-01 2020-06-30 0001679817 OZSC:StockSubscriptionReceivableMember 2019-04-01 2019-06-30 0001679817 OZSC:StockSubscriptionReceivableMember 2020-03-31 0001679817 OZSC:StockSubscriptionReceivableMember 2019-03-31 0001679817 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001679817 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001679817 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001679817 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001679817 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001679817 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001679817 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001679817 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001679817 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001679817 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001679817 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001679817 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001679817 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001679817 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001679817 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001679817 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001679817 us-gaap:RetainedEarningsMember 2020-03-31 0001679817 us-gaap:RetainedEarningsMember 2019-03-31 0001679817 2020-01-01 2020-03-31 0001679817 2019-01-01 2019-03-31 0001679817 2020-03-31 0001679817 us-gaap:TreasuryStockMember 2019-04-01 2019-06-30 0001679817 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0001679817 us-gaap:TreasuryStockMember 2020-04-01 2020-06-30 0001679817 us-gaap:TreasuryStockMember 2019-03-31 0001679817 us-gaap:TreasuryStockMember 2019-06-30 0001679817 us-gaap:TreasuryStockMember 2019-12-31 0001679817 us-gaap:TreasuryStockMember 2020-03-31 0001679817 us-gaap:TreasuryStockMember 2020-06-30 0001679817 us-gaap:PreferredStockMember 2019-04-01 2019-06-30 0001679817 us-gaap:PreferredStockMember 2019-03-31 0001679817 us-gaap:PreferredStockMember 2019-06-30 0001679817 2020-05-26 0001679817 2020-06-26 0001679817 OZSC:SalesRevenueMember OZSC:CustomeAMember 2020-01-01 2020-06-30 0001679817 OZSC:SalesRevenueMember OZSC:CustomeAMember 2019-01-01 2019-06-30 0001679817 OZSC:ProductRevenueMember OZSC:SuppliersAMember 2020-04-01 2020-06-30 0001679817 OZSC:ProductRevenueMember OZSC:SuppliersAMember 2019-04-01 2019-06-30 0001679817 OZSC:DebtPurchaseAgreementMember 2020-06-23 0001679817 OZSC:DebtPurchaseAgreementMember 2020-06-22 2020-06-23 0001679817 OZSC:ConvertiblePromissoryNoteMember us-gaap:InvestorMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteTwoMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:InvestorSevenMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:InvestorSevenMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:MayTwentyNineThousandNinteenMember us-gaap:InvestorMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:MayTwentyNineThousandNinteenMember OZSC:ThirdPartyInvestorMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:JuneTwentyTwoThousandNinteenMember us-gaap:InvestorMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember us-gaap:InvestorMember 2019-08-23 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustTwentyThreeThousandNinteenMember OZSC:ThirdPartyInvestorMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:AugustTwentyNineThousandNinteenMember us-gaap:InvestorMember 2020-06-30 0001679817 OZSC:PurchaserMember OZSC:DebtPurchaseAgreementMember 2020-06-29 0001679817 OZSC:DebtPurchaseAgreementMember us-gaap:InvestorMember 2020-01-01 2020-06-30 0001679817 OZSC:DebtPurchaseAgreementMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:OctoberOneThousandNinteenMember us-gaap:InvestorMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:OctoberEightThousandNinteenMember us-gaap:InvestorMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:OctoberEightThousandNinteenMember OZSC:InvestorConvertedMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementOneMember OZSC:OctoberTwentyFourThousandNinteenMember us-gaap:InvestorMember 2019-12-31 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:OctoberTwentyFourThousandNinteenMember us-gaap:InvestorMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:OctoberTwentyFiveThousandNinteenMember us-gaap:InvestorMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:NovemberTwentySevenThousandNinteenMember us-gaap:InvestorMember 2020-05-15 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:NovemberTwentySevenThousandNinteenMember us-gaap:InvestorMember 2020-05-14 2020-05-15 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:JanuaryEightThousandAndTwentyMember us-gaap:InvestorMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:SecuritiesPurchaseAgreementMember OZSC:JanuaryEightThousandAndTwentyMember us-gaap:InvestorMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementOneMember OZSC:AprilSeventeenThousandAndTwentyMember 2020-04-16 2020-04-17 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementOneMember OZSC:AprilSeventeenThousandAndTwentyMember 2020-04-17 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementOneMember OZSC:AprilSeventeenThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementOneMember OZSC:AprilSeventeenThousandAndTwentyMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember 2020-04-24 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember OZSC:AprilTwentyFourTwoThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember OZSC:AprilTwentyFourTwoThousandAndTwentyMember 2020-06-30 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember 2020-04-27 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember 2020-04-26 2020-04-27 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember OZSC:AfterOIDMember 2020-04-26 2020-04-27 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember OZSC:AprilTwentySevenTwoThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember OZSC:AprilTwentySevenTwoThousandAndTwentyMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember 2020-04-26 2020-04-28 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember 2020-04-28 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember OZSC:AprilTwentyEightTwoThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember OZSC:AprilTwentyEightTwoThousandAndTwentyMember 2020-06-30 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember 2020-04-26 2020-04-28 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember 2020-04-28 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember 2020-05-03 2020-05-04 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember 2020-05-04 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember OZSC:MayFourTwoThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember OZSC:MayFourTwoThousandAndTwentyMember 2020-06-30 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember OZSC:AprilTwentyEightTwoThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember OZSC:AprilTwentyEightTwoThousandAndTwentyMember 2020-06-30 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember 2020-05-03 2020-05-06 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember 2020-05-05 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember 2020-05-03 2020-05-05 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember OZSC:MayFiveTwoThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember OZSC:MayFiveTwoThousandAndTwentyMember 2020-06-30 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember 2020-05-03 2020-05-13 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember 2020-05-07 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember 2020-05-03 2020-05-07 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember OZSC:MaySevenTwoThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember OZSC:MaySevenTwoThousandAndTwentyMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember 2020-05-07 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember 2020-05-03 2020-05-07 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember OZSC:MaySevenTwoThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember OZSC:MaySevenTwoThousandAndTwentyMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember 2020-05-14 2020-05-15 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember 2020-05-15 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember OZSC:MayFifteenTwoThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember OZSC:MayFifteenTwoThousandAndTwentyMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementOneMember 2020-05-15 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementOneMember 2020-05-14 2020-05-15 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementOneMember OZSC:MayFifteenTwoThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementOneMember OZSC:MayFifteenTwoThousandAndTwentyMember 2020-06-30 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember 2020-05-28 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember 2020-05-27 2020-05-28 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember OZSC:MayTwentyEightTwoThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember OZSC:MayTwentyEightTwoThousandAndTwentyMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember 2020-05-28 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember 2020-05-27 2020-05-28 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember OZSC:MayTwentyEightTwoThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember OZSC:MayTwentyEightTwoThousandAndTwentyMember 2020-06-30 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember 2020-05-30 2020-06-01 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember 2020-06-01 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember OZSC:JuneOneTwoThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember OZSC:JuneOneTwoThousandAndTwentyMember 2020-06-30 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember 2020-06-11 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember 2020-06-10 2020-06-11 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember OZSC:JuneElevenTwoThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:TwelvePercentConvertibleRedeemableNoteMember OZSC:JuneElevenTwoThousandAndTwentyMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember 2020-06-22 2020-06-23 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember 2020-06-23 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember OZSC:JuneTwentyThreeTwoThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember OZSC:JuneTwentyThreeTwoThousandAndTwentyMember 2020-06-30 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember 2020-06-30 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember 2020-06-28 2020-06-30 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember OZSC:JuneThirtyTwoThousandAndTwentyMember 2020-01-01 2020-06-30 0001679817 OZSC:FifteenPercentConvertibleRedeemableNoteMember OZSC:JuneThirtyTwoThousandAndTwentyMember 2020-06-30 0001679817 OZSC:LoanAndSecuritiesPurchaseAgreementMember OZSC:PromissoryNoteMember OZSC:LenderMember 2020-06-20 2020-06-23 0001679817 OZSC:LoanAndSecuritiesPurchaseAgreementMember OZSC:PromissoryNoteMember OZSC:LenderMember 2020-06-23 0001679817 2020-02-25 2020-02-26 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2020-06-20 2020-06-25 0001679817 OZSC:PromissoryNoteMember OZSC:HolderMember 2020-06-25 0001679817 OZSC:NotePayableTwoMember 2020-06-30 0001679817 OZSC:NotePayableThreeMember 2019-12-31 0001679817 OZSC:NotePayableThreeMember 2020-06-30 0001679817 OZSC:NotePayableTwoMember 2020-01-01 2020-06-30 0001679817 OZSC:NotePayableThreeMember 2020-01-01 2020-06-30 0001679817 OZSC:NotePayableThreeMember 2019-01-01 2019-12-31 0001679817 srt:ChiefExecutiveOfficerMember 2019-04-01 2019-06-30 0001679817 srt:AffiliatedEntityMember 2019-04-01 2019-06-30 0001679817 srt:ChiefOperatingOfficerMember 2019-04-01 2019-06-30 0001679817 srt:ChiefFinancialOfficerMember 2019-04-01 2019-06-30 0001679817 srt:ChiefExecutiveOfficerMember 2020-04-01 2020-06-30 0001679817 srt:AffiliatedEntityMember 2020-04-01 2020-06-30 0001679817 srt:ChiefOperatingOfficerMember 2020-04-01 2020-06-30 0001679817 srt:ChiefFinancialOfficerMember 2020-04-01 2020-06-30 0001679817 OZSC:OneYearAgreementMember 2020-06-04 2020-06-05 0001679817 us-gaap:SubsequentEventMember OZSC:FifteenPercentConvertibleRedeemableNoteMember us-gaap:InvestorMember 2020-07-03 2020-07-08 0001679817 us-gaap:SubsequentEventMember OZSC:FifteenPercentConvertibleRedeemableNoteMember us-gaap:InvestorMember 2020-07-03 2020-07-09 0001679817 us-gaap:SubsequentEventMember OZSC:CertificatesOfDesignationMember us-gaap:SeriesCPreferredStockMember 2020-07-06 2020-07-07 0001679817 us-gaap:SubsequentEventMember OZSC:CertificatesOfDesignationMember us-gaap:SeriesDPreferredStockMember 2020-07-03 2020-07-07 0001679817 us-gaap:SubsequentEventMember OZSC:CertificatesOfDesignationMember us-gaap:SeriesEPreferredStockMember 2020-07-06 2020-07-07 0001679817 us-gaap:SubsequentEventMember OZSC:SPAMember OZSC:PCTIMember 2020-07-03 2020-07-10 0001679817 us-gaap:SubsequentEventMember OZSC:SPAMember OZSC:PCTIMember 2020-07-10 0001679817 us-gaap:SubsequentEventMember OZSC:SPAMember OZSC:PCTIMember us-gaap:SeriesCPreferredStockMember 2020-07-03 2020-07-10 0001679817 us-gaap:SubsequentEventMember OZSC:SPAMember OZSC:PCTIMember us-gaap:SeriesEPreferredStockMember 2020-07-03 2020-07-10 0001679817 us-gaap:SubsequentEventMember OZSC:SPAMember OZSC:PCTIMember us-gaap:SeriesDPreferredStockMember 2020-07-03 2020-07-10 0001679817 us-gaap:SubsequentEventMember OZSC:FifteenPercentConvertibleRedeemableNoteMember us-gaap:InvestorMember 2020-07-15 0001679817 us-gaap:SubsequentEventMember OZSC:FifteenPercentConvertibleRedeemableNoteMember us-gaap:InvestorMember 2020-07-14 2020-07-15 0001679817 us-gaap:SubsequentEventMember OZSC:FifteenPercentConvertibleRedeemableNoteMember us-gaap:InvestorMember 2020-07-14 2020-07-22 0001679817 us-gaap:SubsequentEventMember OZSC:ConsultingAgreementMember 2020-07-14 2020-07-24 0001679817 us-gaap:SubsequentEventMember OZSC:FifteenPercentConvertibleRedeemableNoteMember us-gaap:InvestorMember 2020-07-28 2020-07-29 0001679817 us-gaap:SubsequentEventMember OZSC:FifteenPercentConvertibleRedeemableNoteMember us-gaap:InvestorMember 2020-07-29 0001679817 us-gaap:SubsequentEventMember OZSC:FifteenPercentConvertibleRedeemableNoteMember us-gaap:InvestorMember 2020-08-02 2020-08-03 0001679817 us-gaap:SubsequentEventMember 2020-08-10 0001679817 OZSC:PreferredStockSeriesCMember 2019-01-01 2019-03-31 0001679817 OZSC:PreferredStockSeriesCMember 2019-04-01 2019-06-30 0001679817 OZSC:PreferredStockSeriesCMember 2020-01-01 2020-03-31 0001679817 OZSC:PreferredStockSeriesCMember 2020-04-01 2020-06-30 0001679817 OZSC:PreferredStockSeriesCMember 2018-12-31 0001679817 OZSC:PreferredStockSeriesCMember 2019-03-31 0001679817 OZSC:PreferredStockSeriesCMember 2019-06-30 0001679817 OZSC:PreferredStockSeriesCMember 2019-12-31 0001679817 OZSC:PreferredStockSeriesCMember 2020-03-31 0001679817 OZSC:PreferredStockSeriesCMember 2020-06-30 0001679817 OZSC:ConvertiblePromissoryNoteMember OZSC:DebtPurchaseAgreementMember 2020-04-23 2020-04-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure OZSC:integer 10-Q false 2020-06-30 Q2 2020 --12-31 OZOP SURGICAL CORP. 0001679817 2904963462 Yes 10000000 10000000 50000 50000 0.001 0.001 0.001 0.001 50000 50000 50000 50000 50000 50000 50000 50000 4990000000 4990000000 219035 1549176877 1000 219035 1549176877 0.001 0.001 1350 1350 194951 194951 2277168 2277168 2002314 258912 29068 219035 1350 35467 1549176877 900 1350 5158493 29630 1350 450 1000 50000 50000 50000 14727584 25000 1000 2416 33656 860561 12102 15714 32021 22587 77844 33479 19239 26567 41584 83398 221683 147689 31106 482742 32063 76000 48933 10000 13483 18792 8833 54000 62000 5000 4375 200000 25000 5000 2500 67365 27500 21250 50151 27500 129500 35000 54033 5000 17783 15625 410370 706702 15625 4738 10877 304676 50903 803250 710000 50000 350000 57675 280000 44250 458500 37500 133250 14000 77900 3000 73300 2800 75000 7250 45000 57000 6000 202250 20000 33000 1750 50000 494950 150000 50000 2625 33500 65000 200000 32400 30000 3900 52375 50000 10000 50000 96250 100000 25000 25000 100000 50000 102000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recorded a gain of $86,856 for the six months ended June 30, 2020 based on the difference of the carrying values of the assets acquired and liabilities that were assumed in the transaction as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Assets</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 77%"><font style="font-size: 10pt">Inventory</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">374,500</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Instruments, net</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">350,825</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Patent rights, net</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,714,204</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Goodwill</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,002,314</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Total assets as of January 16, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,441,843</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Consideration issued and liabilities assumed</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 77%"><font style="font-size: 10pt">Common Stock payable</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">245,000</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">License fee payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,234,089</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Equity Line payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">45,359</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Iberia Note</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">447,153</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Inventory and Instrument note</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">640,699</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Accrued interest</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">16,979</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Option to buy</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,899,420</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Total consideration and liabilities assumed balances</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,528,699</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Gain on termination of license</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">86,856</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the preliminary value of the consideration issued and the preliminary purchase price allocation of the fair value of assets acquired and liabilities assumed in the transaction:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Purchase Price Allocation</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 77%"><font style="font-size: 10pt">Fair value of consideration issued</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">5,286,305</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Liabilities assumed</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">524,387</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Total purchase price</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">5,810,692</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Assets acquired</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">723,524</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Intellectual Property/Technology</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,810,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Goodwill</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,277,168</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5,810,692</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> -3272541 -5167116 -11535918 29 219 1 -269167 -49033 -7600 -7600 8228 7216 1988897 5090936 -4068747 -10208905 35 1549177 1 1 -115065 -7600 -7600 7698 6466 3732533 28452220 -6890144 -41436232 -2348360 -2706380 5158 29 1 1 -295547 -7600 -7600 6475 8415 6223895 2561225 -15880976 -4972903 -9702997 -50000 -100000 1 50 50 50 -50000 100000 -50000 -50000 -50000 -50000 50000 2500 2500 21620570 995815 4939 1439298 6 1127959 51750 21620570 995809 1127959 51750 4939400 231 1439298485 5597 7600 7000000 400000 410370 5000 5000 20000 80000 20000 80000 1350 7600000 2500 1000000 1000000 1000000 50000 50000 205966108 1350 23237756 150631924 6017711 446416 3784352 6379036 23114263 77144 39658500 4336000 7933325 217331 9186036 24394666 26288995 125613294 7881267 241489074 90191785 52946489 2500 160 40 35813035 96727034 3781509 77130 46875 46875 32000 1 0 -422100 -55500 422099 87500 172 1250 1250 171 200 450 450 235982 49033 395720 235982 49033 395720 -717 187 -717 187 -31227327 -2821397 -25555256 -1917241 -5672071 -904156 -25555256 -1917241 -5672071 -904156 -9 -741 -9 -741 0.10 0.12 0.12 0.12 0.08 0.08 0.12 0.12 0.10 0.08 0.10 0.12 0.12 0.12 0.12 0.06 0.08 0.08 0.18 0.06 0.08 0.08 0.06 0.12 0.12 0.12 0.10 0.12 0.12 0.12 0.70 0.70 0.12 0.12 0.12 0.70 0.70 0.18 0.18 0.12 0.12 0.00236 0.50 0.0032 330033 0.00257 0.0053 0.00436 0.0044 0.07891 0.00564 0.00652 0.0074 0.05278 0.00232 0.0063 0.00603 0.0775 0.00785 0.00248 0.00193 0.00494 0.00123 0.00257 0.0014 0.25 0.00185 0.01066 0.00131 0.00218 0.00129 0.00118 0.00133 2462940 9471445 634075 363806 77394 70418 49335 31452 54802 35794 52281 144302 31316 49808 1199514 510230 392403 111500 59909 125982 47117 56049 32229 22953 52457 203637 29063 365757 1321618 76000 121067 86274 55744 51539 105526 251512 42828 311128 626507 465385 44346 510785 203250 52218 207122 15000 25000 442175 339250 500000 150000 165000 85000 31800 80000 38900 85000 45000 66000 225000 36750 53000 53000 250000 330000 112141 445360 150000 19300 157500 3825 37800 15874 68000 248400 38000 50000 242025 50000 202541 330000 3603 80000 50000 60700 38900 24317 45000 68000 37750 103750 48400 225000 36750 53000 38000 93391 77000 198183 200000 66454 47090 91579 203000 127500 127500 1883096 22874 37998 148500 35000 76000 60000 75000 52000 13483 200000 52000 75000 67365 60000 2019-08-29 2020-02-08 2020-10-24 2018-09-06 2018-09-06 2020-01-05 2020-01-05 2022-06-23 2021-04-27 2020-05-23 2020-10-24 2021-01-08 2020-11-27 2021-05-28 2021-06-25 2022-06-23 2021-06-25 2021-06-25 This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of this note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company's common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of this note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company's common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. This note is convertible into shares of the Company's common stock, beginning on the date which is 180 days from the issuance date of the Master Note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of conversion of the Master Note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company's common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of the Master Note. The embedded conversion feature included in the Master Note resulted in an initial debt discount and derivative liability of $38,502. For the three months ended March 31, 2020, amortization of the debt discounts of $4,496 was charged to interest expense. For the three months ended March 31, 2020, the investor converted a total of $4,905 of the face value and $1,500 of fees into 349,000 shares of common stock. As of March 31, 2020, and December 31, 2019, the outstanding principal balance of the Master Note was $6,735 and $11,640, respectively, with a carrying value as of March 31, 2020, and December 31, 2019, of $6,735 and $7,144, respectively. The balance of this note was converted during the six months ended June 30, 2020. In connection with the issuance of this Note, the Company issued warrants to acquire 55,000 shares of common stock, for a three-year period with an exercise price of $1,50 per share, subject to price adjustments. For the three months ended March 31, 2020, the Company valued the warrant on the Black Shoals option pricing model at $12,962 and recorded the amount as derivative expense with the offset to derivative liabilities. This note is convertible into shares of the Company's common stock, at a conversion price equal to 58% of the average of the two lowest trading prices of the Company's common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company. This note is convertible into shares of the Company's common stock, at a conversion price equal to 60% of the lowest closing bid price of the Company's common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company. This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of this note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company's common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 60% multiplied by the average of the lowest two trading prices during the 20 trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company's common stock, at a conversion price equal to 60% of the average of the two lowest trading prices of the Company's common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company. This note was funded on October 10, 2019, This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) $0.05 and (2) 58% multiplied by the average of the 2 lowest trading prices of the Company's common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. This note is convertible at any time following the funding of this note into a variable number of the Company's common stock, based on a conversion ratio of 58% of the average of the two lowest closing bid prices for the 20 days prior to conversion. This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 56% multiplied by the lowest closing bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 65% multiplied by the average of the lowest two trading prices during the 15- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 65% multiplied by the average of the lowest two trading prices during the 15- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 60% multiplied by the average of the lowest two trading prices during the 20 trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 58% multiplied by the average of the lowest two trading prices during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 61% multiplied by the lowest closing bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note is convertible at any time following the funding of this note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the lowest trading price for the 25 days prior to conversion. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. This note is convertible into common stock at a conversion price equal to a 44% discount to the lowest trading price of the common stock for the 20 prior trading days including the day upon which a notice of conversion is received. This note, as amended, is convertible into common stock at a conversion price equal to a 50% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.25 or 50% of the lowest trading price for the thirty trading days prior to the conversion. This note matures on April 27,2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 58% multiplied by the lowest closing bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lower of $0.50 or 58% multiplied by the average of the two lowest closing trading price or bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $03 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.03 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion This note matures on May 7,2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. This note matures on May 28, 2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 58% multiplied by the lowest closing bid price during the twenty trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. For the first nine months interest may accrue on a monthly basis, and the Company has the option to pay the monthly interest or add such interest to the principal balance of the note. Commencing on the tenth month of the note, all accrued interest, if any, shall be added to the principal amount of the note, and interest on the new principal amount shall become due and payable on a monthly basis. Should the Company default on making any interest payments following the initial nine-months, or paying the note by the Maturity Date, the note shall automatically be converted into an 18% convertible debenture. Principal payments shall be made in six installments of $33,333 commencing 180 days from the Issue Date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the Maturity Date. The Holder shall have the right from time to time, and at any time following an event of default, as defined on the agreement, to convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company, at the lower of i) the Trading Price (as defined in the agreement) during the previous five trading days prior to the Issuance Date or ii) the volume weighted average price during the five trading days ending on the day preceding the conversion date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.011 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.011 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. 1-for-1,000 reverse stock split 5528699 524387 274854 0.16 0.18 81 105 1.57 1.77 31 36 0.12 0.24 74 105 11953787 1460123 -8627804 -850248 3682522 653551 425033 446395 45000 50000 45000 330033 50000 162085 162085 210000 175365 176030 87505 45000 22505 20000 283000 133000 90000 60000 30000 163000 88000 45000 30000 30000 470886 419692 100 200 125 144087 144639 162085 162085 112500 112500 51537 250000 250000 0.07 The term of the Agreement is 12 months from the date of the Agreement, however either party may terminate the Agreement anytime upon 15 days written notice. As compensation for its services under the Agreement, Newbridge and its assignees received 172 shares of the Company's common stock. 10000 10000 10000 30000 10000 10000 6108000 595000 For U.S. purposes the NOL deduction for a tax year is equal to the lesser of (1) the aggregate of the NOL carryovers to such year, plus the NOL carry-backs to such year, or (2) 80% of taxable income (determined without regard to the deduction). Generally, NOLs can no longer be carried back but are allowed to be carried forward indefinitely. The special extended carryback provisions are generally repealed, except for certain farming and insurance company losses. The amendments incorporating the 80% limitation apply to losses arising in tax years beginning after Dec. 31, 2017. -31227327 -2823397 0.21 0.21 6557739 592493 289 6198791 417713 358948 174491 1022071 1381018 1022071 1381018 The purchase price for the shares will be 85% of the lowest closing price during the 10-day period prior to each sale, and with each sale, the Investor will receive an issuance premium of 5% to cover the Investor's transaction costs associated with selling the shares and payable by the Company to the Investor in registered shares. The obligation of the Investor to purchase shares pursuant to the Equity Agreement is subject to several conditions, including (i) that the Company has filed a registration statement (the "Registration Statement") with the United States Securities and Exchange Commission (the "SEC") registering the shares to be sold to the Investor within 30 calendar days from the date of the Equity Agreement, with the Registration Statement being declared effective prior to sale of any shares to the Investor; and (ii) that the purchase of shares by the Investor pursuant to the Equity Agreement shall not cause the Investor to own more than 4.99% of the outstanding shares of the Company's common stock. 2774896 636466 1444237885 179688215 92332507 53110926 39959295 99000000 7600 7600 374500 350825 2714204 5441843 245000 1234089 45359 447153 640699 2899420 86856 149820477 18479 18479 58 2500 4998 5000 Yes Non-accelerated Filer true true false false 120000 1.00 1.00 1500000 11016432 12599663 1234089 49000 30000 245000 49000 76000 5000 723524 5500000 400000 22874 3093604 93391 77000 2834692 5810692 274854 5286305 5810692 723524 2810000 16979 0.10 0.10 0.10 0.10 0.00 1.00 0.00 1.00 0.00 1.00 0.00 1.00 1480 1599 816 800 20834 20834 10415 10417 1226 59422 greater than fifty percent likelihood 923181023 138402792 1350 50000 923129673 750 138402042 0 9590 17979 5589 7069 2462940 9471445 2462940 9471445 0.1284 0.1276 0.1290 0.1288 250000 250000 -78125 -98959 2500230 2640450 10000 50000 50000 175000 445360 11640 31800 80000 93391 38900 45000 15874 225000 36750 53000 25000 26188 74990 0 150000 0 0 0 0 0 0 157500 0 55125 0 85000 0 37800 0 0 0 68000 0 66000 0 248400 0 0 0 0 50000 2086 161350 798750 155632 80000 77000 0 0 37998 352695 67 60000 60000 14831 53000 110000 110000 53000 162000 162000 30000 30000 0 83546 115500 30000 30000 103671 127500 127500 53000 53000 20921 129500 129500 2017 Notes matured on their one- year anniversary. The Note matures November 15, 2019. This Note matured January 7, 2020 This Note matures 12 months after the date of issuance. The Note matures 12 months after the date of issuance. The Note matures 12 months after the date of issuance. The Note matures May 19, 2020. The Note matures 12 months after the date of issuance. The Note matures 12 months after the date of issuance. This note matures October 24, 2020 This note bears interest at the rate of 12% per annum and matures 12 months after the date of issuance. This note matures 12 months after the date of issuance This note matures 12 months after the date of issuance. This note matures 12 months after the date of issuance. The Note matures 12 months after the date of issuance. The Note matures 12 months after the date of issuance. This note matures on May 23, 2020 This note matures 12 months after the date of issuance. This note bears interest at the rate of 12% per annum and matures 12 months after the date of issuance. This note matures 6 months after the Issuance Date. This note matures 12 months after the date of issuance This note matures 12 months after the date of issuance. This note matures 6 months after the Issuance Date. This note matures on May 7,2021 This note matures 6 months after the Issuance Date. This note matures 12 months after the date of issuance. This note matures 6 months after the Issuance Date. The note carries an interest rate of 18% and matures and is due in one lump sum on the 24- month anniversary (the “Maturity Date”) of the Execution Date. This note matures 6 months after the Issuance Date This note matures 6 months after the Issuance Date This note matures 6 months after the Issuance Date. 0.35 0.50 0.70 0.70 0.70 0.70 0.70 25500 7144 31800 806003 872945 620075 2416 16500 38502 15714 32021 49335 22587 26566 37998 147689 31106 48374 34635 50000 359500 280000 22105 77394 59909 157500 77844 55125 33479 33656 1800 19239 26416 18452 26717 69167 31067 50000 50000 13483 50000 100000 93958 44167 100000 108000 25000 25625 200000 100000 75000 77000 62563 25000 27500 67365 100000 106250 50000 2849 100000 34635 26970 26970 27500 27500 14000 26188 150730 112403 87390 16000 64650 2750 83263 26188 74990 1476436 259305 121250 36274 42261 1348 1539 5526 151512 17828 111128 526507 63500 388385 75000 19346 443420 83395 103250 2218 658093 52500 107122 881058 2624 4248 2331 39670 4630 39570 28664 3427 2058 13523 247 968 607950 154627 607950 154627 2086 468750 6665 2714 2980 2838 4080 2640 19796 16858 2219 2997 1624 44396 16922 5246 3000 42071 5250 8750 200000 10000 67365 13483 19003 12276 0.55 0.55 0.58 0.60 0.35 0.50 0.12 34500 15000 4000 2750 4100 3900 2750 5000 2300 2750 2000 3000 7500 2500 2500 3000 3000 192025 84849 64650 81521 187130 147584 16086 47979 16313 18434 77311 5644 4626 0 78563 0 79656 21646 51344 18561 37998 41584 47548 221683 202541 63583 48933 10000 16042 8833 54000 4375 8546 52398 2500 21250 2849 0 351000 49500 55000 175000 176000 $47,500 after payment of $2,000 of the Investor's legal fees. 104719899 28333 12500000 43500000 20138746 3967740 3666666 4325000 6375000 6375000 10000000 6375000 12750000 1.50 0.02 1.50 0.015 0.02 0.02 0.02 2 0.02 0.01 25000 1694227 1767505 227200 0.165 2 2 88178 75270 4326 13805 2222 8794 24821 -29147 86856 378061 2987 353985 2724848 2002314 5462195 5592706 2892228 250000 1440 984089 1131771 245000 44200 470886 456185 47500 18667 500 10877 304676 5417 2167 5462195 5478489 706843 4001 10910 171875 151041 5849316 1063745 370640 419355 470886 419692 1694227 1767505 425033 270030 2462940 9471445 5592706 75270 11016432 12423299 50 50 219 1549177 1 1 5090936 28452220 -10208905 -41436232 7600 7600 7216 6466 5849316 1063745 400000 100000 300000 176365 47500 0.001 49123 1521 87505 283000 30000 163000 291241 1048819 170006 453454 63604 10400 378746 1439623 200006 671054 -378746 -1390500 -200006 -669533 12011607 559566 11816065 696241 30906290 1430897 25355250 1247708 -31285036 -2821397 -25555256 -1917241 -31285036 -2821397 -25555256 -1917241 -29147 -86856 -750 -530 -9 -717 -31228077 -2821927 -25555265 -1917958 -0.14 -91.87 -0.06 -59.54 217814987 30711 432058100 32203 44200 44200 35467 1000 68000 35 67999 1 104719899 712475 104720 607755 -57709 22313 22433 86856 -42590 -3249 -7359 481140 137501 -51193 -28924 -440638 -537780 89326 -351312 -537780 -408389 100000 100000 102805 1054250 492145 -750 -530 293799 -46165 47737 3135 202500 66050 1680544 3207320 155440 330000 374500 350825 -2714204 2002314 -1234089 -2899420 -245000 -447153 -45359 -640699 -16979 86856 8389 11716455 4400 11640 31800 38900 3682522 -68372 2148349 -20762 3000 13750 3000 2000 27000 P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 10,000,000 shares of common stock at an exercise price of $02, subject to adjustments and expires on the five-year anniversary of the Issue Date. 200000 102000 100000 50000 20000 3000 Under the terms of the Amendment to Certificate of Designation of Series C Preferred Stock, 50,000 shares of the Company’s preferred remain designated as Series C Preferred Stock. The holders of Series C Preferred Stock have no dividend rights. For so long as any shares of the Series C Preferred Stock remain issued and outstanding, the Holder thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to sixty-seven (67%) percent of the total vote. Under the terms of the Certificate of Designation of Series D Preferred Stock, 20,000 shares of the Company’s preferred stock have been designated as Series D Convertible Preferred Stock. The holders of the Series D Convertible Preferred Stock shall not be entitled to receive dividends. The holders as a group may, at any time convert all of the shares of Series D Convertible Preferred Stock into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion, by 3. Except as provided in the Certificate of Designation or as otherwise required by law, no holder of the Series D Convertible Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Company for their vote, waiver, release or other action. The Series D Convertible Preferred Stock shall not bear any liquidation rights. 1000 400000 1000 47500 18667 500 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 1 - ORGANIZATION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Business</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ozop Surgical Corp. (the&#8221; Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) was originally incorporated as Newmarkt Corp. on July 17, 2015, under the laws of the State of Nevada. Following the acquisition of OZOP Surgical, Inc. (&#8220;Ozop&#8221;) as discussed below, we have been engaged in the business of inventing, designing, developing, manufacturing and distributing innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies, focused on spine, neurological and pain management procedures and specialties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Stock Purchase Agreement</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 28, 2020, the Company entered into a Binding Letter of Intent (the &#8220;LOI&#8221;) with Power Conversion Technologies, Inc., a Pennsylvania corporation (&#8220;PCTI&#8221;), and Catherine Chis (&#8220;Chis&#8221;), PCTI&#8217;s Chief Executive Officer (&#8220;CEO&#8221;) and its sole shareholder. <font style="background-color: white">On June 26, 2020, the Company, PCTI and Chis signed a Stock Purchase Agreement (the &#8220;SPA&#8221;) and o</font>n July 10, 2020, the Company closed the SPA with PCTI and Chis, the sole shareholder of PCTI. Under the terms of the SPA, the Company acquired one thousand (1,000) shares of PCTI, which represents all of the outstanding shares of PCTI, from Chis in exchange for a cash payment of $400,000 (of which $100,000 was paid May 26, 2020, and $300,000 was paid June 26,2020) and is presented as advance for acquisition on the accompanying balance sheet, and the issuance of 47,500 shares of the Company&#8217;s Series C Preferred Stock, 18,667 shares of the Company&#8217;s Series D Preferred Stock, and 500 shares of the Company&#8217;s Series E Preferred Stock to Chis. <font style="background-color: white">PCTI operates in the very high-power niche of the power electronics market, designing and manufacturing leading edge equipment for use in power conversion applications. PCTI serves clients in several industries including energy storage, shore power, DEWs, microgrid, telecommunications, military, transportation, renewable energy, aerospace and mission critical defense systems. PCTI&#8217;s clients include Fortune 500 companies, all branches of the US Department of Defense including the US Army and the US Air Force, NASA as well as other global military organizations</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Acquisition and Termination of Exclusive License Agreement</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 23, 2019, the Company entered into an Exclusive License Agreement (the &#8220;Agreement&#8221;) with Spinal Resources, Inc. (&#8220;SRI&#8221;). Pursuant to the Agreement, SRI granted to the Company an exclusive license, for products, as defined in the Agreement, and utilized in spine and related surgical procedures. In accordance with ASC 805, the Company has determined to account for the Agreement as a business combination. As consideration for the Agreement, the Company agreed to pay license fees equal to $1,500,000, over the eighteen- month term of the Agreement. The Company recorded the liability at its present value of $1,234,089. Additionally, the Company has agreed to issue 6,000 shares of restricted common stock on a quarterly basis, pursuant to the terms of the Agreement, of which 1,000 shares were issued on August 23, 2019. The Company valued the shares issued at $49,000 (based on the market price of the common stock) and included the $49,000 as part of the consideration of the transaction. The remaining 5,000 shares to be issued has been recorded as a $245,000 liability to be paid in common stock and was included in the total consideration issued in the transaction. The Company also issued a Promissory Note (the &#8220;Note&#8221;) to SRI for $723,524 for the purchase of the inventory of the Products (as defined in the Agreement). This note has a stated interest rate of six percent (6%) and payment terms of this note are in eighteen equal instalments, beginning on October 1, 2019. Either party may terminate the Agreement upon written notice if the other party has failed to remedy a material breach within 30 days (or 15 days in the case of a breach of a payment obligation). SRI also granted the Company an option to purchase the Company on or before the termination date of the license for a minimum of $5,500,000 which could have been increased based on the revenue rate at the time the option would be exercised. If the Company did not elect to exercise their option to purchase SRI, SRI can &#8220;put&#8221; the Acquisition to the Company. Any payments made for the license, this note and other liabilities assumed by the Company can be net against the option to buy price. The Company calculated the net minimum purchase price to be $3,093,604 and recorded the liability at its present value of $2,834,692. The difference of $258,912 was charged to interest expense over the option period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the preliminary value of the consideration issued and the preliminary purchase price allocation of the fair value of assets acquired and liabilities assumed in the transaction:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Purchase Price Allocation</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 77%"><font style="font: 10pt Times New Roman, Times, Serif">Fair value of consideration issued</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 20%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,286,305</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Liabilities assumed</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">524,387</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total purchase price</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,810,692</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Assets acquired</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">723,524</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Intellectual Property/Technology</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,810,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Goodwill</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,277,168</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,810,692</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The total purchase price of $5,810,692 has been allocated on a preliminary basis to the tangible and intangible assets acquired and liabilities assumed based on preliminary estimated fair values as of the completion of the transaction. These allocations reflect various preliminary estimates that are currently available and are subject to change upon the valuation being finalized within the measurement period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 16, 2020, the Company received from SRI notice that the Agreement dated August 23, 2019, between SRI and the Company has been revoked, as the Company did not make the required January 6, 2020, license payment nor cure the default. Based on the termination of the Agreement, the Company recorded an impairment charge to goodwill of $274,854 as of December 31, 2019. The impairment charge was calculated as the difference of the carrying values of the assets acquired compared to the consideration and liabilities assumed in the transaction.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recorded a gain of $86,856 for the six months ended June 30, 2020 based on the difference of the carrying values of the assets acquired and liabilities that were assumed in the transaction as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">Assets</font></td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 77%"><font style="font: 10pt Times New Roman, Times, Serif">Inventory</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 20%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">374,500</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Instruments, net</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">350,825</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Patent rights, net</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,714,204</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Goodwill</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,002,314</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total assets as of January 16, 2020</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,441,843</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">Consideration issued and liabilities assumed</font></td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 77%"><font style="font: 10pt Times New Roman, Times, Serif">Common Stock payable</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 20%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">245,000</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">License fee payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,234,089</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Equity Line payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45,359</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Iberia Note</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">447,153</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Inventory and Instrument note</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">640,699</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Accrued interest</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">16,979</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Option to buy</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,899,420</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total consideration and liabilities assumed balances</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,528,699</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Gain on termination of license</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">86,856</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">See Note 12 for further discussion on discontinued operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Corporate Matters</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">OZOP was originally incorporated in Switzerland on November 28, 1998 under the name Perma Consultants Holding AG (&#8220;Perma&#8221;). On July 19, 2016, Mr. Eric Siu (&#8220;Siu&#8221;), a former director purchased 100% of the outstanding capital stock of Perma and changed the name from Perma to Ozop Surgical AG (&#8220;Ozop AG&#8221;). On February 1, 2018, Ozop AG was re-domiciled as a Delaware corporation and changed its name to Ozop Surgical, Inc. On July 28, 2016, Ozop formed as the sole member, Ozop Surgical, LLC (&#8220;Ozop LLC&#8221;), a Wyoming limited liability company. On October 28, 2016, Ozop acquired 100% of Ozop Surgical Limited (&#8220;Ozop HK&#8221;), from Siu, the sole shareholder of Ozop HK. Ozop HK, is a private limited company incorporated in Hong Kong.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>NOTE 2 &#8211; GOING CONCERN AND MANAGEMENT&#8217;S PLANS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. </font>On January 16, 2020, the Company received from SRI notice that the Agreement dated August 23, 2019, between SRI and the Company has been revoked, as the Company did not cure a payment default within the cure period. <font style="background-color: white">As of June 30, 2020, the Company had a stockholders&#8217; deficit of $11,535,918 and a working capital deficit of $11,716,456. In addition, the Company has generated losses since inception. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2019, a novel strain of <u>coronavirus</u> (COVID-19) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to most other countries and infections have been reported globally. Because COVID-19 infections have been reported throughout the United States, certain federal, state and local governmental authorities have issued stay-at-home orders, proclamations and/or directives aimed at minimizing the spread of COVID-19. The ultimate impact of the <u>COVID-19 pandemic</u> on the Company&#8217;s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the <u>COVID-19 outbreak</u>, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but it may have a material adverse impact on our business, financial condition and results of operations. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company&#8217;s business and the duration for which it may have an impact cannot be determined at this time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Management&#8217;s Plans</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As a public company, management believes it will be able <font style="background-color: white">to access the public equities market for fund raising for product development and regulatory approvals, sales and marketing and as we expand our distribution in the US market, we will need to meet increasing inventory requirements.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 10, 2020, the Company entered into the SPA with PCTI, and Chis, PCTI&#8217;s CEO and its sole shareholder (see Note 1).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 3 &#8211; SUMMARY OF SIGNIFICANT ACCOUNTING PRONOUNCEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Basis of Presentation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company&#8217;s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June 30, 2020, and the results of operations and cash flows for the periods presented. The results of operations for the three and six months ended June 30, 2020, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the </font>Company&#8217;s Current Report on Form 10-K filed on May 14, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The unaudited condensed consolidated financial statements include the accounts of the Company <font style="background-color: white">and Ozop and its wholly owned subsidiaries Ozop LLC, Ozop HK and Spinus, LLC (&#8220;Spinus&#8221;). All intercompany accounts and transactions have been eliminated in consolidation.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Emerging Growth Companies</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company qualifies as an &#8220;emerging growth company&#8221; under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging growth company, the Company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company has elected to take advantage of the benefits of this extended transition period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Use of Estimates</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Cash and Cash Equivalents</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Sales Concentration and credit risk</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Following is a summary of customers who accounted for more than ten percent (10%) of the Company&#8217;s revenues for the three and six months ended June 30, 2020, and 2019, and their accounts receivable balance as of June 30, 2020:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Sales % Three Months Ended June 30, 2020</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Sales % Three Months Ended June 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Sales % Six Months Ended June 30, 2020</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Sales % Six <br /> Months Ended <br /> June 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts receivable balance June 30, 2020</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 28%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Customer A</font></td> <td style="width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">N/A</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">N/A</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; width: 9%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%">&#160;</td></tr> <tr> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Accounts Receivable</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Inventory</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory, if any, which consists of finished goods, is valued at the lower of cost or net realizable value. Cost is determined using the first in first out (FIFO) method. Provision for potentially obsolete or slow-moving inventory is made based on management analysis or inventory levels and future sales forecasts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Purchase concentration</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The principal purchases by the Company is comprised of finished goods that the Company sells to its customers. Following is a summary of suppliers who accounted for more than ten percent (10%) of the Company&#8217;s purchases for the three and six months ended June 30, 2020, and 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Purchase % Three Months Ended June 30, 2020</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Purchase % Three Months Ended June 30, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Purchase % Six Months Ended June 30, 2020</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Purchase % Six <br /> Months Ended <br /> June 30, 2019</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Supplier A</font></td> <td style="width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">N/A</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">N/A</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Property, plant and equipment</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%"><font style="font: 10pt Times New Roman, Times, Serif">Office equipment</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 20%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17,979</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 20%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9.590</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less: Accumulated Depreciation</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(7,069</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5,589</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Property and Equipment, Net</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10,910</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,001</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation expense was $816 and $1,480 for the three and six months ended June 30, 2020, respectively, and $800 and $1,599 for the three and six months ended June 30, 2019, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Intangible Assets</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">Intangible assets primarily represent purchased patent and license rights. The Company amortizes these costs over the shorter of the legal life of the patent or its estimated economic life using the straight-line method. The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to future undiscounted cash flows to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. For the year ended December 31, 2019, the Company impaired $44,200 of tradenames as management has decided not to go forward with the use of the trade name Spinus. </font>For the three and six months ended June 30, 2020, the Company recorded amortization expense of $10,415 and $20,833, respectively and the three and six months ended June 30, 2019, $10,417 and $20,834, respectively. In accordance with ASC 350, <i>&#8220;Intangibles&#8212;Goodwill and Other,&#8221; </i>goodwill and other intangible assets with indefinite lives are no longer subject to amortization but are tested for impairment annually or whenever events or changes in circumstances indicate that the asset might be impaired.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Goodwill</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Goodwill is measured as the excess of consideration transferred and the net of the acquisition date fair value of assets acquired, and liabilities assumed in a business acquisition. During the year ended December 31, 2019, the Company recorded goodwill of $2,277,168, included in assets of discontinued operations in the accompanying balance sheet at December 31, 2019, related to the SRI transaction. The Company reviews the goodwill allocated to each of our reporting units for possible impairment annually and whenever events or changes in circumstances indicate carrying amount may not be recoverable. When assessing goodwill for impairment, the Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its&#8217; carrying amount. If, after assessing the totality of events or circumstances, the Company determines it is more likely than not that the fair value of a reporting unit is less than its&#8217; carrying amount, then the Company performs a two-step impairment test. If the Company concludes otherwise, then no further action is taken. The Company also has the option to bypass the qualitative assessment and only perform a quantitative assessment, which is the first step of the two-step impairment test. In the two-step impairment test, the Company measures the recoverability of goodwill by comparing a reporting unit&#8217;s carrying amount, including goodwill, to the estimated fair value of the reporting unit. During the year ended December 31, 2019. <font style="background-color: white">the Company recorded an impairment of goodwill of $274,854, for the termination of the SRI License Agreement due to no known future cash flows being provided by the assets, and as of January 16, 2020, the Company wrote off the remaining Goodwill balance associated with SRI transaction of $2,002,314.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In assessing the qualitative factors, the Company assesses relevant events and circumstances that may impact the fair value and the carrying amount of the reporting unit. The identification of relevant events and circumstances, and how these may impact a reporting unit&#8217;s fair value or carrying amount involve significant judgments and assumptions. The judgment and assumptions include the identification of macroeconomic conditions, industry, and market considerations, cost factors, overall financial performance and share price trends, and making the assessment as to whether each relevant factor will impact the impairment test positively or negatively and the magnitude of any such impact.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The carrying amount of each reporting unit is determined based upon the assignment of our assets and liabilities, including existing goodwill and other intangible assets, to the identified reporting units. Where an acquisition benefits only one reporting unit, the Company allocates, as of the acquisition date, all goodwill for that acquisition to the reporting unit that will benefit. Where the Company has had an acquisition that benefited more than one reporting unit, The Company has assigned the goodwill to our reporting units as of the acquisition date such that the goodwill assigned to a reporting unit is the excess of the fair value of the acquired business, or portion thereof, to be included in that reporting unit over the fair value of the individual assets acquired and liabilities assumed that are assigned to the reporting unit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">If the carrying amount of a reporting unit is in excess of its fair value, an impairment may exist, and the Company must perform the second step of the impairment analysis to measure the amount of the impairment loss, by allocating the reporting unit&#8217;s fair value to its assets and liabilities other than goodwill, comparing the carrying amount of the goodwill to the resulting implied fair value of the goodwill, and recording an impairment charge for any excess.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Discontinued Operations</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC 205-20 <i>Presentation of Financial Statements: Discontinued Operations</i>, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity&#8217;s operations and financial results when the components of an entity meets the criteria in paragraph 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations. .</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 16, 2020, the Company pursuant to the termination of the SRI transaction Agreement (see Note 1) which meets the definition of a discontinued operation. For additional information, see Note 12- Discontinued Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Revenue Recognition</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="background-color: white">Effective January 1, 2018, the Company adopted ASC 606 &#8212; Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. Under ASC 606, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The Company has no outstanding contracts with any of its&#8217; customers. Revenues from Spinus were $1,521 and $47,602 for the three and six months ended June 30, 2019, and are recognized as an agent and are recorded at net. There was no impact on the Company&#8217;s financial statements as a result of adopting Topic 606 for the three and six months ended June 30, 2020, and 2019.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Advertising and Marketing Expenses</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expenses advertising and marketing costs as incurred. For the six months ended June 30, 2020, and 2019, the Company recorded $1,226 and $59,422, respectively, of advertising and marketing expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Research and Development</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Costs and expenses that can be clearly identified as research and development are charged to expense as incurred. For the six months ended June 30, 2020, and 2019, the Company recorded $-0- and $63,604 of research and development expenses, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Convertible Instruments</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of this note transaction and the effective conversion price embedded in this note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Fair Value of Financial Instruments</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following are the hierarchical levels of inputs to measure fair value:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 48px"><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.</font></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.</font></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#9679;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 3 - Unobservable inputs reflecting the Company&#8217;s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying amounts of the Company&#8217;s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table represents the Company&#8217;s derivative instruments that are measured at fair value on a recurring basis as of June 30, 2020, and December 31, 2019, for each fair value hierarchy level:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2020</font></td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Derivative <br /> Liabilities</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Level I</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Level II</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%"><font style="font: 10pt Times New Roman, Times, Serif">Level III</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,471,445</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,471,445</font></td> <td style="width: 1%">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2019</font></td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Derivative <br /> Liabilities</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Level I</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Level II</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%"><font style="font: 10pt Times New Roman, Times, Serif">Level III</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,462,940</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,462,940</font></td> <td style="width: 1%">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Income Taxes</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the deferred tax assets will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tax benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Foreign Currency Translation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">The accounts of the Company&#8217;s Hong Kong subsidiary are maintained in Hong Kong dollars and the accounts of the U.S. companies are maintained in USD. The accounts of the Hong Kong subsidiary were translated into USD in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 830, Foreign Currency Matters. According to Topic 830, all assets and liabilities were translated at the exchange rate on the balance sheet date; stockholders&#8217; equity is translated at historical rates and statement of comprehensive income items are translated at the weighted average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with ASC Topic 220, Comprehensive Income. Gains and losses resulting from the foreign currency transactions are reflected in the statements of comprehensive income.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Relevant exchange rates used in the preparation of the consolidated financial statements are as follows for the periods ended June 30, 2020 and December 31, 2019, (Hong Kong dollar per one U.S. dollar):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%"><font style="font: 10pt Times New Roman, Times, Serif">Balance sheet date</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 20%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">.1290</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 20%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">.1284</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Average rate for statements of operations and comprehensive loss</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">.1288</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">.1276</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Earnings (Loss) Per Share</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company reports earnings (loss) per share in accordance with ASC 260, &#8220;Earnings per Share.&#8221; Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net loss by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. As of June 30, 2020, and 2019, the Company&#8217;s dilutive securities are convertible into approximately 923,181,023 and 138,402,792 shares of common stock, respectively. This amount is not included in the computation of dilutive loss per share because their impact is antidilutive. The following table represents the classes of dilutive securities as of June 30, 2020, and 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2020</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2019</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font: 10pt Times New Roman, Times, Serif">Common stock to be issued</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,350</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">750</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Convertible preferred stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Convertible notes payable</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">923,129,673</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">138,402,042</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">923,181,023</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">138,402,792</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Recent Accounting Pronouncements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There have no recent accounting pronouncements or changes in accounting pronouncements during the period ended June 30, 2020, that are of significance or potential significance to the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 4 &#8211; INTANGIBLE ASSETS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Patents as of June 30, 2020, and December 31, 2019, consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">June 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 56%"><font style="font-size: 10pt">Patents and license rights</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 19%; text-align: right"><font style="font-size: 10pt">250,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 19%; text-align: right"><font style="font-size: 10pt">250,000</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Accumulated amortization</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(98,959</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(78,125</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Net carrying amount</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">151,041</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">171,875</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization expense for the six months ended June 30, 2020, and 2019, was $20,834 respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 5 - CONVERTIBLE NOTES PAYABLE</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2017, OZOP issued 19 convertible promissory notes (the &#8220;2017 Notes&#8221;), in amounts of $10,000 to $50,000. OZOP received proceeds of $710,000 in the aggregate. The 2017 Notes matured on their one- year anniversary and bear interest at ten percent (10%). The initial conversion feature allowed the holders to convert this note and any unpaid interest due, into shares of the Company&#8217;s common stock on the 15<sup>th</sup> business day that the Company becomes listed, at conversion prices equal to discounts of 35%-50% of the average of the three lowest closing prices of the common stock. In August 2018, the Company offered any noteholder to convert their principal and interest into shares of common stock at $0.50 per share. OZOP also issued $25,500 of convertible notes for consulting fees. During the year ended December 31, 2018, the Company issued a $50,000 convertible promissory note (the &#8220;March 2018 Note&#8221;) and received proceeds of $50,000. <font style="background-color: white">The Company determined that the conversion feature of the 2017 Notes and the March 2018 Note (together, the &#8220;Notes&#8221;) did not meet the criteria of an embedded derivative and therefore the conversion feature was not bi-furcated and accounted for as a derivative because the Company was a private company, there was no quoted price and no active market for the Company&#8217;s common stock.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 13, 2018, the Company determined the conversion feature of the Notes represented an embedded derivative since the Notes were convertible into a variable number of shares upon conversion. Accordingly, on April 13, 2018, the Notes were not considered to be conventional debt under ASC 815 and the embedded conversion feature was bifurcated from the debt host and accounted for as a derivative liability. Accordingly, the fair value of the derivative instruments of the Notes that occurred prior to April 13, 2018, were recorded as a liability on April 13, 2018, with the corresponding amount recorded as a discount to the notes. Such discount was amortized from the date of issuance to the maturity dates of the Notes. The change in the fair value of the liability for derivative contracts are recorded in other income or expenses in the reporting period, with the offset to the derivative liability on the balance sheet. The embedded feature included in the Notes resulted in the recognition of a derivative liability. On August 29, 2019, pursuant to a Debt Purchase Agreement, one investor sold the principal balance of $15,000, accrued and unpaid interest of $2,624 and a repayment balance of $5,250 to third party investor, for a total purchase price of $22,874 (see below). Also, on August 29, 2019, pursuant to a Debt Purchase Agreement, a second investor sold the principal balance of $25,000, accrued and unpaid interest of $4,248 and a repayment balance of $8,750 to third party investor, for a total purchase price of $37,998 (see below). On February 18, 2020, an investor purchased two $50,000 convertible notes from investors (see below). On June 23, 2020, pursuant to a Debt Purchase Agreement, one investor sold the principal balance of $50,000 and a repayment balance of $10,000 to third party investor, for a total purchase price of $60,000 (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of the 2017 Notes was $25,000 and $175,000, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 13, 2018, we issued a convertible promissory note in the principal amount of $442,175, pursuant to a Securities Purchase Agreement we entered into with an investor dated April 1, 2018. This note bears interest at the rate of 12% per annum and was due and payable on April 13, 2019. This note is convertible at any time following the funding of this note into a variable number of the Company&#8217;s common stock, based on a conversion ratio of 55% of the average of the lowest trading price for the 25 days prior to conversion. This note was funded on April 13, 2018, when the Company received proceeds of $350,000, after OID of $57,675, and disbursements for the lender&#8217;s transaction costs, fees and expenses of $34,500, of which $25,000 were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. During the year ended December 31, 2019, the investor sold $30,000 of this note to another investor. This note was in default and during the year ended December 31, 2019, the Company recorded additional interest expense of $26,188 and added that amount to the principal amount outstanding. For the six months ended June 30, 2020, the investor converted a total of $52,375 of the face value and $39,670 of accrued interest into 35,813,035 shares of common stock, at an average conversion price of $0.00257. During the six months ended June 30, 2020, the Company wrote off the remaining principal balance of $26,188 and recognized a gain on debt extinguishment of $26,188. As of June 30, 2020, and December 31, 2019, the outstanding principal balance and carrying value of this note was $-0- and $78,563, respectively.&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 29, 2018, we issued a convertible promissory note in the principal amount of $339,250, pursuant to a Securities Purchase Agreement we entered into with the investor. This note bears interest at the rate of 12% per annum and is due and payable on August 29, 2019. This note is convertible at any time following the funding of this note into a variable number of the Company&#8217;s common stock, based on a conversion ratio of 55% of the average of the lowest trading price for the 25 days prior to conversion. This note was funded on August 29, 2018, when the Company received proceeds of $280,000, after OID of $44,250, and disbursements for the lender&#8217;s transaction costs, fees and expenses of $15,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. Periodic payments are due by us on this note at the rate of $1,000 per day (the &#8220;Repayment Amount&#8221;) via direct withdrawal from our bank account, beginning on August 30, 2018, until this note is satisfied in full. From time to time the investor waives any Repayment Amount for a period of time as agreed upon. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. This note was in default and during the year ended December 31, 2019, the Company recorded additional interest expense of $87,390 and added that amount to the principal amount outstanding. For the six months ended June 30, 2020, the investor converted a total of $112,141 of the face value and $4,630 of accrued interest into 23,237,756 shares of common stock at an average conversion price of $0.0053. During the six months ended June 30, 2020, the Company wrote off the remining principal balance of $74,990 and recognized $74,990 as a gain on debt extinguishment. As of June 30, 2020, and December 31, 2019, the outstanding principal balance and carrying value of this note was $-0- and $187,130, respectively.&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 15, 2018, the Company issued a 12% convertible promissory note, in the principal amount of $500,000, pursuant to a Securities Purchase Agreement we entered into with the investor. This note matures November 15, 2019. This note is convertible into shares of the Company&#8217;s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of this note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company&#8217;s common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. Pursuant to this note, the Company agreed to include on its next registration statement filed with the Securities and Exchange Commission, all shares issuable upon conversion of this note. Pursuant to the Security Agreement, all of the obligations under this note are secured by a first security interest in and to all of the Company&#8217;s rights, title and interests in, to and under all assets and all personal property of the Company. The Security Agreement includes customary representations, warranties and covenants by the Company. This note was funded on November 19, 2018, when the Company received proceeds of $458,500 after OID of $37,500, and disbursements for the lender&#8217;s transaction costs, fees and expenses of $4,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, the investor converted a total of $445,360 of the face value and $39,570 of accrued interest and fees into 150,631,924 shares of common stock at an average conversion price of $0.0032. As of June 30, 2020, and December 31, 2019, the outstanding principal balance and carrying value of this note was $-0- and $445,360, respectively. In connection with the issuance of this note, during the six months ended June 30, 2020, the Company issued 43,500,000 shares upon the cashless exercise of warrants issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 7, 2019, the Company issued an 8% convertible promissory note, in the principal amount of $150,000, pursuant to a Securities Purchase Agreement we entered into with the investor. This note matured January 7, 2020. This note is convertible into shares of the Company&#8217;s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of this note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company&#8217;s common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. This note was funded on January 9, 2019, when the Company received proceeds of $133,250 after OID of $14,000, and disbursements for the lender&#8217;s transaction costs, fees and expenses of $2,750, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $2,416 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $150,000 of the face value and $28,664 of accrued interest and fees into 96,727,034 shares of common stock at an average conversion price of $0.00185. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $150,000 with a carrying value of $147,584, as of December 31, 2019, net of unamortized discounts of $2,416.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 5, 2019, the Company issued an 8% convertible promissory note (the &#8220;Master Note&#8221;) in the aggregate principal amount of up to $165,000 in exchange for an aggregate purchase price of up to $148,500 with an original issue discount of $16,500 to cover the Investor&#8217;s accounting fees, due diligence fees, monitoring and other transactional costs incurred in connection with the purchase and sale of the Master Note, which is included in the principal balance of this note. On February 8, 2019, the Investor funded the first tranche under the Master Note, with a maturity date of February 8, 2020, and the Company received $49,500 ($47,500 after payment of $2,000 of the Investor&#8217;s legal fees) for this first tranche of $55,000 under the Master Note and on the same date, the Company issued this note to the Investor. This note is convertible into shares of the Company&#8217;s common stock, beginning on the date which is 180 days from the issuance date of the Master Note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of conversion of the Master Note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company&#8217;s common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of the Master Note. The embedded conversion feature included in the Master Note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $12,102 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $22,105 of the face value and $4,400 of fees into 6,017,711 shares of common stock at an average conversion price of $0.0044. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of the Master Note was $-0- and $11,640, respectively, with a carrying value as of December 31, 2019, of $7,144, net of unamortized discounts of $4,496. In connection with the issuance of this Note, during the six months ended June 30, 2020, the Company issued 20,138,746 shares upon the cashless exercise of warrants issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 7, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $85,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company&#8217;s common stock, at a conversion price equal to 58% of the average of the two lowest trading prices of the Company&#8217;s common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company. This note was funded on March 11, 2019, when the Company received proceeds of $77,900 after OID of $3,000, and disbursements for the lender&#8217;s transaction costs, fees and expenses of $4,100, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $15,714 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $31,800 of the face value and $3,427 of accrued interest into 446,416 shares of common stock at an average conversion price of $0.07891. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $31,800, respectively, with a carrying value as of December 31, 2019, of $16,086, net of unamortized discounts of $15,714.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 29, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $80,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company&#8217;s common stock, at a conversion price equal to 58% of the average of the two lowest trading prices of the Company&#8217;s common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company. This note was funded on March 29, 2019, when the Company received proceeds of $73,300 after OID of $2,800, and disbursements for the lender&#8217;s transaction costs, fees and expenses of $3,900, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $32,021 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $19,300 of the face value and $2,058 of accrued interest into 3,784,352 shares of common stock at an average conversion price of $0.00564. On May 28, 2020, pursuant to a Debt Purchase Agreement, the investor sold the principal balance of $60,700 and accrued and unpaid interest of $6,665 to third party investor, for a total purchase price of 67,365 (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $80,000, respectively, with a carrying value on December 31, 2019, of $47,979, net of unamortized discounts of $32,021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 5, 2019, an investor (the &#8220;Purchaser&#8221;) pursuant to an Assignment Agreement, purchased a convertible note issued by the Company on December 5, 2018, with a maturity date of December 5, 2019. The Purchaser paid $93,391 to acquire this note. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company&#8217;s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 65% multiplied by the average of the lowest two trading prices during the 15- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. The embedded conversion feature pursuant to the Assignment Agreement resulted in the recognition of a derivative liability. On April 17, 2020, the Purchaser sold the note to another third- party investor (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of assigned note was $-0- and $93,391, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 7, 2019, an investor (the &#8220;Purchaser&#8221;) pursuant to an Assignment Agreement, purchased a convertible note issued by the Company on October 19, 2018, with a maturity date of October 19, 2019. The Purchaser paid $77,000 to acquire this note. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company&#8217;s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 65% multiplied by the average of the lowest two trading prices during the 15- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. The embedded conversion feature pursuant to the Assignment Agreement resulted in the recognition of a derivative liability. On April 24, 2020, the Purchaser sold the note to another third- party investor (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of assigned note was $-0- and $77,000, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 22, 2019, the Company issued a 10% convertible promissory note, in the principal amount of $38,900, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company&#8217;s common stock, at a conversion price equal to 60% of the lowest closing bid price of the Company&#8217;s common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company. This note was funded on July 24, 2019, when the Company received proceeds of $30,000 after OID of $3,900, and disbursements for the lender&#8217;s transaction costs, fees and expenses of $5,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $22,587 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $38,900 of the face value and $2,714 of accrued interest into 6,379,036 shares of common stock at an average conversion price of $0.00652. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $38,900, respectively, with a carrying value as of December 31, 2019, of $16,313, net of unamortized discounts of $22,587.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 2, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $157,500, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company&#8217;s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 60% multiplied by the average of the lowest two trading prices during the 20 trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note was funded on August 2, 2019, when the Company received proceeds of $150,000 after disbursements for the lender&#8217;s transaction costs, fees and expenses of $7,500, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $77,844 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $157,500 of the face value and $13,523 of accrued interest into 23,114,263 shares of common stock at an average conversion price of $0.0074. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $157,500, respectively, with a carrying value as of December 31, 2019, of $79,656, net of unamortized discounts of $77,844.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 21, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $55,125, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company&#8217;s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 58% multiplied by the average of the lowest two trading prices during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note was funded on August 21, 2019, when the Company received proceeds of $50,000 after OID of $2,625, and disbursements for the lender&#8217;s transaction costs, fees and expenses of $2,500, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability . For the six months ended June 30, 2020, amortization of the debt discounts of $33,479 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $3,825 of the face value and $247 of accrued interest into 77,144 shares of common stock at an average conversion price of $0.05278, and on March 9, 2020, sold the remining portion of this note to a third part investor (see below) for $76,000. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $55,125, respectively, with a carrying value of $21,646, as of December 31, 2019, net of unamortized discounts of $33,479. On March 9, 2020, the Company also issued a warrant for $25,000 to the investor in consideration of the sale of this note. The exercise price of the warrant is equal to a 42% discount of the average of the two lowest trading prices of the Company&#8217;s common stock for the twenty days preceding the exercise and the warrant expires September 9, 2020. For the six months ended June 30, 2020, the Company issued 3,967,740 shares of common stock upon the cashless exercises of the warrant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 19, 2019, the Company issued an 8% convertible promissory note, in the principal amount of $85,000, pursuant to a Securities Purchase Agreement we entered into with the investor. This note matures May 19, 2020. This note is convertible into shares of the Company&#8217;s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of this note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company&#8217;s common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. This note was funded on August 22, 2019, when the Company received proceeds of $75,000 after OID of $7,250, and disbursements for the lender&#8217;s transaction costs, fees and expenses of $2,750, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $33,656 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $85,000 of the face value and $7,121 of accrued interest into 39,658,500 shares of common stock at an average conversion price of $0.00232. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $85,000, respectively, with a carrying value as of December 31, 2019, of $51,344, net of unamortized discounts of $33,656. The Company also issued a five- year warrant to purchase 28,333 shares of common stock at an exercise price of $1.50, subject to adjustments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 23, 2019, the Company issued to a third-party investor a convertible redeemable promissory note with a face value of $37,800, including an original issue discount of $1,800. This note matures on May 23, 2020, has a stated interest of 10% and is convertible into a variable number of the Company&#8217;s common stock, based on a conversion ratio of 58% of the average of the two lowest trading prices for the 20 days prior to conversion. This note was funded on August 26, 2019, when the Company received proceeds of $33,500, after disbursements for the lender&#8217;s transaction costs, fees and expenses of $2,500, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $19,239 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $24,317 of the face value and $2,980 of accrued interest into 4,336,000 shares of common stock at an average conversion price of $0.0063, and on April 28, 2020, sold the remining portion of $13,483 of this note to a third- party investor (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $0-0 and $37,800, respectively, with a carrying value as of December 31, 2019, of $18,561, net of unamortized discounts of $19,239.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 29, 2019, the Company issued a 10% convertible promissory note, in the principal amount of $45,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company&#8217;s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 60% multiplied by the average of the lowest two trading prices during the 20 trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note was funded on September 4, 2019, when the Company received proceeds of $40,000 after disbursements for the lender&#8217;s transaction costs, fees and expenses of $5,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $26,567 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $45,000 of the face value and $2,838 of accrued interest into 7,933,325 shares of common stock at an average conversion price of $0.00603. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $45,000, respectively, with a carrying value as of December 31, 2019, of $18,434, net of unamortized discounts of $26,566.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 29, 2019, an investor (the &#8220;Purchaser&#8221;) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note issued by the Company on September 1, 2017 (see above). The Purchaser paid $22,874 to acquire this note. This note, as amended, is convertible into common stock at a conversion price equal to a 35% discount to the average of the 3 lowest closing prices of the common stock for fifteen prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, the investor converted a total of $15,874 of the face value and $968 of accrued interest into 217,331 shares of common stock at an average conversion price of $0.0775. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of assigned note was $-0- and $15,874, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 29, 2019, an investor (the &#8220;Purchaser&#8221;) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note issued by the Company on October 2, 2017 (see above). The Purchaser paid $37,998 to acquire this note. This note, as amended, is convertible into common stock at a conversion price equal to a 35% discount to the average of the 3 lowest closing prices of the common stock for fifteen prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, the investor converted a total of $37,998 of the face value and $2,331 of accrued interest into 3,781,509 shares of common stock at an average conversion price of $0.01066. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of assigned note was $-0- and $37,998, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 1, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $68,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company&#8217;s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 61% multiplied by the lowest closing bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note was funded on October 2, 2019, when the Company received proceeds of $65,000 after disbursements for the lender&#8217;s transaction costs, fees and expenses of $3,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $41,584 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $68,000 of the face value and $4,080 of accrued interest into 9.186,036 shares of common stock at an average conversion price of $0.00785. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $68,000, respectively, with a carrying value as of December 31, 2019, of $26,416, net of unamortized discounts of $41,584.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 8, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $66,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company&#8217;s common stock, at a conversion price equal to 60% of the average of the two lowest trading prices of the Company&#8217;s common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company. This note was funded on October 10, 2019, when the Company received proceeds of $57,000 after OID of $6,000, and disbursements for the lender&#8217;s transaction costs, fees and expenses of $2,300, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $83,398 was charged to interest expense. For the six months ended June 30, 2020, the investor added $37,750 od defaults to the principal balance of the note. For the six months ended June 30, 2020, the investor converted a total of $103,750 of principal and $2,640 of accrued interest into 24,394,666 shares of common stock at an average conversion price of $0.00436. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $66,000, respectively, with a carrying value as of December 31, 2019, of $18,452, net of unamortized discounts of $47,548.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 24, 2019, the Company issued a convertible promissory note in the principal amount of $248,400, pursuant to a Securities Purchase Agreement we entered into with the investor. This note bears interest at the rate of 12% per annum and matures 12 months after the date of issuance. This note is convertible at any time following the funding of this note into a variable number of the Company&#8217;s common stock, based on a conversion ratio of 60% of the lowest trading price for the 25 days prior to conversion. This note was funded on October 28, 2019, when the Company received proceeds of $200,000, after OID of $32,400, and disbursements for the lender&#8217;s transaction costs, fees and expenses of $16,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months June 30, 2020, amortization of the debt discounts of $221,683 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $48,400 of principal and $16,796 of accrued interest into 26,288,995 shares of common stock at an average conversion price of $0.00248, and on May 7, 2020, sold the remining portion of $200,000 of this note to a third- party investor (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $248,400, respectively, with a carrying value as of December 31, 2019, of $26,717, net of unamortized discounts of $221,683.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 24, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $225,000, pursuant to a Securities Purchase Agreement we entered into with the investor. This note matures October 24, 2020. This note is convertible into shares of the Company&#8217;s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) $0.05 and (2) 58% multiplied by the average of the 2 lowest trading prices of the Company&#8217;s common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. This note was funded on October 31, 2019, when the Company received proceeds of $202,250 after OID of $20,000, and disbursements for the lender&#8217;s transaction costs, fees and expenses of $2,750, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $147,689 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $225,000 of principal and $16,858 of accrued interest into 125,613,294 shares of common stock at an average conversion price of $0.00193. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $225,000, respectively, with a carrying value as of December 31, 2019, of $77,311, net of unamortized discounts of $147,689.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 25, 2019, the Company issued a convertible promissory note in the principal amount of $36,750, pursuant to a Securities Purchase Agreement we entered into with the investor. This note bears interest at the rate of 12% per annum and matures 12 months after the date of issuance. This note is convertible at any time following the funding of this note into a variable number of the Company&#8217;s common stock, based on a conversion ratio of 58% of the average of the two lowest closing bid prices for the 20 days prior to conversion. This note was funded on October 25, 2019, when the Company received proceeds of $33,000, after OID of $1,750, and disbursements for the lender&#8217;s transaction costs, fees and expenses of $2,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months June 30, 2020, amortization of the debt discounts of $31,106 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $36,750 of principal and $2,219 of accrued interest into 7,881,267 shares of common stock at an average conversion price of $0.00494. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $36,750, respectively, with a carrying value as of December 31, 2019, of $5,644, net of unamortized discounts of $31,106.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 27, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $53,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company&#8217;s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 56% multiplied by the lowest closing bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note was funded on December 2, 2019, when the Company received proceeds of $50,000 after disbursements for the lender&#8217;s transaction costs, fees and expenses of $3,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the three months ended March 31, 2020, amortization of the debt discounts of $48,2742 was charged to interest expense. On May 15, 2020, pursuant to a Debt Purchase Agreement, the investor sold the principal balance of $53,000, accrued and unpaid interest of $2,997 and a prepayment of $19,003, which was recognized as interest expense, to a third- party investor, for a total purchase price of $75,000 (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $53,000, respectively, with a carrying value as of December 31, 2019, of $4,626, net of unamortized discounts of $48,374.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 8, 2020, the Company entered into a securities purchase agreement (the &#8220;SPA&#8221;) with an investor (the &#8220;Investor&#8221;), pursuant to which the Company agreed to issue to the Investor a 12% Convertible Promissory Note, in the principal amount of $38,000 in exchange for a purchase price of $35,000. This note was funded by the Investor on January 13, 2020, and on such date pursuant to the SPA, the Company reimbursed the Investor for expenses for legal fees and due diligence of $3,000. This note proceeds will be used by the Company for general working capital purposes. The SPA includes customary representations, warranties and covenants by the Company and customary closing conditions. The embedded conversion feature included in this note resulted in an initial debt discount and derivative liability of $29,063. For the six months ended June 30, 2020, amortization of the debt discounts of $32,063 was charged to interest expense. On May 15, 2020, pursuant to a Debt Purchase Agreement, the investor sold the principal balance of $38,000, accrued and unpaid interest of $1,624 and a prepayment of $12,276, which was recognized as interest expense, to a third- party investor, for a total purchase price of $52,000 (see below). As of June 30, 2020, the outstanding principal balance of this note was $-0-.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 18, 2020, an investor (the &#8220;Purchaser&#8221;) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note issued by the Company on August 18, 2017 (see above). The Purchaser agreed to pay $50,000 to acquire this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for the thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended March 31, 2020, the Company recorded additional interest expense of $154,627 due to various defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in interest expense of $607,950 (since the purchased note was past its&#8217; maturity date and was in default) with the offset recorded to derivative liabilities. For the six months ended June 30, 2020, the investor converted a total of $202,541 of principal and $64,650 accrued interest and fees into 90,191,785 shares of common stock at an average conversion price of $0.00257. As of June 30, 2020, the outstanding principal balance of assigned note was $2,086.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Also, on February 18, 2020, an investor (the &#8220;Purchaser&#8221;) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note issued by the Company on August 18, 2017 (see above). The Purchaser agreed to pay $50,000 to acquire this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for the thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended June 30, 2020, the Company recorded additional interest expense of $192,025 due to various defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in interest expense of $607,950 (since the purchased note was past its&#8217; maturity date and was in default) with the offset recorded to derivative liabilities. For the six months ended June 30, 2020, the investor converted a total of $242,025 of principal and $84,849 accrued interest and fees into 241,489,074 shares of common stock at an average conversion price of $0.00123. As of June 30, 2020, the outstanding principal balance of assigned note was $-0-.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 26, 2020, the Company entered into a securities purchase agreement (the &#8220;SPA&#8221;) with an investor (the &#8220;Investor&#8221;), pursuant to which the Company agreed to issue to the Investor a 12% secured convertible promissory note in the aggregate principal amount of $132,750 in exchange for a purchase price of $117,750. Pursuant to the SPA, the Company agreed to pay the Investor $15,000 to cover the Investor&#8217;s due diligence expenses incurred in connection with the SPA and Note, which is to be offset against the proceeds of this note. This note was funded by the Investor on February 26, 2020, and on such date pursuant to the SPA, the Company reimbursed the Investor for expenses for legal fees and due diligence of $2,750. This note proceeds will be used by the Company for general working capital purposes. The SPA includes customary representations, warranties and covenants by the Company and customary closing conditions. In conjunction with this note, the Company issued a warrant to purchase 2,212,500 shares of common stock at an exercise price of $0.03, subject to adjustments and expiring on the five-year anniversary of the Issuance Date. The embedded conversion feature included in this note resulted in an initial debt discount and derivative liability of $86,001. For the six months ended June 30, 2020, amortization of the debt discounts of $34,584 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $132,750 with a carrying value of $63,583, net of unamortized discounts of $69,167.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 26, 2020, the Company and an investor (the &#8220;Investor&#8221;) agreed to exchange $330,000 of notes payable into a 12% convertible note with a face value of $330,000. This note is convertible into common stock at a conversion price equal to a 44% discount to the lowest trading price of the common stock for the 20 prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature included in this note resulted in interest expense of $365,757 with the offset to derivative liabilities. On March 3, 2020, a third-party investor (the &#8220;Purchaser&#8221;), pursuant to a Debt Purchase Agreement, purchased this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended June 30, 2020, the Company recorded additional interest expense of $468,750 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in interest expense of $1,321,618 with the offset recorded to derivative liabilities. As of June 30, 2020, the outstanding principal balance of assigned note was $798,750. This note was fully converted as of August 13, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 9, 2020, an investor (the &#8220;Purchaser&#8221;) pursuant to a Debt Purchase Agreement, purchased a convertible note issued by the Company on August 19, 2019, with a maturity date of May 19, 2020 (see above). The Purchaser paid $76,000 to acquire this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount and derivative liability of $76,000. For the six months ended June 30, 2020, the Company recorded additional interest expense of $83,263 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. For the six months ended June 30, 2020, amortization of the debt discounts of $76,000 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $3,603 of the face value and $81,521 of accrued interest and fees into 52,946,489 shares of common stock at an average conversion price of $0.0014. As of June 30, 2020, the outstanding principal balance of assigned note was $155,632. This note was fully converted as of August 13, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 9, 2020, (the &#8220;Issuance Date&#8221;) the Company issued a 12% convertible promissory note, in the principal amount of $80,000, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company&#8217;s common stock beginning on the Issuance Date at $.25 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.25 or 50% of the lowest trading price for the thirty trading days prior to the conversion. The embedded conversion feature included in this note resulted in an initial debt discount of $57,000, interest expense of $64,067 and an initial derivative liability of $121,067. For the six months ended June 30, 2020, amortization of the debt discounts of $48,933 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $80,000 with a carrying value of $48,933, net of unamortized discounts of $31,067.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 17, 2020, an investor (the &#8220;Purchaser&#8221;) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note initially issued by the Company on December 5, 2018, and thereafter was acquired on June 5, 2019 (see above). The Purchaser acquired the note balance of $93,391. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in interest expense of $1,476,436 (since the purchased note was past its&#8217; maturity date and was in default) with the offset recorded to derivative liabilities. For the six months ended June 30, 2020, the Company recorded additional interest expense of $259,305 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. As of June 30, 2020, the outstanding principal balance of assigned note was $352,695. This note was fully converted as of August 13, 2020.&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 24, 2020, an investor (the &#8220;Purchaser&#8221;) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note initially issued by the Company on October 19, 2018, and thereafter was acquired on June 7, 2019 (see above). The Purchaser acquired the note balance of $77,000. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in interest expense of $881,058 (since the purchased note was past its&#8217; maturity date and was in default) with the offset recorded to derivative liabilities. For the six months ended June 30, 2020, the Company recorded additional interest expense of $121,250 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. For the six months ended June 30, 2020, the investor converted a total of $198,183 of the face value and $44,396 of accrued interest and fees into 179,688,215 shares of common stock at an average conversion price of $0.00131. As of June 30, 2020, the outstanding principal balance of assigned note was $67.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 27, 2020, the Company issued a 15% convertible redeemable note in the principal amount of $60,000. This note matures on April 27,2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company. This note was funded on April 27, 2020, when the Company received proceeds of $50,000, after OID of $10,000, which was recorded as a discount against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in an initial debt discount of $50,000, interest expense of $36,274 and an initial derivative liability of $86,274. For the six months June 30, 2020, amortization of the debt discounts of $10,000 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $60,000 with a carrying value of $10,000, net of unamortized discounts of $50,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 28, 2020, an investor (the &#8220;Purchaser&#8221;) pursuant to a Debt Purchase Agreement, purchased a convertible note issued by the Company on August 23, 2019 with a maturity date of May 23, 2020 (see above). The Purchaser acquired $13,483 of this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount of $13,483, interest expense of $42,261 and an initial derivative liability of $55,744. For the six months ended June 30, 2020, the Company recorded additional interest expense of $1,348 due to a default of this note and the amount was added to the principal balance owed the Purchaser. For the six months ended June 30, 2020, amortization of the debt discounts of $13,483 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of assigned note was $14,831.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 28, 2020, the Company issued a 12% convertible promissory note, (the &#8220;Note&#8221;) in the principal amount of $53,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company&#8217;s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 58% multiplied by the lowest closing bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. The Company received proceeds of $50,000 (including direct payments from the lender to certain Company vendors) on May 4, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $3,000. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $50,000, interest expense of $1,539 and an initial derivative liability of $51,539. For the six months June 30, 2020, amortization of the debt discounts of $8,833 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $53,000 with a carrying value of $8,833, net of unamortized discounts of $44,167.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 4, 2020, the Company issued a 12% convertible promissory note, (the &#8220;Note&#8221;) in the principal amount of $110,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company&#8217;s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lower of $0.50 or 58% multiplied by the average of the two lowest closing trading price or bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. The Company received proceeds of $96,250 on May 6, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $13,750. This note proceeds will be used by the Company for general working capital purposes. In conjunction with this note, the Company issued a warrant to purchase 3,666,666 shares of common stock at an exercise price of $0.015, subject to adjustments and expiring on the five-year anniversary of the Issuance Date. The embedded conversion feature included in this note resulted in an initial debt discount of $100,000, interest expense of $5,526 and an initial derivative liability of $105,526. For the six months ended June 30, 2020, amortization of the debt discounts of $18,792 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $110,000 with a carrying value of $16,042, net of unamortized discounts of $93,958.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 5, 2020, (the &#8220;Issuance Date&#8221;) the Company issued a 12% convertible promissory note, (the &#8220;Note&#8221;) in the principal amount of $162,000, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company&#8217;s common stock beginning on the Issuance Date at $03 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.03 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $100,000 on May 13, 2020, and this note included an original issue discount of $62,000. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $100,000, interest expense of $151,512 and an initial derivative liability of $251,512. For the six months ended June 30, 2020, amortization of the debt discounts of $54,000 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $162,000 with a carrying value of $54,000, net of unamortized discounts of $108,000. In conjunction with this note, the Company issued a warrant to purchase 4,325,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 7, 2020, the Company issued a 15% convertible redeemable note in the principal amount of $30,000. This note matures on May 7,2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company. The Company received proceeds of $25,000 on May 7, 2020, and this note included an original issue discount of $5,000, which was recorded as a discount against the debt to be amortized into interest expense through maturity This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $25,000, interest expense of $17,828 and an initial derivative liability of $42,828. For the six months June 30, 2020, amortization of the debt discounts of $4,375 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $30,000 with a carrying value of $4,375, net of unamortized discounts of $25,625.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 7, 2020, an investor (the &#8220;Purchaser&#8221;) pursuant to a Debt Purchase Agreement, purchased a convertible note issued by the Company on October 24, 2019, with a maturity date of October 24, 2020 (see above). The Purchaser acquired $200,000 of this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount of $200,000, interest expense of $111,128 and an initial derivative liability of $311,128. For the six months ended June 30, 2020, amortization of the debt discounts of $200,000 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $200,000 of the face value and $16,922 of accrued interest and fees into 92,332,507 shares of common stock at an average conversion price of $0.00218. As of June 30, 2020, the outstanding principal balance of assigned note was $-0-.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 15, 2020, an investor (the &#8220;Purchaser&#8221;) pursuant to a Debt Purchase Agreement, purchased a convertible note initially issued by the Company on January 8, 2020, with a maturity date of January 8, 2021 (see above). The Purchaser paid $52,000 for the note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended June 30, 2020, the Company recorded additional interest expense of $63,500 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount of $100,000, interest expense of $526,507 and an initial derivative liability of $626,507. For the six months ended June 30, 2020, amortization of the debt discounts of $25,000 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $66,454 of the face value and $5,246 of accrued interest and fees into 53,110,926 shares of common stock at an average conversion price of $0.00129. As of June 30, 2020, the outstanding principal balance of assigned note was $83,546, with a carrying value of $8,546, net of unamortized discounts of $75,000. This note was fully converted as of August 13, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 15, 2020, an investor (the &#8220;Purchaser&#8221;) pursuant to a Debt Purchase Agreement, purchased a convertible note initially issued by the Company on November 27, 2019, with a maturity date of November 27, 2020 (see above). The Purchaser paid $75,000 for the note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended June 30, 2020, the Company recorded additional interest expense of $75,000 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount of $77,000, interest expense of $388,385 and an initial derivative liability of $465,385. As of June 30, 2020, the outstanding principal balance of assigned note was $115,500, with a carrying value of $52,398, net of unamortized discounts of $62,563. This note was fully converted as of August 13, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 28, 2020, the Company issued a 15% convertible redeemable note in the principal amount of $30,000. This note matures on May 28, 2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company. The Company received proceeds of $25,000 on May 28, 2020, and this note included an original issue discount of $5,000. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $25,000, interest expense of $19,346 and an initial derivative liability of $44,346. For the six months June 30, 2020, amortization of the debt discounts of $2,500 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $30,000 with a carrying value of $2,500, net of unamortized discounts of $27,500.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 28, 2020, an investor (the &#8220;Purchaser&#8221;) pursuant to a Debt Purchase Agreement, purchased a convertible note issued by the Company on May 29, 2019 (see above). The Purchaser acquired $67,365 of this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount of $67,365, interest expense of $443,420 and an initial derivative liability of $510,785. For the six months ended June 30, 2020, the Company recorded additional interest expense of $83,395 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. For the six months ended June 30, 2020, amortization of the debt discounts of $67,365 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $47,090 of the face value and $3,000 of accrued interest and fees into 39,959,295 shares of common stock at an average conversion price of $0.00118. As of June 30, 2020, the outstanding principal balance of assigned note was $103,671. This note was fully converted as of August 13, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 1, 2020, (the &#8220;Issuance Date&#8221;) the Company issued a 12% convertible promissory note, (the &#8220;Note&#8221;) in the principal amount of $127,500, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company&#8217;s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $100,000 on June 1, 2020, and this note included an original issue discount of $27,500. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $100,000, interest expense of $103,250 and an initial derivative liability of $203,250. For the six months ended June 30, 2020, amortization of the debt discounts of $21,250 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $127,500 with a carrying value of $21,250, net of unamortized discounts of $106,250. In conjunction with this note, the Company issued a warrant to purchase 6,375,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 11, 2020, the Company issued a 12% convertible promissory note, (the &#8220;Note&#8221;) in the principal amount of $53,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company&#8217;s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 58% multiplied by the lowest closing bid price during the twenty trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. The Company received proceeds of $50,000 on June 12, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $3,000. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $50,000, interest expense of $2,218 and an initial derivative liability of $52,218. For the six months June 30, 2020, amortization of the debt discounts of $2,849 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $53,000 with a carrying value of $2,849, net of unamortized discounts of $50,151.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 23, 2020, an investor (the &#8220;Purchaser&#8221;) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note initially issued by the Company on October 6, 2017 (see above). The Purchaser paid $60,000 for the note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended June 30, 2020, the Company recorded additional interest expense of $52,500 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in interest expense of $658.093 (since the purchased note was past its&#8217; maturity date and was in default) with the offset recorded to derivative liabilities. For the six months ended June 30, 2020, the investor converted a total of $91,579 of the face value and $42,071 of accrued interest and fees into 99,000,000 shares of common stock at an average conversion price of $0.00133. As of June 30, 2020, the outstanding principal balance of assigned note was $20,921. This note was fully converted as of August 13, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 30, 2020, (the &#8220;Issuance Date&#8221;) the Company issued a 15% convertible promissory note, (the &#8220;Note&#8221;) in the principal amount of $129,500, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company&#8217;s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $102,000 on July 1, 2020, and this note included an original issue discount of $27,500 and lender costs of $2,000. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $100,000, interest expense of $107,122 and an initial derivative liability of $207,122. As of June 30, 2020, the outstanding principal balance of this note was $129,500 with a carrying value of $-0-, net of unamortized discounts of $129,500. In conjunction with this note, the Company issued a warrant to purchase 6,375,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of the convertible note balance as of June 30, 2020, and December 31, 2019, is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%"><font style="font: 10pt Times New Roman, Times, Serif">Principal balance</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 20%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,640,450</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 20%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,500,230</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Unamortized discount</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(872,945</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(806,003</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Ending balance, net</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,767,505</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,694,227</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 6 &#8211; DERIVATIVE LIABILITIES </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company determined the conversion feature of these notes, which all contain variable conversion rates, represented an embedded derivative since the notes were convertible into a variable number of shares upon conversion. Accordingly, the notes are not considered to be conventional debt under ASC 815 and the embedded conversion feature was bifurcated from the debt host and accounted for as a derivative liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company valued the derivative liabilities at June 30, 2020, and December 31, 2019, at $9,471,445 and $2,462,490, respectively. The Company used the Monte Carlo simulation valuation model with the following assumptions as of June 30, 2020, risk free interest rates from 0.16% to 0.18%, and volatility of 81% to 105% and as of December 31, 2019, risk-free interest rates from 1.57% to 1.77% and volatility of 31% to 36%. The initial derivative liabilities for convertible notes issued during the six months ended June 30, 2020, used the following assumptions; risk-free interest rates from 0.12% to .24% and volatility of 74% to 105%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of the activity related to derivative liabilities for the six months ended June 30, 2020, and the year ended December 31, 2019, is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 79%"><font style="font-size: 10pt">Balance- January 1, 2019</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 18%; text-align: right"><font style="font-size: 10pt">1,199,514</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Issued during period</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,460,123</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Converted or paid</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(850,248</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Change in fair value recognized in operations</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">653,551</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Balance- December 31, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,462,940</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Issued during the period</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">11,953,787</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Converted or paid</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(8,627,804</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Change in fair value recognized in operations</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3,682,522</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Balance June 30, 2020</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">9,471,445</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 7 &#8211; NOTES PAYABLE</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has the following note payables outstanding:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%"><font style="font: 10pt Times New Roman, Times, Serif">Note payable, interest at 8%, matured September 6, 2018, in default</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 20%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">330,033</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Notes payable, interest at 8%, matured January 5, 2020, currently in default</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Other, due on demand, interest at 6%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">50,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Note payable, interest at 18%, matures June 23, 2022, net of discount of $34,635</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">175,365</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Note payable, interest at 12%, matures June 25, 2021, net of discount of $26,970</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">176,030</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Sub- total notes payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">446,395</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">425,033</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less long-term portion, net of discount</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">176,365</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Current portion of notes payable, net of discount</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">270,030</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">425,033</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 26, 2020, the Company and the noteholder agreed to convert $330,033 of principal note balances to a 12% convertible note with a face value of $330,000 (see Note 5).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 23, 2020 (the &#8220;Execution Date&#8221;), the Company entered into a Loan and Securities Purchase Agreement with a third- party (the &#8220;Lender&#8221;). Pursuant to the agreement in exchange for a $210,000 Promissory Note, inclusive of an original issue discount of $35,000 the Company received proceeds of $175,000 from the Lender. The note carries an interest rate of 18% and matures and is due in one lump sum on the 24- month anniversary (the &#8220;Maturity Date&#8221;) of the Execution Date. For the first nine months interest may accrue on a monthly basis, and the Company has the option to pay the monthly interest or add such interest to the principal balance of the note. Commencing on the tenth month of the note, all accrued interest, if any, shall be added to the principal amount of the note, and interest on the new principal amount shall become due and payable on a monthly basis. Should the Company default on making any interest payments following the initial nine-months, or paying the note by the Maturity Date, the note shall automatically be converted into an 18% convertible debenture.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25 (the &#8220;Issue Date&#8221;), 2020, the Company entered into a 12%, $203,000 face value promissory note with a third-party (the &#8220;Holder&#8221;) due June 25, 2021 (the &#8220;Maturity Date&#8221;). Principal payments shall be made in six instalments of $33,333 commencing 180 days from the Issue Date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the Maturity Date. The Holder shall have the right from time to time, and at any time following an event of default, as defined on the agreement, to convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company, at the lower of i) the Trading Price (as defined in the agreement) during the previous five trading days prior to the Issuance Date or ii) the volume weighted average price during the five trading days ending on the day preceding the conversion date. The Company received proceeds of $176,000 on June 26, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $27,000. In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 10,000,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expires on the five-year anniversary of the Issue Date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8 &#8211; RELATED PARTY TRANSACTIONS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Employment Agreement</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 28, 2020, the Company and Mr. Conway entered into an employment agreement (the &#8220;Employment Agreement&#8221;). Pursuant to the terms of the Employment Agreement, Mr. Conway is to receive an annual salary of $120,000, for his position of CEO of the Company, payable monthly. Mr. Conway was also issued 2,500 shares of Series C Preferred Stock. The Company valued the shares at $5,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Management Fees and related party payables</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three and six months ended June 30, 2020, and 2019, the Company recorded expenses to its officers in the following amounts:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Three months ended <br /> June 30,</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Six months ended <br /> June 30,</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%"><font style="font-size: 10pt">CEO, parent (includes $5,000 stock-based compensation six months ended June 30, 2020)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">30,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">45,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">CEO, former</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">88,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">22,505</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">133,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">COO, former</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">45,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">90,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">CFO, former</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">30,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">20,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">60,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">30,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">163,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">87,505</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">283,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2020, and December 31, 2019, included in accounts payable and accrued expenses, related party is $456,185 and $470,886, respectively, for the following amounts owed the Company&#8217;s former officers for accrued fees, accounts payable and loans made. The loans have no terms of repayment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Former CEO, former (1)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">200</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">125</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Former CEO, subsidiary (2)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">144,087</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">144,639</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Former COO and CCO (3)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">162,085</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">162,085</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Former COO (4)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">112,500</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">112,500</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Former CFO (5)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">51,537</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">CEO</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">419,692</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">470,866</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(1)The former CEO, parent resigned February 28, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(2) The former CEO, subsidiary resigned on March 4, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(3) The Former COO and CCO resigned from those positions on October 1, 2018, and March 4, 2019, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(4) The former COO resigned on October 23, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(5) The former CFO resigned effective February 28, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Other</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 9, 2018, the Company recorded a stock subscription receivable from its officers and directors of $7,600 related to the issuance of 7,600,000 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 9 &#8211; COMMITMENTS AND CONTINGENCIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Licenses</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 1, 2018, Spinus entered into an Intellectual Property Licensing Agreement (the &#8220;Licensing Agreement&#8221;). The Company assumed the obligations under the Licensing Agreement and pledged the assets of Spinus as security. Pursuant to the terms of the Licensing Agreement, in consideration of $250,000 Spinus has the exclusive rights to certain patents and the non-exclusive rights to other patents. The patents surround mechanical or inflatable expandable interbody implant products. The Company paid the $250,000 on November 20, 2018. The Company also will pay a royalty of 7% of net sales on any product sold utilizing any of the patents. There have not been any sales of the licensed products and accordingly, no royalties have been incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Consulting Agreements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 4, 2019, the Company entered into a Separation Agreement (the &#8220;Separation Agreement&#8221;) with Salman J. Chaudhry, pursuant to which Mr. Chaudry resigned immediately from his positions as the CCO and Secretary of the Company and as a member of the Board and from all positions with the Company effective immediately and pursuant to which the Company agreed to pay Mr. Chaudry $227,200 (the &#8220;Outstanding Fees&#8221;) in certain increments as set forth in the Separation Agreement. Mr. Chaudry&#8217;s resignation was <font style="background-color: white">not the result of any disagreement with the Company on any matter relating to the Company&#8217;s operations, policies or practices. As of June 30, 2020, and December 31, 2019, the balance owed Mr. Chaudhry is $162,085.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 24, 2019, the Company and Newbridge Securities Corporation (&#8220;Newbridge&#8221;) entered into an Investment Banking Engagement Agreement (the &#8220;Agreement&#8221;). Under the terms of the Agreement, Newbridge will provide investment banking and financial advisory services to the Company, including, but not limited to assisting the Company with an up-listing process to a national exchange in the United States, introducing the Company to other investment banking firms focused on servicing emerging growth companies; rendering advice related to capital structures, capital market opportunities, evaluating potential capital raise transactions and assisting the Company to develop growth optimization strategies. The term of the Agreement is 12 months from the date of the Agreement, however either party may terminate the Agreement anytime upon 15 days written notice. As compensation for its services under the Agreement, Newbridge and its assignees received 172 shares of the Company&#8217;s common stock. The Agreement contains customary terms relating to payment of expenses, indemnification and other matters. The Agreement also includes customary representations, warranties and covenants by the Company. The Company valued the shares at $77,130, based on the market price of the common stock on the date of the agreement, to be amortized over the one-year term of the contract. For the six months ended June 30, 2020, the Company amortized $17,783 as stock-based compensation expense. As of June 30, 2020, the expense has been fully recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 2, 2019, the Company entered Consulting Agreement (the &#8220;Agreement&#8221;) with a consultant to act as the Company&#8217;s Executive Vice President, Sales and Marketing (the &#8220;EVP&#8221;) through December 31, 2019, and to provide the Company with customary services of an EVP. The Company has agreed to compensate the consultant $10,000 per month. Either party may terminate the Agreement in its sole and absolute discretion. The parties have agreed that they will negotiate follow up agreement with terms and conditions to include salary, commission, bonuses and stock and or option grants or awards, to be consistent with industry standards for like size companies prior to the termination of the Agreement. For the year ended December 31, 2019, the Company has expensed $30,000. As of June 30, 2020, and December 31, 2019, the Company owes the EVP $10,000, included in liabilities of discontinued operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 3, 2019, the Company entered into an Investor Relations Agreement (the &#8220;Agreement&#8221;) with a consultant. Under the terms of the Agreement, the consultant will provide consulting services to the Company, including, but not limited to assisting the Company in the conception and implementation of the Company&#8217;s corporate and business development plan. The term of the Agreement is 6 months from the date of the Agreement. As compensation for its services under the Agreement, the consultant received 1,250 shares of the Company&#8217;s common stock. The Agreement contains customary terms relating to payment of expenses, indemnification and other matters. The Agreement also includes customary representations, warranties and covenants by the Company. The Company valued the shares at $46,875, based on the market price of the common stock on the date of the agreement, to be amortized over the term of the contract. For the six months ended June 30, 2020, the Company amortized $15,625 as stock-based compensation expense. As of June 30, 2020, the expense has been fully recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 3, 2019, the Company entered into a Consulting Agreement (the &#8220;Agreement&#8221;) with a consultant. Under the terms of the Agreement, the consultant will provide consulting services to the Company, including, but not limited to assisting the Company in its general strategy for corporate communications. The term of the Agreement is 6 months from the date of the Agreement. As compensation for its services under the Agreement, the consultant received 1,250 shares of the Company&#8217;s common stock. The Agreement contains customary terms relating to payment of expenses, indemnification and other matters. The Agreement also includes customary representations, warranties and covenants by the Company. The Company valued the shares at $46,875, based on the market price of the common stock on the date of the agreement, to be amortized over the term of the contract. For the six months ended June 30, 2020, the Company amortized $15,625 as stock-based compensation expense. As of June 30, 2020, the expense has been fully recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On June 5, 2020, the Company entered into a one-year agreement for media relations services with a third-party. Pursuant to the Agreement, the Company will pay the consultants $10,000 per month for the development and execution of a comprehensive media relations plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>NOTE 10 - INCOME TAXES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company was incorporated in the United States and has operations in two tax jurisdictions - the United States and Hong Kong. The Company&#8217;s HK subsidiary is subject to a 16.5% profit tax based on its taxable net profit. The Company&#8217;s U.S. operations are subject to income tax according to U.S. tax law.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">A reconciliation of the provision for income taxes determined at the U.S. statutory rate to the Company&#8217;s effective income tax rate is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Six Months Ended</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>June 30,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2020</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 72%"><font style="font: 10pt Times New Roman, Times, Serif">Pre-tax loss</font></td> <td style="width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; width: 11%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(31,227,327</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; width: 11%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2,823,397</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">U.S. federal corporate income tax rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">21</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">21</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Expected U.S. income tax benefit</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(6,557,739</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(592,493</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Tax rate difference between U.S. and foreign operations</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">289</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Permanent differences</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,198,791</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">417,713</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Change of valuation allowance</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">358,948</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">174,491</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Effective tax expense</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company had deferred tax assets as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font: 10pt Times New Roman, Times, Serif">Net operating losses carried forward</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,381,018</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,022,071</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less: Valuation allowance</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,381,018</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,022,071</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Net deferred tax assets</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">As of June 30, 2020, the Company has approximately $6,108,000 and $595,000 net operating loss carryforwards available in the United States and Hong Kong, respectively, to reduce future taxable income. The net operating loss from Hong Kong operations can be carried forward with no time limit from the year of the initial loss pursuant to relevant Hong Kong tax laws and regulations. <font style="background-color: white">For U.S. purposes the NOL deduction for a tax year is equal to the lesser of (1) the aggregate of the NOL carryovers to such year, plus the NOL carry-backs to such year, or (2) 80% of taxable income (determined without regard to the deduction). Generally, NOLs can no longer be carried back but are allowed to be carried forward indefinitely. The special extended carryback provisions are generally repealed, except for certain farming and insurance company losses. The amendments incorporating the 80% limitation apply to losses arising in tax years beginning after Dec. 31, 2017. </font>It is more likely than not that the deferred tax assets cannot be utilized in the future because there will not be significant future earnings from the entity which generated the net operating loss. Therefore, the Company recorded a full valuation allowance on its deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2020, and December 31, 2019, the Company has no material unrecognized tax benefits which would favourably affect the effective income tax rate in future periods, and does not believe that there will be any significant increases or decreases of unrecognized tax benefits within the next twelve months. No interest or penalties relating to income tax matters have been imposed on the Company during the three and six months ended June 30, 2020, and 2019, and no provision for interest and penalties is deemed necessary as of June 30, 2020, and 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Since the Company&#8217;s foreign subsidiaries have not generated income since inception, the Company believes that Tax Act will not have significant impact on the Company&#8217;s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 11 &#8211; STOCKHOLDERS&#8217; EQUITY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 21, 2020, the Company filed an amendment to its Certificate of Incorporation, with the Nevada Secretary of State, for 1-for-1,000 reverse stock split of our common stock (the &#8220;Reverse Stock Split&#8221;) effective February 10, 2020. The number of shares of common stock subject to outstanding options, warrants and convertible securities were also reduced by a factor of one- thousand and no fractional shares were issued. All historical share in this report have been adjusted to reflect the Reverse Stock Split. There were no changes to the authorized number of shares and the par value of our common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Common stock</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 5, 2019, the Company entered into an <i>Equity Financing Agreement</i> (the &#8220;Equity Agreement&#8221;) with GHS Investments, LLC, a Nevada limited liability company (the &#8220;Investor&#8221;), with the Investor committing to purchase up to $7,000,000 of the Company&#8217;s common stock in tranches of up to $400,000, following an effective registration of the shares and subject to restrictions regarding the timing of each sale and total percentage stock ownership held by the Investor. The purchase price for the shares will be 85% of the lowest closing price during the 10-day period prior to each sale, and with each sale, the Investor will receive an issuance premium of 5% to cover the Investor&#8217;s transaction costs associated with selling the shares and payable by the Company to the Investor in registered shares. The obligation of the Investor to purchase shares pursuant to the Equity Agreement is subject to several conditions, including (i) that the Company has filed a registration statement (the &#8220;Registration Statement&#8221;) with the United States Securities and Exchange Commission (the &#8220;SEC&#8221;) registering the shares to be sold to the Investor within 30 calendar days from the date of the Equity Agreement, with the Registration Statement being declared effective prior to sale of any shares to the Investor; and (ii) that the purchase of shares by the Investor pursuant to the Equity Agreement shall not cause the Investor to own more than 4.99% of the outstanding shares of the Company&#8217;s common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the Equity Agreement, on July 5, 2019, the Company also entered into a <i>Registration Rights Agreement</i> with the Investor (the &#8220;Registration Rights Agreement&#8221;). On October 1, 2019, the SEC issued a Notice of Effectiveness of the Company&#8217;s Registration Statement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended June 30, 2020, holders of an aggregate of $2,774,896 in principal and $636,466 of accrued interest and fees of convertible notes issued by the Company, converted their debt into 1,444,237,885 shares of our common stock at an average conversion price of $0.00236 per share. The Company also issued 104,719,899 shares of common stock upon the cashless exercise of common stock purchase warrants.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2020, the Company has 4,990,000,000 shares of $0.001 par value common stock authorized and there are 1,549,176,877 shares of common stock issued and outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Common stock to be issued</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended December 31, 2019, the Company recorded 1,350 shares (post reverse stock split) of common stock to be issued, and valued the shares at $410,370, based on the market price of the common stock on the date of the shares being earned. For the year ended December 31, 2019, the company amortized $410,370 as stock-based compensation expense. As of June 30, 2020, and December 31, 2019, there are 1,350 shares of common stock to be issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Preferred stock</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2020, 10,000,000 shares have been authorized as preferred stock, par value $0.001 (the &#8220;Preferred Stock&#8221;), which such Preferred Stock shall be issuable in such series, and with such designations, rights and preferences as the Board of Directors may determine from time to time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 28, 2019, the Company filed a Certificate of Designation with the Secretary of State of Nevada to designate 1,000,000 shares as Series B Preferred Stock. The Series B Preferred Stock is not convertible into common stock, nor does the Series B Preferred Stock have any right to dividends and any liquidation preference. The Series B Preferred Stock entitles its holder to a number of votes per share equal to 50 votes. On April 1, 2019, the Company issued 1,000,000 shares of Series B Preferred Stock to the Company&#8217;s CEO at the time. This resulted in a change in control of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 18, 2019, the Company filed a Certificate of Designation with the Secretary of State of Nevada to designate 50,000 shares as Series C Preferred Stock. Each share of Series C Preferred Stock shall be convertible, at the option of the holder thereof, at any time after the date of issuance, into one share of fully paid and non-assessable share of common stock. Each share of Series C Preferred Stock shall entitle the holder thereof to ten thousand (10,000) votes on all matters submitted to a vote of the stockholders of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 19, 2019, the Company issued 50,000 shares of its Series C Preferred Stock to the Company&#8217;s CEO and Director, at the time, in consideration of the cancellation and return of 1,000,000 shares of the Company&#8217;s Series B Preferred Stock. <font style="background-color: white">On September 20, 2019, the Company filed a Certificate of Withdrawal of Certificate of Designation (the &#8220;Certificate of Withdrawal&#8221;) for the Company&#8217;s Series B Preferred Stock, pursuant to which the prior designation of the Company&#8217;s Series B Stock was cancelled.</font> On February 28, 2020, pursuant to a share redemption agreement between the Company and Mr. Chermak pursuant to which, the Company agreed to redeem his 50,000 shares of Series C Preferred Stock for $100,000, ($2 per share), the Company redeemed 2,500 shares of series C Preferred Stock from Mr. Chermak, and issued 2,500 shares of Series C Preferred Stock to Mr. Conway, pursuant to Mr. Conway&#8217;s employment agreement. The Company valued the 2,500 shares issued to Mr. Conway at $5,000 ($2 per share). On April 28, 2020, the Company redeemed the remaining 47,500 shares of Series C Preferred Stock from the former CEO. <font style="background-color: white">As of June 30, 2020, and December 31, 2019, there are 50,000 shares of Series C Preferred Stock outstanding, respectively, and no shares of Series B Preferred Stock outstanding. </font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 4, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company&#8217;s Series C Preferred Stock. The voting rights associated with the Series C Preferred Stock were amended whereby each share of Series C Preferred Stock shall entitle the holder thereof to have voting rights equal to two times the sum of all the number of shares of other classes of Company capital stock eligible to vote on all matters submitted to a vote of the stockholders of the Company, divided by the number of shares of Preferred Stock issued and outstanding at the time of voting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Stock subscription receivable</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 9, 2018, the Company recorded a stock subscription receivable from its officers and directors of $7,600 related to the issuance of 7,600 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 12 &#8211; DISCONTINUED OPERATIONS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 205-20 &#8220;Discontinued Operations&#8221; establishes that the disposal or abandonment of a component of an entity or a group of components of an entity should be reported in discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity&#8217;s operations and financial results. As a result, the component&#8217;s results of operations have been reclassified as discontinued operations on a retrospective basis for all periods presented. Accordingly, the assets and liabilities of this component are separately reported as &#8220;assets and liabilities held for disposal&#8221; as of December 31, 2019. The results of operations of this component, for all periods, are separately reported as &#8220;discontinued operations&#8221;. There have been no transactions between the Company and SRI since the termination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A reconciliation of the major classes of line items constituting the gain from discontinued operations, net of income taxes as is presented in the Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2020, are summarized below; there was no activity of the SRI business for the three and six months ended June 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 79%; padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Cost of goods sold</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 1%"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; width: 18%; text-align: right"><font style="font-size: 10pt">4,326</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Operating expenses:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Depreciation expense</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">13,805</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Rent expense</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,222</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Interest expense</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">8.794</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 20pt; text-align: justify"><font style="font-size: 10pt">Total operating expenses</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">24,821</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Loss from discontinued operations</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(29,147</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Gain from license termination</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">86,856</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Liabilities of discontinued operations at June 30, 2020, of $75,270 consist of accounts payable and accrued expenses related to SRI.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents the reconciliation of carrying amounts of major classes of assets and liabilities of the Company classified as discontinued operations in the condensed consolidated balance sheet at December 31, 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Carrying amounts of major classes of assets </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>included as part of assets held for discontinued operations</b></p></td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 79%"><font style="font-size: 10pt">Inventory</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 18%; text-align: right"><font style="font-size: 10pt">378,061</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Prepaid expenses</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,987</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Property and equipment, net</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">353,985</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">License rights, net</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,724,848</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Goodwill</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,002,314</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total assets included in the assets of discontinued operations</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5,462,195</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Carrying amounts of major classes of liabilities </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>included as part of liabilities of discontinued operations</b></p></td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 79%"><font style="font-size: 10pt">Accounts payable and accrued expenses</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 18%; text-align: right"><font style="font-size: 10pt">88,178</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Liability for common stock payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">245,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Current portion of notes payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,131,771</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Current portion of license fee payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">984,089</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Long term portion of notes payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,440</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Long term portion of license fee payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">250,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Put option payable</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,892,228</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total liabilities included in the liabilities of discontinued operations</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5,592,706</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 13 &#8211; SUBSEQUENT EVENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From July 1, 2020, through August 10, 2020, the Company has issued 1,205,966,108 shares of common stock upon the conversion of $1,883,096 of principal, accrued interest and fees of convertible notes. The Company also issued 149,820,477 shares of common stock upon the cashless exercise of warrants.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 8, 2020, (the &#8220;Issuance Date&#8221;) the Company issued a 15% convertible promissory note, in the principal amount of $250,000, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company&#8217;s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $200,000 on July 9, 2020, and this note included an original issue discount of $50,000. This note proceeds will be used by the Company for general working capital purposes. In conjunction with this note, the Company issued a warrant to purchase 12,500,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 7, 2020, the Company filed with the Secretary of State of the State of Nevada an Amendment to Certificate of Designation of Series C Preferred Stock, a Certificate of Designation of Series D Preferred Stock, and a Certificate of Designation of Series E Preferred Stock (collectively, the &#8220;Certificates of Designation&#8221;).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the terms of the Amendment to Certificate of Designation of Series C Preferred Stock, 50,000 shares of the Company&#8217;s preferred remain designated as Series C Preferred Stock. The holders of Series C Preferred Stock have no dividend rights. For so long as any shares of the Series C Preferred Stock remain issued and outstanding, the Holder thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to sixty-seven (67%) percent of the total vote.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the terms of the Certificate of Designation of Series D Preferred Stock, 20,000 shares of the Company&#8217;s preferred stock have been designated as Series D Convertible Preferred Stock. The holders of the Series D Convertible Preferred Stock shall not be entitled to receive dividends. The holders as a group may, at any time convert all of the shares of Series D Convertible Preferred Stock into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion, by 3. Except as provided in the Certificate of Designation or as otherwise required by law, no holder of the Series D Convertible Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Company for their vote, waiver, release or other action. The Series D Convertible Preferred Stock shall not bear any liquidation rights.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the terms of the Certificate of Designation of Series E Preferred Stock, 3,000 shares of the Company&#8217;s preferred stock have been designated as Series E Preferred Stock. The holders of the Series E Convertible Preferred Stock shall not be entitled to receive dividends. No holder of the Series E Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Corporation for their vote, waiver, release or other action, except as may be otherwise expressly required by law. At any time, the Corporation may redeem for cash out of funds legally available therefor, any or all of the outstanding Preferred Stock (&#8220;Optional Redemption&#8221;) at $1,000 (one thousand dollars) per share. The shares of Series E Preferred Stock have not been registered under the Securities Act of 1933 or the laws of any state of the United States and may not be transferred without such registration or an exemption from registration.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 10, 2020, the Company closed the SPA with (&#8220;PCTI&#8221;) and Chis, the sole shareholder of PCTI. Under the terms of the SPA, the Company acquired one thousand (1,000) shares of PCTI, which represents all of the outstanding shares of PCTI, from Catherine Chis in exchange for a cash payment of $400,000 (paid as of June 30, 2020) and the issuance of 47,500 shares of the Company&#8217;s Series C Preferred Stock, 18,667 shares of the Company&#8217;s Series D Preferred Stock, and 500 shares of the Company&#8217;s Series E Preferred Stock to Chis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 15, 2020, (the &#8220;Issuance Date&#8221;) the Company issued a 15% convertible promissory note, in the principal amount of $127,500, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company&#8217;s common stock beginning on the Issuance Date at $0.011 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $102,000 on July 22, 2020, and this note included an original issue discount of $27,500. This note proceeds will be used by the Company for general working capital purposes. In conjunction with this note, the Company issued a warrant to purchase 6,375,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 24, 2020, PCTI, the Company&#8217;s wholly owned subsidiary, entered into a three- month consulting agreement with a third-party. Pursuant to the agreement, the Company will pay the consultant $10,000 per month and the consultant will provide services, including, but not limited to, <font style="color: #222222; background-color: #FCFCFC">identifying PCTI&#8217;s best path forward into the renewable energy and energy storage industries as well as advance their presence in the maritime/transportation industry.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #222222">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 29, 2020, (the &#8220;Issuance Date&#8221;) the Company issued a 15% convertible promissory note, in the principal amount of $127,500, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company&#8217;s common stock beginning on the Issuance Date at $0.011 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $100,000 on August 3, 2020, and this note included an original issue discount of $27,500. This note proceeds will be used by the Company for general working capital purposes. In conjunction with this note, the Company issued a warrant to purchase 12,750,000 shares of common stock at an exercise price of $0.01, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements, except as stated herein.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A reconciliation of the major classes of line items constituting the gain from discontinued operations, net of income taxes as is presented in the Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2020, are summarized below; there was no activity of the SRI business for the three and six months ended June 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 79%; padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Cost of goods sold</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 1%"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; width: 18%; text-align: right"><font style="font-size: 10pt">4,326</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Operating expenses:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Depreciation expense</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">13,805</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Rent expense</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,222</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Interest expense</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">8.794</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 20pt; text-align: justify"><font style="font-size: 10pt">Total operating expenses</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">24,821</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Loss from discontinued operations</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(29,147</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Gain from license termination</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">86,856</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents the reconciliation of carrying amounts of major classes of assets and liabilities of the Company classified as discontinued operations in the condensed consolidated balance sheet at December 31, 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Carrying amounts of major classes of assets </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>included as part of assets held for discontinued operations</b></p></td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 79%"><font style="font-size: 10pt">Inventory</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 18%; text-align: right"><font style="font-size: 10pt">378,061</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Prepaid expenses</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,987</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Property and equipment, net</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">353,985</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">License rights, net</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,724,848</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Goodwill</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,002,314</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total assets included in the assets of discontinued operations</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5,462,195</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Carrying amounts of major classes of liabilities </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>included as part of liabilities of discontinued operations</b></p></td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 79%"><font style="font-size: 10pt">Accounts payable and accrued expenses</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 18%; text-align: right"><font style="font-size: 10pt">88,178</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Liability for common stock payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">245,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Current portion of notes payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,131,771</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Current portion of license fee payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">984,089</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Long term portion of notes payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,440</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Long term portion of license fee payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">250,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Put option payable</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,892,228</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total liabilities included in the liabilities of discontinued operations</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5,592,706</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company had deferred tax assets as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Net operating losses carried forward</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,381,018</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,022,071</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less: Valuation allowance</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,381,018</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,022,071</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Net deferred tax assets</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">&#8212;</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">&#8212;</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">A reconciliation of the provision for income taxes determined at the U.S. statutory rate to the Company&#8217;s effective income tax rate is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="text-align: center"><font style="font-size: 10pt"><b>Six Months Ended</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 72%; padding-bottom: 2.5pt"><font style="font-size: 10pt">Pre-tax loss</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; width: 11%; text-align: right"><font style="font-size: 10pt">(31,227,327</font></td> <td style="width: 1%; padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; width: 11%; text-align: right"><font style="font-size: 10pt">(2,823,397</font></td> <td style="width: 1%; padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">U.S. federal corporate income tax rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">21</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">21</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Expected U.S. income tax benefit</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(6,557,739</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(592,493</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Tax rate difference between U.S. and foreign operations</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">289</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Permanent differences</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,198,791</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">417,713</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Change of valuation allowance</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">358,948</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">174,491</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Effective tax expense</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">&#8212;</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">&#8212;</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Former CEO, former (1)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">200</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">125</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Former CEO, subsidiary (2)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">144,087</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">144,639</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Former COO and CCO (3)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">162,085</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">162,085</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Former COO (4)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">112,500</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">112,500</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Former CFO (5)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">51,537</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">CEO</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">419,692</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">470,866</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(1)The former CEO, parent resigned February 28, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(2) The former CEO, subsidiary resigned on March 4, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(3) The Former COO and CCO resigned from those positions on October 1, 2018, and March 4, 2019, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(4) The former COO resigned on October 23, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(5) The former CFO resigned effective February 28, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three and six months ended June 30, 2020, and 2019, the Company recorded expenses to its officers in the following amounts:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Three months ended <br /> June 30,</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Six months ended <br /> June 30,</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%"><font style="font-size: 10pt">CEO, parent (includes $5,000 stock-based compensation six months ended June 30, 2020)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">30,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">45,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">CEO, former</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">88,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">22,505</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">133,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">COO, former</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">45,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">90,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">CFO, former</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">30,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">20,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">60,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">30,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">163,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">87,505</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">283,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has the following note payables outstanding:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%"><font style="font: 10pt Times New Roman, Times, Serif">Note payable, interest at 8%, matured September 6, 2018, in default</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 20%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">330,033</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Notes payable, interest at 8%, matured January 5, 2020, currently in default</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Other, due on demand, interest at 6%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">50,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Note payable, interest at 18%, matures June 23, 2022, net of discount of $34,635</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">175,365</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Note payable, interest at 12%, matures June 25, 2021, net of discount of $26,970</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">176,030</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Sub- total notes payable</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">446,395</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">425,033</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less long-term portion, net of discount</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">176,365</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Current portion of notes payable, net of discount</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">270,030</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">425,033</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of the activity related to derivative liabilities for the six months ended June 30, 2020, and the year ended December 31, 2019, is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 79%"><font style="font-size: 10pt">Balance- January 1, 2019</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 18%; text-align: right"><font style="font-size: 10pt">1,199,514</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Issued during period</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,460,123</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Converted or paid</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(850,248</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Change in fair value recognized in operations</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">653,551</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Balance- December 31, 2019</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,462,940</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Issued during the period</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">11,953,787</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Converted or paid</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(8,627,804</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Change in fair value recognized in operations</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3,682,522</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Balance June 30, 2020</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">9,471,445</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of the convertible note balance as of June 30, 2020, and December 31, 2019, is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%"><font style="font-size: 10pt">Principal balance</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">2,640,450</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">2,500,230</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Unamortized discount</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(872,945</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(806,003</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Ending balance, net</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,767,505</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,694,227</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Patents as of June 30, 2020, and December 31, 2019, consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">June 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 56%"><font style="font-size: 10pt">Patents and license rights</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 19%; text-align: right"><font style="font-size: 10pt">250,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 19%; text-align: right"><font style="font-size: 10pt">250,000</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Accumulated amortization</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(98,959</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(78,125</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Net carrying amount</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">151,041</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">171,875</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table represents the classes of dilutive securities as of June 30, 2020, and 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">June 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">June 30, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Common stock to be issued</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,350</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">750</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Convertible preferred stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Convertible notes payable</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">923,129,673</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">138,402,042</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">923,181,023</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">138,402,792</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Relevant exchange rates used in the preparation of the consolidated financial statements are as follows for the periods ended June 30, 2020 and December 31, 2019, (Hong Kong dollar per one U.S. dollar):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%"><font style="font-size: 10pt">Balance sheet date</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">.1290</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">.1284</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Average rate for statements of operations and comprehensive loss</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">.1288</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">.1276</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table represents the Company&#8217;s derivative instruments that are measured at fair value on a recurring basis as of June 30, 2020, and December 31, 2019, for each fair value hierarchy level:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">June 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Derivative <br /> Liabilities</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Total</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Level I</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Level II</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%"><font style="font-size: 10pt">Level III</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">9,471,445</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">9,471,445</font></td> <td style="width: 1%">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Derivative <br /> Liabilities</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Total</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Level I</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Level II</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%"><font style="font-size: 10pt">Level III</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">2,462,940</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">2,462,940</font></td> <td style="width: 1%">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated useful lives of property and equipment is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%"><font style="font-size: 10pt">Office equipment</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">17,979</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">9.590</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less: Accumulated Depreciation</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(7,069</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(5,589</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Property and Equipment, Net</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">10,910</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">4,001</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Following is a summary of customers who accounted for more than ten percent (10%) of the Company&#8217;s revenues for the three and six months ended June 30, 2020, and 2019, and their accounts receivable balance as of June 30, 2020:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Sales % Three Months Ended June 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Sales % Three Months Ended June 30, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Sales % Six Months Ended June 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Sales % Six <br /> Months Ended <br /> June 30, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Accounts receivable balance June 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 28%; padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Customer A</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font-size: 10pt">N/A</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="width: 1%; padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font-size: 10pt">N/A</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="width: 1%; padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; width: 9%; text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin-top: 0; margin-bottom: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Following is a summary of suppliers who accounted for more than ten percent (10%) of the Company&#8217;s purchases for the three and six months ended June 30, 2020, and 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Purchase % Three Months Ended June 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Purchase % Three Months Ended June 30, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Purchase % Six Months Ended June 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Purchase % Six <br /> Months Ended <br /> June 30, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%; padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Supplier A</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font-size: 10pt">N/A</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="width: 1%; padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font-size: 10pt">N/A</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="width: 1%; padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td></tr> <tr> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Recent Accounting Pronouncements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There have no recent accounting pronouncements or changes in accounting pronouncements during the period ended June 30, 2020, that are of significance or potential significance to the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Earnings (Loss) Per Share</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company reports earnings (loss) per share in accordance with ASC 260, &#8220;Earnings per Share.&#8221; Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net loss by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. As of June 30, 2020, and 2019, the Company&#8217;s dilutive securities are convertible into approximately 923,181,023 and 138,402,792 shares of common stock, respectively. This amount is not included in the computation of dilutive loss per share because their impact is antidilutive. The following table represents the classes of dilutive securities as of June 30, 2020, and 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">June 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">June 30, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Common stock to be issued</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,350</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">750</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Convertible preferred stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Convertible notes payable</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">923,129,673</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">138,402,042</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">923,181,023</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">138,402,792</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Foreign Currency Translation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">The accounts of the Company&#8217;s Hong Kong subsidiary are maintained in Hong Kong dollars and the accounts of the U.S. companies are maintained in USD. The accounts of the Hong Kong subsidiary were translated into USD in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 830, Foreign Currency Matters. According to Topic 830, all assets and liabilities were translated at the exchange rate on the balance sheet date; stockholders&#8217; equity is translated at historical rates and statement of comprehensive income items are translated at the weighted average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with ASC Topic 220, Comprehensive Income. Gains and losses resulting from the foreign currency transactions are reflected in the statements of comprehensive income.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Relevant exchange rates used in the preparation of the consolidated financial statements are as follows for the periods ended June 30, 2020 and December 31, 2019, (Hong Kong dollar per one U.S. dollar):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%"><font style="font-size: 10pt">Balance sheet date</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">.1290</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">.1284</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Average rate for statements of operations and comprehensive loss</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">.1288</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">.1276</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Income Taxes</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the deferred tax assets will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tax benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Fair Value of Financial Instruments</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following are the hierarchical levels of inputs to measure fair value:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 48px"><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt">Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.</font></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt">Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.</font></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td><font style="font-size: 10pt">&#9679;</font></td> <td style="text-align: justify"><font style="font-size: 10pt">Level 3 - Unobservable inputs reflecting the Company&#8217;s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying amounts of the Company&#8217;s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table represents the Company&#8217;s derivative instruments that are measured at fair value on a recurring basis as of June 30, 2020, and December 31, 2019, for each fair value hierarchy level:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">June 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Derivative <br /> Liabilities</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Total</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Level I</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Level II</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%"><font style="font-size: 10pt">Level III</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">9,471,445</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">9,471,445</font></td> <td style="width: 1%">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">December 31, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Derivative <br /> Liabilities</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Total</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Level I</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Level II</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%"><font style="font-size: 10pt">Level III</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">2,462,940</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">2,462,940</font></td> <td style="width: 1%">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Convertible Instruments</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of this note transaction and the effective conversion price embedded in this note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Research and Development</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Costs and expenses that can be clearly identified as research and development are charged to expense as incurred. For the six months ended June 30, 2020, and 2019, the Company recorded $-0- and $63,604 of research and development expenses, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Advertising and Marketing Expenses</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expenses advertising and marketing costs as incurred. For the six months ended June 30, 2020, and 2019, the Company recorded $1,226 and $59,422, respectively, of advertising and marketing expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Revenue Recognition</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="background-color: white">Effective January 1, 2018, the Company adopted ASC 606 &#8212; Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. Under ASC 606, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The Company has no outstanding contracts with any of its&#8217; customers. Revenues from Spinus were $1,521 and $47,602 for the three and six months ended June 30, 2019, and are recognized as an agent and are recorded at net. There was no impact on the Company&#8217;s financial statements as a result of adopting Topic 606 for the three and six months ended June 30, 2020, and 2019.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Discontinued Operations</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC 205-20 <i>Presentation of Financial Statements: Discontinued Operations</i>, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity&#8217;s operations and financial results when the components of an entity meets the criteria in paragraph 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations. .</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 16, 2020, the Company pursuant to the termination of the SRI transaction Agreement (see Note 1) which meets the definition of a discontinued operation.. For additional information, see Note 12- Discontinued Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Goodwill</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Goodwill is measured as the excess of consideration transferred and the net of the acquisition date fair value of assets acquired, and liabilities assumed in a business acquisition. During the year ended December 31, 2019, the Company recorded goodwill of $2,277,168, included in assets of discontinued operations in the accompanying balance sheet at December 31, 2019, related to the SRI transaction. The Company reviews the goodwill allocated to each of our reporting units for possible impairment annually and whenever events or changes in circumstances indicate carrying amount may not be recoverable. When assessing goodwill for impairment, the Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its&#8217; carrying amount. If, after assessing the totality of events or circumstances, the Company determines it is more likely than not that the fair value of a reporting unit is less than its&#8217; carrying amount, then the Company performs a two-step impairment test. If the Company concludes otherwise, then no further action is taken. The Company also has the option to bypass the qualitative assessment and only perform a quantitative assessment, which is the first step of the two-step impairment test. In the two-step impairment test, the Company measures the recoverability of goodwill by comparing a reporting unit&#8217;s carrying amount, including goodwill, to the estimated fair value of the reporting unit. During the year ended December 31, 2019. <font style="background-color: white">the Company recorded an impairment of goodwill of $274,854, for the termination of the SRI License Agreement due to no known future cash flows being provided by the assets, and as of January 16, 2020, the Company wrote off the remaining Goodwill balance associated with SRI transaction of $2,002,314.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In assessing the qualitative factors, the Company assesses relevant events and circumstances that may impact the fair value and the carrying amount of the reporting unit. The identification of relevant events and circumstances, and how these may impact a reporting unit&#8217;s fair value or carrying amount involve significant judgments and assumptions. The judgment and assumptions include the identification of macroeconomic conditions, industry, and market considerations, cost factors, overall financial performance and share price trends, and making the assessment as to whether each relevant factor will impact the impairment test positively or negatively and the magnitude of any such impact.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The carrying amount of each reporting unit is determined based upon the assignment of our assets and liabilities, including existing goodwill and other intangible assets, to the identified reporting units. Where an acquisition benefits only one reporting unit, the Company allocates, as of the acquisition date, all goodwill for that acquisition to the reporting unit that will benefit. Where the Company has had an acquisition that benefited more than one reporting unit, The Company has assigned the goodwill to our reporting units as of the acquisition date such that the goodwill assigned to a reporting unit is the excess of the fair value of the acquired business, or portion thereof, to be included in that reporting unit over the fair value of the individual assets acquired and liabilities assumed that are assigned to the reporting unit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">If the carrying amount of a reporting unit is in excess of its fair value, an impairment may exist, and the Company must perform the second step of the impairment analysis to measure the amount of the impairment loss, by allocating the reporting unit&#8217;s fair value to its assets and liabilities other than goodwill, comparing the carrying amount of the goodwill to the resulting implied fair value of the goodwill, and recording an impairment charge for any excess.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Intangible Assets</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">Intangible assets primarily represent purchased patent and license rights. The Company amortizes these costs over the shorter of the legal life of the patent or its estimated economic life using the straight-line method. The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to future undiscounted cash flows to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. For the year ended December 31, 2019, the Company impaired $44,200 of tradenames as management has decided not to go forward with the use of the trade name Spinus. </font>For the three and six months ended June 30, 2020, the Company recorded amortization expense of $10,415 and $20,833, respectively and the three and six months ended June 30, 2019, $10,417 and $20,834, respectively. In accordance with ASC 350, <i>&#8220;Intangibles&#8212;Goodwill and Other,&#8221; </i>goodwill and other intangible assets with indefinite lives are no longer subject to amortization but are tested for impairment annually or whenever events or changes in circumstances indicate that the asset might be impaired.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Property, plant and equipment</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>June 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%"><font style="font-size: 10pt">Office equipment</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">17,979</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">9.590</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less: Accumulated Depreciation</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(7,069</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(5,589</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Property and Equipment, Net</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">10,910</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">4,001</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation expense was $816 and $1,480 for the three and six months ended June 30, 2020, respectively, and $800 and $1,599 for the three and six months ended June 30, 2019, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Purchase concentration</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The principal purchases by the Company is comprised of finished goods that the Company sells to its customers. Following is a summary of suppliers who accounted for more than ten percent (10%) of the Company&#8217;s purchases for the three and six months ended June 30, 2020, and 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Purchase % Three Months Ended June 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Purchase % Three Months Ended June 30, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Purchase % Six Months Ended June 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Purchase % Six <br /> Months Ended <br /> June 30, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%; padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Supplier A</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font-size: 10pt">N/A</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="width: 1%; padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font-size: 10pt">N/A</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="width: 1%; padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Inventory</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory, if any, which consists of finished goods, is valued at the lower of cost or net realizable value. Cost is determined using the first in first out (FIFO) method. Provision for potentially obsolete or slow-moving inventory is made based on management analysis or inventory levels and future sales forecasts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Accounts Receivable</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Sales Concentration and credit risk</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Following is a summary of customers who accounted for more than ten percent (10%) of the Company&#8217;s revenues for the three and six months ended June 30, 2020, and 2019, and their accounts receivable balance as of June 30, 2020:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Sales % Three Months Ended June 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Sales % Three Months Ended June 30, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Sales % Six Months Ended June 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Sales % Six <br /> Months Ended <br /> June 30, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Accounts receivable balance June 30, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 28%; padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Customer A</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font-size: 10pt">N/A</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="width: 1%; padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font-size: 10pt">N/A</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 12%; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="width: 1%; padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; width: 9%; text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Cash and Cash Equivalents</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Use of Estimates</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Emerging Growth Companies</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company qualifies as an &#8220;emerging growth company&#8221; under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging growth company, the Company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company has elected to take advantage of the benefits of this extended transition period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Basis of Presentation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company&#8217;s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June 30, 2020, and the results of operations and cash flows for the periods presented. The results of operations for the three and six months ended June 30, 2020, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the </font>Company&#8217;s Current Report on Form 10-K filed on May 14, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The unaudited condensed consolidated financial statements include the accounts of the Company <font style="background-color: white">and Ozop and its wholly owned subsidiaries Ozop LLC, Ozop HK and Spinus, LLC (&#8220;Spinus&#8221;). All intercompany accounts and transactions have been eliminated in consolidation.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> 100000 49033 15212160 939703 11390835 572229 The former CEO, parent resigned February 28, 2020 The former CEO, subsidiary resigned on March 4, 2019. The Former COO and CCO resigned from those positions on October 1, 2018, and March 4, 2019, respectively. The former COO resigned on October 23, 2019. The former CFO resigned effective February 28, 2020 EX-101.SCH 6 ozsc-20200630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheet (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheet (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statement of Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statement of Changes in Stockholders' Deficit (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statement of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Going Concern and Management's Plans link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summary of Significant Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Convertible Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Derivative Liabilities link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Summary of Significant Accounting Pronouncements (Policies) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Organization (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Summary of Significant Accounting Pronouncements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Convertible Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Derivative Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Related Party Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Discontinued Operations (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Organization (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Organization - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Going Concern and Management's Plans (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Summary of Significant Accounting Pronouncements (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Summary of Significant Accounting Pronouncements - Schedule of Concentration Risk (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Summary of Significant Accounting Pronouncements - Schedule of Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Summary of Significant Accounting Pronouncements - Schedule of Fair Value of Derivative Instruments on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Summary of Significant Accounting Pronouncements - Schedule of Foreign Exchange Rates (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Summary of Significant Accounting Pronouncements - Schedule of Antidilutive Securities (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Intangible Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Convertible Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Convertible Notes Payable - Summary of Convertible Note Balance (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Derivative Liabilities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Derivative Liabilities - Schedule of Derivative Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Related Party Transaction (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Related Party Transactions - Schedule of Expenses to Officers (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Related Party Transactions - Schedule of Expenses to Officers (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Related Party Transactions - Schedule of Former Officers for Accrued Fees, Accounts Payable and Loans (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Income Taxes - Schedule of Provision for Income Tax (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Stockholders' Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Discontinued Operations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - Discontinued Operations - Schedule of Discontinued Operations Condensed Consolidated Statements (Details) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 ozsc-20200630_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 ozsc-20200630_def.xml XBRL DEFINITION FILE EX-101.LAB 9 ozsc-20200630_lab.xml XBRL LABEL FILE Equity Components [Axis] Series C Preferred Stock [Member] Equity Components [Axis] Common Stock [Member] Common Stock to be Issued [Member] Deferred Stock Compensation [Member] Stock Subscription Receivable [Member] Accumulated Comprehensive Income [Member] Additional Paid-in Capital [Member] Accumulated Deficit [Member] Series B Preferred Stock [Member] Debt Instrument [Axis] 2017 Notes [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] 2018 Notes [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Debt Purchase Agreement [Member] Title of Individual [Axis] One Investor [Member] Second Investor [Member] Convertible Promissory Note [Member] Scenario [Axis] After OID [Member] Investor [Member] Convertible Promissory Note One [Member] Investor Two [Member] Investor Six [Member] Securities Purchase Agreement [Member] First Tranche [Member] Master Note [Member] Award Date [Axis] March 7, 2019 [Member] May 29, 2019 [Member] Purchaser [Member] Assignment Agreement [Member] June 22, 2019 [Member] August 29, 2019 [Member] October 24, 2019 [Member] October 25, 2019 [Member] November 27, 2019 [Member] Exclusive License Agreement [Member] Business Acquisition [Axis] Spinal Resources, Inc [Member] Spinal Resources, Inc [Member] Perma Consultants Holding AG [Member] Legal Entity [Axis] Property, Plant and Equipment, Type [Axis] Office Equipment [Member] Fair Value Hierarchy and NAV [Axis] Level I [Member] Level II [Member] Level III [Member] Balance Sheet Date [Member] Award Type [Axis] Hong Kong, Dollars [Member] Average Rate for Statements of Operations and Comprehensive Loss [Member] Finite-Lived Intangible Assets by Major Class [Axis] Patents and License Rights [Member] Measurement Input Type [Axis] Risk-Free Interest Rates [Member] Volatility [Member] Financial Instrument [Axis] Derivative Liabilities [Member] Short-term Debt, Type [Axis] Note Payable [Member] Note Payable One [Member] Note Payable Two [Member] Other [Member] CEO [Member] Related Party [Axis] CEO Former [Member] COO Former [Member] CFO Former [Member] CEO [Member] Licensing Agreement [Member] Separation Agreement [Member] Salman J. Chaudhry [Member] Newbridge Securities Corporation [Member] Investment Banking Engagement Agreement [Member] Consulting Agreement [Member] Executive Vice President [Member] Investor Relations Agreement [Member] Income Tax Authority, Name [Axis] United States Hong Kong Investment Type [Axis] Tranches [Member] CEO and Director [Member] Subsequent Event Type [Axis] Subsequent Event [Member] 15% Convertible Redeemable Note [Member] Employment Agreement [Member] Mr Conway [Member] Concentration Risk Benchmark [Axis] Sales Revenue [Member] Customer [Axis] Customer [Member] Product Revenue [Member] Suppliers [Member] Customer A [Member] Suppliers A [Member] Antidilutive Securities [Axis] Convertible Preferred Stock [Member] Convertible Notes Payable [Member] June 7, 2019 [Member] August 2, 2019 [Member] August 21, 2019 [Member] August 19, 2019 [Member] August 23, 2019 [Member] October 1, 2019 [Member] October 8, 2019 [Member] Securities Purchase Agreement One [Member] January 8, 2020 [Member] February 18, 2020 [Member] Debt Purchase Agreement One [Member] February 26, 2020 [Member] March 9, 2020 [Member] Mr. Chermak [Member] Officers and Directors [Member] Former CEO, Former [Member] Former CEO, Subsidiary [Member] Former COO and CCO [Member] Former COO [Member] Former CFO [Member] Binding Letter of Intent [Member] Series D Preferred Stock [Member] Series E Preferred Stock [Member] Treasury Stock [Member] Series B Preferred Stock [Member] Convertible Promissory Note Two [Member] Investor Seven [Member] Third Party Investor [Member] Investor Converted [Member] April 17, 2020 [Member] April 24, 2020 [Member] April 27, 2020 [Member] April 28, 2020 [Member] 12% Convertible Redeemable Note [Member] May 04, 2020 [Member] May 05, 2020 [Member] May 07, 2020 [Member] May 15, 2020 [Member] May 28, 2020 [Member] June 01, 2020 [Member] June 11, 2020 [Member] June 23, 2020 [Member] June 30, 2020 [Member] Loan and Securities Purchase Agreement [Member] Promissory Note [Member] Lender [Member] Holder [Member] Note Payable Three [Member] One Year Agreement [Member] Certificates of Designation [Member] SPA [Member] PCTI [Member] Series C Preferred Stock [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Flag Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets Cash Advance for acquisition Prepaid expenses Assets of discontinued operations Total Current Assets Property and equipment, net Goodwill License Rights, net of accumulated amortization TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' DEFICIT Liabilities Current Liabilities Accounts payable and accrued expenses Accounts payable and accrued expenses, related parties Convertible notes payable, net of discounts Current portion of notes payable Derivative liabilities Liabilities of discontinued operations Total Current Liabilities Long Term Liabilities Note payable, net of discount TOTAL LIABILITIES Stockholders' Deficit Preferred stock (10,000,000 shares authorized, par value $0.001, 50,000 shares issued and outstanding) Series C Preferred Stock (50,000 shares authorized and 50,000 issued and outstanding, par value $0.001) Common stock (4,990,000,000 shares authorized par value $0.001; 1,549,176,877 and 219,035 shares issued and outstanding June 30, 2020, and December 31, 2019, respectively) Deferred stock compensation Treasury stock, Series C Preferred Stock (47,500 shares, par value $0.001) Common stock to be issued (1,350 shares issuable) Additional paid in capital Accumulated Deficit Stock subscription receivable Accumulated comprehensive gain Total Stockholders' Deficit TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT Statement [Table] Statement [Line Items] Class of Stock [Axis] Preferred stock, shares authorized Preferred stock, par value Preferred stock, shares issued Preferred stock, shares outstanding Common stock, shares authorized Common stock, par value Common stock, shares issued Common stock, shares outstanding Treasury stock, shares Treasury stock, par value Common stock to be issued, shares issuable Income Statement [Abstract] Revenue Operating expenses: General and administrative, related parties General and administrative, other Research and development Impairment Total operating expenses Operating loss Other (income) expenses: Interest expense Loss (Gain) on change in fair value of derivatives Loss on extinguishment of debt Total Other Expenses Loss from continuing operations before income taxes Income tax provision Loss from continuing operations Discontinued operations: Loss from discontinued operations, net of income taxes Gain from license termination, net of income taxes Net loss Other comprehensive income (loss): Foreign currency translation adjustment Comprehensive loss Loss per share basic and fully diluted Weighted average shares outstanding Basic and diluted Beginning balance Beginning balance, shares Shares issued for conversions of note and interest payable Shares issued for conversions of note and interest payable, shares Shares issued in private placement Shares issued in private placement, shares Share issued and to be issued for services Share issued and to be issued for services, shares Reclassification of derivatives for payments of convertible notes Amortization of deferred stock compensation Unrealized gain on foreign translation Adjustment for rounding of reverse split Adjustment for rounding of reverse split, shares Redemption Series C Preferred stock Redemption Series C Preferred stock, shares Issuance Series C Preferred stock as compensation Issuance Series C Preferred stock as compensation, shares Foreign currency translation adjustment Shares of Series B Preferred Stock issued Shares of Series B Preferred Stock issued, shares Shares issued upon cashless exercise of warrants Shares issued upon cashless exercise of warrants, shares Net loss Ending balance Ending balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Net loss from continuing operations Net gain from discontinued operations Adjustments to reconcile net loss to net cash used in operations Non-cash interest expense Amortization and depreciation Loss (Gain) on fair value change of derivatives Stock compensation expense Gain on termination of license Changes in operating assets and liabilities: Accounts receivable Prepaid expenses Accounts payable and accrued expenses Accounts payable and accrued expenses, related parties Net cash used in operating activities-continuing operations Net cash provided by operating activities-discontinued operations Net cash used in operating activities Cash flows from investing activities: Purchase of office and computer equipment Advance for acquisition Net cash used in investing activities Cash flows from financing activities: Redemption of preferred stock Proceeds from sale of common stock Proceeds from issuances of convertible notes payable Proceeds from issuances of notes payable Payments of principal of convertible note payable and notes payable Net cash provided by financing activities Effects of exchange rate on cash Net increase (decrease) in cash Cash, Beginning of period Cash, End of period Supplemental disclosure of cash flow information: Cash paid for interest Cash paid for income taxes Schedule of non-cash Investing or Financing Activity: Original issue discount included in convertible notes payable Default penalties added to convertible notes payable Issuance of common stock upon convertible note and accrued interest conversion Reclassification of notes payable to convertible notes payable Carrying value of assets and liabilities at termination of license with Spinal Resources, Inc. Inventory Implant instruments, net Patent rights, net Goodwill License fee payable Present value of option to buy SRI Common stock payable Iberia Note Equity line payable Note issued for inventory and instruments Accrued interest Gain on termination Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization Going Concern and Management's Plans Accounting Policies [Abstract] Summary of Significant Accounting Pronouncements Goodwill and Intangible Assets Disclosure [Abstract] Intangible Assets Debt Disclosure [Abstract] Convertible Notes Payable Fair Value Disclosures [Abstract] Derivative Liabilities Notes Payable Related Party Transactions [Abstract] Related Party Transactions Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Income Tax Disclosure [Abstract] Income Taxes Equity [Abstract] Stockholders' Equity Discontinued Operations and Disposal Groups [Abstract] Discontinued Operations Subsequent Events [Abstract] Subsequent Events Basis of Presentation Emerging Growth Companies Use of Estimates Cash and Cash Equivalents Sales Concentration and Credit Risk Accounts Receivable Inventory Purchase Concentration Property, Plant and Equipment Intangible Assets Goodwill Discontinued Operations Revenue Recognition Advertising and Marketing Expenses Research and Development Convertible Instruments Fair Value of Financial Instruments Income Taxes Foreign Currency Translation Earnings (Loss) Per Share Recent Accounting Pronouncements Schedule of Fair Value of Assets Acquired and Liabilities Assumed Schedule of Concentration Risk Schedule of Property, Plant and Equipment Schedule of Fair Value of Derivative Instruments on Recurring Basis Schedule of Foreign Exchange Rates Schedule of Antidilutive Securities Schedule of Intangible Assets Summary of Convertible Note Balance Schedule of Derivative Liabilities Schedule of Notes Payable Schedule of Expenses to Officers Schedule of Former Officers for Accrued Fees, Accounts Payable and Loans Schedule of Provision for Income Tax Schedule of Deferred Tax Assets Schedule of Discontinued Operations Condensed Consolidated Statements Payments to acquire businesses Equity ownership percentage Stock issued during period, shares, acquisitions Business combination, consideration transferred License fees Liability Common stock shares issued Number of restricted common stock Consideration of the transaction Number of shares issued on transaction Promissory note Debt instrument interest rate Option to purchase grants Present value of liability Interest expense Total purchase price allocation Impairment on acquisition Gain on termination of license Fair value of consideration issued Liabilities assumed Total purchase price Assets acquired Intellectual Property/Technology Inventory Instruments, net Patent rights, net Goodwill Total assets as of January 16, 2020 Common Stock payable License fee payable Equity Line payable Iberia Note Inventory and Instrument note Accrued interest Option to buy Total consideration and liabilities assumed balances Stockholders' deficit Working capital deficit Concentration of credit risk Depreciation expense Impairments of tradenames Amortization expense Impairment of goodwill Revenues Advertising and marketing expenses Research and development expenses Income tax likelihood description Anti-dilutive shares of common stock Accounts receivable balance Long-Lived Tangible Asset [Axis] Property and Equipment, Gross Less: Accumulated Depreciation Property and Equipment, Net Derivative Liabilities Total Foreign currency exchange rate Gross carrying amount Accumulated amortization Net carrying amount Convertible promissory notes Proceeds form convertible notes Maturity date, description Discount rate Conversion stock price per share Consulting fees Debt instrument carrying value Initial debt discount Interest expenses Initial derivative liability Debt instrument face amount Accrued interest Repayment of debt to third party Purchase price Debt instrument maturity Debt conversion ratio Transaction costs, fees and expenses Amortization of debt discount Debt instrument, periodic payment Diligence expenses Repayment amount for notes Sale of stock Debt instrument carrying value Debt instrument otstanding amount Number of shares of common stock Threshold description Notes payable received Notes payable description Fees payable Payment settled fully Funds received Number of warrants issued to acquire shares of common stock Warrants exercise price Warrants term Payment to acquire Warrants and rights outstanding Debt instrument conversion shares Legal fee Principal balance Unamortized discount Ending balance, net Derivative liability, measurement input Derivative liability, beginning balance Issued during period Converted or paid Change in fair value recognized in operations Derivative liability, ending balance Convertible principal amount Convertible precentage Notes payable Original discount Proceeds from notes payable Debt instrument description Debt instrument face value Warrants issued description Sub total notes payable Less long-term portion, net of discount Current portion of notes payable, net of discount Debt instrument discount Annual salary Common stock issued during the period, shares Number of shares of common stock, share Accrued liabilities - related party Total Stock-based compensation Due to related party Patents and the non-exclusive rights Royalty percentage Outstanding fees Agreement description Stock issued during the period, shares Common stock issued during the period, value Stock- based compensation expense Consulting services General and administrative Accounts payable and accrued expenses Deferred stock compensation Net profit income tax, percentage Net operating loss carryforwards Income tax, description Provision for interest and penalties Pre-tax loss U.S. federal corporate income tax rate Expected U.S. income tax benefit Tax rate difference between U.S. and foreign operations Permanent differences Change of valuation allowance Effective tax expense Net operating losses carried forward Less: Valuation allowance Net deferred tax assets Product and Service [Axis] Reverse stock split Common stock issued during the period Sale of Stock, Description Conversion of convertible debt, aggregate principal Conversion of convertible debt, accrued interest Conversion of convertible debt, shares issued Conversion of convertible debt, conversion price Common stock, authorized Common stock, issued Common stock, outstanding Preferred stock, authorized Number of redeemed shares Number of redeemed shares, value Share price Stock subscription receivable, shares Stock subscription receivable, values Accounts payable and accrued expenses Cost of goods sold Depreciation expense Rent expense Interest expense Total operating expenses Loss from discontinued operations Gain from license termination Inventory Prepaid expenses Property and equipment, net License rights, net Goodwill Total assets included in the assets of discontinued operations Liability for common stock payable Current portion of notes payable Current portion of license fee payable Long term portion of notes payable Long term portion of license fee payable Put option payable Total liabilities included in the liabilities of discontinued operations Number of shares issued upon exercise of warrants Debt instrument, maturity description Debt instrument, description Proceeds received Original issue discount Designation of preferred stock Voting rights Optional redemption per share Shares for acquisition Cash payment Accounts payable and accrued expenses, related parties. Accrued Liabilities Related [Member] Acquisition of Newmarkt [Member] Acquisition of Spinal Resources, Inc [Member] Acquisition of Spinus, LLC [Member] After OID [Member] Agreement description. Assignment Agreement [Member] August 29, 2019 [Member] Average Rate for Statements of Operations and Comprehensive Loss [Member] Balance Sheet Date [Member] Bank Line of Credit [Member] Binding Letter of Intent [Member] Board of Directors [Member] Goodwill. Instruments, net. Common Stock payable Equity Line payable Inventory and Instrument note. License fee payable Iberia Note. Option to buy. Patent rights, net. Former CCO [Member] CEO and Director [Member] CEO and Director [Member] Common Stock [Member] October PPM [Member] Common Stock to be Issued [Member] Common stock to be issued, shares issuable. Common stock to be issued. Consulting Agreement [Member] Consulting Agreement One [Member] Consulting services. Converted or paid. Convertible instruments [Policy Text Block]. Convertible Promissory Note Four [Member] Convertible Promissory Note [Member] Convertible Promissory Note One [Member] Convertible Promissory Note Three [Member] Convertible Promissory Note Two [Member] Customer A [Member] Customer B [Member] Customer C [Member] Customer [Member] Debt Purchase Agreement [Member] Denis Razvodovskij [Member] Issued during period. Draper Inc. [Member] Emerging growth companies [Policy Text Block]. Employment Agreement [Member] Equity Line of Credit [Member] Exclusive License Agreement [Member] Executive Officers and Directors [Member] First Tranche [Member] Former COO and CCO [Member] Former Officers [Member] General and administrative, related parties. Hong Kong, Dollars [Member] Income tax, description. Initial Noteholder [Member] Investment Banking Engagement Agreement [Member] Investor Five [Member] Investor Four [Member] Investor Relations Agreement [Member] Investor Six [Member] Investor Three [Member] Investor Two [Member] June 22, 2019 [Member] Kingdom Building, Inc. [Member] License fee payable. Licensing Agreement [Member] March 7, 2019 [Member] Master Note [Member] May 7, 2019 [Member] May 3, 2019 [Member] May 29, 2019 [Member] Monthly [Member] Newbridge Securities Corporation [Member] Non-Officer Affiliate [Member] Patent rights. Note Assignment Agreement [Member] Note Payable [Member] Note Payable One [Member] Note Payable Two [Member] Notes Payable [Text Block]. November 27, 2019 [Member] Number of shares issued upon exercise of warrants. OZOP Shareholders [Member] October 25, 2019 [Member] October 24, 2019 [Member] One Investor [Member] Original issue discount included in convertible notes payable. Other [Member] Patents and License Rights [Member] Patents and the non-exclusive rights. Perma Consultants Holding AG [Member] Pledge Agreement [Member] Present value of option to buy. Prdouct Revenue [Member] Purchase concentration [Policy Text Block]. Purchase price. Purchaser [Member] Redemption Agreement [Member] Royalty percentage. SRI Agreement [Member] Sales Revenue [Member] Salman J. Chaudhry [Member] Schedule of foreign exchange rates [Table Text Block]. Schedule of notes payable [Table Text Block]. Second Investor [Member] Second Tranche [Member] Securities Purchase Agreement [Member] Seperation Agreement [Member] Share Exchange Agreement [Member] Shares issued for conversions of note and interest payable, shares. Shares issued for conversions of note and interest payable. Spinal Instruments [Member] Spinal Resource, Inc. [Member] Spinal Resources, Inc [Member] Spinal Resources, Inc [Member] Spinus LLC [Member] Stock-based Compensation Expense-Related Parties [Member] Stock subscription receivable, shares. Stock subscription receivable, values. Stock Subscription Receivable [Member] Non-officer affiliate [Member] Suppliers A [Member] Suppliers B [Member] Suppliers C [Member] Suppliers [Member] Third Parties [Member] 2018 Notes [Member] 2017 Notes [Member] Web-Site Development Services Reclassification of derivatives for payments of convertible notes. Adjustment for rounding of reverse split. Adjustment for rounding of reverse split, shares. Issuance Series C Preferred stock as compensation. Issuance Series C Preferred stock as compensation, shares. Common stock payable. Iberia Note. Equity line payable. Note issued for inventory and instruments. Accrued interest. Gain on termination. Gain On Termination Of License. Reclassification of notes payable to convertible notes payable. Implant instruments, net. Default penalties added to convertible notes payable. Mr Conway [Member] Promissory Note. present value of Liability. Impairment on acquisition. Fair value of consideration issued. Total purchase price. Assets acquired. Accrued interest. Working capital deficit. Impairments of tradenames. June 7, 2019 [Member] August 2, 2019 [Member] August 21, 2019 [Member] August 19, 2019 [Member] August 23, 2019 [Member] October 1, 2019 [Member] October 8, 2019 [Member] Securities Purchase Agreement One [Member] January 8, 2020 [Member] February 18, 2020 [Member] Debt Purchase Agreement One [Member] February 26, 2020 [Member] March 9, 2020 [Member] Discount rate. Consulting fees. Debt instrument carrying value. Diligence expenses. Notes payable description. Funds received. Outstanding fees. Net profit income tax, percentage. Mr. Chermak [Member] Officers and Directors [Member] Rent expense. Gain from license termination. Discontinued operations license rights, net. Discontinued operations liability for common stock payable. Discontinued operations current portion of notes payable. Discontinued operations current portion of license fee payable. Discontinued operations long term portion of notes payable. Discontinued operations long term portion of license fee payable. Discontinued operations put option payable. Promissory Note [Member] Gain from license termination, net of income taxes. Accrued liabilities - related party. Schedule of Former Officers for Accrued Fees, Accounts Payable and Loans [Table Text Block] Former CEO, Former [Member] Former CEO, Subsidiary [Member] Former COO and CCO [Member] Former COO [Member] Former CFO [Member] Advance for acquisition. Treasury stock, par value. Shares of Series B Preferred Stock issued. Shares of Series B Preferred Stock issued, shares. Shares issued upon cashless exercise of warrants. Shares issued upon cashless exercise of warrants, shares. Investor Seven [Member] Third Part yInvestor [Member] Debt instrument otstanding amount. Investor Converted Member. April Seventeen Thousand And Twenty [Member] April 24, 2020 [Member] 15% Convertible Redeemable Note [Member] April 28, 2020 [Member] 12% Convertible Redeemable Note [Member] Legal fee. May 04, 2020 [Member] April 27, 2020 [Member] May 05, 2020 [Member] May 07, 2020 [Member] May 15, 2020 [Member] May 28, 2020 [Member] June 01, 2020 [Member] June 11, 2020 [Member] June 23, 2020 [Member] June 30, 2020 [Member] Loan and Securities Purchase Agreement [Member] Lender [Member] Holder [Member] Warrants issued description. Note Payable Three [Member] One Year Agreement [Member] Designation of preferred stock. Certificates of Designation [Member] Optional redemption per share. SPA [Member] PCTI [Member] Series C Preferred Stock [Member] Equity Components [Axis] [Default Label] SpinalResourcesIncMember Non-officer affiliate Preferred Stock [Member] PreferredStockSeriesCMember Assets, Current Assets Liabilities, Current Treasury Stock, Value Common Stock, Share Subscribed but Unissued, Subscriptions Receivable Liabilities and Equity Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest GainFromLicenseTerminationNetOfIncomeTaxes Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding Temporary Equity, Foreign Currency Translation Adjustments Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax GainOnTerminationOfLicense Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Accounts Payable, Related Parties Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Payments for Repurchase of Preferred Stock and Preference Stock Repayments of Notes Payable Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired3 Noncash or Part Noncash Acquisition, Intangible Assets Acquired Inventory, Policy [Policy Text Block] Intangible Assets, Finite-Lived, Policy [Policy Text Block] Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Discontinued Operations, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] Interest Expense Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesLicenseFeePayable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNote BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccruedInterest Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Derivative Assets (Liabilities), at Fair Value, Net Interest Payable Debt Instrument, Convertible, Carrying Amount of Equity Component Salary and Wage, Excluding Cost of Good and Service Sold Accounts Payable and Accrued Liabilities Effective Income Tax Rate Reconciliation, Tax Credit, Amount Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities Disposal Group, Including Discontinued Operation, Depreciation and Amortization Disposal Group, Including Discontinued Operation, Interest Expense Disposal Group, Including Discontinued Operation, Operating Expense Disposal Group, Including Discontinued Operation, Operating Income (Loss) Disposal Group, Including Discontinued Operation, Inventory Disposal Group, Including Discontinued Operation, Prepaid and Other Assets Disposal Group, Including Discontinued Operation, Property, Plant and Equipment Disposal Group, Including Discontinued Operation, Goodwill Disposal Group, Including Discontinued Operation, Assets DisposalGroupIncludingDiscontinuedOperationNotesPayableCurrent Disposal Group, Including Discontinued Operation, Liabilities EX-101.PRE 10 ozsc-20200630_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document and Entity Information - shares
 6 Months Ended
Jun. 30, 2020
Aug. 10, 2020
Document And Entity Information    
Entity Registrant Name OZOP SURGICAL CORP.  
Entity Central Index Key 0001679817  
Document Type 10-Q  
Document Period End Date Jun. 30, 2020  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business Flag true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   2,904,963,462
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2020  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheet (Unaudited) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Current Assets    
Cash $ 304,676 $ 10,877
Advance for acquisition 400,000
Prepaid expenses 2,167 5,417
Assets of discontinued operations 5,462,195
Total Current Assets 706,843 5,478,489
Property and equipment, net 10,910 4,001
Goodwill 194,951 194,951
License Rights, net of accumulated amortization 151,041 171,875
TOTAL ASSETS 1,063,745 5,849,316
Current Liabilities    
Accounts payable and accrued expenses 419,355 370,640
Accounts payable and accrued expenses, related parties 419,692 470,886
Convertible notes payable, net of discounts 1,767,505 1,694,227
Current portion of notes payable 270,030 425,033
Derivative liabilities 9,471,445 2,462,940
Liabilities of discontinued operations 75,270 5,592,706
Total Current Liabilities 12,423,299 11,016,432
Long Term Liabilities    
Note payable, net of discount 176,365
TOTAL LIABILITIES 12,599,663 11,016,432
Stockholders' Deficit    
Preferred stock (10,000,000 shares authorized, par value $0.001, 50,000 shares issued and outstanding) Series C Preferred Stock (50,000 shares authorized and 50,000 issued and outstanding, par value $0.001) 50 50
Common stock (4,990,000,000 shares authorized par value $0.001; 1,549,176,877 and 219,035 shares issued and outstanding June 30, 2020, and December 31, 2019, respectively) 1,549,177 219
Deferred stock compensation (49,033)
Treasury stock, Series C Preferred Stock (47,500 shares, par value $0.001) (100,000)
Common stock to be issued (1,350 shares issuable) 1 1
Additional paid in capital 28,452,220 5,090,936
Accumulated Deficit (41,436,232) (10,208,905)
Stock subscription receivable (7,600) (7,600)
Accumulated comprehensive gain 6,466 7,216
Total Stockholders' Deficit (11,535,918) (5,167,116)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 1,063,745 $ 5,849,316
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheet (Unaudited) (Parenthetical) - $ / shares
Jun. 30, 2020
Dec. 31, 2019
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares issued 50,000 50,000
Preferred stock, shares outstanding 50,000 50,000
Common stock, shares authorized 4,990,000,000 4,990,000,000
Common stock, par value $ 0.001 $ 0.001
Common stock, shares issued 1,549,176,877 219,035
Common stock, shares outstanding 1,549,176,877 219,035
Common stock to be issued, shares issuable 1,350 1,350
Series C Preferred Stock [Member]    
Preferred stock, shares authorized 50,000 50,000
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares issued 50,000 50,000
Preferred stock, shares outstanding 50,000 50,000
Treasury stock, shares 47,500  
Treasury stock, par value $ 0.001  
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statement of Comprehensive Loss (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Revenue $ 1,521 $ 49,123
Operating expenses:        
General and administrative, related parties 30,000 163,000 87,505 283,000
General and administrative, other 170,006 453,454 291,241 1,048,819
Research and development 10,400 63,604
Impairment 44,200 44,200
Total operating expenses 200,006 671,054 378,746 1,439,623
Operating loss (200,006) (669,533) (378,746) (1,390,500)
Other (income) expenses:        
Interest expense 11,390,835 572,229 15,212,160 939,703
Loss (Gain) on change in fair value of derivatives 2,148,349 (20,762) 3,682,522 (68,372)
Loss on extinguishment of debt 11,816,065 696,241 12,011,607 559,566
Total Other Expenses 25,355,250 1,247,708 30,906,290 1,430,897
Loss from continuing operations before income taxes (25,555,256) (1,917,241) (31,285,036) (2,821,397)
Income tax provision
Loss from continuing operations (25,555,256) (1,917,241) (31,285,036) (2,821,397)
Discontinued operations:        
Loss from discontinued operations, net of income taxes (29,147)
Gain from license termination, net of income taxes 86,856
Net loss (25,555,256) (1,917,241) (31,227,327) (2,821,397)
Other comprehensive income (loss):        
Foreign currency translation adjustment (9) (717) (750) (530)
Comprehensive loss $ (25,555,265) $ (1,917,958) $ (31,228,077) $ (2,821,927)
Loss per share basic and fully diluted $ (0.06) $ (59.54) $ (0.14) $ (91.87)
Weighted average shares outstanding Basic and diluted 432,058,100 32,203 217,814,987 30,711
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statement of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Common Stock [Member]
Common Stock to be Issued [Member]
Series B Preferred Stock [Member]
Treasury Stock [Member]
Series C Preferred Stock [Member]
Deferred Stock Compensation [Member]
Stock Subscription Receivable [Member]
Accumulated Comprehensive Income [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Beginning balance at Dec. 31, 2018 $ 29     $ (269,167) $ (7,600) $ 8,228 $ 1,988,897 $ (4,068,747) $ (2,348,360)
Beginning balance, shares at Dec. 31, 2018 29,068                
Shares issued for conversions of note and interest payable     51,750 51,750
Shares issued for conversions of note and interest payable, shares 231                    
Shares issued in private placement     80,000   80,000
Shares issued in private placement, shares 160                    
Share issued and to be issued for services $ 1     (422,100) 422,099
Share issued and to be issued for services, shares 171 450                  
Reclassification of derivatives for payments of convertible notes     18,479 18,479
Amortization of deferred stock compensation     395,720 395,720
Unrealized gain on foreign translation     187 187
Net loss     (904,156) (904,156)
Ending balance at Mar. 31, 2019 $ 29 $ 1 (295,547) (7,600) 8,415 2,561,225 (4,972,903) (2,706,380)
Ending balance, shares at Mar. 31, 2019 29,630 450              
Beginning balance at Dec. 31, 2018 $ 29     (269,167) (7,600) 8,228 1,988,897 (4,068,747) (2,348,360)
Beginning balance, shares at Dec. 31, 2018 29,068                
Net loss                     (2,821,397)
Ending balance at Jun. 30, 2019 $ 35 $ 1 $ 1 (115,065) (7,600) 7,698 3,732,533 (6,890,144) (3,272,541)
Ending balance, shares at Jun. 30, 2019 35,467 900 1,000            
Beginning balance at Dec. 31, 2018 $ 29     (269,167) (7,600) 8,228 1,988,897 (4,068,747) (2,348,360)
Beginning balance, shares at Dec. 31, 2018 29,068                
Shares issued in private placement                     $ 410,370
Shares issued in private placement, shares                     1,350
Ending balance at Dec. 31, 2019 $ 219 $ 1   $ 50 (49,033) (7,600) 7,216 5,090,936 (10,208,905) $ (5,167,116)
Ending balance, shares at Dec. 31, 2019 219,035 1,350     50,000            
Beginning balance at Mar. 31, 2019 $ 29 $ 1 (295,547) (7,600) 8,415 2,561,225 (4,972,903) (2,706,380)
Beginning balance, shares at Mar. 31, 2019 29,630 450              
Shares issued for conversions of note and interest payable $ 6 995,809 995,815
Shares issued for conversions of note and interest payable, shares 5,597                    
Shares issued in private placement 20,000 20,000
Shares issued in private placement, shares 40                    
Share issued and to be issued for services $ 0   (55,500)   87,500 32,000
Share issued and to be issued for services, shares 200 450                  
Amortization of deferred stock compensation 235,982 235,982
Unrealized gain on foreign translation (717) (717)
Shares of Series B Preferred Stock issued $ 35 $ 1 67,999 68,000
Shares of Series B Preferred Stock issued, shares 35,467 1,000                
Net loss (1,917,241) (1,917,241)
Ending balance at Jun. 30, 2019 $ 35 $ 1 $ 1 (115,065) (7,600) 7,698 3,732,533 (6,890,144) (3,272,541)
Ending balance, shares at Jun. 30, 2019 35,467 900 1,000            
Beginning balance at Dec. 31, 2019 $ 219 $ 1   $ 50 (49,033) (7,600) 7,216 5,090,936 (10,208,905) (5,167,116)
Beginning balance, shares at Dec. 31, 2019 219,035 1,350     50,000            
Shares issued for conversions of note and interest payable $ 4,939   1,127,959 1,127,959
Shares issued for conversions of note and interest payable, shares 4,939,400                    
Amortization of deferred stock compensation   49,033 49,033
Adjustment for rounding of reverse split  
Adjustment for rounding of reverse split, shares 58                    
Redemption Series C Preferred stock   $ (50,000)   (50,000)
Redemption Series C Preferred stock, shares   (2,500)            
Issuance Series C Preferred stock as compensation   4,998 5,000
Issuance Series C Preferred stock as compensation, shares   2,500            
Foreign currency translation adjustment   (741) (741)
Net loss   (5,672,071) (5,672,071)
Ending balance at Mar. 31, 2020 $ 5,158 $ 1   $ (50,000) $ 50 (7,600) 6,475 6,223,895 (15,880,976) (9,702,997)
Ending balance, shares at Mar. 31, 2020 5,158,493 1,350   50,000            
Beginning balance at Dec. 31, 2019 $ 219 $ 1   $ 50 (49,033) (7,600) 7,216 5,090,936 (10,208,905) $ (5,167,116)
Beginning balance, shares at Dec. 31, 2019 219,035 1,350     50,000            
Shares issued in private placement, shares                     1,350
Redemption Series C Preferred stock                     $ (50,000)
Net loss                     (31,227,327)
Ending balance at Jun. 30, 2020 $ 1,549,177 $ 1   (100,000) $ 50 (7,600) 6,466 28,452,220 (41,436,232) (11,535,918)
Ending balance, shares at Jun. 30, 2020 1,549,176,877 1,350     50,000            
Beginning balance at Mar. 31, 2020 $ 5,158 $ 1   $ (50,000) $ 50 (7,600) 6,475 6,223,895 (15,880,976) (9,702,997)
Beginning balance, shares at Mar. 31, 2020 5,158,493 1,350   50,000            
Shares issued for conversions of note and interest payable $ 1,439,298   21,620,570 21,620,570
Shares issued for conversions of note and interest payable, shares 1,439,298,485                
Redemption Series C Preferred stock   $ (50,000) (50,000)
Redemption Series C Preferred stock, shares                
Foreign currency translation adjustment   (9) (9)
Shares issued upon cashless exercise of warrants $ 104,720   607,755 712,475
Shares issued upon cashless exercise of warrants, shares 104,719,899                    
Net loss   (25,555,256) (25,555,256)
Ending balance at Jun. 30, 2020 $ 1,549,177 $ 1   $ (100,000) $ 50 $ (7,600) $ 6,466 $ 28,452,220 $ (41,436,232) $ (11,535,918)
Ending balance, shares at Jun. 30, 2020 1,549,176,877 1,350     50,000            
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Cash flows from operating activities:          
Net loss from continuing operations $ (25,555,256) $ (1,917,241) $ (31,285,036) $ (2,821,397)  
Net gain from discontinued operations     57,709  
Adjustments to reconcile net loss to net cash used in operations          
Non-cash interest expense     14,727,584 860,561  
Amortization and depreciation     22,313 22,433  
Loss (Gain) on fair value change of derivatives 2,148,349 (20,762) 3,682,522 (68,372)  
Loss on extinguishment of debt 11,816,065 696,241 12,011,607 559,566  
Stock compensation expense     54,033 706,702 $ 410,370
Gain on termination of license     (86,856)  
Impairment 44,200 44,200  
Changes in operating assets and liabilities:          
Accounts receivable     42,590  
Prepaid expenses     3,249 7,359  
Accounts payable and accrued expenses     481,140 137,501  
Accounts payable and accrued expenses, related parties     (51,193) (28,924)  
Net cash used in operating activities-continuing operations     (440,638) (537,780)  
Net cash provided by operating activities-discontinued operations     89,326  
Net cash used in operating activities     (351,312) (537,780)  
Cash flows from investing activities:          
Purchase of office and computer equipment     (8,389)  
Advance for acquisition     (400,000)  
Net cash used in investing activities     (408,389)  
Cash flows from financing activities:          
Redemption of preferred stock     (100,000)  
Proceeds from sale of common stock     100,000  
Proceeds from issuances of convertible notes payable     803,250 494,950  
Proceeds from issuances of notes payable     351,000  
Payments of principal of convertible note payable and notes payable     (102,805)  
Net cash provided by financing activities     1,054,250 492,145  
Effects of exchange rate on cash     (750) (530)  
Net increase (decrease) in cash     293,799 (46,165)  
Cash, Beginning of period     10,877 50,903 50,903
Cash, End of period $ 304,676 $ 4,738 304,676 4,738 $ 10,877
Supplemental disclosure of cash flow information:          
Cash paid for interest     47,737 3,135  
Cash paid for income taxes      
Schedule of non-cash Investing or Financing Activity:          
Original issue discount included in convertible notes payable     202,500 66,050  
Default penalties added to convertible notes payable     1,680,544  
Issuance of common stock upon convertible note and accrued interest conversion     3,207,320 155,440  
Reclassification of notes payable to convertible notes payable     330,000  
Carrying value of assets and liabilities at termination of license with Spinal Resources, Inc.          
Inventory     374,500  
Implant instruments, net     350,825  
Patent rights, net     2,714,204  
Goodwill     2,002,314  
License fee payable     (1,234,089)  
Present value of option to buy SRI     (2,899,420)  
Common stock payable     (245,000)    
Iberia Note     (447,153)  
Equity line payable     (45,359)  
Note issued for inventory and instruments     (640,699)  
Accrued interest     (16,979)  
Gain on termination     $ 86,856  
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Organization
 6 Months Ended
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization

NOTE 1 - ORGANIZATION

 

Business

 

Ozop Surgical Corp. (the” Company,” “we,” “us” or “our”) was originally incorporated as Newmarkt Corp. on July 17, 2015, under the laws of the State of Nevada. Following the acquisition of OZOP Surgical, Inc. (“Ozop”) as discussed below, we have been engaged in the business of inventing, designing, developing, manufacturing and distributing innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies, focused on spine, neurological and pain management procedures and specialties.

 

Stock Purchase Agreement

 

On February 28, 2020, the Company entered into a Binding Letter of Intent (the “LOI”) with Power Conversion Technologies, Inc., a Pennsylvania corporation (“PCTI”), and Catherine Chis (“Chis”), PCTI’s Chief Executive Officer (“CEO”) and its sole shareholder. On June 26, 2020, the Company, PCTI and Chis signed a Stock Purchase Agreement (the “SPA”) and on July 10, 2020, the Company closed the SPA with PCTI and Chis, the sole shareholder of PCTI. Under the terms of the SPA, the Company acquired one thousand (1,000) shares of PCTI, which represents all of the outstanding shares of PCTI, from Chis in exchange for a cash payment of $400,000 (of which $100,000 was paid May 26, 2020, and $300,000 was paid June 26,2020) and is presented as advance for acquisition on the accompanying balance sheet, and the issuance of 47,500 shares of the Company’s Series C Preferred Stock, 18,667 shares of the Company’s Series D Preferred Stock, and 500 shares of the Company’s Series E Preferred Stock to Chis. PCTI operates in the very high-power niche of the power electronics market, designing and manufacturing leading edge equipment for use in power conversion applications. PCTI serves clients in several industries including energy storage, shore power, DEWs, microgrid, telecommunications, military, transportation, renewable energy, aerospace and mission critical defense systems. PCTI’s clients include Fortune 500 companies, all branches of the US Department of Defense including the US Army and the US Air Force, NASA as well as other global military organizations

 

Acquisition and Termination of Exclusive License Agreement

 

On August 23, 2019, the Company entered into an Exclusive License Agreement (the “Agreement”) with Spinal Resources, Inc. (“SRI”). Pursuant to the Agreement, SRI granted to the Company an exclusive license, for products, as defined in the Agreement, and utilized in spine and related surgical procedures. In accordance with ASC 805, the Company has determined to account for the Agreement as a business combination. As consideration for the Agreement, the Company agreed to pay license fees equal to $1,500,000, over the eighteen- month term of the Agreement. The Company recorded the liability at its present value of $1,234,089. Additionally, the Company has agreed to issue 6,000 shares of restricted common stock on a quarterly basis, pursuant to the terms of the Agreement, of which 1,000 shares were issued on August 23, 2019. The Company valued the shares issued at $49,000 (based on the market price of the common stock) and included the $49,000 as part of the consideration of the transaction. The remaining 5,000 shares to be issued has been recorded as a $245,000 liability to be paid in common stock and was included in the total consideration issued in the transaction. The Company also issued a Promissory Note (the “Note”) to SRI for $723,524 for the purchase of the inventory of the Products (as defined in the Agreement). This note has a stated interest rate of six percent (6%) and payment terms of this note are in eighteen equal instalments, beginning on October 1, 2019. Either party may terminate the Agreement upon written notice if the other party has failed to remedy a material breach within 30 days (or 15 days in the case of a breach of a payment obligation). SRI also granted the Company an option to purchase the Company on or before the termination date of the license for a minimum of $5,500,000 which could have been increased based on the revenue rate at the time the option would be exercised. If the Company did not elect to exercise their option to purchase SRI, SRI can “put” the Acquisition to the Company. Any payments made for the license, this note and other liabilities assumed by the Company can be net against the option to buy price. The Company calculated the net minimum purchase price to be $3,093,604 and recorded the liability at its present value of $2,834,692. The difference of $258,912 was charged to interest expense over the option period.

 

The following table summarizes the preliminary value of the consideration issued and the preliminary purchase price allocation of the fair value of assets acquired and liabilities assumed in the transaction:

 

    Purchase Price Allocation  
Fair value of consideration issued   $ 5,286,305  
Liabilities assumed     524,387  
Total purchase price   $ 5,810,692  
Assets acquired   $ 723,524  
Intellectual Property/Technology     2,810,000  
Goodwill     2,277,168  
    $ 5,810,692  

 

The total purchase price of $5,810,692 has been allocated on a preliminary basis to the tangible and intangible assets acquired and liabilities assumed based on preliminary estimated fair values as of the completion of the transaction. These allocations reflect various preliminary estimates that are currently available and are subject to change upon the valuation being finalized within the measurement period.

 

On January 16, 2020, the Company received from SRI notice that the Agreement dated August 23, 2019, between SRI and the Company has been revoked, as the Company did not make the required January 6, 2020, license payment nor cure the default. Based on the termination of the Agreement, the Company recorded an impairment charge to goodwill of $274,854 as of December 31, 2019. The impairment charge was calculated as the difference of the carrying values of the assets acquired compared to the consideration and liabilities assumed in the transaction.

 

The Company recorded a gain of $86,856 for the six months ended June 30, 2020 based on the difference of the carrying values of the assets acquired and liabilities that were assumed in the transaction as follows:

 

Assets      
Inventory   $ 374,500  
Instruments, net     350,825  
Patent rights, net     2,714,204  
Goodwill     2,002,314  
Total assets as of January 16, 2020   $ 5,441,843  

 

Consideration issued and liabilities assumed      
Common Stock payable   $ 245,000  
License fee payable     1,234,089  
Equity Line payable     45,359  
Iberia Note     447,153  
Inventory and Instrument note     640,699  
Accrued interest     16,979  
Option to buy     2,899,420  
Total consideration and liabilities assumed balances   $ 5,528,699  
Gain on termination of license   $ 86,856  

 

See Note 12 for further discussion on discontinued operations.

 

Corporate Matters

 

OZOP was originally incorporated in Switzerland on November 28, 1998 under the name Perma Consultants Holding AG (“Perma”). On July 19, 2016, Mr. Eric Siu (“Siu”), a former director purchased 100% of the outstanding capital stock of Perma and changed the name from Perma to Ozop Surgical AG (“Ozop AG”). On February 1, 2018, Ozop AG was re-domiciled as a Delaware corporation and changed its name to Ozop Surgical, Inc. On July 28, 2016, Ozop formed as the sole member, Ozop Surgical, LLC (“Ozop LLC”), a Wyoming limited liability company. On October 28, 2016, Ozop acquired 100% of Ozop Surgical Limited (“Ozop HK”), from Siu, the sole shareholder of Ozop HK. Ozop HK, is a private limited company incorporated in Hong Kong.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Going Concern and Management's Plans
 6 Months Ended
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Going Concern and Management's Plans

NOTE 2 – GOING CONCERN AND MANAGEMENT’S PLANS

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. On January 16, 2020, the Company received from SRI notice that the Agreement dated August 23, 2019, between SRI and the Company has been revoked, as the Company did not cure a payment default within the cure period. As of June 30, 2020, the Company had a stockholders’ deficit of $11,535,918 and a working capital deficit of $11,716,456. In addition, the Company has generated losses since inception. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern.

 

In December 2019, a novel strain of coronavirus (COVID-19) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to most other countries and infections have been reported globally. Because COVID-19 infections have been reported throughout the United States, certain federal, state and local governmental authorities have issued stay-at-home orders, proclamations and/or directives aimed at minimizing the spread of COVID-19. The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but it may have a material adverse impact on our business, financial condition and results of operations. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which it may have an impact cannot be determined at this time.

 

Management’s Plans

 

As a public company, management believes it will be able to access the public equities market for fund raising for product development and regulatory approvals, sales and marketing and as we expand our distribution in the US market, we will need to meet increasing inventory requirements.

 

On July 10, 2020, the Company entered into the SPA with PCTI, and Chis, PCTI’s CEO and its sole shareholder (see Note 1).

 

The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Pronouncements
 6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Summary of Significant Accounting Pronouncements

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING PRONOUNCEMENTS

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June 30, 2020, and the results of operations and cash flows for the periods presented. The results of operations for the three and six months ended June 30, 2020, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Current Report on Form 10-K filed on May 14, 2020.

 

The unaudited condensed consolidated financial statements include the accounts of the Company and Ozop and its wholly owned subsidiaries Ozop LLC, Ozop HK and Spinus, LLC (“Spinus”). All intercompany accounts and transactions have been eliminated in consolidation.

 

Emerging Growth Companies

 

The Company qualifies as an “emerging growth company” under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging growth company, the Company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company has elected to take advantage of the benefits of this extended transition period.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits

 

Sales Concentration and credit risk

 

Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the three and six months ended June 30, 2020, and 2019, and their accounts receivable balance as of June 30, 2020:

 

    Sales % Three Months Ended June 30, 2020     Sales % Three Months Ended June 30, 2019     Sales % Six Months Ended June 30, 2020     Sales % Six
Months Ended
June 30, 2019		     Accounts receivable balance June 30, 2020  
Customer A     N/A       100 %     N/A       100 %   $       -  
                                         

 

Accounts Receivable

 

The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.

 

Inventory

 

Inventory, if any, which consists of finished goods, is valued at the lower of cost or net realizable value. Cost is determined using the first in first out (FIFO) method. Provision for potentially obsolete or slow-moving inventory is made based on management analysis or inventory levels and future sales forecasts.

 

Purchase concentration

 

The principal purchases by the Company is comprised of finished goods that the Company sells to its customers. Following is a summary of suppliers who accounted for more than ten percent (10%) of the Company’s purchases for the three and six months ended June 30, 2020, and 2019:

 

    Purchase % Three Months Ended June 30, 2020     Purchase % Three Months Ended June 30, 2019     Purchase % Six Months Ended June 30, 2020     Purchase % Six
Months Ended
June 30, 2019		  
Supplier A     N/A       100 %     N/A       100 %
                                 

 

Property, plant and equipment

 

Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets.

 

The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows:

 

    June 30, 2020     December 31, 2019  
Office equipment   $ 17,979     $ 9.590  
Less: Accumulated Depreciation     (7,069 )     (5,589 )
Property and Equipment, Net   $ 10,910     $ 4,001  

 

Depreciation expense was $816 and $1,480 for the three and six months ended June 30, 2020, respectively, and $800 and $1,599 for the three and six months ended June 30, 2019, respectively.

 

Intangible Assets

 

Intangible assets primarily represent purchased patent and license rights. The Company amortizes these costs over the shorter of the legal life of the patent or its estimated economic life using the straight-line method. The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to future undiscounted cash flows to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. For the year ended December 31, 2019, the Company impaired $44,200 of tradenames as management has decided not to go forward with the use of the trade name Spinus. For the three and six months ended June 30, 2020, the Company recorded amortization expense of $10,415 and $20,833, respectively and the three and six months ended June 30, 2019, $10,417 and $20,834, respectively. In accordance with ASC 350, “Intangibles—Goodwill and Other,” goodwill and other intangible assets with indefinite lives are no longer subject to amortization but are tested for impairment annually or whenever events or changes in circumstances indicate that the asset might be impaired.

 

Goodwill

 

Goodwill is measured as the excess of consideration transferred and the net of the acquisition date fair value of assets acquired, and liabilities assumed in a business acquisition. During the year ended December 31, 2019, the Company recorded goodwill of $2,277,168, included in assets of discontinued operations in the accompanying balance sheet at December 31, 2019, related to the SRI transaction. The Company reviews the goodwill allocated to each of our reporting units for possible impairment annually and whenever events or changes in circumstances indicate carrying amount may not be recoverable. When assessing goodwill for impairment, the Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its’ carrying amount. If, after assessing the totality of events or circumstances, the Company determines it is more likely than not that the fair value of a reporting unit is less than its’ carrying amount, then the Company performs a two-step impairment test. If the Company concludes otherwise, then no further action is taken. The Company also has the option to bypass the qualitative assessment and only perform a quantitative assessment, which is the first step of the two-step impairment test. In the two-step impairment test, the Company measures the recoverability of goodwill by comparing a reporting unit’s carrying amount, including goodwill, to the estimated fair value of the reporting unit. During the year ended December 31, 2019. the Company recorded an impairment of goodwill of $274,854, for the termination of the SRI License Agreement due to no known future cash flows being provided by the assets, and as of January 16, 2020, the Company wrote off the remaining Goodwill balance associated with SRI transaction of $2,002,314.

 

In assessing the qualitative factors, the Company assesses relevant events and circumstances that may impact the fair value and the carrying amount of the reporting unit. The identification of relevant events and circumstances, and how these may impact a reporting unit’s fair value or carrying amount involve significant judgments and assumptions. The judgment and assumptions include the identification of macroeconomic conditions, industry, and market considerations, cost factors, overall financial performance and share price trends, and making the assessment as to whether each relevant factor will impact the impairment test positively or negatively and the magnitude of any such impact.

 

The carrying amount of each reporting unit is determined based upon the assignment of our assets and liabilities, including existing goodwill and other intangible assets, to the identified reporting units. Where an acquisition benefits only one reporting unit, the Company allocates, as of the acquisition date, all goodwill for that acquisition to the reporting unit that will benefit. Where the Company has had an acquisition that benefited more than one reporting unit, The Company has assigned the goodwill to our reporting units as of the acquisition date such that the goodwill assigned to a reporting unit is the excess of the fair value of the acquired business, or portion thereof, to be included in that reporting unit over the fair value of the individual assets acquired and liabilities assumed that are assigned to the reporting unit.

 

If the carrying amount of a reporting unit is in excess of its fair value, an impairment may exist, and the Company must perform the second step of the impairment analysis to measure the amount of the impairment loss, by allocating the reporting unit’s fair value to its assets and liabilities other than goodwill, comparing the carrying amount of the goodwill to the resulting implied fair value of the goodwill, and recording an impairment charge for any excess.

 

Discontinued Operations

 

In accordance with ASC 205-20 Presentation of Financial Statements: Discontinued Operations, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when the components of an entity meets the criteria in paragraph 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations. .

 

On January 16, 2020, the Company pursuant to the termination of the SRI transaction Agreement (see Note 1) which meets the definition of a discontinued operation. For additional information, see Note 12- Discontinued Operations.

 

Revenue Recognition

 

Effective January 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. Under ASC 606, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The Company has no outstanding contracts with any of its’ customers. Revenues from Spinus were $1,521 and $47,602 for the three and six months ended June 30, 2019, and are recognized as an agent and are recorded at net. There was no impact on the Company’s financial statements as a result of adopting Topic 606 for the three and six months ended June 30, 2020, and 2019.

 

Advertising and Marketing Expenses

 

The Company expenses advertising and marketing costs as incurred. For the six months ended June 30, 2020, and 2019, the Company recorded $1,226 and $59,422, respectively, of advertising and marketing expenses.

 

Research and Development

 

Costs and expenses that can be clearly identified as research and development are charged to expense as incurred. For the six months ended June 30, 2020, and 2019, the Company recorded $-0- and $63,604 of research and development expenses, respectively.

 

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

 

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

 

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of this note transaction and the effective conversion price embedded in this note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.

 

The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.

 

Fair Value of Financial Instruments

 

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

 

The following are the hierarchical levels of inputs to measure fair value:

 

  ● Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
  ● Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
  ● Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.

 

The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of June 30, 2020, and December 31, 2019, for each fair value hierarchy level:

 

June 30, 2020   Derivative
Liabilities		     Total  
Level I   $ -     $ -  
Level II   $ -     $ -  
Level III   $ 9,471,445     $ 9,471,445  

 

December 31, 2019   Derivative
Liabilities		     Total  
Level I   $ -     $ -  
Level II   $ -     $ -  
Level III   $ 2,462,940     $ 2,462,940  

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the deferred tax assets will not be realized.

 

Tax benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting periods presented.

 

Foreign Currency Translation

 

The accounts of the Company’s Hong Kong subsidiary are maintained in Hong Kong dollars and the accounts of the U.S. companies are maintained in USD. The accounts of the Hong Kong subsidiary were translated into USD in accordance with Accounting Standards Codification (“ASC”) Topic 830, Foreign Currency Matters. According to Topic 830, all assets and liabilities were translated at the exchange rate on the balance sheet date; stockholders’ equity is translated at historical rates and statement of comprehensive income items are translated at the weighted average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with ASC Topic 220, Comprehensive Income. Gains and losses resulting from the foreign currency transactions are reflected in the statements of comprehensive income.

 

Relevant exchange rates used in the preparation of the consolidated financial statements are as follows for the periods ended June 30, 2020 and December 31, 2019, (Hong Kong dollar per one U.S. dollar):

 

    June 30, 2020     December 31, 2019  
Balance sheet date     .1290       .1284  
Average rate for statements of operations and comprehensive loss     .1288       .1276  

 

Earnings (Loss) Per Share

 

The Company reports earnings (loss) per share in accordance with ASC 260, “Earnings per Share.” Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net loss by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. As of June 30, 2020, and 2019, the Company’s dilutive securities are convertible into approximately 923,181,023 and 138,402,792 shares of common stock, respectively. This amount is not included in the computation of dilutive loss per share because their impact is antidilutive. The following table represents the classes of dilutive securities as of June 30, 2020, and 2019:

 

    June 30, 2020     June 30, 2019  
Common stock to be issued     1,350       750  
Convertible preferred stock     50,000       -  
Convertible notes payable     923,129,673       138,402,042  
      923,181,023       138,402,792  

 

Recent Accounting Pronouncements

 

There have no recent accounting pronouncements or changes in accounting pronouncements during the period ended June 30, 2020, that are of significance or potential significance to the Company.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets
 6 Months Ended
Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets

NOTE 4 – INTANGIBLE ASSETS

 

Patents as of June 30, 2020, and December 31, 2019, consist of the following:

 

    June 30, 2020     December 31, 2019  
Patents and license rights   $ 250,000     $ 250,000  
Accumulated amortization     (98,959 )     (78,125 )
Net carrying amount   $ 151,041     $ 171,875  

 

Amortization expense for the six months ended June 30, 2020, and 2019, was $20,834 respectively.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Convertible Notes Payable
 6 Months Ended
Jun. 30, 2020
Debt Disclosure [Abstract]  
Convertible Notes Payable

NOTE 5 - CONVERTIBLE NOTES PAYABLE

 

During the year ended December 31, 2017, OZOP issued 19 convertible promissory notes (the “2017 Notes”), in amounts of $10,000 to $50,000. OZOP received proceeds of $710,000 in the aggregate. The 2017 Notes matured on their one- year anniversary and bear interest at ten percent (10%). The initial conversion feature allowed the holders to convert this note and any unpaid interest due, into shares of the Company’s common stock on the 15th business day that the Company becomes listed, at conversion prices equal to discounts of 35%-50% of the average of the three lowest closing prices of the common stock. In August 2018, the Company offered any noteholder to convert their principal and interest into shares of common stock at $0.50 per share. OZOP also issued $25,500 of convertible notes for consulting fees. During the year ended December 31, 2018, the Company issued a $50,000 convertible promissory note (the “March 2018 Note”) and received proceeds of $50,000. The Company determined that the conversion feature of the 2017 Notes and the March 2018 Note (together, the “Notes”) did not meet the criteria of an embedded derivative and therefore the conversion feature was not bi-furcated and accounted for as a derivative because the Company was a private company, there was no quoted price and no active market for the Company’s common stock.

 

On April 13, 2018, the Company determined the conversion feature of the Notes represented an embedded derivative since the Notes were convertible into a variable number of shares upon conversion. Accordingly, on April 13, 2018, the Notes were not considered to be conventional debt under ASC 815 and the embedded conversion feature was bifurcated from the debt host and accounted for as a derivative liability. Accordingly, the fair value of the derivative instruments of the Notes that occurred prior to April 13, 2018, were recorded as a liability on April 13, 2018, with the corresponding amount recorded as a discount to the notes. Such discount was amortized from the date of issuance to the maturity dates of the Notes. The change in the fair value of the liability for derivative contracts are recorded in other income or expenses in the reporting period, with the offset to the derivative liability on the balance sheet. The embedded feature included in the Notes resulted in the recognition of a derivative liability. On August 29, 2019, pursuant to a Debt Purchase Agreement, one investor sold the principal balance of $15,000, accrued and unpaid interest of $2,624 and a repayment balance of $5,250 to third party investor, for a total purchase price of $22,874 (see below). Also, on August 29, 2019, pursuant to a Debt Purchase Agreement, a second investor sold the principal balance of $25,000, accrued and unpaid interest of $4,248 and a repayment balance of $8,750 to third party investor, for a total purchase price of $37,998 (see below). On February 18, 2020, an investor purchased two $50,000 convertible notes from investors (see below). On June 23, 2020, pursuant to a Debt Purchase Agreement, one investor sold the principal balance of $50,000 and a repayment balance of $10,000 to third party investor, for a total purchase price of $60,000 (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of the 2017 Notes was $25,000 and $175,000, respectively.

 

On April 13, 2018, we issued a convertible promissory note in the principal amount of $442,175, pursuant to a Securities Purchase Agreement we entered into with an investor dated April 1, 2018. This note bears interest at the rate of 12% per annum and was due and payable on April 13, 2019. This note is convertible at any time following the funding of this note into a variable number of the Company’s common stock, based on a conversion ratio of 55% of the average of the lowest trading price for the 25 days prior to conversion. This note was funded on April 13, 2018, when the Company received proceeds of $350,000, after OID of $57,675, and disbursements for the lender’s transaction costs, fees and expenses of $34,500, of which $25,000 were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. During the year ended December 31, 2019, the investor sold $30,000 of this note to another investor. This note was in default and during the year ended December 31, 2019, the Company recorded additional interest expense of $26,188 and added that amount to the principal amount outstanding. For the six months ended June 30, 2020, the investor converted a total of $52,375 of the face value and $39,670 of accrued interest into 35,813,035 shares of common stock, at an average conversion price of $0.00257. During the six months ended June 30, 2020, the Company wrote off the remaining principal balance of $26,188 and recognized a gain on debt extinguishment of $26,188. As of June 30, 2020, and December 31, 2019, the outstanding principal balance and carrying value of this note was $-0- and $78,563, respectively. 

 

On August 29, 2018, we issued a convertible promissory note in the principal amount of $339,250, pursuant to a Securities Purchase Agreement we entered into with the investor. This note bears interest at the rate of 12% per annum and is due and payable on August 29, 2019. This note is convertible at any time following the funding of this note into a variable number of the Company’s common stock, based on a conversion ratio of 55% of the average of the lowest trading price for the 25 days prior to conversion. This note was funded on August 29, 2018, when the Company received proceeds of $280,000, after OID of $44,250, and disbursements for the lender’s transaction costs, fees and expenses of $15,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. Periodic payments are due by us on this note at the rate of $1,000 per day (the “Repayment Amount”) via direct withdrawal from our bank account, beginning on August 30, 2018, until this note is satisfied in full. From time to time the investor waives any Repayment Amount for a period of time as agreed upon. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. This note was in default and during the year ended December 31, 2019, the Company recorded additional interest expense of $87,390 and added that amount to the principal amount outstanding. For the six months ended June 30, 2020, the investor converted a total of $112,141 of the face value and $4,630 of accrued interest into 23,237,756 shares of common stock at an average conversion price of $0.0053. During the six months ended June 30, 2020, the Company wrote off the remining principal balance of $74,990 and recognized $74,990 as a gain on debt extinguishment. As of June 30, 2020, and December 31, 2019, the outstanding principal balance and carrying value of this note was $-0- and $187,130, respectively. 

 

On November 15, 2018, the Company issued a 12% convertible promissory note, in the principal amount of $500,000, pursuant to a Securities Purchase Agreement we entered into with the investor. This note matures November 15, 2019. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of this note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company’s common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. Pursuant to this note, the Company agreed to include on its next registration statement filed with the Securities and Exchange Commission, all shares issuable upon conversion of this note. Pursuant to the Security Agreement, all of the obligations under this note are secured by a first security interest in and to all of the Company’s rights, title and interests in, to and under all assets and all personal property of the Company. The Security Agreement includes customary representations, warranties and covenants by the Company. This note was funded on November 19, 2018, when the Company received proceeds of $458,500 after OID of $37,500, and disbursements for the lender’s transaction costs, fees and expenses of $4,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, the investor converted a total of $445,360 of the face value and $39,570 of accrued interest and fees into 150,631,924 shares of common stock at an average conversion price of $0.0032. As of June 30, 2020, and December 31, 2019, the outstanding principal balance and carrying value of this note was $-0- and $445,360, respectively. In connection with the issuance of this note, during the six months ended June 30, 2020, the Company issued 43,500,000 shares upon the cashless exercise of warrants issued.

 

On January 7, 2019, the Company issued an 8% convertible promissory note, in the principal amount of $150,000, pursuant to a Securities Purchase Agreement we entered into with the investor. This note matured January 7, 2020. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of this note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company’s common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. This note was funded on January 9, 2019, when the Company received proceeds of $133,250 after OID of $14,000, and disbursements for the lender’s transaction costs, fees and expenses of $2,750, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $2,416 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $150,000 of the face value and $28,664 of accrued interest and fees into 96,727,034 shares of common stock at an average conversion price of $0.00185. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $150,000 with a carrying value of $147,584, as of December 31, 2019, net of unamortized discounts of $2,416.

 

On February 5, 2019, the Company issued an 8% convertible promissory note (the “Master Note”) in the aggregate principal amount of up to $165,000 in exchange for an aggregate purchase price of up to $148,500 with an original issue discount of $16,500 to cover the Investor’s accounting fees, due diligence fees, monitoring and other transactional costs incurred in connection with the purchase and sale of the Master Note, which is included in the principal balance of this note. On February 8, 2019, the Investor funded the first tranche under the Master Note, with a maturity date of February 8, 2020, and the Company received $49,500 ($47,500 after payment of $2,000 of the Investor’s legal fees) for this first tranche of $55,000 under the Master Note and on the same date, the Company issued this note to the Investor. This note is convertible into shares of the Company’s common stock, beginning on the date which is 180 days from the issuance date of the Master Note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of conversion of the Master Note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company’s common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of the Master Note. The embedded conversion feature included in the Master Note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $12,102 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $22,105 of the face value and $4,400 of fees into 6,017,711 shares of common stock at an average conversion price of $0.0044. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of the Master Note was $-0- and $11,640, respectively, with a carrying value as of December 31, 2019, of $7,144, net of unamortized discounts of $4,496. In connection with the issuance of this Note, during the six months ended June 30, 2020, the Company issued 20,138,746 shares upon the cashless exercise of warrants issued.

 

On March 7, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $85,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock, at a conversion price equal to 58% of the average of the two lowest trading prices of the Company’s common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company. This note was funded on March 11, 2019, when the Company received proceeds of $77,900 after OID of $3,000, and disbursements for the lender’s transaction costs, fees and expenses of $4,100, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $15,714 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $31,800 of the face value and $3,427 of accrued interest into 446,416 shares of common stock at an average conversion price of $0.07891. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $31,800, respectively, with a carrying value as of December 31, 2019, of $16,086, net of unamortized discounts of $15,714.

 

On May 29, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $80,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock, at a conversion price equal to 58% of the average of the two lowest trading prices of the Company’s common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company. This note was funded on March 29, 2019, when the Company received proceeds of $73,300 after OID of $2,800, and disbursements for the lender’s transaction costs, fees and expenses of $3,900, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $32,021 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $19,300 of the face value and $2,058 of accrued interest into 3,784,352 shares of common stock at an average conversion price of $0.00564. On May 28, 2020, pursuant to a Debt Purchase Agreement, the investor sold the principal balance of $60,700 and accrued and unpaid interest of $6,665 to third party investor, for a total purchase price of 67,365 (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $80,000, respectively, with a carrying value on December 31, 2019, of $47,979, net of unamortized discounts of $32,021.

 

On June 5, 2019, an investor (the “Purchaser”) pursuant to an Assignment Agreement, purchased a convertible note issued by the Company on December 5, 2018, with a maturity date of December 5, 2019. The Purchaser paid $93,391 to acquire this note. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 65% multiplied by the average of the lowest two trading prices during the 15- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. The embedded conversion feature pursuant to the Assignment Agreement resulted in the recognition of a derivative liability. On April 17, 2020, the Purchaser sold the note to another third- party investor (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of assigned note was $-0- and $93,391, respectively.

 

On June 7, 2019, an investor (the “Purchaser”) pursuant to an Assignment Agreement, purchased a convertible note issued by the Company on October 19, 2018, with a maturity date of October 19, 2019. The Purchaser paid $77,000 to acquire this note. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 65% multiplied by the average of the lowest two trading prices during the 15- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. The embedded conversion feature pursuant to the Assignment Agreement resulted in the recognition of a derivative liability. On April 24, 2020, the Purchaser sold the note to another third- party investor (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of assigned note was $-0- and $77,000, respectively.

 

On July 22, 2019, the Company issued a 10% convertible promissory note, in the principal amount of $38,900, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock, at a conversion price equal to 60% of the lowest closing bid price of the Company’s common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company. This note was funded on July 24, 2019, when the Company received proceeds of $30,000 after OID of $3,900, and disbursements for the lender’s transaction costs, fees and expenses of $5,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $22,587 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $38,900 of the face value and $2,714 of accrued interest into 6,379,036 shares of common stock at an average conversion price of $0.00652. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $38,900, respectively, with a carrying value as of December 31, 2019, of $16,313, net of unamortized discounts of $22,587.

 

On August 2, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $157,500, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 60% multiplied by the average of the lowest two trading prices during the 20 trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note was funded on August 2, 2019, when the Company received proceeds of $150,000 after disbursements for the lender’s transaction costs, fees and expenses of $7,500, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $77,844 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $157,500 of the face value and $13,523 of accrued interest into 23,114,263 shares of common stock at an average conversion price of $0.0074. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $157,500, respectively, with a carrying value as of December 31, 2019, of $79,656, net of unamortized discounts of $77,844.

 

On August 21, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $55,125, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 58% multiplied by the average of the lowest two trading prices during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note was funded on August 21, 2019, when the Company received proceeds of $50,000 after OID of $2,625, and disbursements for the lender’s transaction costs, fees and expenses of $2,500, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability . For the six months ended June 30, 2020, amortization of the debt discounts of $33,479 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $3,825 of the face value and $247 of accrued interest into 77,144 shares of common stock at an average conversion price of $0.05278, and on March 9, 2020, sold the remining portion of this note to a third part investor (see below) for $76,000. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $55,125, respectively, with a carrying value of $21,646, as of December 31, 2019, net of unamortized discounts of $33,479. On March 9, 2020, the Company also issued a warrant for $25,000 to the investor in consideration of the sale of this note. The exercise price of the warrant is equal to a 42% discount of the average of the two lowest trading prices of the Company’s common stock for the twenty days preceding the exercise and the warrant expires September 9, 2020. For the six months ended June 30, 2020, the Company issued 3,967,740 shares of common stock upon the cashless exercises of the warrant.

 

On August 19, 2019, the Company issued an 8% convertible promissory note, in the principal amount of $85,000, pursuant to a Securities Purchase Agreement we entered into with the investor. This note matures May 19, 2020. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of this note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company’s common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. This note was funded on August 22, 2019, when the Company received proceeds of $75,000 after OID of $7,250, and disbursements for the lender’s transaction costs, fees and expenses of $2,750, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $33,656 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $85,000 of the face value and $7,121 of accrued interest into 39,658,500 shares of common stock at an average conversion price of $0.00232. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $85,000, respectively, with a carrying value as of December 31, 2019, of $51,344, net of unamortized discounts of $33,656. The Company also issued a five- year warrant to purchase 28,333 shares of common stock at an exercise price of $1.50, subject to adjustments.

 

On August 23, 2019, the Company issued to a third-party investor a convertible redeemable promissory note with a face value of $37,800, including an original issue discount of $1,800. This note matures on May 23, 2020, has a stated interest of 10% and is convertible into a variable number of the Company’s common stock, based on a conversion ratio of 58% of the average of the two lowest trading prices for the 20 days prior to conversion. This note was funded on August 26, 2019, when the Company received proceeds of $33,500, after disbursements for the lender’s transaction costs, fees and expenses of $2,500, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $19,239 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $24,317 of the face value and $2,980 of accrued interest into 4,336,000 shares of common stock at an average conversion price of $0.0063, and on April 28, 2020, sold the remining portion of $13,483 of this note to a third- party investor (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $0-0 and $37,800, respectively, with a carrying value as of December 31, 2019, of $18,561, net of unamortized discounts of $19,239.

 

On August 29, 2019, the Company issued a 10% convertible promissory note, in the principal amount of $45,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 60% multiplied by the average of the lowest two trading prices during the 20 trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note was funded on September 4, 2019, when the Company received proceeds of $40,000 after disbursements for the lender’s transaction costs, fees and expenses of $5,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $26,567 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $45,000 of the face value and $2,838 of accrued interest into 7,933,325 shares of common stock at an average conversion price of $0.00603. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $45,000, respectively, with a carrying value as of December 31, 2019, of $18,434, net of unamortized discounts of $26,566.

 

On August 29, 2019, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note issued by the Company on September 1, 2017 (see above). The Purchaser paid $22,874 to acquire this note. This note, as amended, is convertible into common stock at a conversion price equal to a 35% discount to the average of the 3 lowest closing prices of the common stock for fifteen prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, the investor converted a total of $15,874 of the face value and $968 of accrued interest into 217,331 shares of common stock at an average conversion price of $0.0775. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of assigned note was $-0- and $15,874, respectively.

 

On August 29, 2019, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note issued by the Company on October 2, 2017 (see above). The Purchaser paid $37,998 to acquire this note. This note, as amended, is convertible into common stock at a conversion price equal to a 35% discount to the average of the 3 lowest closing prices of the common stock for fifteen prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, the investor converted a total of $37,998 of the face value and $2,331 of accrued interest into 3,781,509 shares of common stock at an average conversion price of $0.01066. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of assigned note was $-0- and $37,998, respectively.

 

On October 1, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $68,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 61% multiplied by the lowest closing bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note was funded on October 2, 2019, when the Company received proceeds of $65,000 after disbursements for the lender’s transaction costs, fees and expenses of $3,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $41,584 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $68,000 of the face value and $4,080 of accrued interest into 9.186,036 shares of common stock at an average conversion price of $0.00785. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $68,000, respectively, with a carrying value as of December 31, 2019, of $26,416, net of unamortized discounts of $41,584.

 

On October 8, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $66,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock, at a conversion price equal to 60% of the average of the two lowest trading prices of the Company’s common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company. This note was funded on October 10, 2019, when the Company received proceeds of $57,000 after OID of $6,000, and disbursements for the lender’s transaction costs, fees and expenses of $2,300, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $83,398 was charged to interest expense. For the six months ended June 30, 2020, the investor added $37,750 od defaults to the principal balance of the note. For the six months ended June 30, 2020, the investor converted a total of $103,750 of principal and $2,640 of accrued interest into 24,394,666 shares of common stock at an average conversion price of $0.00436. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $66,000, respectively, with a carrying value as of December 31, 2019, of $18,452, net of unamortized discounts of $47,548.

 

On October 24, 2019, the Company issued a convertible promissory note in the principal amount of $248,400, pursuant to a Securities Purchase Agreement we entered into with the investor. This note bears interest at the rate of 12% per annum and matures 12 months after the date of issuance. This note is convertible at any time following the funding of this note into a variable number of the Company’s common stock, based on a conversion ratio of 60% of the lowest trading price for the 25 days prior to conversion. This note was funded on October 28, 2019, when the Company received proceeds of $200,000, after OID of $32,400, and disbursements for the lender’s transaction costs, fees and expenses of $16,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months June 30, 2020, amortization of the debt discounts of $221,683 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $48,400 of principal and $16,796 of accrued interest into 26,288,995 shares of common stock at an average conversion price of $0.00248, and on May 7, 2020, sold the remining portion of $200,000 of this note to a third- party investor (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $248,400, respectively, with a carrying value as of December 31, 2019, of $26,717, net of unamortized discounts of $221,683.

 

On October 24, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $225,000, pursuant to a Securities Purchase Agreement we entered into with the investor. This note matures October 24, 2020. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) $0.05 and (2) 58% multiplied by the average of the 2 lowest trading prices of the Company’s common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. This note was funded on October 31, 2019, when the Company received proceeds of $202,250 after OID of $20,000, and disbursements for the lender’s transaction costs, fees and expenses of $2,750, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months ended June 30, 2020, amortization of the debt discounts of $147,689 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $225,000 of principal and $16,858 of accrued interest into 125,613,294 shares of common stock at an average conversion price of $0.00193. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $225,000, respectively, with a carrying value as of December 31, 2019, of $77,311, net of unamortized discounts of $147,689.

 

On October 25, 2019, the Company issued a convertible promissory note in the principal amount of $36,750, pursuant to a Securities Purchase Agreement we entered into with the investor. This note bears interest at the rate of 12% per annum and matures 12 months after the date of issuance. This note is convertible at any time following the funding of this note into a variable number of the Company’s common stock, based on a conversion ratio of 58% of the average of the two lowest closing bid prices for the 20 days prior to conversion. This note was funded on October 25, 2019, when the Company received proceeds of $33,000, after OID of $1,750, and disbursements for the lender’s transaction costs, fees and expenses of $2,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the six months June 30, 2020, amortization of the debt discounts of $31,106 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $36,750 of principal and $2,219 of accrued interest into 7,881,267 shares of common stock at an average conversion price of $0.00494. As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $36,750, respectively, with a carrying value as of December 31, 2019, of $5,644, net of unamortized discounts of $31,106.

 

On November 27, 2019, the Company issued a 12% convertible promissory note, in the principal amount of $53,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 56% multiplied by the lowest closing bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note was funded on December 2, 2019, when the Company received proceeds of $50,000 after disbursements for the lender’s transaction costs, fees and expenses of $3,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in the recognition of a derivative liability. For the three months ended March 31, 2020, amortization of the debt discounts of $48,2742 was charged to interest expense. On May 15, 2020, pursuant to a Debt Purchase Agreement, the investor sold the principal balance of $53,000, accrued and unpaid interest of $2,997 and a prepayment of $19,003, which was recognized as interest expense, to a third- party investor, for a total purchase price of $75,000 (see below). As of June 30, 2020, and December 31, 2019, the outstanding principal balance of this note was $-0- and $53,000, respectively, with a carrying value as of December 31, 2019, of $4,626, net of unamortized discounts of $48,374.

 

On January 8, 2020, the Company entered into a securities purchase agreement (the “SPA”) with an investor (the “Investor”), pursuant to which the Company agreed to issue to the Investor a 12% Convertible Promissory Note, in the principal amount of $38,000 in exchange for a purchase price of $35,000. This note was funded by the Investor on January 13, 2020, and on such date pursuant to the SPA, the Company reimbursed the Investor for expenses for legal fees and due diligence of $3,000. This note proceeds will be used by the Company for general working capital purposes. The SPA includes customary representations, warranties and covenants by the Company and customary closing conditions. The embedded conversion feature included in this note resulted in an initial debt discount and derivative liability of $29,063. For the six months ended June 30, 2020, amortization of the debt discounts of $32,063 was charged to interest expense. On May 15, 2020, pursuant to a Debt Purchase Agreement, the investor sold the principal balance of $38,000, accrued and unpaid interest of $1,624 and a prepayment of $12,276, which was recognized as interest expense, to a third- party investor, for a total purchase price of $52,000 (see below). As of June 30, 2020, the outstanding principal balance of this note was $-0-.

 

On February 18, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note issued by the Company on August 18, 2017 (see above). The Purchaser agreed to pay $50,000 to acquire this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for the thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended March 31, 2020, the Company recorded additional interest expense of $154,627 due to various defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in interest expense of $607,950 (since the purchased note was past its’ maturity date and was in default) with the offset recorded to derivative liabilities. For the six months ended June 30, 2020, the investor converted a total of $202,541 of principal and $64,650 accrued interest and fees into 90,191,785 shares of common stock at an average conversion price of $0.00257. As of June 30, 2020, the outstanding principal balance of assigned note was $2,086.

 

Also, on February 18, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note issued by the Company on August 18, 2017 (see above). The Purchaser agreed to pay $50,000 to acquire this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for the thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended June 30, 2020, the Company recorded additional interest expense of $192,025 due to various defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in interest expense of $607,950 (since the purchased note was past its’ maturity date and was in default) with the offset recorded to derivative liabilities. For the six months ended June 30, 2020, the investor converted a total of $242,025 of principal and $84,849 accrued interest and fees into 241,489,074 shares of common stock at an average conversion price of $0.00123. As of June 30, 2020, the outstanding principal balance of assigned note was $-0-.

 

On February 26, 2020, the Company entered into a securities purchase agreement (the “SPA”) with an investor (the “Investor”), pursuant to which the Company agreed to issue to the Investor a 12% secured convertible promissory note in the aggregate principal amount of $132,750 in exchange for a purchase price of $117,750. Pursuant to the SPA, the Company agreed to pay the Investor $15,000 to cover the Investor’s due diligence expenses incurred in connection with the SPA and Note, which is to be offset against the proceeds of this note. This note was funded by the Investor on February 26, 2020, and on such date pursuant to the SPA, the Company reimbursed the Investor for expenses for legal fees and due diligence of $2,750. This note proceeds will be used by the Company for general working capital purposes. The SPA includes customary representations, warranties and covenants by the Company and customary closing conditions. In conjunction with this note, the Company issued a warrant to purchase 2,212,500 shares of common stock at an exercise price of $0.03, subject to adjustments and expiring on the five-year anniversary of the Issuance Date. The embedded conversion feature included in this note resulted in an initial debt discount and derivative liability of $86,001. For the six months ended June 30, 2020, amortization of the debt discounts of $34,584 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $132,750 with a carrying value of $63,583, net of unamortized discounts of $69,167.

 

On February 26, 2020, the Company and an investor (the “Investor”) agreed to exchange $330,000 of notes payable into a 12% convertible note with a face value of $330,000. This note is convertible into common stock at a conversion price equal to a 44% discount to the lowest trading price of the common stock for the 20 prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature included in this note resulted in interest expense of $365,757 with the offset to derivative liabilities. On March 3, 2020, a third-party investor (the “Purchaser”), pursuant to a Debt Purchase Agreement, purchased this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended June 30, 2020, the Company recorded additional interest expense of $468,750 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in interest expense of $1,321,618 with the offset recorded to derivative liabilities. As of June 30, 2020, the outstanding principal balance of assigned note was $798,750. This note was fully converted as of August 13, 2020.

 

On March 9, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a convertible note issued by the Company on August 19, 2019, with a maturity date of May 19, 2020 (see above). The Purchaser paid $76,000 to acquire this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount and derivative liability of $76,000. For the six months ended June 30, 2020, the Company recorded additional interest expense of $83,263 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. For the six months ended June 30, 2020, amortization of the debt discounts of $76,000 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $3,603 of the face value and $81,521 of accrued interest and fees into 52,946,489 shares of common stock at an average conversion price of $0.0014. As of June 30, 2020, the outstanding principal balance of assigned note was $155,632. This note was fully converted as of August 13, 2020.

 

On March 9, 2020, (the “Issuance Date”) the Company issued a 12% convertible promissory note, in the principal amount of $80,000, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $.25 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.25 or 50% of the lowest trading price for the thirty trading days prior to the conversion. The embedded conversion feature included in this note resulted in an initial debt discount of $57,000, interest expense of $64,067 and an initial derivative liability of $121,067. For the six months ended June 30, 2020, amortization of the debt discounts of $48,933 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $80,000 with a carrying value of $48,933, net of unamortized discounts of $31,067.

 

On April 17, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note initially issued by the Company on December 5, 2018, and thereafter was acquired on June 5, 2019 (see above). The Purchaser acquired the note balance of $93,391. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in interest expense of $1,476,436 (since the purchased note was past its’ maturity date and was in default) with the offset recorded to derivative liabilities. For the six months ended June 30, 2020, the Company recorded additional interest expense of $259,305 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. As of June 30, 2020, the outstanding principal balance of assigned note was $352,695. This note was fully converted as of August 13, 2020. 

 

On April 24, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note initially issued by the Company on October 19, 2018, and thereafter was acquired on June 7, 2019 (see above). The Purchaser acquired the note balance of $77,000. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in interest expense of $881,058 (since the purchased note was past its’ maturity date and was in default) with the offset recorded to derivative liabilities. For the six months ended June 30, 2020, the Company recorded additional interest expense of $121,250 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. For the six months ended June 30, 2020, the investor converted a total of $198,183 of the face value and $44,396 of accrued interest and fees into 179,688,215 shares of common stock at an average conversion price of $0.00131. As of June 30, 2020, the outstanding principal balance of assigned note was $67.

 

On April 27, 2020, the Company issued a 15% convertible redeemable note in the principal amount of $60,000. This note matures on April 27,2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company. This note was funded on April 27, 2020, when the Company received proceeds of $50,000, after OID of $10,000, which was recorded as a discount against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in this note resulted in an initial debt discount of $50,000, interest expense of $36,274 and an initial derivative liability of $86,274. For the six months June 30, 2020, amortization of the debt discounts of $10,000 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $60,000 with a carrying value of $10,000, net of unamortized discounts of $50,000.

 

On April 28, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a convertible note issued by the Company on August 23, 2019 with a maturity date of May 23, 2020 (see above). The Purchaser acquired $13,483 of this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount of $13,483, interest expense of $42,261 and an initial derivative liability of $55,744. For the six months ended June 30, 2020, the Company recorded additional interest expense of $1,348 due to a default of this note and the amount was added to the principal balance owed the Purchaser. For the six months ended June 30, 2020, amortization of the debt discounts of $13,483 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of assigned note was $14,831.

 

On April 28, 2020, the Company issued a 12% convertible promissory note, (the “Note”) in the principal amount of $53,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 58% multiplied by the lowest closing bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. The Company received proceeds of $50,000 (including direct payments from the lender to certain Company vendors) on May 4, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $3,000. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $50,000, interest expense of $1,539 and an initial derivative liability of $51,539. For the six months June 30, 2020, amortization of the debt discounts of $8,833 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $53,000 with a carrying value of $8,833, net of unamortized discounts of $44,167.

 

On May 4, 2020, the Company issued a 12% convertible promissory note, (the “Note”) in the principal amount of $110,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lower of $0.50 or 58% multiplied by the average of the two lowest closing trading price or bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. The Company received proceeds of $96,250 on May 6, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $13,750. This note proceeds will be used by the Company for general working capital purposes. In conjunction with this note, the Company issued a warrant to purchase 3,666,666 shares of common stock at an exercise price of $0.015, subject to adjustments and expiring on the five-year anniversary of the Issuance Date. The embedded conversion feature included in this note resulted in an initial debt discount of $100,000, interest expense of $5,526 and an initial derivative liability of $105,526. For the six months ended June 30, 2020, amortization of the debt discounts of $18,792 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $110,000 with a carrying value of $16,042, net of unamortized discounts of $93,958.

 

On May 5, 2020, (the “Issuance Date”) the Company issued a 12% convertible promissory note, (the “Note”) in the principal amount of $162,000, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $03 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.03 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $100,000 on May 13, 2020, and this note included an original issue discount of $62,000. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $100,000, interest expense of $151,512 and an initial derivative liability of $251,512. For the six months ended June 30, 2020, amortization of the debt discounts of $54,000 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $162,000 with a carrying value of $54,000, net of unamortized discounts of $108,000. In conjunction with this note, the Company issued a warrant to purchase 4,325,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.

 

On May 7, 2020, the Company issued a 15% convertible redeemable note in the principal amount of $30,000. This note matures on May 7,2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company. The Company received proceeds of $25,000 on May 7, 2020, and this note included an original issue discount of $5,000, which was recorded as a discount against the debt to be amortized into interest expense through maturity This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $25,000, interest expense of $17,828 and an initial derivative liability of $42,828. For the six months June 30, 2020, amortization of the debt discounts of $4,375 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $30,000 with a carrying value of $4,375, net of unamortized discounts of $25,625.

 

On May 7, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a convertible note issued by the Company on October 24, 2019, with a maturity date of October 24, 2020 (see above). The Purchaser acquired $200,000 of this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount of $200,000, interest expense of $111,128 and an initial derivative liability of $311,128. For the six months ended June 30, 2020, amortization of the debt discounts of $200,000 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $200,000 of the face value and $16,922 of accrued interest and fees into 92,332,507 shares of common stock at an average conversion price of $0.00218. As of June 30, 2020, the outstanding principal balance of assigned note was $-0-.

 

On May 15, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a convertible note initially issued by the Company on January 8, 2020, with a maturity date of January 8, 2021 (see above). The Purchaser paid $52,000 for the note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended June 30, 2020, the Company recorded additional interest expense of $63,500 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount of $100,000, interest expense of $526,507 and an initial derivative liability of $626,507. For the six months ended June 30, 2020, amortization of the debt discounts of $25,000 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $66,454 of the face value and $5,246 of accrued interest and fees into 53,110,926 shares of common stock at an average conversion price of $0.00129. As of June 30, 2020, the outstanding principal balance of assigned note was $83,546, with a carrying value of $8,546, net of unamortized discounts of $75,000. This note was fully converted as of August 13, 2020.

 

On May 15, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a convertible note initially issued by the Company on November 27, 2019, with a maturity date of November 27, 2020 (see above). The Purchaser paid $75,000 for the note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended June 30, 2020, the Company recorded additional interest expense of $75,000 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount of $77,000, interest expense of $388,385 and an initial derivative liability of $465,385. As of June 30, 2020, the outstanding principal balance of assigned note was $115,500, with a carrying value of $52,398, net of unamortized discounts of $62,563. This note was fully converted as of August 13, 2020.

 

On May 28, 2020, the Company issued a 15% convertible redeemable note in the principal amount of $30,000. This note matures on May 28, 2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company. The Company received proceeds of $25,000 on May 28, 2020, and this note included an original issue discount of $5,000. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $25,000, interest expense of $19,346 and an initial derivative liability of $44,346. For the six months June 30, 2020, amortization of the debt discounts of $2,500 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $30,000 with a carrying value of $2,500, net of unamortized discounts of $27,500.

 

On May 28, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a convertible note issued by the Company on May 29, 2019 (see above). The Purchaser acquired $67,365 of this note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. The embedded conversion feature pursuant to this agreement resulted in an initial debt discount of $67,365, interest expense of $443,420 and an initial derivative liability of $510,785. For the six months ended June 30, 2020, the Company recorded additional interest expense of $83,395 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. For the six months ended June 30, 2020, amortization of the debt discounts of $67,365 was charged to interest expense. For the six months ended June 30, 2020, the investor converted a total of $47,090 of the face value and $3,000 of accrued interest and fees into 39,959,295 shares of common stock at an average conversion price of $0.00118. As of June 30, 2020, the outstanding principal balance of assigned note was $103,671. This note was fully converted as of August 13, 2020.

 

On June 1, 2020, (the “Issuance Date”) the Company issued a 12% convertible promissory note, (the “Note”) in the principal amount of $127,500, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $100,000 on June 1, 2020, and this note included an original issue discount of $27,500. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $100,000, interest expense of $103,250 and an initial derivative liability of $203,250. For the six months ended June 30, 2020, amortization of the debt discounts of $21,250 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $127,500 with a carrying value of $21,250, net of unamortized discounts of $106,250. In conjunction with this note, the Company issued a warrant to purchase 6,375,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.

 

On June 11, 2020, the Company issued a 12% convertible promissory note, (the “Note”) in the principal amount of $53,000, pursuant to a Securities Purchase Agreement we entered into with an investor. This note matures 12 months after the date of issuance. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 58% multiplied by the lowest closing bid price during the twenty trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. The Company received proceeds of $50,000 on June 12, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $3,000. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $50,000, interest expense of $2,218 and an initial derivative liability of $52,218. For the six months June 30, 2020, amortization of the debt discounts of $2,849 was charged to interest expense. As of June 30, 2020, the outstanding principal balance of this note was $53,000 with a carrying value of $2,849, net of unamortized discounts of $50,151.

 

On June 23, 2020, an investor (the “Purchaser”) pursuant to a Debt Purchase Agreement, purchased a past-due convertible note initially issued by the Company on October 6, 2017 (see above). The Purchaser paid $60,000 for the note. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. For the six months ended June 30, 2020, the Company recorded additional interest expense of $52,500 due to defaults of this note and the amount was added to the principal balance owed the Purchaser. The embedded conversion feature pursuant to this agreement resulted in interest expense of $658.093 (since the purchased note was past its’ maturity date and was in default) with the offset recorded to derivative liabilities. For the six months ended June 30, 2020, the investor converted a total of $91,579 of the face value and $42,071 of accrued interest and fees into 99,000,000 shares of common stock at an average conversion price of $0.00133. As of June 30, 2020, the outstanding principal balance of assigned note was $20,921. This note was fully converted as of August 13, 2020.

 

On June 30, 2020, (the “Issuance Date”) the Company issued a 15% convertible promissory note, (the “Note”) in the principal amount of $129,500, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $102,000 on July 1, 2020, and this note included an original issue discount of $27,500 and lender costs of $2,000. This note proceeds will be used by the Company for general working capital purposes. The embedded conversion feature included in this note resulted in an initial debt discount of $100,000, interest expense of $107,122 and an initial derivative liability of $207,122. As of June 30, 2020, the outstanding principal balance of this note was $129,500 with a carrying value of $-0-, net of unamortized discounts of $129,500. In conjunction with this note, the Company issued a warrant to purchase 6,375,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.

 

A summary of the convertible note balance as of June 30, 2020, and December 31, 2019, is as follows:

 

    June 30, 2020     December 31, 2019  
             
Principal balance   $ 2,640,450     $ 2,500,230  
Unamortized discount     (872,945 )     (806,003 )
Ending balance, net   $ 1,767,505     $ 1,694,227  
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Derivative Liabilities
 6 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Derivative Liabilities

NOTE 6 – DERIVATIVE LIABILITIES

 

The Company determined the conversion feature of these notes, which all contain variable conversion rates, represented an embedded derivative since the notes were convertible into a variable number of shares upon conversion. Accordingly, the notes are not considered to be conventional debt under ASC 815 and the embedded conversion feature was bifurcated from the debt host and accounted for as a derivative liability.

 

The Company valued the derivative liabilities at June 30, 2020, and December 31, 2019, at $9,471,445 and $2,462,490, respectively. The Company used the Monte Carlo simulation valuation model with the following assumptions as of June 30, 2020, risk free interest rates from 0.16% to 0.18%, and volatility of 81% to 105% and as of December 31, 2019, risk-free interest rates from 1.57% to 1.77% and volatility of 31% to 36%. The initial derivative liabilities for convertible notes issued during the six months ended June 30, 2020, used the following assumptions; risk-free interest rates from 0.12% to .24% and volatility of 74% to 105%.

 

A summary of the activity related to derivative liabilities for the six months ended June 30, 2020, and the year ended December 31, 2019, is as follows:

 

Balance- January 1, 2019   $ 1,199,514  
Issued during period     1,460,123  
Converted or paid     (850,248 )
Change in fair value recognized in operations     653,551  
Balance- December 31, 2019     2,462,940  
Issued during the period     11,953,787  
Converted or paid     (8,627,804 )
Change in fair value recognized in operations     3,682,522  
Balance June 30, 2020   $ 9,471,445  
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.20.2
Notes Payable
 6 Months Ended
Jun. 30, 2020
Debt Disclosure [Abstract]  
Notes Payable

NOTE 7 – NOTES PAYABLE

 

The Company has the following note payables outstanding:

 

    June 30, 2020     December 31, 2019  
Note payable, interest at 8%, matured September 6, 2018, in default   $ -     $ 330,033  
Notes payable, interest at 8%, matured January 5, 2020, currently in default     45,000       45,000  
Other, due on demand, interest at 6%     50,000       50,000  
Note payable, interest at 18%, matures June 23, 2022, net of discount of $34,635     175,365       -  
Note payable, interest at 12%, matures June 25, 2021, net of discount of $26,970     176,030       -  
Sub- total notes payable     446,395       425,033  
Less long-term portion, net of discount     176,365       -  
Current portion of notes payable, net of discount   $ 270,030     $ 425,033  

 

On February 26, 2020, the Company and the noteholder agreed to convert $330,033 of principal note balances to a 12% convertible note with a face value of $330,000 (see Note 5).

 

On June 23, 2020 (the “Execution Date”), the Company entered into a Loan and Securities Purchase Agreement with a third- party (the “Lender”). Pursuant to the agreement in exchange for a $210,000 Promissory Note, inclusive of an original issue discount of $35,000 the Company received proceeds of $175,000 from the Lender. The note carries an interest rate of 18% and matures and is due in one lump sum on the 24- month anniversary (the “Maturity Date”) of the Execution Date. For the first nine months interest may accrue on a monthly basis, and the Company has the option to pay the monthly interest or add such interest to the principal balance of the note. Commencing on the tenth month of the note, all accrued interest, if any, shall be added to the principal amount of the note, and interest on the new principal amount shall become due and payable on a monthly basis. Should the Company default on making any interest payments following the initial nine-months, or paying the note by the Maturity Date, the note shall automatically be converted into an 18% convertible debenture.

 

On June 25 (the “Issue Date”), 2020, the Company entered into a 12%, $203,000 face value promissory note with a third-party (the “Holder”) due June 25, 2021 (the “Maturity Date”). Principal payments shall be made in six instalments of $33,333 commencing 180 days from the Issue Date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the Maturity Date. The Holder shall have the right from time to time, and at any time following an event of default, as defined on the agreement, to convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company, at the lower of i) the Trading Price (as defined in the agreement) during the previous five trading days prior to the Issuance Date or ii) the volume weighted average price during the five trading days ending on the day preceding the conversion date. The Company received proceeds of $176,000 on June 26, 2020, and the Company reimbursed the investor for expenses for legal fees and due diligence of $27,000. In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 10,000,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expires on the five-year anniversary of the Issue Date.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transactions
 6 Months Ended
Jun. 30, 2020
Related Party Transactions [Abstract]  
Related Party Transactions

NOTE 8 – RELATED PARTY TRANSACTIONS

 

Employment Agreement

 

On February 28, 2020, the Company and Mr. Conway entered into an employment agreement (the “Employment Agreement”). Pursuant to the terms of the Employment Agreement, Mr. Conway is to receive an annual salary of $120,000, for his position of CEO of the Company, payable monthly. Mr. Conway was also issued 2,500 shares of Series C Preferred Stock. The Company valued the shares at $5,000.

 

Management Fees and related party payables

 

For the three and six months ended June 30, 2020, and 2019, the Company recorded expenses to its officers in the following amounts:

 

    Three months ended
June 30,		     Six months ended
June 30,		  
    2020     2019     2020     2019  
CEO, parent (includes $5,000 stock-based compensation six months ended June 30, 2020)   $ 30,000     $ -     $ 45,000     $ -  
CEO, former     -       88,000       22,505       133,000  
COO, former     -       45,000       -       90,000  
CFO, former     -       30,000       20,000       60,000  
Total   $ 30,000     $ 163,000     $ 87,505     $ 283,000  

 

As of June 30, 2020, and December 31, 2019, included in accounts payable and accrued expenses, related party is $456,185 and $470,886, respectively, for the following amounts owed the Company’s former officers for accrued fees, accounts payable and loans made. The loans have no terms of repayment.

 

    June 30, 2020     December 31, 2019  
Former CEO, former (1)   $ 200     $ 125  
Former CEO, subsidiary (2)     144,087       144,639  
Former COO and CCO (3)     162,085       162,085  
Former COO (4)     112,500       112,500  
Former CFO (5)     -       51,537  
CEO     100       -  
Total   $ 419,692     $ 470,866  

 

(1)The former CEO, parent resigned February 28, 2020.

(2) The former CEO, subsidiary resigned on March 4, 2019.

(3) The Former COO and CCO resigned from those positions on October 1, 2018, and March 4, 2019, respectively.

(4) The former COO resigned on October 23, 2019.

(5) The former CFO resigned effective February 28, 2020.

 

Other

 

On February 9, 2018, the Company recorded a stock subscription receivable from its officers and directors of $7,600 related to the issuance of 7,600,000 shares of common stock.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies
 6 Months Ended
Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

NOTE 9 – COMMITMENTS AND CONTINGENCIES

 

Licenses

 

On February 1, 2018, Spinus entered into an Intellectual Property Licensing Agreement (the “Licensing Agreement”). The Company assumed the obligations under the Licensing Agreement and pledged the assets of Spinus as security. Pursuant to the terms of the Licensing Agreement, in consideration of $250,000 Spinus has the exclusive rights to certain patents and the non-exclusive rights to other patents. The patents surround mechanical or inflatable expandable interbody implant products. The Company paid the $250,000 on November 20, 2018. The Company also will pay a royalty of 7% of net sales on any product sold utilizing any of the patents. There have not been any sales of the licensed products and accordingly, no royalties have been incurred.

 

Consulting Agreements

 

On March 4, 2019, the Company entered into a Separation Agreement (the “Separation Agreement”) with Salman J. Chaudhry, pursuant to which Mr. Chaudry resigned immediately from his positions as the CCO and Secretary of the Company and as a member of the Board and from all positions with the Company effective immediately and pursuant to which the Company agreed to pay Mr. Chaudry $227,200 (the “Outstanding Fees”) in certain increments as set forth in the Separation Agreement. Mr. Chaudry’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. As of June 30, 2020, and December 31, 2019, the balance owed Mr. Chaudhry is $162,085.

 

On March 24, 2019, the Company and Newbridge Securities Corporation (“Newbridge”) entered into an Investment Banking Engagement Agreement (the “Agreement”). Under the terms of the Agreement, Newbridge will provide investment banking and financial advisory services to the Company, including, but not limited to assisting the Company with an up-listing process to a national exchange in the United States, introducing the Company to other investment banking firms focused on servicing emerging growth companies; rendering advice related to capital structures, capital market opportunities, evaluating potential capital raise transactions and assisting the Company to develop growth optimization strategies. The term of the Agreement is 12 months from the date of the Agreement, however either party may terminate the Agreement anytime upon 15 days written notice. As compensation for its services under the Agreement, Newbridge and its assignees received 172 shares of the Company’s common stock. The Agreement contains customary terms relating to payment of expenses, indemnification and other matters. The Agreement also includes customary representations, warranties and covenants by the Company. The Company valued the shares at $77,130, based on the market price of the common stock on the date of the agreement, to be amortized over the one-year term of the contract. For the six months ended June 30, 2020, the Company amortized $17,783 as stock-based compensation expense. As of June 30, 2020, the expense has been fully recognized.

 

On September 2, 2019, the Company entered Consulting Agreement (the “Agreement”) with a consultant to act as the Company’s Executive Vice President, Sales and Marketing (the “EVP”) through December 31, 2019, and to provide the Company with customary services of an EVP. The Company has agreed to compensate the consultant $10,000 per month. Either party may terminate the Agreement in its sole and absolute discretion. The parties have agreed that they will negotiate follow up agreement with terms and conditions to include salary, commission, bonuses and stock and or option grants or awards, to be consistent with industry standards for like size companies prior to the termination of the Agreement. For the year ended December 31, 2019, the Company has expensed $30,000. As of June 30, 2020, and December 31, 2019, the Company owes the EVP $10,000, included in liabilities of discontinued operations.

 

On September 3, 2019, the Company entered into an Investor Relations Agreement (the “Agreement”) with a consultant. Under the terms of the Agreement, the consultant will provide consulting services to the Company, including, but not limited to assisting the Company in the conception and implementation of the Company’s corporate and business development plan. The term of the Agreement is 6 months from the date of the Agreement. As compensation for its services under the Agreement, the consultant received 1,250 shares of the Company’s common stock. The Agreement contains customary terms relating to payment of expenses, indemnification and other matters. The Agreement also includes customary representations, warranties and covenants by the Company. The Company valued the shares at $46,875, based on the market price of the common stock on the date of the agreement, to be amortized over the term of the contract. For the six months ended June 30, 2020, the Company amortized $15,625 as stock-based compensation expense. As of June 30, 2020, the expense has been fully recognized.

 

On September 3, 2019, the Company entered into a Consulting Agreement (the “Agreement”) with a consultant. Under the terms of the Agreement, the consultant will provide consulting services to the Company, including, but not limited to assisting the Company in its general strategy for corporate communications. The term of the Agreement is 6 months from the date of the Agreement. As compensation for its services under the Agreement, the consultant received 1,250 shares of the Company’s common stock. The Agreement contains customary terms relating to payment of expenses, indemnification and other matters. The Agreement also includes customary representations, warranties and covenants by the Company. The Company valued the shares at $46,875, based on the market price of the common stock on the date of the agreement, to be amortized over the term of the contract. For the six months ended June 30, 2020, the Company amortized $15,625 as stock-based compensation expense. As of June 30, 2020, the expense has been fully recognized.

 

On June 5, 2020, the Company entered into a one-year agreement for media relations services with a third-party. Pursuant to the Agreement, the Company will pay the consultants $10,000 per month for the development and execution of a comprehensive media relations plan.

 
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.20.2
Income Taxes
 6 Months Ended
Jun. 30, 2020
Income Tax Disclosure [Abstract]  
Income Taxes

NOTE 10 - INCOME TAXES

 

The Company was incorporated in the United States and has operations in two tax jurisdictions - the United States and Hong Kong. The Company’s HK subsidiary is subject to a 16.5% profit tax based on its taxable net profit. The Company’s U.S. operations are subject to income tax according to U.S. tax law.

 

A reconciliation of the provision for income taxes determined at the U.S. statutory rate to the Company’s effective income tax rate is as follows:

 

    Six Months Ended  
    June 30,  
    2020     2019  
Pre-tax loss   $ (31,227,327 )   $ (2,823,397 )
U.S. federal corporate income tax rate     21 %     21 %
Expected U.S. income tax benefit     (6,557,739 )     (592,493 )
Tax rate difference between U.S. and foreign operations     -       289  
Permanent differences     6,198,791       417,713  
Change of valuation allowance     358,948       174,491  
Effective tax expense   $ —     $ —  

 

The Company had deferred tax assets as follows:

 

    June 30, 2020     December 31, 2019  
Net operating losses carried forward   $ 1,381,018     $ 1,022,071  
Less: Valuation allowance     (1,381,018 )     (1,022,071 )
Net deferred tax assets   $ —     $ —  

 

As of June 30, 2020, the Company has approximately $6,108,000 and $595,000 net operating loss carryforwards available in the United States and Hong Kong, respectively, to reduce future taxable income. The net operating loss from Hong Kong operations can be carried forward with no time limit from the year of the initial loss pursuant to relevant Hong Kong tax laws and regulations. For U.S. purposes the NOL deduction for a tax year is equal to the lesser of (1) the aggregate of the NOL carryovers to such year, plus the NOL carry-backs to such year, or (2) 80% of taxable income (determined without regard to the deduction). Generally, NOLs can no longer be carried back but are allowed to be carried forward indefinitely. The special extended carryback provisions are generally repealed, except for certain farming and insurance company losses. The amendments incorporating the 80% limitation apply to losses arising in tax years beginning after Dec. 31, 2017. It is more likely than not that the deferred tax assets cannot be utilized in the future because there will not be significant future earnings from the entity which generated the net operating loss. Therefore, the Company recorded a full valuation allowance on its deferred tax assets.

 

As of June 30, 2020, and December 31, 2019, the Company has no material unrecognized tax benefits which would favourably affect the effective income tax rate in future periods, and does not believe that there will be any significant increases or decreases of unrecognized tax benefits within the next twelve months. No interest or penalties relating to income tax matters have been imposed on the Company during the three and six months ended June 30, 2020, and 2019, and no provision for interest and penalties is deemed necessary as of June 30, 2020, and 2019.

 

Since the Company’s foreign subsidiaries have not generated income since inception, the Company believes that Tax Act will not have significant impact on the Company’s consolidated financial statements.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity
 6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Stockholders' Equity

NOTE 11 – STOCKHOLDERS’ EQUITY

 

On January 21, 2020, the Company filed an amendment to its Certificate of Incorporation, with the Nevada Secretary of State, for 1-for-1,000 reverse stock split of our common stock (the “Reverse Stock Split”) effective February 10, 2020. The number of shares of common stock subject to outstanding options, warrants and convertible securities were also reduced by a factor of one- thousand and no fractional shares were issued. All historical share in this report have been adjusted to reflect the Reverse Stock Split. There were no changes to the authorized number of shares and the par value of our common stock.

 

Common stock

 

On July 5, 2019, the Company entered into an Equity Financing Agreement (the “Equity Agreement”) with GHS Investments, LLC, a Nevada limited liability company (the “Investor”), with the Investor committing to purchase up to $7,000,000 of the Company’s common stock in tranches of up to $400,000, following an effective registration of the shares and subject to restrictions regarding the timing of each sale and total percentage stock ownership held by the Investor. The purchase price for the shares will be 85% of the lowest closing price during the 10-day period prior to each sale, and with each sale, the Investor will receive an issuance premium of 5% to cover the Investor’s transaction costs associated with selling the shares and payable by the Company to the Investor in registered shares. The obligation of the Investor to purchase shares pursuant to the Equity Agreement is subject to several conditions, including (i) that the Company has filed a registration statement (the “Registration Statement”) with the United States Securities and Exchange Commission (the “SEC”) registering the shares to be sold to the Investor within 30 calendar days from the date of the Equity Agreement, with the Registration Statement being declared effective prior to sale of any shares to the Investor; and (ii) that the purchase of shares by the Investor pursuant to the Equity Agreement shall not cause the Investor to own more than 4.99% of the outstanding shares of the Company’s common stock.

 

In connection with the Equity Agreement, on July 5, 2019, the Company also entered into a Registration Rights Agreement with the Investor (the “Registration Rights Agreement”). On October 1, 2019, the SEC issued a Notice of Effectiveness of the Company’s Registration Statement.

 

During the six months ended June 30, 2020, holders of an aggregate of $2,774,896 in principal and $636,466 of accrued interest and fees of convertible notes issued by the Company, converted their debt into 1,444,237,885 shares of our common stock at an average conversion price of $0.00236 per share. The Company also issued 104,719,899 shares of common stock upon the cashless exercise of common stock purchase warrants.

 

As of June 30, 2020, the Company has 4,990,000,000 shares of $0.001 par value common stock authorized and there are 1,549,176,877 shares of common stock issued and outstanding.

 

Common stock to be issued

 

For the year ended December 31, 2019, the Company recorded 1,350 shares (post reverse stock split) of common stock to be issued, and valued the shares at $410,370, based on the market price of the common stock on the date of the shares being earned. For the year ended December 31, 2019, the company amortized $410,370 as stock-based compensation expense. As of June 30, 2020, and December 31, 2019, there are 1,350 shares of common stock to be issued.

 

Preferred stock

 

As of June 30, 2020, 10,000,000 shares have been authorized as preferred stock, par value $0.001 (the “Preferred Stock”), which such Preferred Stock shall be issuable in such series, and with such designations, rights and preferences as the Board of Directors may determine from time to time.

 

On March 28, 2019, the Company filed a Certificate of Designation with the Secretary of State of Nevada to designate 1,000,000 shares as Series B Preferred Stock. The Series B Preferred Stock is not convertible into common stock, nor does the Series B Preferred Stock have any right to dividends and any liquidation preference. The Series B Preferred Stock entitles its holder to a number of votes per share equal to 50 votes. On April 1, 2019, the Company issued 1,000,000 shares of Series B Preferred Stock to the Company’s CEO at the time. This resulted in a change in control of the Company.

 

On September 18, 2019, the Company filed a Certificate of Designation with the Secretary of State of Nevada to designate 50,000 shares as Series C Preferred Stock. Each share of Series C Preferred Stock shall be convertible, at the option of the holder thereof, at any time after the date of issuance, into one share of fully paid and non-assessable share of common stock. Each share of Series C Preferred Stock shall entitle the holder thereof to ten thousand (10,000) votes on all matters submitted to a vote of the stockholders of the Company.

 

On September 19, 2019, the Company issued 50,000 shares of its Series C Preferred Stock to the Company’s CEO and Director, at the time, in consideration of the cancellation and return of 1,000,000 shares of the Company’s Series B Preferred Stock. On September 20, 2019, the Company filed a Certificate of Withdrawal of Certificate of Designation (the “Certificate of Withdrawal”) for the Company’s Series B Preferred Stock, pursuant to which the prior designation of the Company’s Series B Stock was cancelled. On February 28, 2020, pursuant to a share redemption agreement between the Company and Mr. Chermak pursuant to which, the Company agreed to redeem his 50,000 shares of Series C Preferred Stock for $100,000, ($2 per share), the Company redeemed 2,500 shares of series C Preferred Stock from Mr. Chermak, and issued 2,500 shares of Series C Preferred Stock to Mr. Conway, pursuant to Mr. Conway’s employment agreement. The Company valued the 2,500 shares issued to Mr. Conway at $5,000 ($2 per share). On April 28, 2020, the Company redeemed the remaining 47,500 shares of Series C Preferred Stock from the former CEO. As of June 30, 2020, and December 31, 2019, there are 50,000 shares of Series C Preferred Stock outstanding, respectively, and no shares of Series B Preferred Stock outstanding.

 

On February 4, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company’s Series C Preferred Stock. The voting rights associated with the Series C Preferred Stock were amended whereby each share of Series C Preferred Stock shall entitle the holder thereof to have voting rights equal to two times the sum of all the number of shares of other classes of Company capital stock eligible to vote on all matters submitted to a vote of the stockholders of the Company, divided by the number of shares of Preferred Stock issued and outstanding at the time of voting.

 

Stock subscription receivable

 

On February 9, 2018, the Company recorded a stock subscription receivable from its officers and directors of $7,600 related to the issuance of 7,600 shares of common stock.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Discontinued Operations
 6 Months Ended
Jun. 30, 2020
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations

NOTE 12 – DISCONTINUED OPERATIONS

 

ASC 205-20 “Discontinued Operations” establishes that the disposal or abandonment of a component of an entity or a group of components of an entity should be reported in discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results. As a result, the component’s results of operations have been reclassified as discontinued operations on a retrospective basis for all periods presented. Accordingly, the assets and liabilities of this component are separately reported as “assets and liabilities held for disposal” as of December 31, 2019. The results of operations of this component, for all periods, are separately reported as “discontinued operations”. There have been no transactions between the Company and SRI since the termination.

 

A reconciliation of the major classes of line items constituting the gain from discontinued operations, net of income taxes as is presented in the Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2020, are summarized below; there was no activity of the SRI business for the three and six months ended June 30, 2019.

 

Cost of goods sold   $ 4,326  
Operating expenses:        
Depreciation expense     13,805  
Rent expense     2,222  
Interest expense     8.794  
Total operating expenses     24,821  
Loss from discontinued operations   $ (29,147 )
         
Gain from license termination   $ 86,856  

 

Liabilities of discontinued operations at June 30, 2020, of $75,270 consist of accounts payable and accrued expenses related to SRI.

 

The following table presents the reconciliation of carrying amounts of major classes of assets and liabilities of the Company classified as discontinued operations in the condensed consolidated balance sheet at December 31, 2019:

 

Carrying amounts of major classes of assets

included as part of assets held for discontinued operations

      
Inventory   $ 378,061  
Prepaid expenses     2,987  
Property and equipment, net     353,985  
License rights, net     2,724,848  
Goodwill     2,002,314  
Total assets included in the assets of discontinued operations   $ 5,462,195  

 

Carrying amounts of major classes of liabilities

included as part of liabilities of discontinued operations

      
Accounts payable and accrued expenses   $ 88,178  
Liability for common stock payable     245,000  
Current portion of notes payable     1,131,771  
Current portion of license fee payable     984,089  
Long term portion of notes payable     1,440  
Long term portion of license fee payable     250,000  
Put option payable     2,892,228  
Total liabilities included in the liabilities of discontinued operations   $ 5,592,706  
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events
 6 Months Ended
Jun. 30, 2020
Subsequent Events [Abstract]  
Subsequent Events

NOTE 13 – SUBSEQUENT EVENTS

 

From July 1, 2020, through August 10, 2020, the Company has issued 1,205,966,108 shares of common stock upon the conversion of $1,883,096 of principal, accrued interest and fees of convertible notes. The Company also issued 149,820,477 shares of common stock upon the cashless exercise of warrants.

 

On July 8, 2020, (the “Issuance Date”) the Company issued a 15% convertible promissory note, in the principal amount of $250,000, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $200,000 on July 9, 2020, and this note included an original issue discount of $50,000. This note proceeds will be used by the Company for general working capital purposes. In conjunction with this note, the Company issued a warrant to purchase 12,500,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.

 

On July 7, 2020, the Company filed with the Secretary of State of the State of Nevada an Amendment to Certificate of Designation of Series C Preferred Stock, a Certificate of Designation of Series D Preferred Stock, and a Certificate of Designation of Series E Preferred Stock (collectively, the “Certificates of Designation”).

 

Under the terms of the Amendment to Certificate of Designation of Series C Preferred Stock, 50,000 shares of the Company’s preferred remain designated as Series C Preferred Stock. The holders of Series C Preferred Stock have no dividend rights. For so long as any shares of the Series C Preferred Stock remain issued and outstanding, the Holder thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to sixty-seven (67%) percent of the total vote.

 

Under the terms of the Certificate of Designation of Series D Preferred Stock, 20,000 shares of the Company’s preferred stock have been designated as Series D Convertible Preferred Stock. The holders of the Series D Convertible Preferred Stock shall not be entitled to receive dividends. The holders as a group may, at any time convert all of the shares of Series D Convertible Preferred Stock into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion, by 3. Except as provided in the Certificate of Designation or as otherwise required by law, no holder of the Series D Convertible Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Company for their vote, waiver, release or other action. The Series D Convertible Preferred Stock shall not bear any liquidation rights.

 

Under the terms of the Certificate of Designation of Series E Preferred Stock, 3,000 shares of the Company’s preferred stock have been designated as Series E Preferred Stock. The holders of the Series E Convertible Preferred Stock shall not be entitled to receive dividends. No holder of the Series E Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Corporation for their vote, waiver, release or other action, except as may be otherwise expressly required by law. At any time, the Corporation may redeem for cash out of funds legally available therefor, any or all of the outstanding Preferred Stock (“Optional Redemption”) at $1,000 (one thousand dollars) per share. The shares of Series E Preferred Stock have not been registered under the Securities Act of 1933 or the laws of any state of the United States and may not be transferred without such registration or an exemption from registration.

 

On July 10, 2020, the Company closed the SPA with (“PCTI”) and Chis, the sole shareholder of PCTI. Under the terms of the SPA, the Company acquired one thousand (1,000) shares of PCTI, which represents all of the outstanding shares of PCTI, from Catherine Chis in exchange for a cash payment of $400,000 (paid as of June 30, 2020) and the issuance of 47,500 shares of the Company’s Series C Preferred Stock, 18,667 shares of the Company’s Series D Preferred Stock, and 500 shares of the Company’s Series E Preferred Stock to Chis.

  

On July 15, 2020, (the “Issuance Date”) the Company issued a 15% convertible promissory note, in the principal amount of $127,500, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.011 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $102,000 on July 22, 2020, and this note included an original issue discount of $27,500. This note proceeds will be used by the Company for general working capital purposes. In conjunction with this note, the Company issued a warrant to purchase 6,375,000 shares of common stock at an exercise price of $0.02, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.

 

On July 24, 2020, PCTI, the Company’s wholly owned subsidiary, entered into a three- month consulting agreement with a third-party. Pursuant to the agreement, the Company will pay the consultant $10,000 per month and the consultant will provide services, including, but not limited to, identifying PCTI’s best path forward into the renewable energy and energy storage industries as well as advance their presence in the maritime/transportation industry.

 

On July 29, 2020, (the “Issuance Date”) the Company issued a 15% convertible promissory note, in the principal amount of $127,500, to an investor. This note matures 6 months after the Issuance Date. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.011 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. The Company received proceeds of $100,000 on August 3, 2020, and this note included an original issue discount of $27,500. This note proceeds will be used by the Company for general working capital purposes. In conjunction with this note, the Company issued a warrant to purchase 12,750,000 shares of common stock at an exercise price of $0.01, subject to adjustments and expiring on the five-year anniversary of the Issuance Date.

 

The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements, except as stated herein.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Pronouncements (Policies)
 6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June 30, 2020, and the results of operations and cash flows for the periods presented. The results of operations for the three and six months ended June 30, 2020, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Current Report on Form 10-K filed on May 14, 2020.

 

The unaudited condensed consolidated financial statements include the accounts of the Company and Ozop and its wholly owned subsidiaries Ozop LLC, Ozop HK and Spinus, LLC (“Spinus”). All intercompany accounts and transactions have been eliminated in consolidation.

 
Emerging Growth Companies

Emerging Growth Companies

 

The Company qualifies as an “emerging growth company” under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging growth company, the Company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company has elected to take advantage of the benefits of this extended transition period.

 
Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.
Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits
Sales Concentration and Credit Risk

Sales Concentration and credit risk

 

Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the three and six months ended June 30, 2020, and 2019, and their accounts receivable balance as of June 30, 2020:

 

    Sales % Three Months Ended June 30, 2020     Sales % Three Months Ended June 30, 2019     Sales % Six Months Ended June 30, 2020     Sales % Six
Months Ended
June 30, 2019		     Accounts receivable balance June 30, 2020  
Customer A     N/A       100 %     N/A       100 %   $       -  
Accounts Receivable

Accounts Receivable

 

The Company records accounts receivable at the time products and services are delivered. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.
Inventory

Inventory

 

Inventory, if any, which consists of finished goods, is valued at the lower of cost or net realizable value. Cost is determined using the first in first out (FIFO) method. Provision for potentially obsolete or slow-moving inventory is made based on management analysis or inventory levels and future sales forecasts.

 
Purchase Concentration

Purchase concentration

 

The principal purchases by the Company is comprised of finished goods that the Company sells to its customers. Following is a summary of suppliers who accounted for more than ten percent (10%) of the Company’s purchases for the three and six months ended June 30, 2020, and 2019:

 

    Purchase % Three Months Ended June 30, 2020     Purchase % Three Months Ended June 30, 2019     Purchase % Six Months Ended June 30, 2020     Purchase % Six
Months Ended
June 30, 2019		  
Supplier A     N/A       100 %     N/A       100 %
Property, Plant and Equipment

Property, plant and equipment

 

Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets.

 

The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows:

 

    June 30, 2020     December 31, 2019  
Office equipment   $ 17,979     $ 9.590  
Less: Accumulated Depreciation     (7,069 )     (5,589 )
Property and Equipment, Net   $ 10,910     $ 4,001  

 

Depreciation expense was $816 and $1,480 for the three and six months ended June 30, 2020, respectively, and $800 and $1,599 for the three and six months ended June 30, 2019, respectively.
Intangible Assets

Intangible Assets

 

Intangible assets primarily represent purchased patent and license rights. The Company amortizes these costs over the shorter of the legal life of the patent or its estimated economic life using the straight-line method. The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to future undiscounted cash flows to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. For the year ended December 31, 2019, the Company impaired $44,200 of tradenames as management has decided not to go forward with the use of the trade name Spinus. For the three and six months ended June 30, 2020, the Company recorded amortization expense of $10,415 and $20,833, respectively and the three and six months ended June 30, 2019, $10,417 and $20,834, respectively. In accordance with ASC 350, “Intangibles—Goodwill and Other,” goodwill and other intangible assets with indefinite lives are no longer subject to amortization but are tested for impairment annually or whenever events or changes in circumstances indicate that the asset might be impaired.
Goodwill

Goodwill

 

Goodwill is measured as the excess of consideration transferred and the net of the acquisition date fair value of assets acquired, and liabilities assumed in a business acquisition. During the year ended December 31, 2019, the Company recorded goodwill of $2,277,168, included in assets of discontinued operations in the accompanying balance sheet at December 31, 2019, related to the SRI transaction. The Company reviews the goodwill allocated to each of our reporting units for possible impairment annually and whenever events or changes in circumstances indicate carrying amount may not be recoverable. When assessing goodwill for impairment, the Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its’ carrying amount. If, after assessing the totality of events or circumstances, the Company determines it is more likely than not that the fair value of a reporting unit is less than its’ carrying amount, then the Company performs a two-step impairment test. If the Company concludes otherwise, then no further action is taken. The Company also has the option to bypass the qualitative assessment and only perform a quantitative assessment, which is the first step of the two-step impairment test. In the two-step impairment test, the Company measures the recoverability of goodwill by comparing a reporting unit’s carrying amount, including goodwill, to the estimated fair value of the reporting unit. During the year ended December 31, 2019. the Company recorded an impairment of goodwill of $274,854, for the termination of the SRI License Agreement due to no known future cash flows being provided by the assets, and as of January 16, 2020, the Company wrote off the remaining Goodwill balance associated with SRI transaction of $2,002,314.

 

In assessing the qualitative factors, the Company assesses relevant events and circumstances that may impact the fair value and the carrying amount of the reporting unit. The identification of relevant events and circumstances, and how these may impact a reporting unit’s fair value or carrying amount involve significant judgments and assumptions. The judgment and assumptions include the identification of macroeconomic conditions, industry, and market considerations, cost factors, overall financial performance and share price trends, and making the assessment as to whether each relevant factor will impact the impairment test positively or negatively and the magnitude of any such impact.

 

The carrying amount of each reporting unit is determined based upon the assignment of our assets and liabilities, including existing goodwill and other intangible assets, to the identified reporting units. Where an acquisition benefits only one reporting unit, the Company allocates, as of the acquisition date, all goodwill for that acquisition to the reporting unit that will benefit. Where the Company has had an acquisition that benefited more than one reporting unit, The Company has assigned the goodwill to our reporting units as of the acquisition date such that the goodwill assigned to a reporting unit is the excess of the fair value of the acquired business, or portion thereof, to be included in that reporting unit over the fair value of the individual assets acquired and liabilities assumed that are assigned to the reporting unit.

 

If the carrying amount of a reporting unit is in excess of its fair value, an impairment may exist, and the Company must perform the second step of the impairment analysis to measure the amount of the impairment loss, by allocating the reporting unit’s fair value to its assets and liabilities other than goodwill, comparing the carrying amount of the goodwill to the resulting implied fair value of the goodwill, and recording an impairment charge for any excess.
Discontinued Operations

Discontinued Operations

 

In accordance with ASC 205-20 Presentation of Financial Statements: Discontinued Operations, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when the components of an entity meets the criteria in paragraph 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations. .

 

On January 16, 2020, the Company pursuant to the termination of the SRI transaction Agreement (see Note 1) which meets the definition of a discontinued operation.. For additional information, see Note 12- Discontinued Operations.
Revenue Recognition

Revenue Recognition

 

Effective January 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. Under ASC 606, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The Company has no outstanding contracts with any of its’ customers. Revenues from Spinus were $1,521 and $47,602 for the three and six months ended June 30, 2019, and are recognized as an agent and are recorded at net. There was no impact on the Company’s financial statements as a result of adopting Topic 606 for the three and six months ended June 30, 2020, and 2019.
Advertising and Marketing Expenses

Advertising and Marketing Expenses

 

The Company expenses advertising and marketing costs as incurred. For the six months ended June 30, 2020, and 2019, the Company recorded $1,226 and $59,422, respectively, of advertising and marketing expenses.
Research and Development

Research and Development

 

Costs and expenses that can be clearly identified as research and development are charged to expense as incurred. For the six months ended June 30, 2020, and 2019, the Company recorded $-0- and $63,604 of research and development expenses, respectively.
Convertible Instruments

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

 

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

 

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of this note transaction and the effective conversion price embedded in this note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.

 

The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.
Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

 

The following are the hierarchical levels of inputs to measure fair value:

 

  ● Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
  ● Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
  ● Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.

 

The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of June 30, 2020, and December 31, 2019, for each fair value hierarchy level:

 

June 30, 2020   Derivative
Liabilities		     Total  
Level I   $ -     $ -  
Level II   $ -     $ -  
Level III   $ 9,471,445     $ 9,471,445  

 

December 31, 2019   Derivative
Liabilities		     Total  
Level I   $ -     $ -  
Level II   $ -     $ -  
Level III   $ 2,462,940     $ 2,462,940  
Income Taxes

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the deferred tax assets will not be realized.

 

Tax benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting periods presented.
Foreign Currency Translation

Foreign Currency Translation

 

The accounts of the Company’s Hong Kong subsidiary are maintained in Hong Kong dollars and the accounts of the U.S. companies are maintained in USD. The accounts of the Hong Kong subsidiary were translated into USD in accordance with Accounting Standards Codification (“ASC”) Topic 830, Foreign Currency Matters. According to Topic 830, all assets and liabilities were translated at the exchange rate on the balance sheet date; stockholders’ equity is translated at historical rates and statement of comprehensive income items are translated at the weighted average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with ASC Topic 220, Comprehensive Income. Gains and losses resulting from the foreign currency transactions are reflected in the statements of comprehensive income.

 

Relevant exchange rates used in the preparation of the consolidated financial statements are as follows for the periods ended June 30, 2020 and December 31, 2019, (Hong Kong dollar per one U.S. dollar):

 

    June 30, 2020     December 31, 2019  
Balance sheet date     .1290       .1284  
Average rate for statements of operations and comprehensive loss     .1288       .1276  
Earnings (Loss) Per Share

Earnings (Loss) Per Share

 

The Company reports earnings (loss) per share in accordance with ASC 260, “Earnings per Share.” Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net loss by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. As of June 30, 2020, and 2019, the Company’s dilutive securities are convertible into approximately 923,181,023 and 138,402,792 shares of common stock, respectively. This amount is not included in the computation of dilutive loss per share because their impact is antidilutive. The following table represents the classes of dilutive securities as of June 30, 2020, and 2019:

 

    June 30, 2020     June 30, 2019  
Common stock to be issued     1,350       750  
Convertible preferred stock     50,000       -  
Convertible notes payable     923,129,673       138,402,042  
      923,181,023       138,402,792  
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

There have no recent accounting pronouncements or changes in accounting pronouncements during the period ended June 30, 2020, that are of significance or potential significance to the Company.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Organization (Tables)
 6 Months Ended
Jun. 30, 2020
Schedule of Fair Value of Assets Acquired and Liabilities Assumed

The Company recorded a gain of $86,856 for the six months ended June 30, 2020 based on the difference of the carrying values of the assets acquired and liabilities that were assumed in the transaction as follows:

 

Assets      
Inventory   $ 374,500  
Instruments, net     350,825  
Patent rights, net     2,714,204  
Goodwill     2,002,314  
Total assets as of January 16, 2020   $ 5,441,843  

 

Consideration issued and liabilities assumed      
Common Stock payable   $ 245,000  
License fee payable     1,234,089  
Equity Line payable     45,359  
Iberia Note     447,153  
Inventory and Instrument note     640,699  
Accrued interest     16,979  
Option to buy     2,899,420  
Total consideration and liabilities assumed balances   $ 5,528,699  
Gain on termination of license   $ 86,856  
Spinal Resources, Inc [Member]  
Schedule of Fair Value of Assets Acquired and Liabilities Assumed

The following table summarizes the preliminary value of the consideration issued and the preliminary purchase price allocation of the fair value of assets acquired and liabilities assumed in the transaction:

 

    Purchase Price Allocation  
Fair value of consideration issued   $ 5,286,305  
Liabilities assumed     524,387  
Total purchase price   $ 5,810,692  
Assets acquired   $ 723,524  
Intellectual Property/Technology     2,810,000  
Goodwill     2,277,168  
    $ 5,810,692  
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Pronouncements (Tables)
 6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Schedule of Concentration Risk

Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the three and six months ended June 30, 2020, and 2019, and their accounts receivable balance as of June 30, 2020:

 

    Sales % Three Months Ended June 30, 2020     Sales % Three Months Ended June 30, 2019     Sales % Six Months Ended June 30, 2020     Sales % Six
Months Ended
June 30, 2019		     Accounts receivable balance June 30, 2020  
Customer A     N/A       100 %     N/A       100 %   $       -  

 

Following is a summary of suppliers who accounted for more than ten percent (10%) of the Company’s purchases for the three and six months ended June 30, 2020, and 2019:

 

    Purchase % Three Months Ended June 30, 2020     Purchase % Three Months Ended June 30, 2019     Purchase % Six Months Ended June 30, 2020     Purchase % Six
Months Ended
June 30, 2019		  
Supplier A     N/A       100 %     N/A       100 %
                                 

 
Schedule of Property, Plant and Equipment

The estimated useful lives of property and equipment is as follows:

 

    June 30, 2020     December 31, 2019  
Office equipment   $ 17,979     $ 9.590  
Less: Accumulated Depreciation     (7,069 )     (5,589 )
Property and Equipment, Net   $ 10,910     $ 4,001  
Schedule of Fair Value of Derivative Instruments on Recurring Basis

The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of June 30, 2020, and December 31, 2019, for each fair value hierarchy level:

 

June 30, 2020   Derivative
Liabilities		     Total  
Level I   $ -     $ -  
Level II   $ -     $ -  
Level III   $ 9,471,445     $ 9,471,445  

 

December 31, 2019   Derivative
Liabilities		     Total  
Level I   $ -     $ -  
Level II   $ -     $ -  
Level III   $ 2,462,940     $ 2,462,940  
Schedule of Foreign Exchange Rates

Relevant exchange rates used in the preparation of the consolidated financial statements are as follows for the periods ended June 30, 2020 and December 31, 2019, (Hong Kong dollar per one U.S. dollar):

 

    June 30, 2020     December 31, 2019  
Balance sheet date     .1290       .1284  
Average rate for statements of operations and comprehensive loss     .1288       .1276  

 
Schedule of Antidilutive Securities

The following table represents the classes of dilutive securities as of June 30, 2020, and 2019:

 

    June 30, 2020     June 30, 2019  
Common stock to be issued     1,350       750  
Convertible preferred stock     50,000       -  
Convertible notes payable     923,129,673       138,402,042  
      923,181,023       138,402,792  
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets (Tables)
 6 Months Ended
Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets

Patents as of June 30, 2020, and December 31, 2019, consist of the following:

 

    June 30, 2020     December 31, 2019  
Patents and license rights   $ 250,000     $ 250,000  
Accumulated amortization     (98,959 )     (78,125 )
Net carrying amount   $ 151,041     $ 171,875  
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Convertible Notes Payable (Tables)
 6 Months Ended
Jun. 30, 2020
Debt Disclosure [Abstract]  
Summary of Convertible Note Balance

A summary of the convertible note balance as of June 30, 2020, and December 31, 2019, is as follows:

 

    June 30, 2020     December 31, 2019  
             
Principal balance   $ 2,640,450     $ 2,500,230  
Unamortized discount     (872,945 )     (806,003 )
Ending balance, net   $ 1,767,505     $ 1,694,227  
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Derivative Liabilities (Tables)
 6 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Schedule of Derivative Liabilities

A summary of the activity related to derivative liabilities for the six months ended June 30, 2020, and the year ended December 31, 2019, is as follows:

 

Balance- January 1, 2019   $ 1,199,514  
Issued during period     1,460,123  
Converted or paid     (850,248 )
Change in fair value recognized in operations     653,551  
Balance- December 31, 2019     2,462,940  
Issued during the period     11,953,787  
Converted or paid     (8,627,804 )
Change in fair value recognized in operations     3,682,522  
Balance June 30, 2020   $ 9,471,445  
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Notes Payable (Tables)
 6 Months Ended
Jun. 30, 2020
Debt Disclosure [Abstract]  
Schedule of Notes Payable

The Company has the following note payables outstanding:

 

    June 30, 2020     December 31, 2019  
Note payable, interest at 8%, matured September 6, 2018, in default   $ -     $ 330,033  
Notes payable, interest at 8%, matured January 5, 2020, currently in default     45,000       45,000  
Other, due on demand, interest at 6%     50,000       50,000  
Note payable, interest at 18%, matures June 23, 2022, net of discount of $34,635     175,365       -  
Note payable, interest at 12%, matures June 25, 2021, net of discount of $26,970     176,030       -  
Sub- total notes payable     446,395       425,033  
Less long-term portion, net of discount     176,365       -  
Current portion of notes payable, net of discount   $ 270,030     $ 425,033  
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transactions (Tables)
 6 Months Ended
Jun. 30, 2020
Related Party Transactions [Abstract]  
Schedule of Expenses to Officers

For the three and six months ended June 30, 2020, and 2019, the Company recorded expenses to its officers in the following amounts:

 

    Three months ended
June 30,		     Six months ended
June 30,		  
    2020     2019     2020     2019  
CEO, parent (includes $5,000 stock-based compensation six months ended June 30, 2020)   $ 30,000     $ -     $ 45,000     $ -  
CEO, former     -       88,000       22,505       133,000  
COO, former     -       45,000       -       90,000  
CFO, former     -       30,000       20,000       60,000  
Total   $ 30,000     $ 163,000     $ 87,505     $ 283,000  
Schedule of Former Officers for Accrued Fees, Accounts Payable and Loans
    June 30, 2020     December 31, 2019  
Former CEO, former (1)   $ 200     $ 125  
Former CEO, subsidiary (2)     144,087       144,639  
Former COO and CCO (3)     162,085       162,085  
Former COO (4)     112,500       112,500  
Former CFO (5)     -       51,537  
CEO     100       -  
Total   $ 419,692     $ 470,866  

 

(1)The former CEO, parent resigned February 28, 2020.

(2) The former CEO, subsidiary resigned on March 4, 2019.

(3) The Former COO and CCO resigned from those positions on October 1, 2018, and March 4, 2019, respectively.

(4) The former COO resigned on October 23, 2019.

(5) The former CFO resigned effective February 28, 2020.
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Income Taxes (Tables)
 6 Months Ended
Jun. 30, 2020
Income Tax Disclosure [Abstract]  
Schedule of Provision for Income Tax

A reconciliation of the provision for income taxes determined at the U.S. statutory rate to the Company’s effective income tax rate is as follows:

 

    Six Months Ended  
    June 30,  
    2020     2019  
Pre-tax loss   $ (31,227,327 )   $ (2,823,397 )
U.S. federal corporate income tax rate     21 %     21 %
Expected U.S. income tax benefit     (6,557,739 )     (592,493 )
Tax rate difference between U.S. and foreign operations     -       289  
Permanent differences     6,198,791       417,713  
Change of valuation allowance     358,948       174,491  
Effective tax expense   $ —     $ —  
Schedule of Deferred Tax Assets

The Company had deferred tax assets as follows:

 

    June 30, 2020     December 31, 2019  
Net operating losses carried forward   $ 1,381,018     $ 1,022,071  
Less: Valuation allowance     (1,381,018 )     (1,022,071 )
Net deferred tax assets   $ —     $ —  
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.20.2
Discontinued Operations (Tables)
 6 Months Ended
Jun. 30, 2020
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Discontinued Operations Condensed Consolidated Statements

A reconciliation of the major classes of line items constituting the gain from discontinued operations, net of income taxes as is presented in the Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2020, are summarized below; there was no activity of the SRI business for the three and six months ended June 30, 2019.

 

Cost of goods sold   $ 4,326  
Operating expenses:        
Depreciation expense     13,805  
Rent expense     2,222  
Interest expense     8.794  
Total operating expenses     24,821  
Loss from discontinued operations   $ (29,147 )
         
Gain from license termination   $ 86,856  

 

The following table presents the reconciliation of carrying amounts of major classes of assets and liabilities of the Company classified as discontinued operations in the condensed consolidated balance sheet at December 31, 2019:

 

Carrying amounts of major classes of assets

included as part of assets held for discontinued operations

      
Inventory   $ 378,061  
Prepaid expenses     2,987  
Property and equipment, net     353,985  
License rights, net     2,724,848  
Goodwill     2,002,314  
Total assets included in the assets of discontinued operations   $ 5,462,195  

 

Carrying amounts of major classes of liabilities

included as part of liabilities of discontinued operations

      
Accounts payable and accrued expenses   $ 88,178  
Liability for common stock payable     245,000  
Current portion of notes payable     1,131,771  
Current portion of license fee payable     984,089  
Long term portion of notes payable     1,440  
Long term portion of license fee payable     250,000  
Put option payable     2,892,228  
Total liabilities included in the liabilities of discontinued operations   $ 5,592,706  
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Organization (Details Narrative) - USD ($)
 6 Months Ended 12 Months Ended
Feb. 28, 2020
Aug. 23, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Jun. 26, 2020
May 26, 2020
Oct. 28, 2016
Jul. 19, 2016
Payments to acquire businesses     $ 400,000          
Advance for acquisition     400,000   $ 300,000 $ 100,000    
Equity ownership percentage               100.00%  
Liability     $ 12,599,663   $ 11,016,432        
Common stock shares issued     1,549,176,877   219,035        
Gain on termination of license     $ 86,856            
Spinal Resources, Inc [Member]                  
Impairment on acquisition         $ 274,854        
Spinal Resources, Inc [Member]                  
Total purchase price allocation   $ 5,810,692              
Perma Consultants Holding AG [Member]                  
Equity ownership percentage                 100.00%
Securities Purchase Agreement [Member] | Binding Letter of Intent [Member] | Series C Preferred Stock [Member]                  
Stock issued during period, shares, acquisitions 47,500                
Securities Purchase Agreement [Member] | Binding Letter of Intent [Member] | Series D Preferred Stock [Member]                  
Stock issued during period, shares, acquisitions 18,667                
Securities Purchase Agreement [Member] | Binding Letter of Intent [Member] | Series E Preferred Stock [Member]                  
Stock issued during period, shares, acquisitions 500                
Exclusive License Agreement [Member] | Spinal Resources, Inc [Member]                  
Payments to acquire businesses   3,093,604              
License fees   1,500,000              
Liability   $ 1,234,089              
Common stock shares issued   1,000              
Number of restricted common stock     49,000            
Consideration of the transaction   $ 245,000 $ 49,000            
Number of shares issued on transaction   5,000              
Promissory note   $ 723,524              
Debt instrument interest rate   6.00%              
Option to purchase grants   $ 5,500,000              
Present value of liability   2,834,692              
Interest expense   $ 258,912              
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Organization - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Aug. 23, 2019
Liabilities assumed $ 5,528,699    
Goodwill 194,951 $ 194,951  
Inventory 374,500    
Instruments, net 350,825    
Patent rights, net 2,714,204    
Goodwill    
Total assets as of January 16, 2020 5,441,843    
Common Stock payable 245,000    
License fee payable 1,234,089    
Equity Line payable 45,359    
Iberia Note 447,153    
Inventory and Instrument note 640,699    
Accrued interest 16,979    
Option to buy 2,899,420    
Total consideration and liabilities assumed balances 5,528,699    
Gain on termination of license $ 86,856    
Spinal Resources, Inc [Member]      
Fair value of consideration issued     $ 5,286,305
Liabilities assumed     524,387
Total purchase price     5,810,692
Assets acquired     723,524
Intellectual Property/Technology     2,810,000
Goodwill     2,277,168
Total purchase price allocation     5,810,692
Total consideration and liabilities assumed balances     $ 524,387
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Going Concern and Management's Plans (Details Narrative) - USD ($)
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]            
Stockholders' deficit $ (11,535,918) $ (9,702,997) $ (5,167,116) $ (3,272,541) $ (2,706,380) $ (2,348,360)
Working capital deficit $ 11,716,455          
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Pronouncements (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Jan. 16, 2020
Depreciation expense $ 816 $ 800 $ 1,480 $ 1,599    
Impairments of tradenames         $ 44,200  
Amortization expense 10,415 10,417 20,834 20,834    
Goodwill 194,951   194,951   194,951  
Impairment of goodwill         274,854  
Revenues 1,521 49,123    
Advertising and marketing expenses     1,226 59,422    
Research and development expenses $ 10,400 $ 63,604    
Income tax likelihood description     greater than fifty percent likelihood      
Anti-dilutive shares of common stock     923,181,023 138,402,792    
Spinal Resources, Inc [Member]            
Goodwill         $ 2,277,168 $ 2,002,314
Sales Revenue [Member] | Customer [Member]            
Concentration of credit risk     10.00% 10.00%    
Product Revenue [Member] | Suppliers [Member]            
Concentration of credit risk     10.00% 10.00%    
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Pronouncements - Schedule of Concentration Risk (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Customer A [Member]        
Accounts receivable balance $ 0   $ 0  
Sales Revenue [Member] | Customer A [Member]        
Concentration of credit risk 0.00% 100.00% 0.00% 100.00%
Product Revenue [Member] | Suppliers A [Member]        
Concentration of credit risk 0.00% 100.00% 0.00% 100.00%
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Pronouncements - Schedule of Property, Plant and Equipment (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Less: Accumulated Depreciation $ (7,069) $ (5,589)
Property and Equipment, Net 10,910 4,001
Office Equipment [Member]    
Property and Equipment, Gross $ 17,979 $ 9,590
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Pronouncements - Schedule of Fair Value of Derivative Instruments on Recurring Basis (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Level I [Member]    
Derivative Liabilities
Total
Level II [Member]    
Derivative Liabilities
Total
Level III [Member]    
Derivative Liabilities 9,471,445 2,462,940
Total $ 9,471,445 $ 2,462,940
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Pronouncements - Schedule of Foreign Exchange Rates (Details) - Hong Kong, Dollars [Member]
Jun. 30, 2020
Dec. 31, 2019
Balance Sheet Date [Member]    
Foreign currency exchange rate 0.1290 0.1284
Average Rate for Statements of Operations and Comprehensive Loss [Member]    
Foreign currency exchange rate 0.1288 0.1276
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Pronouncements - Schedule of Antidilutive Securities (Details) - shares
 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Anti-dilutive shares of common stock 923,181,023 138,402,792
Common Stock to be Issued [Member]    
Anti-dilutive shares of common stock 1,350 750
Convertible Preferred Stock [Member]    
Anti-dilutive shares of common stock 50,000
Convertible Notes Payable [Member]    
Anti-dilutive shares of common stock 923,129,673 138,402,042
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]        
Amortization expense $ 10,415 $ 10,417 $ 20,834 $ 20,834
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Accumulated amortization $ (98,959) $ (78,125)
Net carrying amount 151,041 171,875
Patents and License Rights [Member]    
Gross carrying amount $ 250,000 $ 250,000
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Convertible Notes Payable (Details Narrative)
 6 Months Ended 12 Months Ended
Jun. 30, 2020
USD ($)
$ / shares
shares
Jun. 23, 2020
USD ($)
Jun. 11, 2020
USD ($)
Jun. 01, 2020
USD ($)
May 28, 2020
USD ($)
May 15, 2020
USD ($)
May 13, 2020
USD ($)
May 07, 2020
USD ($)
May 06, 2020
USD ($)
May 05, 2020
USD ($)
May 04, 2020
USD ($)
$ / shares
shares
Apr. 28, 2020
USD ($)
Apr. 27, 2020
USD ($)
Apr. 24, 2020
USD ($)
Apr. 17, 2020
USD ($)
Mar. 09, 2020
USD ($)
$ / shares
Feb. 26, 2020
USD ($)
$ / shares
Feb. 18, 2020
USD ($)
Jan. 08, 2020
USD ($)
Nov. 27, 2019
USD ($)
Oct. 25, 2019
USD ($)
Oct. 24, 2019
USD ($)
Oct. 08, 2019
USD ($)
Oct. 01, 2019
USD ($)
Aug. 29, 2019
USD ($)
Aug. 23, 2019
USD ($)
Aug. 21, 2019
USD ($)
Aug. 19, 2019
USD ($)
$ / shares
shares
Aug. 02, 2019
USD ($)
Jul. 24, 2019
USD ($)
Jun. 22, 2019
USD ($)
Jun. 07, 2019
USD ($)
Jun. 05, 2019
USD ($)
May 29, 2019
USD ($)
Mar. 07, 2019
USD ($)
Feb. 26, 2019
USD ($)
Feb. 08, 2019
USD ($)
Feb. 05, 2019
USD ($)
Jan. 07, 2019
USD ($)
Nov. 19, 2018
USD ($)
Nov. 15, 2018
USD ($)
Apr. 29, 2018
USD ($)
Apr. 13, 2018
USD ($)
Feb. 09, 2018
shares
Jun. 30, 2020
USD ($)
$ / shares
shares
Jun. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
$ / shares
Jun. 29, 2020
USD ($)
$ / shares
Convertible promissory notes $ 2,640,450                                                                                       $ 2,640,450   $ 2,500,230      
Proceeds form convertible notes                                                                                         $ 803,250 $ 494,950        
Conversion stock price per share | $ / shares $ 0.00236                               $ 330,033                                                       $ 0.00236          
Debt instrument carrying value                                                                                                  
Initial debt discount $ 872,945                                                                                   620,075   $ 872,945   806,003      
Interest expenses                                                                                     14,000              
Initial derivative liability $ 9,471,445                                                                                   634,075   9,471,445   $ 2,462,940 $ 1,199,514    
Debt instrument face amount                                 $ 330,000                                                                  
Debt conversion ratio                                 0.12                                                                  
Amortization of debt discount                                                                                         $ 14,727,584 860,561        
Number of shares of common stock | shares                                                                                       7,600,000 1,350   1,350      
Notes payable received                                                                                         $ 351,000        
Number of warrants issued to acquire shares of common stock | shares 104,719,899                                                                                       104,719,899          
Payment to acquire                                                                                         $ 400,000        
Debt instrument conversion shares | shares                                                                                         1,444,237,885          
Debt Purchase Agreement [Member]                                                                                                    
Convertible promissory notes                                                                                             $ 37,998      
Debt instrument face amount   $ 50,000                                                                                                
Repayment of debt to third party   10,000                                                                                                
Purchase price   $ 60,000                                                                                                
Debt Purchase Agreement [Member] | One Investor [Member]                                                                                                    
Debt instrument face amount                                                 $ 15,000                                                  
Accrued interest                                                 2,624                                                  
Repayment of debt to third party                                                 5,250                                                  
Purchase price                                                 22,874                                                  
Debt Purchase Agreement [Member] | Second Investor [Member]                                                                                                    
Debt instrument face amount                                                 25,000                                                  
Accrued interest                                                 4,248                                                  
Repayment of debt to third party                                                 8,750                                                  
Purchase price                                                 $ 37,998                                                  
Debt Purchase Agreement [Member] | Investor [Member]                                                                                                    
Number of shares of common stock | shares                                                                                         3,781,509          
Debt Purchase Agreement [Member] | Purchaser [Member]                                                                                                    
Convertible promissory notes $ 0                                                                                       $ 0   15,874     $ 0
Conversion stock price per share | $ / shares $ 0.0775                                                                                       $ 0.0775         $ 0.01066
Initial debt discount                                                                                             37,998      
Initial derivative liability $ 22,953                                                                                       $ 22,953          
Debt instrument face amount 15,874                                                                                       15,874          
Accrued interest 968                                                                                       968   2,331      
Debt conversion ratio                                                 0.35                                                  
Debt instrument carrying value 37,998                                                                                       $ 37,998          
Number of shares of common stock | shares                                                                                         217,331          
Payment to acquire                                                 $ 22,874                                                  
Assignment Agreement [Member] | Purchaser [Member]                                                                                                    
Convertible promissory notes 0                                                                                       $ 0   93,391      
Maturity date, description                                                               This note matures 12 months after the date of issuance. This note matures 12 months after the date of issuance.                                  
Initial debt discount                                                               $ 49,335 $ 59,909                                  
Initial derivative liability                                                               $ 49,335 $ 59,909                                  
Threshold description                                                               This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 65% multiplied by the average of the lowest two trading prices during the 15- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 65% multiplied by the average of the lowest two trading prices during the 15- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion.                                  
Payment to acquire                                                               $ 77,000 $ 93,391                                  
Assignment Agreement [Member] | Purchaser [Member] | June 7, 2019 [Member]                                                                                                    
Convertible promissory notes 0                                                                                       0   77,000      
2017 Notes [Member]                                                                                                    
Convertible promissory notes 25,000                                                                                       25,000   175,000      
Proceeds form convertible notes                                                                                                 $ 710,000  
Maturity date, description                                                                                                 2017 Notes matured on their one- year anniversary.  
Debt instrument interest rate                                                                                                 10.00%  
Conversion stock price per share | $ / shares                                                                                                 $ 0.50  
Consulting fees                                                                                                 $ 25,500  
2017 Notes [Member] | Minimum [Member]                                                                                                    
Convertible promissory notes                                                                                                 $ 10,000  
Discount rate                                                                                                 35.00%  
2017 Notes [Member] | Maximum [Member]                                                                                                    
Convertible promissory notes                                                                                                 $ 50,000  
Discount rate                                                                                                 50.00%  
2018 Notes [Member]                                                                                                    
Convertible promissory notes                                                                                               50,000    
Proceeds form convertible notes                                                                                               $ 50,000    
Convertible Promissory Note [Member]                                                                                                    
Proceeds form convertible notes                                                                                     $ 350,000              
Debt instrument interest rate                                                                           8.00%         12.00%              
Initial debt discount 359,500                                                                         $ 16,500             359,500          
Interest expenses                                                                                         150,730          
Initial derivative liability 510,230                                                                                       510,230          
Debt instrument face amount                                                                           165,000         $ 442,175              
Purchase price                                                                           $ 148,500                        
Debt instrument maturity                                                                                                  
Debt conversion ratio                                                                                     0.55              
Transaction costs, fees and expenses                                                                                     $ 34,500              
Amortization of debt discount                                                                                     25,000              
Threshold description                                                                           This note is convertible into shares of the Company's common stock, beginning on the date which is 180 days from the issuance date of the Master Note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of conversion of the Master Note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company's common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of the Master Note. The embedded conversion feature included in the Master Note resulted in an initial debt discount and derivative liability of $38,502. For the three months ended March 31, 2020, amortization of the debt discounts of $4,496 was charged to interest expense. For the three months ended March 31, 2020, the investor converted a total of $4,905 of the face value and $1,500 of fees into 349,000 shares of common stock. As of March 31, 2020, and December 31, 2019, the outstanding principal balance of the Master Note was $6,735 and $11,640, respectively, with a carrying value as of March 31, 2020, and December 31, 2019, of $6,735 and $7,144, respectively. The balance of this note was converted during the six months ended June 30, 2020. In connection with the issuance of this Note, the Company issued warrants to acquire 55,000 shares of common stock, for a three-year period with an exercise price of $1,50 per share, subject to price adjustments. For the three months ended March 31, 2020, the Company valued the warrant on the Black Shoals option pricing model at $12,962 and recorded the amount as derivative expense with the offset to derivative liabilities.                        
Notes payable received                                                                           $ 49,500                        
Notes payable description                                                                           $47,500 after payment of $2,000 of the Investor's legal fees.                        
Convertible Promissory Note [Member] | October 8, 2019 [Member]                                                                                                    
Convertible promissory notes 0                                                                                       0   66,000      
Initial debt discount                                                                                             18,452      
Debt instrument carrying value                                                                                             47,548      
Convertible Promissory Note [Member] | After OID [Member]                                                                                                    
Proceeds form convertible notes                                                                                   $ 44,250 57,675              
Convertible Promissory Note [Member] | Investor [Member]                                                                                                    
Convertible promissory notes $ 26,188                                                                                       26,188          
Proceeds form convertible notes                                                                                         $ 52,375          
Conversion stock price per share | $ / shares $ 0.00257                                                                                       $ 0.00257          
Interest expenses                                                                                         $ 26,188   26,188      
Accrued interest $ 39,670                                                                                       39,670          
Sale of stock                                                                                             30,000      
Debt instrument carrying value 0                                                                                       $ 0 $ 78,563        
Number of shares of common stock | shares                                                                                         35,813,035          
Convertible Promissory Note [Member] | Investor [Member] | October 8, 2019 [Member]                                                                                                    
Debt instrument face amount 37,750                                                                                       $ 37,750          
Convertible Promissory Note [Member] | Investor Six [Member]                                                                                                    
Convertible promissory notes 0                                                                                       0   $ 445,360      
Conversion stock price per share | $ / shares                                                                                             $ 0.0032      
Debt instrument face amount 445,360                                                                                       445,360          
Accrued interest $ 39,570                                                                                       $ 39,570          
Number of shares of common stock | shares                                                                                         150,631,924          
Number of warrants issued to acquire shares of common stock | shares 43,500,000                                                                                       43,500,000          
Convertible Promissory Note [Member] | Investor Seven [Member]                                                                                                    
Convertible promissory notes                                                                                             $ 0      
Conversion stock price per share | $ / shares                                                                                             $ 0.00185      
Debt instrument otstanding amount                                                                                                  
Number of shares of common stock | shares                                                                                         96,727,034          
Convertible Promissory Note [Member] | First Tranche [Member]                                                                                                    
Debt instrument maturity                                                                         Feb. 08, 2020                          
Notes payable received                                                                         $ 55,000                          
Convertible Promissory Note [Member] | Investor Converted [Member] | October 8, 2019 [Member]                                                                                                    
Debt instrument face amount                                                                                             103,750      
Accrued interest                                                                                             2,640      
Convertible Promissory Note [Member] | Debt Purchase Agreement [Member]                                                                                                    
Convertible promissory notes                                   $ 50,000                                                                
Debt instrument interest rate                           70.00%       70.00%                                                                
Discount rate   70.00%     70.00% 70.00%   70.00%                                                                                    
Initial debt discount         $ 67,365 $ 100,000   $ 200,000       $ 13,483                                                                            
Interest expenses   $ 658,093     443,420 526,507   111,128       42,261   $ 881,058       $ 64,650                                                                
Initial derivative liability         510,785 626,507   311,128       55,744       $ 76,000                                                                    
Debt instrument face amount                           $ 77,000       50,000                                                                
Accrued interest                                   607,950                                                                
Purchase price   $ 60,000     $ 67,365 $ 52,000   $ 200,000       $ 13,483       $ 76,000                                                                    
Debt instrument maturity           Jan. 08, 2021   Oct. 24, 2020       May 23, 2020                                                                            
Transaction costs, fees and expenses                                   $ 192,025                                                                
Threshold description   This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received.     This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received. This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received.   This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received.       This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received.       This note, as amended, is convertible into common stock at a conversion price equal to a 50% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received.   This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received.                                                                
Convertible Promissory Note [Member] | Debt Purchase Agreement [Member] | February 18, 2020 [Member]                                                                                                    
Convertible promissory notes $ 2,086                                                                                       $ 2,086          
Conversion stock price per share | $ / shares $ 0.00123                                                                                       $ 0.00123          
Debt instrument face amount $ 242,025                                                                                       $ 242,025          
Accrued interest 154,627                                                                                       154,627          
Transaction costs, fees and expenses                                                                                         84,849          
Debt instrument carrying value 202,541                                                                                       $ 202,541          
Number of shares of common stock | shares                                                                                         241,489,074          
Convertible Promissory Note [Member] | Debt Purchase Agreement [Member] | March 9, 2020 [Member]                                                                                                    
Convertible promissory notes $ 155,632                                                                                       $ 155,632          
Conversion stock price per share | $ / shares $ 0.0014                                                                                       $ 0.0014          
Interest expenses                                                                                         $ 83,263          
Debt instrument face amount $ 3,603                                                                                       3,603          
Transaction costs, fees and expenses                                                                                         81,521          
Amortization of debt discount                                                                                         $ 76,000          
Number of shares of common stock | shares                                                                                         52,946,489          
Convertible Promissory Note [Member] | Debt Purchase Agreement [Member] | April 24, 2020 [Member]                                                                                                    
Convertible promissory notes $ 67                                                                                       $ 67          
Conversion stock price per share | $ / shares $ 0.00131                                                                                       $ 0.00131          
Interest expenses                                                                                         $ 121,250          
Debt instrument face amount $ 198,183                                                                                       198,183          
Accrued interest 44,396                                                                                       $ 44,396          
Debt instrument conversion shares | shares                                                                                         179,688,215          
Convertible Promissory Note [Member] | Debt Purchase Agreement [Member] | April 28, 2020 [Member]                                                                                                    
Convertible promissory notes 14,831                                                                                       $ 14,831          
Interest expenses                                                                                         1,348          
Amortization of debt discount                                                                                         13,483          
Convertible Promissory Note [Member] | Debt Purchase Agreement [Member] | May 07, 2020 [Member]                                                                                                    
Convertible promissory notes $ 0                                                                                       $ 0          
Conversion stock price per share | $ / shares $ 0.00218                                                                                       $ 0.00218          
Debt instrument face amount $ 200,000                                                                                       $ 200,000          
Accrued interest 16,922                                                                                       16,922          
Amortization of debt discount                                                                                         $ 200,000          
Debt instrument conversion shares | shares                                                                                         92,332,507          
Convertible Promissory Note [Member] | Debt Purchase Agreement [Member] | May 15, 2020 [Member]                                                                                                    
Convertible promissory notes $ 83,546                                                                                       $ 83,546          
Conversion stock price per share | $ / shares $ 0.00129                                                                                       $ 0.00129          
Initial debt discount $ 75,000                                                                                       $ 75,000          
Interest expenses                                                                                         63,500          
Debt instrument face amount 66,454                                                                                       66,454          
Accrued interest 5,246                                                                                       5,246          
Amortization of debt discount                                                                                         25,000          
Debt instrument carrying value 8,546                                                                                       $ 8,546          
Debt instrument conversion shares | shares                                                                                         53,110,926          
Convertible Promissory Note [Member] | Debt Purchase Agreement [Member] | May 28, 2020 [Member]                                                                                                    
Convertible promissory notes $ 103,671                                                                                       $ 103,671          
Conversion stock price per share | $ / shares $ 0.00118                                                                                       $ 0.00118          
Interest expenses                                                                                         $ 83,395          
Debt instrument face amount $ 47,090                                                                                       47,090          
Accrued interest 3,000                                                                                       3,000          
Amortization of debt discount                                                                                         $ 67,365          
Debt instrument conversion shares | shares                                                                                         39,959,295          
Convertible Promissory Note [Member] | Debt Purchase Agreement [Member] | June 23, 2020 [Member]                                                                                                    
Convertible promissory notes $ 20,921                                                                                       $ 20,921          
Conversion stock price per share | $ / shares $ 0.00133                                                                                       $ 0.00133          
Interest expenses                                                                                         $ 52,500          
Debt instrument face amount $ 91,579                                                                                       91,579          
Accrued interest 42,071                                                                                       $ 42,071          
Debt instrument conversion shares | shares                                                                                         99,000,000          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member]                                                                                                    
Convertible promissory notes $ 150,000                                                                                       $ 150,000          
Proceeds form convertible notes                                       $ 50,000 $ 33,000 $ 202,250 $ 57,000 $ 65,000 $ 45,000 $ 33,500 $ 50,000 $ 75,000 $ 150,000 $ 30,000       $ 73,300 $ 77,900       $ 133,250                      
Maturity date, description                                       This note matures 12 months after the date of issuance This note bears interest at the rate of 12% per annum and matures 12 months after the date of issuance. This note matures October 24, 2020 The Note matures 12 months after the date of issuance. This note matures 12 months after the date of issuance. The Note matures 12 months after the date of issuance. This note matures on May 23, 2020 The Note matures 12 months after the date of issuance. The Note matures May 19, 2020. The Note matures 12 months after the date of issuance.   The Note matures 12 months after the date of issuance.     The Note matures 12 months after the date of issuance. This Note matures 12 months after the date of issuance.       This Note matured January 7, 2020                      
Debt instrument interest rate                                     12.00% 12.00% 12.00% 12.00% 12.00% 12.00% 10.00% 10.00% 12.00% 8.00% 12.00%   10.00%     12.00% 12.00% 12.00%     8.00%                      
Conversion stock price per share | $ / shares $ 0.00436                                                                                       $ 0.00436          
Initial debt discount                                                   $ 1,800 $ 55,125   $ 157,500                                   2,416      
Interest expenses                                                                       $ 2,750                            
Initial derivative liability $ 111,500                                   $ 29,063 $ 49,808 $ 31,316 $ 144,302 $ 52,281 $ 52,457 $ 35,794 32,229 $ 47,117 $ 54,802 $ 125,982   $ 31,452     $ 70,418 $ 77,394                 $ 111,500          
Debt instrument face amount 150,000                                   38,000 53,000 $ 36,750 $ 225,000 66,000 68,000 45,000 37,800   85,000     $ 38,900     80,000 $ 85,000     $ 150,000           150,000          
Accrued interest $ 28,664                                                                                       28,664          
Purchase price                                     35,000                                                            
Debt instrument maturity                                           Oct. 24, 2020                                                        
Debt conversion ratio                                                             0.60       0.58                              
Transaction costs, fees and expenses                                     $ 3,000 $ 3,000   $ 2,750 $ 2,300 $ 3,000 $ 5,000 2,500   $ 2,750           $ 3,900 $ 4,100 64,650     $ 2,750                      
Amortization of debt discount                                                                                         $ 83,398   2,416      
Diligence expenses                                                                                                  
Debt instrument carrying value                                                                                             147,584      
Number of shares of common stock | shares                                                                                         24,394,666          
Threshold description                                       This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 56% multiplied by the lowest closing bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note is convertible at any time following the funding of this note into a variable number of the Company's common stock, based on a conversion ratio of 58% of the average of the two lowest closing bid prices for the 20 days prior to conversion.   This note matures 12 months after the date of issuance. This note is convertible into shares of the Company's common stock, at a conversion price equal to 60% of the average of the two lowest trading prices of the Company's common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company. This note was funded on October 10, 2019, This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 61% multiplied by the lowest closing bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 60% multiplied by the average of the lowest two trading prices during the 20 trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion.   This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 58% multiplied by the average of the lowest two trading prices during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of this note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company's common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note. This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 60% multiplied by the average of the lowest two trading prices during the 20 trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion.   This note is convertible into shares of the Company's common stock, at a conversion price equal to 60% of the lowest closing bid price of the Company's common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company.     This note is convertible into shares of the Company's common stock, at a conversion price equal to 58% of the average of the two lowest trading prices of the Company's common stock for the previous 20 trading day period ending on the date the notice of conversion of this note is received by the Company.         This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of this note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company's common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note.                      
Number of warrants issued to acquire shares of common stock | shares                                                       28,333                                            
Warrants exercise price | $ / shares                                                       $ 1.50                                            
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | March 7, 2019 [Member]                                                                                                    
Amortization of debt discount                                                                                         $ 15,714          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | May 29, 2019 [Member]                                                                                                    
Convertible promissory notes                                                                                             80,000      
Conversion stock price per share | $ / shares $ 0.00564                                                                                       $ 0.00564          
Initial debt discount                                                                                             32,021      
Debt instrument face amount $ 19,300                                                                                       $ 19,300          
Accrued interest 2,058                                                                                       2,058          
Amortization of debt discount                                                                                         $ 32,021          
Debt instrument carrying value                                                                                             47,979      
Number of shares of common stock | shares                                                                                         3,784,352          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | June 22, 2019 [Member]                                                                                                    
Convertible promissory notes $ 0                                                                                       $ 0   38,900      
Conversion stock price per share | $ / shares $ 0.00652                                                                                       $ 0.00652          
Initial debt discount                                                                                             22,587      
Amortization of debt discount                                                                                         $ 22,587          
Debt instrument carrying value                                                                                             16,313      
Debt instrument otstanding amount                                                                                             38,900      
Number of shares of common stock | shares                                                                                         6,379,036          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | August 2, 2019 [Member]                                                                                                    
Convertible promissory notes $ 0                                                                                       $ 0   157,500      
Conversion stock price per share | $ / shares $ 0.0074                                                                                       $ 0.0074          
Initial debt discount                                                                                             77,844      
Debt instrument face amount $ 157,500                                                                                       $ 157,500          
Accrued interest 13,523                                                                                       13,523          
Amortization of debt discount                                                                                         $ 77,844          
Debt instrument carrying value                                                                                             79,656      
Number of shares of common stock | shares                                                                                         23,114,263          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | August 21, 2019 [Member]                                                                                                    
Convertible promissory notes $ 0                                                                                       $ 0   55,125      
Conversion stock price per share | $ / shares $ 0.05278                                                                                       $ 0.05278          
Initial debt discount                                                                                             33,479      
Initial derivative liability                                                                                             56,049      
Debt instrument face amount $ 3,825                                                                                       $ 3,825          
Accrued interest $ 247                                                                                       247          
Amortization of debt discount                                                                                         33,479          
Sale of stock                                                                                         $ 76,000          
Debt instrument carrying value                                                                                             21,646      
Number of shares of common stock | shares                                                                                         77,144          
Number of warrants issued to acquire shares of common stock | shares 3,967,740                                                                                       3,967,740          
Warrants and rights outstanding                                                                                             25,000      
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | August 19, 2019 [Member]                                                                                                    
Convertible promissory notes $ 0                                                                                       $ 0   85,000      
Conversion stock price per share | $ / shares $ 0.00232                                                                                       $ 0.00232          
Initial debt discount                                                                                             33,656      
Debt instrument carrying value                                                                                             51,344      
Number of shares of common stock | shares                                                                                         39,658,500          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | August 23, 2019 [Member]                                                                                                    
Convertible promissory notes $ 0                                                                                       $ 0   37,800      
Conversion stock price per share | $ / shares $ 0.0063                                                                                       $ 0.0063          
Initial debt discount                                                                                             19,239      
Amortization of debt discount                                                                                         $ 19,239          
Debt instrument carrying value                                                                                             18,561      
Number of shares of common stock | shares                                                                                         4,336,000          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | August 29, 2019 [Member]                                                                                                    
Convertible promissory notes $ 0                                                                                       $ 0   45,000      
Conversion stock price per share | $ / shares $ 0.00603                                                                                       $ 0.00603          
Initial debt discount                                                                                             26,566      
Amortization of debt discount                                                                                         $ 26,567          
Debt instrument carrying value                                                                                             18,434      
Number of shares of common stock | shares                                                                                         7,933,325          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | October 1, 2019 [Member]                                                                                                    
Convertible promissory notes $ 0                                                                                       $ 0   68,000      
Conversion stock price per share | $ / shares $ 0.00785                                                                                       $ 0.00785          
Initial debt discount                                                                                             26,416      
Amortization of debt discount                                                                                             41,584      
Debt instrument carrying value                                                                                             $ 41,584      
Number of shares of common stock | shares                                                                                             9,186,036      
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | October 24, 2019 [Member]                                                                                                    
Convertible promissory notes $ 0                                                                                       $ 0   $ 225,000      
Conversion stock price per share | $ / shares $ 0.00193                                                                                       $ 0.00193          
Initial debt discount                                                                                             147,689      
Amortization of debt discount                                                                                         $ 147,689          
Debt instrument carrying value                                                                                             77,311      
Number of shares of common stock | shares                                                                                         125,613,294          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | October 25, 2019 [Member]                                                                                                    
Convertible promissory notes $ 0                                                                                       $ 0   36,750      
Conversion stock price per share | $ / shares $ 0.00494                                                                                       $ 0.00494          
Initial debt discount                                                                                             31,106      
Amortization of debt discount                                                                                         $ 31,106          
Debt instrument carrying value                                                                                             5,644      
Number of shares of common stock | shares                                                                                         7,881,267          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | November 27, 2019 [Member]                                                                                                    
Convertible promissory notes $ 0                                                                                       $ 0   53,000      
Initial debt discount                                                                                             48,374      
Debt instrument face amount                                                                                             53,000      
Amortization of debt discount                                                                                         482,742          
Debt instrument carrying value                                                                                             4,626      
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | January 8, 2020 [Member]                                                                                                    
Convertible promissory notes 0                                                                                       0          
Amortization of debt discount                                                                                         32,063          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | February 26, 2020 [Member]                                                                                                    
Convertible promissory notes                                                                                                
Initial debt discount 69,167                                                                                       69,167          
Accrued interest 2,086                                                                                       2,086          
Debt instrument carrying value 63,583                                                                                       $ 63,583          
Number of shares of common stock | shares                                                                                         90,191,785          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | After OID [Member]                                                                                                    
Proceeds form convertible notes                                         $ 1,750 $ 20,000 $ 6,000       $ 2,625 $ 7,250   $ 3,900       $ 2,800 $ 3,000       $ 14,000                      
Transaction costs, fees and expenses                                         $ 2,000           $ 2,500   $ 7,500                                          
Amortization of debt discount                                                       $ 33,656                                            
Threshold description                                           This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) $0.05 and (2) 58% multiplied by the average of the 2 lowest trading prices of the Company's common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note.                                                        
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | Investor [Member]                                                                                                    
Debt instrument face amount                                                   24,317                                                
Accrued interest                                                   $ 2,980                                                
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | Investor [Member] | March 7, 2019 [Member]                                                                                                    
Convertible promissory notes $ 0                                                                                       $ 0   31,800      
Conversion stock price per share | $ / shares $ 0.07891                                                                                       $ 0.07891          
Debt instrument carrying value $ 31,800                                                                                       $ 31,800          
Initial debt discount 77,394                                                                                       77,394   15,714      
Debt instrument face amount                                                                                             31,800      
Accrued interest 3,427                                                                                       $ 3,427          
Debt instrument carrying value                                                                                             16,086      
Debt instrument otstanding amount                                                                                             31,800      
Number of shares of common stock | shares                                                                                         446,416          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | Investor [Member] | May 29, 2019 [Member]                                                                                                    
Debt instrument face amount 60,700                                                                                       $ 60,700          
Accrued interest 6,665                                                                                       6,665          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | Investor [Member] | June 22, 2019 [Member]                                                                                                    
Debt instrument face amount 38,900                                                                                       38,900          
Accrued interest 2,714                                                                                       2,714          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | Investor [Member] | August 29, 2019 [Member]                                                                                                    
Debt instrument face amount 45,000                                                                                       45,000          
Accrued interest 2,838                                                                                       2,838          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | Investor [Member] | October 1, 2019 [Member]                                                                                                    
Debt instrument face amount 68,000                                                                                       68,000          
Accrued interest 4,080                                                                                       4,080          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | Investor [Member] | October 24, 2019 [Member]                                                                                                    
Debt instrument face amount 225,000                                                                                       225,000          
Accrued interest 16,858                                                                                       16,858          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | Investor [Member] | October 25, 2019 [Member]                                                                                                    
Debt instrument face amount 36,750                                                                                       36,750          
Accrued interest 2,219                                                                                       2,219          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | Investor [Member] | November 27, 2019 [Member]                                                                                                    
Debt instrument face amount           $ 53,000                                                                                        
Accrued interest           2,997                                                                                        
Repayment of debt to third party           19,003                                                                                        
Purchase price           $ 75,000                                                                                        
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | Investor [Member] | January 8, 2020 [Member]                                                                                                    
Debt instrument face amount 38,000                                                                                       38,000          
Accrued interest 1,624                                                                                       1,624          
Repayment of debt to third party                                                                                         12,276          
Purchase price                                                                                         52,000          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | Third Party Investor [Member] | May 29, 2019 [Member]                                                                                                    
Repayment of debt to third party                                                                                         67,365          
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member] | Third Party Investor [Member] | August 23, 2019 [Member]                                                                                                    
Repayment of debt to third party                                                                                         13,483          
Convertible Promissory Note [Member] | Assignment Agreement [Member]                                                                                                    
Initial derivative liability                                                                       $ 1,321,618                            
Convertible Promissory Note [Member] | Securities Purchase Agreement One [Member]                                                                                                    
Proceeds form convertible notes                                           $ 200,000                                                        
Maturity date, description                                           This note bears interest at the rate of 12% per annum and matures 12 months after the date of issuance.                                                        
Debt instrument interest rate                                           12.00%                           12.00%                            
Interest expenses                                           $ 16,000                                                        
Initial derivative liability                                           203,637                           $ 365,757                            
Debt instrument face amount                                           248,400                           330,000                            
Accrued interest                                                                       $ 468,750                            
Threshold description                                                                       This note is convertible into common stock at a conversion price equal to a 44% discount to the lowest trading price of the common stock for the 20 prior trading days including the day upon which a notice of conversion is received.                            
Convertible Promissory Note [Member] | Securities Purchase Agreement One [Member] | October 24, 2019 [Member]                                                                                                    
Convertible promissory notes $ 0                                                                                       $ 0   248,400      
Conversion stock price per share | $ / shares $ 0.00248                                                                                       $ 0.00248          
Initial debt discount                                                                                             26,717      
Repayment of debt to third party                                                                                         $ 200,000          
Amortization of debt discount                                                                                         $ 221,683          
Debt instrument carrying value                                                                                             221,683      
Number of shares of common stock | shares                                                                                         26,288,995          
Convertible Promissory Note [Member] | Securities Purchase Agreement One [Member] | February 26, 2020 [Member]                                                                                                    
Convertible promissory notes $ 798,750                                                                                       $ 798,750          
Convertible Promissory Note [Member] | Securities Purchase Agreement One [Member] | After OID [Member]                                                                                                    
Proceeds form convertible notes                                           $ 32,400                                                        
Threshold description                                           This note is convertible at any time following the funding of this note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the lowest trading price for the 25 days prior to conversion.                                                        
Convertible Promissory Note [Member] | Securities Purchase Agreement One [Member] | Investor [Member] | October 24, 2019 [Member]                                                                                                    
Debt instrument face amount                                                                                             48,400      
Accrued interest                                                                                             19,796      
Convertible Promissory Note [Member] | Debt Purchase Agreement One [Member]                                                                                                    
Maturity date, description                               This note matures 6 months after the Issuance Date.                                                                    
Debt instrument interest rate                               12.00%   70.00%                                                                
Discount rate           70.00%                                                                                        
Conversion stock price per share | $ / shares                               $ 0.25                                                                    
Initial debt discount           $ 77,000                                                                                        
Interest expenses           388,385                                                                                        
Initial derivative liability           465,385                   $ 121,067                                                                    
Debt instrument face amount                               $ 80,000   $ 50,000                                                                
Accrued interest                                   $ 607,950                                                                
Purchase price           $ 75,000                                                                                        
Debt instrument maturity           Nov. 27, 2020                                                                                        
Threshold description           This note, as amended, is convertible into common stock at a conversion price equal to a 70% discount to the lowest closing prices of the common stock for thirty prior trading days including the day upon which a notice of conversion is received.                   After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.25 or 50% of the lowest trading price for the thirty trading days prior to the conversion.                                                                    
Convertible Promissory Note [Member] | Debt Purchase Agreement One [Member] | February 18, 2020 [Member]                                                                                                    
Convertible promissory notes $ 161,350                                                                                       $ 161,350          
Conversion stock price per share | $ / shares $ 0.00257                                                                                       $ 0.00257          
Debt instrument face amount $ 202,541                                                                                       $ 202,541          
Accrued interest 154,627                                                                                       154,627          
Convertible Promissory Note [Member] | Debt Purchase Agreement One [Member] | March 9, 2020 [Member]                                                                                                    
Convertible promissory notes 80,000                                                                                       80,000          
Initial debt discount 31,067                                                                                       31,067          
Amortization of debt discount                                                                                         48,933          
Debt instrument carrying value 48,933                                                                                       48,933          
Convertible Promissory Note [Member] | Debt Purchase Agreement One [Member] | April 17, 2020 [Member]                                                                                                    
Convertible promissory notes 352,695                                                                                       352,695          
Debt instrument interest rate                             70.00%                                                                      
Interest expenses                             $ 1,476,436                                                           259,305          
Debt instrument face amount                             $ 93,391                                                                      
Convertible Promissory Note [Member] | Debt Purchase Agreement One [Member] | May 15, 2020 [Member]                                                                                                    
Convertible promissory notes 115,500                                                                                       115,500          
Initial debt discount 62,563                                                                                       62,563          
Interest expenses                                                                                         75,000          
Debt instrument carrying value 52,398                                                                                       52,398          
Convertible Promissory Note One [Member]                                                                                                    
Proceeds form convertible notes                                                                               $ 458,500     $ 280,000              
Maturity date, description                                                                                 The Note matures November 15, 2019.                  
Debt instrument interest rate                                                                                 12.00% 12.00%                
Initial debt discount 280,000                                                                                       280,000          
Interest expenses                                                                                         112,403          
Initial derivative liability 392,403                                                                               $ 363,806       392,403          
Debt instrument face amount 112,141                                                                               $ 500,000 $ 339,250     112,141          
Debt instrument maturity                                                                                     Aug. 29, 2019              
Debt conversion ratio                                                                                     0.55              
Transaction costs, fees and expenses                                                                               4,000     $ 15,000              
Amortization of debt discount                                                                                     $ 1,000              
Threshold description                                                                                 This note is convertible into shares of the Company's common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lesser of (1) the lowest trading price during the previous 20 trading day period ending on the last completed trading date prior to the date of this note and (2) 65% multiplied by the average of the 3 lowest trading prices of the Company's common stock during the 20 day trading period ending on the latest completed trading day of the common stock prior to the date of conversion of this note.                  
Convertible Promissory Note One [Member] | After OID [Member]                                                                                                    
Proceeds form convertible notes                                                                               $ 37,500                    
Convertible Promissory Note One [Member] | Investor Two [Member]                                                                                                    
Convertible promissory notes $ 74,990                                                                                       $ 74,990          
Conversion stock price per share | $ / shares $ 0.0053                                                                                       $ 0.0053          
Interest expenses                                                                                         $ 87,390          
Accrued interest $ 4,630                                                                                       4,630          
Debt instrument carrying value 0                                                                                       $ 0   187,130      
Number of shares of common stock | shares                                                                                         23,237,756          
Convertible Promissory Note Two [Member]                                                                                                    
Interest expenses                                                                                         $ 74,990          
Master Note [Member]                                                                                                    
Convertible promissory notes $ 0                                                                                       $ 0   11,640      
Conversion stock price per share | $ / shares $ 0.0044                                                                                       $ 0.0044          
Debt instrument carrying value                                                                                             7,144      
Initial debt discount $ 22,105                                                                         $ 38,502             $ 22,105          
Amortization of debt discount                                                                                         $ 12,102          
Debt instrument otstanding amount                                                                                             $ 11,640      
Number of shares of common stock | shares                                                                                         6,017,711          
Fees payable $ 4,400                                                                                       $ 4,400          
Number of warrants issued to acquire shares of common stock | shares 20,138,746                                                                                       20,138,746          
Warrants exercise price | $ / shares $ 1.50                                                                                       $ 1.50          
15% Convertible Redeemable Note [Member]                                                                                                    
Convertible promissory notes $ 129,500       $ 30,000     $ 30,000         $ 60,000                                                               $ 129,500          
Proceeds form convertible notes $ 102,000       25,000     $ 25,000         50,000                                                                          
Maturity date, description This note matures 6 months after the Issuance Date.             This note matures on May 7,2021                                                                                    
Initial debt discount $ 100,000       25,000     $ 25,000         50,000                                                               100,000          
Interest expenses 107,122       19,346     17,828         36,274                                                                          
Initial derivative liability 207,122       $ 44,346     42,828         $ 86,274                                                               207,122          
Debt instrument maturity         May 28, 2021               Apr. 27, 2021                                                                          
Debt conversion ratio                         0.50                                                                          
Amortization of debt discount $ 27,500       $ 5,000     $ 5,000                                                                                    
Threshold description This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion.       This note matures on May 28, 2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company.     This note matures on May 7,2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company         This note matures on April 27,2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company                                                                          
15% Convertible Redeemable Note [Member] | April 27, 2020 [Member]                                                                                                    
Convertible promissory notes $ 60,000                                                                                       60,000          
Initial debt discount 50,000                                                                                       50,000          
Amortization of debt discount                                                                                         10,000          
Debt instrument carrying value 10,000                                                                                       10,000          
15% Convertible Redeemable Note [Member] | May 07, 2020 [Member]                                                                                                    
Convertible promissory notes 30,000                                                                                       30,000          
Initial debt discount 25,625                                                                                       25,625          
Amortization of debt discount                                                                                         4,375          
Debt instrument carrying value 4,375                                                                                       4,375          
15% Convertible Redeemable Note [Member] | May 28, 2020 [Member]                                                                                                    
Convertible promissory notes 30,000                                                                                       30,000          
Initial debt discount 27,500                                                                                       27,500          
Amortization of debt discount                                                                                         2,500          
Debt instrument carrying value 2,500                                                                                       2,500          
15% Convertible Redeemable Note [Member] | June 30, 2020 [Member]                                                                                                    
Convertible promissory notes 129,500                                                                                       129,500          
Amortization of debt discount                                                                                         129,500          
Debt instrument carrying value $ 0                                                                                       $ 0          
Number of warrants issued to acquire shares of common stock | shares 6,375,000                                                                                       6,375,000          
Warrants exercise price | $ / shares $ 0.02                                                                                       $ 0.02          
Warrants term 5 years                                                                                       5 years          
Legal fee                                                                                         $ 2,000          
15% Convertible Redeemable Note [Member] | After OID [Member]                                                                                                    
Proceeds form convertible notes                         $ 10,000                                                                          
12% Convertible Redeemable Note [Member]                                                                                                    
Convertible promissory notes     $ 53,000 $ 127,500           $ 162,000 $ 110,000 $ 53,000                                                                            
Proceeds form convertible notes     $ 50,000 $ 100,000     $ 100,000   $ 96,250     $ 50,000                                                                            
Maturity date, description     This note matures 12 months after the date of issuance. This note matures 6 months after the Issuance Date.           This note matures 6 months after the Issuance Date. This note matures 12 months after the date of issuance. This note matures 12 months after the date of issuance                                                                            
Initial debt discount     $ 50,000 $ 100,000           $ 100,000 $ 100,000 $ 50,000                                                                            
Interest expenses     2,218 103,250           151,512 5,526 1,539                                                                            
Initial derivative liability     $ 52,218 203,250           $ 251,512 $ 105,526 $ 51,539                                                                            
Amortization of debt discount       $ 27,500     $ 62,000                                                                                      
Threshold description     This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 58% multiplied by the lowest closing bid price during the twenty trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion.           This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $03 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.03 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to the lower of $0.50 or 58% multiplied by the average of the two lowest closing trading price or bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion. This note is convertible into shares of the Company’s common stock beginning on the date which is 180 days from the issuance date of this note, at a conversion price equal to 58% multiplied by the lowest closing bid price during the 20- trading day period ending on the last completed trading date in the OTC Markets prior to the date of conversion.                                                                            
Number of warrants issued to acquire shares of common stock | shares                     3,666,666                                                                              
Warrants exercise price | $ / shares                     $ 0.015                                                                              
Warrants term                     5 years                                                                              
Legal fee     $ 3,000           $ 13,750     $ 3,000                                                                            
12% Convertible Redeemable Note [Member] | April 28, 2020 [Member]                                                                                                    
Convertible promissory notes $ 53,000                                                                                       53,000          
Initial debt discount 44,167                                                                                       44,167          
Amortization of debt discount                                                                                         8,833          
Debt instrument carrying value 8,833                                                                                       8,833          
12% Convertible Redeemable Note [Member] | May 04, 2020 [Member]                                                                                                    
Convertible promissory notes 110,000                                                                                       110,000          
Initial debt discount 93,958                                                                                       93,958          
Amortization of debt discount                                                                                         18,792          
Debt instrument carrying value 16,042                                                                                       16,042          
12% Convertible Redeemable Note [Member] | May 05, 2020 [Member]                                                                                                    
Convertible promissory notes 162,000                                                                                       162,000          
Initial debt discount 108,000                                                                                       108,000          
Amortization of debt discount                                                                                         54,000          
Debt instrument carrying value $ 54,000                                                                                       $ 54,000          
Number of warrants issued to acquire shares of common stock | shares 4,325,000                                                                                       4,325,000          
Warrants exercise price | $ / shares $ 0.02                                                                                       $ 0.02          
Warrants term 5 years                                                                                       5 years          
12% Convertible Redeemable Note [Member] | June 01, 2020 [Member]                                                                                                    
Convertible promissory notes $ 127,500                                                                                       $ 127,500          
Initial debt discount 106,250                                                                                       106,250          
Amortization of debt discount                                                                                         21,250          
Debt instrument carrying value $ 21,250                                                                                       $ 21,250          
Number of warrants issued to acquire shares of common stock | shares 6,375,000                                                                                       6,375,000          
Warrants exercise price | $ / shares $ 0.02                                                                                       $ 0.02          
Warrants term 5 years                                                                                       5 years          
12% Convertible Redeemable Note [Member] | June 11, 2020 [Member]                                                                                                    
Convertible promissory notes $ 53,000                                                                                       $ 53,000          
Initial debt discount 2,849                                                                                       2,849          
Amortization of debt discount                                                                                         50,151          
Debt instrument carrying value $ 2,849                                                                                       $ 2,849          
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.20.2
Convertible Notes Payable - Summary of Convertible Note Balance (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Apr. 13, 2018
Debt Disclosure [Abstract]      
Principal balance $ 2,640,450 $ 2,500,230  
Unamortized discount (872,945) (806,003) $ (620,075)
Ending balance, net $ 1,767,505 $ 1,694,227  
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.20.2
Derivative Liabilities (Details Narrative)
Jun. 30, 2020
USD ($)
integer
Dec. 31, 2019
USD ($)
integer
Derivative liabilities | $ $ 9,471,445 $ 2,462,940
Risk-Free Interest Rates [Member] | Minimum [Member]    
Derivative liability, measurement input 0.16 1.57
Risk-Free Interest Rates [Member] | Minimum [Member] | Derivative Liabilities [Member]    
Derivative liability, measurement input 0.12  
Risk-Free Interest Rates [Member] | Maximum [Member]    
Derivative liability, measurement input 0.18 1.77
Risk-Free Interest Rates [Member] | Maximum [Member] | Derivative Liabilities [Member]    
Derivative liability, measurement input 0.24  
Volatility [Member] | Minimum [Member]    
Derivative liability, measurement input 81 31
Volatility [Member] | Minimum [Member] | Derivative Liabilities [Member]    
Derivative liability, measurement input 74  
Volatility [Member] | Maximum [Member]    
Derivative liability, measurement input 105 36
Volatility [Member] | Maximum [Member] | Derivative Liabilities [Member]    
Derivative liability, measurement input 105  
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.20.2
Derivative Liabilities - Schedule of Derivative Liabilities (Details) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2020
Dec. 31, 2019
Fair Value Disclosures [Abstract]    
Derivative liability, beginning balance $ 2,462,940 $ 1,199,514
Issued during period 11,953,787 1,460,123
Converted or paid (8,627,804) (850,248)
Change in fair value recognized in operations 3,682,522 653,551
Derivative liability, ending balance $ 9,471,445 $ 2,462,940
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.20.2
Notes Payable (Details Narrative)
 6 Months Ended
Jun. 25, 2020
USD ($)
$ / shares
shares
Jun. 23, 2020
USD ($)
Feb. 26, 2020
USD ($)
$ / shares
Jun. 30, 2020
USD ($)
$ / shares
shares
Jun. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Convertible principal amount | $ / shares     $ 330,033 $ 0.00236    
Convertible precentage     0.12      
Debt instrument face amount     $ 330,000      
Notes payable       $ 446,395   $ 425,033
Original discount       14,727,584 $ 860,561  
Proceeds from notes payable       $ 351,000  
Debt instrument face value     $ 330,000      
Number of warrants issued to acquire shares of common stock | shares       104,719,899    
Promissory Note [Member] | Holder [Member]            
Debt instrument face amount $ 203,000          
Proceeds from notes payable $ 176,000          
Debt instrument description Principal payments shall be made in six installments of $33,333 commencing 180 days from the Issue Date and continuing each 30 days thereafter for 5 months and the final payment of principal and interest due on the Maturity Date. The Holder shall have the right from time to time, and at any time following an event of default, as defined on the agreement, to convert all or any part of the outstanding and unpaid principal, interest and any other amounts due into fully paid and non-assessable shares of common stock of the Company, at the lower of i) the Trading Price (as defined in the agreement) during the previous five trading days prior to the Issuance Date or ii) the volume weighted average price during the five trading days ending on the day preceding the conversion date.          
Debt instrument face value $ 203,000          
Debt instrument maturity Jun. 25, 2021          
Legal fee $ 27,000          
Number of warrants issued to acquire shares of common stock | shares 10,000,000          
Warrants exercise price | $ / shares $ 2          
Warrants term 5 years          
Warrants issued description In conjunction with this Note, the Company issued 2 common stock purchase warrants; each warrant entitles the Holder to purchase 10,000,000 shares of common stock at an exercise price of $02, subject to adjustments and expires on the five-year anniversary of the Issue Date.          
Loan and Securities Purchase Agreement [Member] | Promissory Note [Member] | Lender [Member]            
Notes payable   $ 210,000        
Original discount   35,000        
Proceeds from notes payable   $ 175,000        
Debt instrument interest rate   18.00%        
Maturity date, description   The note carries an interest rate of 18% and matures and is due in one lump sum on the 24- month anniversary (the “Maturity Date”) of the Execution Date.        
Debt instrument description   For the first nine months interest may accrue on a monthly basis, and the Company has the option to pay the monthly interest or add such interest to the principal balance of the note. Commencing on the tenth month of the note, all accrued interest, if any, shall be added to the principal amount of the note, and interest on the new principal amount shall become due and payable on a monthly basis. Should the Company default on making any interest payments following the initial nine-months, or paying the note by the Maturity Date, the note shall automatically be converted into an 18% convertible debenture.        
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.20.2
Notes Payable - Schedule of Notes Payable (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Sub total notes payable $ 446,395 $ 425,033
Less long-term portion, net of discount 176,365
Current portion of notes payable, net of discount 270,030 425,033
Note Payable [Member]    
Sub total notes payable 330,033
Note Payable One [Member]    
Sub total notes payable 45,000 45,000
Other [Member]    
Sub total notes payable 50,000 50,000
Note Payable Two [Member]    
Sub total notes payable 175,365
Note Payable Three [Member]    
Sub total notes payable $ 176,030
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.20.2
Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2020
Dec. 31, 2019
Apr. 13, 2018
Debt instrument discount $ 872,945 $ 806,003 $ 620,075
Note Payable [Member]      
Debt instrument interest rate 8.00% 8.00%  
Debt instrument maturity Sep. 06, 2018 Sep. 06, 2018  
Note Payable One [Member]      
Debt instrument interest rate 8.00% 8.00%  
Debt instrument maturity Jan. 05, 2020 Jan. 05, 2020  
Other [Member]      
Debt instrument interest rate 6.00% 6.00%  
Note Payable Two [Member]      
Debt instrument interest rate 18.00% 18.00%  
Debt instrument maturity Jun. 23, 2022 Jun. 23, 2022  
Debt instrument discount $ 34,635 $ 34,635  
Note Payable Three [Member]      
Debt instrument interest rate 12.00% 12.00%  
Debt instrument maturity Jun. 25, 2021 Jun. 25, 2021  
Debt instrument discount $ 26,970 $ 26,970  
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transaction (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Feb. 28, 2020
Sep. 18, 2019
Jul. 05, 2019
Feb. 09, 2018
Jun. 30, 2019
Mar. 31, 2019
Jun. 30, 2020
Dec. 31, 2019
Common stock issued during the period, shares       7,600,000     1,350 1,350
Number of shares of common stock, share $ 5,000   $ 7,000,000 $ 7,600 $ 20,000 $ 80,000   $ 410,370
Accrued liabilities - related party             $ 456,185 $ 470,886
Series C Preferred Stock [Member]                
Common stock issued during the period, shares   50,000            
Series C Preferred Stock [Member] | CEO [Member]                
Common stock issued during the period, shares 2,500              
Employment Agreement [Member] | Mr Conway [Member]                
Annual salary $ 120,000              
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transactions - Schedule of Expenses to Officers (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Total $ 30,000 $ 163,000 $ 87,505 $ 283,000
CEO [Member]        
Total 30,000 45,000
CEO Former [Member]        
Total 88,000 22,505 133,000
COO Former [Member]        
Total 45,000 90,000
CFO Former [Member]        
Total $ 30,000 $ 20,000 $ 60,000
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transactions - Schedule of Expenses to Officers (Details) (Parenthetical) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Stock-based compensation $ 54,033 $ 706,702 $ 410,370
CEO [Member]      
Stock-based compensation $ 5,000    
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transactions - Schedule of Former Officers for Accrued Fees, Accounts Payable and Loans (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Due to related party $ 419,692 $ 470,886
Former CEO, Former [Member]    
Due to related party [1] 200 125
Former CEO, Subsidiary [Member]    
Due to related party [2] 144,087 144,639
Former COO and CCO [Member]    
Due to related party [3] 162,085 162,085
Former COO [Member]    
Due to related party [4] 112,500 112,500
Former CFO [Member]    
Due to related party [5] 51,537
CEO [Member]    
Due to related party $ 100
[1] The former CEO, parent resigned February 28, 2020
[2] The former CEO, subsidiary resigned on March 4, 2019.
[3] The Former COO and CCO resigned from those positions on October 1, 2018, and March 4, 2019, respectively.
[4] The former COO resigned on October 23, 2019.
[5] The former CFO resigned effective February 28, 2020
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 05, 2020
Sep. 03, 2019
Sep. 02, 2019
Mar. 24, 2019
Nov. 20, 2018
Feb. 01, 2018
Jun. 30, 2019
Mar. 31, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Mar. 04, 2019
Notes payable                 $ 446,395   $ 425,033  
Common stock issued during the period, value             $ 32,000        
Stock- based compensation expense                 54,033 $ 706,702 410,370  
Deferred stock compensation                   49,033  
Licensing Agreement [Member]                        
Patents and the non-exclusive rights         $ 250,000 $ 250,000            
Royalty percentage           7.00%            
Separation Agreement [Member] | Salman J. Chaudhry [Member]                        
Outstanding fees                       $ 227,200
Notes payable                 162,085   162,085  
Investment Banking Engagement Agreement [Member] | Newbridge Securities Corporation [Member]                        
Agreement description       The term of the Agreement is 12 months from the date of the Agreement, however either party may terminate the Agreement anytime upon 15 days written notice. As compensation for its services under the Agreement, Newbridge and its assignees received 172 shares of the Company's common stock.                
Stock issued during the period, shares       172                
Common stock issued during the period, value       $ 77,130                
Stock- based compensation expense                 17,783      
Consulting Agreement [Member]                        
Stock issued during the period, shares   1,250                    
Common stock issued during the period, value   $ 46,875                    
Stock- based compensation expense                 15,625      
Consulting Agreement [Member] | Executive Vice President [Member]                        
Consulting services     $ 10,000                  
General and administrative                     30,000  
Accounts payable and accrued expenses                 10,000   $ 10,000  
Investor Relations Agreement [Member]                        
Stock issued during the period, shares   1,250                    
Common stock issued during the period, value   $ 46,875                    
Stock- based compensation expense                 $ 15,625      
One Year Agreement [Member]                        
Consulting services $ 10,000                      
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.20.2
Income Taxes (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Net profit income tax, percentage     16.50%  
Income tax, description     For U.S. purposes the NOL deduction for a tax year is equal to the lesser of (1) the aggregate of the NOL carryovers to such year, plus the NOL carry-backs to such year, or (2) 80% of taxable income (determined without regard to the deduction). Generally, NOLs can no longer be carried back but are allowed to be carried forward indefinitely. The special extended carryback provisions are generally repealed, except for certain farming and insurance company losses. The amendments incorporating the 80% limitation apply to losses arising in tax years beginning after Dec. 31, 2017.  
Provision for interest and penalties
United States        
Net operating loss carryforwards 6,108,000   6,108,000  
Hong Kong        
Net operating loss carryforwards $ 595,000   $ 595,000  
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.20.2
Income Taxes - Schedule of Provision for Income Tax (Details) - USD ($)
 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Income Tax Disclosure [Abstract]    
Pre-tax loss $ (31,227,327) $ (2,823,397)
U.S. federal corporate income tax rate 21.00% 21.00%
Expected U.S. income tax benefit $ (6,557,739) $ (592,493)
Tax rate difference between U.S. and foreign operations 289
Permanent differences 6,198,791 417,713
Change of valuation allowance 358,948 174,491
Effective tax expense
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.20.2
Income Taxes - Schedule of Deferred Tax Assets (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Income Tax Disclosure [Abstract]    
Net operating losses carried forward $ 1,381,018 $ 1,022,071
Less: Valuation allowance (1,381,018) (1,022,071)
Net deferred tax assets
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Feb. 28, 2020
Feb. 28, 2020
Jan. 21, 2020
Sep. 19, 2019
Sep. 18, 2019
Jul. 05, 2019
Apr. 02, 2019
Mar. 28, 2019
Feb. 09, 2018
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2019
Mar. 31, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Feb. 26, 2020
Reverse stock split     1-for-1,000 reverse stock split                            
Common stock issued during the period $ 5,000         $ 7,000,000     $ 7,600     $ 20,000 $ 80,000     $ 410,370  
Sale of Stock, Description           The purchase price for the shares will be 85% of the lowest closing price during the 10-day period prior to each sale, and with each sale, the Investor will receive an issuance premium of 5% to cover the Investor's transaction costs associated with selling the shares and payable by the Company to the Investor in registered shares. The obligation of the Investor to purchase shares pursuant to the Equity Agreement is subject to several conditions, including (i) that the Company has filed a registration statement (the "Registration Statement") with the United States Securities and Exchange Commission (the "SEC") registering the shares to be sold to the Investor within 30 calendar days from the date of the Equity Agreement, with the Registration Statement being declared effective prior to sale of any shares to the Investor; and (ii) that the purchase of shares by the Investor pursuant to the Equity Agreement shall not cause the Investor to own more than 4.99% of the outstanding shares of the Company's common stock.                      
Conversion of convertible debt, aggregate principal                           $ 2,774,896      
Conversion of convertible debt, accrued interest                           $ 636,466      
Conversion of convertible debt, shares issued                           1,444,237,885      
Conversion of convertible debt, conversion price                   $ 0.00236       $ 0.00236     $ 330,033
Common stock, authorized                   4,990,000,000       4,990,000,000   4,990,000,000  
Common stock, par value                   $ 0.001       $ 0.001   $ 0.001  
Common stock, issued                   1,549,176,877       1,549,176,877   219,035  
Common stock, outstanding                   1,549,176,877       1,549,176,877   219,035  
Number of shares of common stock                 7,600,000         1,350   1,350  
Stock-based compensation                           $ 54,033 $ 706,702 $ 410,370  
Preferred stock, authorized                   10,000,000       10,000,000   10,000,000  
Preferred stock, par value                   $ 0.001       $ 0.001   $ 0.001  
Preferred stock, shares outstanding                   50,000       50,000   50,000  
Number of redeemed shares, value                   $ (50,000) $ (50,000)     $ (50,000)      
Number of warrants issued to acquire shares of common stock                   104,719,899       104,719,899      
Officers and Directors [Member]                                  
Stock subscription receivable, shares                 7,600                
Stock subscription receivable, values                 $ 7,600                
Series B Preferred Stock [Member]                                  
Number of shares of common stock       1,000,000       1,000,000                  
Preferred stock, shares outstanding                            
Series B Preferred Stock [Member] | CEO [Member]                                  
Number of shares of common stock             1,000,000                    
Series C Preferred Stock [Member]                                  
Number of shares of common stock         50,000                        
Preferred stock, authorized                   50,000       50,000   50,000  
Preferred stock, par value                   $ 0.001       $ 0.001   $ 0.001  
Preferred stock, shares outstanding                   50,000       50,000   50,000  
Number of redeemed shares   2,500                              
Series C Preferred Stock [Member] | CEO [Member]                                  
Number of shares of common stock 2,500                                
Series C Preferred Stock [Member] | CEO and Director [Member]                                  
Number of shares of common stock       50,000                          
Series C Preferred Stock [Member] | Mr. Chermak [Member]                                  
Number of redeemed shares   50,000                              
Number of redeemed shares, value   $ 100,000                              
Share price $ 2 $ 2                              
Series C Preferred Stock [Member] | Mr Conway [Member]                                  
Common stock issued during the period   $ 5,000                              
Number of shares of common stock   2,500                              
Share price $ 2 $ 2                              
Tranches [Member]                                  
Common stock issued during the period           $ 400,000                      
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.20.2
Discontinued Operations (Details Narrative) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Accounts payable and accrued expenses   $ 88,178
Spinal Resources, Inc [Member]    
Accounts payable and accrued expenses $ 75,270  
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.20.2
Discontinued Operations - Schedule of Discontinued Operations Condensed Consolidated Statements (Details) - USD ($)
 6 Months Ended
Jun. 30, 2020
Dec. 31, 2019
Discontinued Operations and Disposal Groups [Abstract]    
Cost of goods sold $ 4,326  
Depreciation expense 13,805  
Rent expense 2,222  
Interest expense 8,794  
Total operating expenses 24,821  
Loss from discontinued operations (29,147)  
Gain from license termination $ 86,856  
Inventory   $ 378,061
Prepaid expenses   2,987
Property and equipment, net   353,985
License rights, net   2,724,848
Goodwill   2,002,314
Total assets included in the assets of discontinued operations   5,462,195
Accounts payable and accrued expenses   88,178
Liability for common stock payable   245,000
Current portion of notes payable   1,131,771
Current portion of license fee payable   984,089
Long term portion of notes payable   1,440
Long term portion of license fee payable   250,000
Put option payable   2,892,228
Total liabilities included in the liabilities of discontinued operations   $ 5,592,706
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events (Details Narrative) - USD ($)
 1 Months Ended 6 Months Ended 12 Months Ended
Aug. 03, 2020
Jul. 29, 2020
Jul. 24, 2020
Jul. 22, 2020
Jul. 15, 2020
Jul. 10, 2020
Jul. 09, 2020
Jul. 08, 2020
Jul. 07, 2020
Jul. 07, 2020
Jun. 30, 2020
May 28, 2020
May 07, 2020
Apr. 27, 2020
Sep. 18, 2019
Feb. 09, 2018
Aug. 10, 2020
Jun. 30, 2020
Dec. 31, 2019
Feb. 26, 2020
Apr. 13, 2018
Number of shares of common stock                               7,600,000   1,350 1,350    
Debt instrument face amount                                       $ 330,000  
Original issue discount                     $ 872,945             $ 872,945 $ 806,003   $ 620,075
Number of warrants issued to acquire shares of common stock                     104,719,899             104,719,899      
Series C Preferred Stock [Member]                                          
Number of shares of common stock                             50,000            
15% Convertible Redeemable Note [Member]                                          
Debt instrument maturity                       May 28, 2021   Apr. 27, 2021              
Debt instrument, maturity description                     This note matures 6 months after the Issuance Date.   This note matures on May 7,2021                
Debt instrument, description                     This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion. This note matures on May 28, 2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company. This note matures on May 7,2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company This note matures on April 27,2021 and is convertible into shares of common stock at a conversion price equal to 50% of the lowest traded price for the twenty-five prior trading days including the day upon which a conversion notice is received by the Company              
Original issue discount                     $ 100,000 $ 25,000 $ 25,000 $ 50,000       $ 100,000      
Subsequent Event [Member]                                          
Number of shares of common stock                                 205,966,108        
Debt instrument face amount                                 $ 1,883,096        
Number of shares issued upon exercise of warrants                                 149,820,477        
Subsequent Event [Member] | Certificates of Designation [Member] | Series C Preferred Stock [Member]                                          
Designation of preferred stock                 50,000                        
Voting rights                 Under the terms of the Amendment to Certificate of Designation of Series C Preferred Stock, 50,000 shares of the Company’s preferred remain designated as Series C Preferred Stock. The holders of Series C Preferred Stock have no dividend rights. For so long as any shares of the Series C Preferred Stock remain issued and outstanding, the Holder thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to sixty-seven (67%) percent of the total vote.                        
Subsequent Event [Member] | Certificates of Designation [Member] | Series D Preferred Stock [Member]                                          
Designation of preferred stock                   20,000                      
Voting rights                   Under the terms of the Certificate of Designation of Series D Preferred Stock, 20,000 shares of the Company’s preferred stock have been designated as Series D Convertible Preferred Stock. The holders of the Series D Convertible Preferred Stock shall not be entitled to receive dividends. The holders as a group may, at any time convert all of the shares of Series D Convertible Preferred Stock into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion, by 3. Except as provided in the Certificate of Designation or as otherwise required by law, no holder of the Series D Convertible Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Company for their vote, waiver, release or other action. The Series D Convertible Preferred Stock shall not bear any liquidation rights.                      
Subsequent Event [Member] | Certificates of Designation [Member] | Series E Preferred Stock [Member]                                          
Designation of preferred stock                 3,000                        
Optional redemption per share                 $ 1,000                        
Subsequent Event [Member] | SPA [Member] | PCTI [Member]                                          
Shares for acquisition           1,000                              
Cash payment           $ 400,000                              
Subsequent Event [Member] | SPA [Member] | Series C Preferred Stock [Member] | PCTI [Member]                                          
Shares for acquisition           47,500                              
Subsequent Event [Member] | SPA [Member] | Series D Preferred Stock [Member] | PCTI [Member]                                          
Shares for acquisition           500                              
Subsequent Event [Member] | SPA [Member] | Series E Preferred Stock [Member] | PCTI [Member]                                          
Shares for acquisition           18,667                              
Subsequent Event [Member] | Consulting Agreement [Member]                                          
Consulting services     $ 10,000                                    
Subsequent Event [Member] | 15% Convertible Redeemable Note [Member] | Investor [Member]                                          
Debt instrument face amount   $ 127,500     $ 127,500     $ 250,000                          
Debt instrument interest rate               12.00%                          
Debt instrument, maturity description   This note matures 6 months after the Issuance Date.     This note matures 6 months after the Issuance Date     This note matures 6 months after the Issuance Date                          
Debt instrument, description   This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.011 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion.     This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.011 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion.     This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025 for the first three months after the Issuance Date. After the first three months after the Issuance Date, the conversion price shall be equal to the lower of (i) $.025 or 50% of the lowest trading price for the thirty-five trading days prior to the conversion.                          
Proceeds received $ 100,000     $ 102,000     $ 200,000                            
Original issue discount   $ 27,500     $ 27,500     $ 50,000                          
Number of warrants issued to acquire shares of common stock   12,750,000     6,375,000     12,500,000                          
Warrants exercise price   $ 0.01     $ 0.02     $ 0.02                          
Warrants term   5 years     5 years     5 years                          
EXCEL 70 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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ŝ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�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end XML 71 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 72 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 73 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 544 413 1 true 140 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://ir.ozopsurgical.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheet (Unaudited) Sheet http://ir.ozopsurgical.com/role/BalanceSheet Condensed Consolidated Balance Sheet (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheet (Unaudited) (Parenthetical) Sheet http://ir.ozopsurgical.com/role/BalanceSheetParenthetical Condensed Consolidated Balance Sheet (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statement of Comprehensive Loss (Unaudited) Sheet http://ir.ozopsurgical.com/role/StatementOfComprehensiveLoss Condensed Consolidated Statement of Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statement of Changes in Stockholders' Deficit (Unaudited) Sheet http://ir.ozopsurgical.com/role/StatementOfChangesInStockholdersDeficit Consolidated Statement of Changes in Stockholders' Deficit (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statement of Cash Flows (Unaudited) Sheet http://ir.ozopsurgical.com/role/StatementOfCashFlows Condensed Consolidated Statement of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Organization Sheet http://ir.ozopsurgical.com/role/Organization Organization Notes 7 false false R8.htm 00000008 - Disclosure - Going Concern and Management's Plans Sheet http://ir.ozopsurgical.com/role/GoingConcernAndManagementsPlans Going Concern and Management's Plans Notes 8 false false R9.htm 00000009 - Disclosure - Summary of Significant Accounting Pronouncements Sheet http://ir.ozopsurgical.com/role/SummaryOfSignificantAccountingPronouncements Summary of Significant Accounting Pronouncements Notes 9 false false R10.htm 00000010 - Disclosure - Intangible Assets Sheet http://ir.ozopsurgical.com/role/IntangibleAssets Intangible Assets Notes 10 false false R11.htm 00000011 - Disclosure - Convertible Notes Payable Notes http://ir.ozopsurgical.com/role/ConvertibleNotesPayable Convertible Notes Payable Notes 11 false false R12.htm 00000012 - Disclosure - Derivative Liabilities Sheet http://ir.ozopsurgical.com/role/DerivativeLiabilities Derivative Liabilities Notes 12 false false R13.htm 00000013 - Disclosure - Notes Payable Notes http://ir.ozopsurgical.com/role/NotesPayable Notes Payable Notes 13 false false R14.htm 00000014 - Disclosure - Related Party Transactions Sheet http://ir.ozopsurgical.com/role/RelatedPartyTransactions Related Party Transactions Notes 14 false false R15.htm 00000015 - Disclosure - Commitments and Contingencies Sheet http://ir.ozopsurgical.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 00000016 - Disclosure - Income Taxes Sheet http://ir.ozopsurgical.com/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 00000017 - Disclosure - Stockholders' Equity Sheet http://ir.ozopsurgical.com/role/StockholdersEquity Stockholders' Equity Notes 17 false false R18.htm 00000018 - Disclosure - Discontinued Operations Sheet http://ir.ozopsurgical.com/role/DiscontinuedOperations Discontinued Operations Notes 18 false false R19.htm 00000019 - Disclosure - Subsequent Events Sheet http://ir.ozopsurgical.com/role/SubsequentEvents Subsequent Events Notes 19 false false R20.htm 00000020 - Disclosure - Summary of Significant Accounting Pronouncements (Policies) Sheet http://ir.ozopsurgical.com/role/SummaryOfSignificantAccountingPronouncementsPolicies Summary of Significant Accounting Pronouncements (Policies) Policies http://ir.ozopsurgical.com/role/SummaryOfSignificantAccountingPronouncements 20 false false R21.htm 00000021 - Disclosure - Organization (Tables) Sheet http://ir.ozopsurgical.com/role/OrganizationTables Organization (Tables) Tables http://ir.ozopsurgical.com/role/Organization 21 false false R22.htm 00000022 - Disclosure - Summary of Significant Accounting Pronouncements (Tables) Sheet http://ir.ozopsurgical.com/role/SummaryOfSignificantAccountingPronouncementsTables Summary of Significant Accounting Pronouncements (Tables) Tables http://ir.ozopsurgical.com/role/SummaryOfSignificantAccountingPronouncements 22 false false R23.htm 00000023 - Disclosure - Intangible Assets (Tables) Sheet http://ir.ozopsurgical.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://ir.ozopsurgical.com/role/IntangibleAssets 23 false false R24.htm 00000024 - Disclosure - Convertible Notes Payable (Tables) Notes http://ir.ozopsurgical.com/role/ConvertibleNotesPayableTables Convertible Notes Payable (Tables) Tables http://ir.ozopsurgical.com/role/ConvertibleNotesPayable 24 false false R25.htm 00000025 - Disclosure - Derivative Liabilities (Tables) Sheet http://ir.ozopsurgical.com/role/DerivativeLiabilitiesTables Derivative Liabilities (Tables) Tables http://ir.ozopsurgical.com/role/DerivativeLiabilities 25 false false R26.htm 00000026 - Disclosure - Notes Payable (Tables) Notes http://ir.ozopsurgical.com/role/NotesPayableTables Notes Payable (Tables) Tables http://ir.ozopsurgical.com/role/NotesPayable 26 false false R27.htm 00000027 - Disclosure - Related Party Transactions (Tables) Sheet http://ir.ozopsurgical.com/role/RelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://ir.ozopsurgical.com/role/RelatedPartyTransactions 27 false false R28.htm 00000028 - Disclosure - Income Taxes (Tables) Sheet http://ir.ozopsurgical.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://ir.ozopsurgical.com/role/IncomeTaxes 28 false false R29.htm 00000029 - Disclosure - Discontinued Operations (Tables) Sheet http://ir.ozopsurgical.com/role/DiscontinuedOperationsTables Discontinued Operations (Tables) Tables http://ir.ozopsurgical.com/role/DiscontinuedOperations 29 false false R30.htm 00000030 - Disclosure - Organization (Details Narrative) Sheet http://ir.ozopsurgical.com/role/OrganizationDetailsNarrative Organization (Details Narrative) Details http://ir.ozopsurgical.com/role/OrganizationTables 30 false false R31.htm 00000031 - Disclosure - Organization - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details) Sheet http://ir.ozopsurgical.com/role/Organization-ScheduleOfFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails Organization - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details) Details 31 false false R32.htm 00000032 - Disclosure - Going Concern and Management's Plans (Details Narrative) Sheet http://ir.ozopsurgical.com/role/GoingConcernAndManagementsPlansDetailsNarrative Going Concern and Management's Plans (Details Narrative) Details http://ir.ozopsurgical.com/role/GoingConcernAndManagementsPlans 32 false false R33.htm 00000033 - Disclosure - Summary of Significant Accounting Pronouncements (Details Narrative) Sheet http://ir.ozopsurgical.com/role/SummaryOfSignificantAccountingPronouncementsDetailsNarrative Summary of Significant Accounting Pronouncements (Details Narrative) Details http://ir.ozopsurgical.com/role/SummaryOfSignificantAccountingPronouncementsTables 33 false false R34.htm 00000034 - Disclosure - Summary of Significant Accounting Pronouncements - Schedule of Concentration Risk (Details) Sheet http://ir.ozopsurgical.com/role/SummaryOfSignificantAccountingPronouncements-ScheduleOfConcentrationRiskDetails Summary of Significant Accounting Pronouncements - Schedule of Concentration Risk (Details) Details 34 false false R35.htm 00000035 - Disclosure - Summary of Significant Accounting Pronouncements - Schedule of Property, Plant and Equipment (Details) Sheet http://ir.ozopsurgical.com/role/SummaryOfSignificantAccountingPronouncements-ScheduleOfPropertyPlantAndEquipmentDetails Summary of Significant Accounting Pronouncements - Schedule of Property, Plant and Equipment (Details) Details 35 false false R36.htm 00000036 - Disclosure - Summary of Significant Accounting Pronouncements - Schedule of Fair Value of Derivative Instruments on Recurring Basis (Details) Sheet http://ir.ozopsurgical.com/role/SummaryOfSignificantAccountingPronouncements-ScheduleOfFairValueOfDerivativeInstrumentsOnRecurringBasisDetails Summary of Significant Accounting Pronouncements - Schedule of Fair Value of Derivative Instruments on Recurring Basis (Details) Details 36 false false R37.htm 00000037 - Disclosure - Summary of Significant Accounting Pronouncements - Schedule of Foreign Exchange Rates (Details) Sheet http://ir.ozopsurgical.com/role/SummaryOfSignificantAccountingPronouncements-ScheduleOfForeignExchangeRatesDetails Summary of Significant Accounting Pronouncements - Schedule of Foreign Exchange Rates (Details) Details 37 false false R38.htm 00000038 - Disclosure - Summary of Significant Accounting Pronouncements - Schedule of Antidilutive Securities (Details) Sheet http://ir.ozopsurgical.com/role/SummaryOfSignificantAccountingPronouncements-ScheduleOfAntidilutiveSecuritiesDetails Summary of Significant Accounting Pronouncements - Schedule of Antidilutive Securities (Details) Details 38 false false R39.htm 00000039 - Disclosure - Intangible Assets (Details Narrative) Sheet http://ir.ozopsurgical.com/role/IntangibleAssetsDetailsNarrative Intangible Assets (Details Narrative) Details http://ir.ozopsurgical.com/role/IntangibleAssetsTables 39 false false R40.htm 00000040 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details) Sheet http://ir.ozopsurgical.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails Intangible Assets - Schedule of Intangible Assets (Details) Details 40 false false R41.htm 00000041 - Disclosure - Convertible Notes Payable (Details Narrative) Notes http://ir.ozopsurgical.com/role/ConvertibleNotesPayableDetailsNarrative Convertible Notes Payable (Details Narrative) Details http://ir.ozopsurgical.com/role/ConvertibleNotesPayableTables 41 false false R42.htm 00000042 - Disclosure - Convertible Notes Payable - Summary of Convertible Note Balance (Details) Notes http://ir.ozopsurgical.com/role/ConvertibleNotesPayable-SummaryOfConvertibleNoteBalanceDetails Convertible Notes Payable - Summary of Convertible Note Balance (Details) Details 42 false false R43.htm 00000043 - Disclosure - Derivative Liabilities (Details Narrative) Sheet http://ir.ozopsurgical.com/role/DerivativeLiabilitiesDetailsNarrative Derivative Liabilities (Details Narrative) Details http://ir.ozopsurgical.com/role/DerivativeLiabilitiesTables 43 false false R44.htm 00000044 - Disclosure - Derivative Liabilities - Schedule of Derivative Liabilities (Details) Sheet http://ir.ozopsurgical.com/role/DerivativeLiabilities-ScheduleOfDerivativeLiabilitiesDetails Derivative Liabilities - Schedule of Derivative Liabilities (Details) Details 44 false false R45.htm 00000045 - Disclosure - Notes Payable (Details Narrative) Notes http://ir.ozopsurgical.com/role/NotesPayableDetailsNarrative Notes Payable (Details Narrative) Details http://ir.ozopsurgical.com/role/NotesPayableTables 45 false false R46.htm 00000046 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) Notes http://ir.ozopsurgical.com/role/NotesPayable-ScheduleOfNotesPayableDetails Notes Payable - Schedule of Notes Payable (Details) Details 46 false false R47.htm 00000047 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) Notes http://ir.ozopsurgical.com/role/NotesPayable-ScheduleOfNotesPayableDetailsParenthetical Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) Details 47 false false R48.htm 00000048 - Disclosure - Related Party Transaction (Details Narrative) Sheet http://ir.ozopsurgical.com/role/RelatedPartyTransactionDetailsNarrative Related Party Transaction (Details Narrative) Details http://ir.ozopsurgical.com/role/RelatedPartyTransactionsTables 48 false false R49.htm 00000049 - Disclosure - Related Party Transactions - Schedule of Expenses to Officers (Details) Sheet http://ir.ozopsurgical.com/role/RelatedPartyTransactions-ScheduleOfExpensesToOfficersDetails Related Party Transactions - Schedule of Expenses to Officers (Details) Details 49 false false R50.htm 00000050 - Disclosure - Related Party Transactions - Schedule of Expenses to Officers (Details) (Parenthetical) Sheet http://ir.ozopsurgical.com/role/RelatedPartyTransactions-ScheduleOfExpensesToOfficersDetailsParenthetical Related Party Transactions - Schedule of Expenses to Officers (Details) (Parenthetical) Details 50 false false R51.htm 00000051 - Disclosure - Related Party Transactions - Schedule of Former Officers for Accrued Fees, Accounts Payable and Loans (Details) Sheet http://ir.ozopsurgical.com/role/RelatedPartyTransactions-ScheduleOfFormerOfficersForAccruedFeesAccountsPayableAndLoansDetails Related Party Transactions - Schedule of Former Officers for Accrued Fees, Accounts Payable and Loans (Details) Details 51 false false R52.htm 00000052 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://ir.ozopsurgical.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://ir.ozopsurgical.com/role/CommitmentsAndContingencies 52 false false R53.htm 00000053 - Disclosure - Income Taxes (Details Narrative) Sheet http://ir.ozopsurgical.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://ir.ozopsurgical.com/role/IncomeTaxesTables 53 false false R54.htm 00000054 - Disclosure - Income Taxes - Schedule of Provision for Income Tax (Details) Sheet http://ir.ozopsurgical.com/role/IncomeTaxes-ScheduleOfProvisionForIncomeTaxDetails Income Taxes - Schedule of Provision for Income Tax (Details) Details 54 false false R55.htm 00000055 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details) Sheet http://ir.ozopsurgical.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails Income Taxes - Schedule of Deferred Tax Assets (Details) Details 55 false false R56.htm 00000056 - Disclosure - Stockholders' Equity (Details Narrative) Sheet http://ir.ozopsurgical.com/role/StockholdersEquityDetailsNarrative Stockholders' Equity (Details Narrative) Details http://ir.ozopsurgical.com/role/StockholdersEquity 56 false false R57.htm 00000057 - Disclosure - Discontinued Operations (Details Narrative) Sheet http://ir.ozopsurgical.com/role/DiscontinuedOperationsDetailsNarrative Discontinued Operations (Details Narrative) Details http://ir.ozopsurgical.com/role/DiscontinuedOperationsTables 57 false false R58.htm 00000058 - Disclosure - Discontinued Operations - Schedule of Discontinued Operations Condensed Consolidated Statements (Details) Sheet http://ir.ozopsurgical.com/role/DiscontinuedOperations-ScheduleOfDiscontinuedOperationsCondensedConsolidatedStatementsDetails Discontinued Operations - Schedule of Discontinued Operations Condensed Consolidated Statements (Details) Details 58 false false R59.htm 00000059 - Disclosure - Subsequent Events (Details Narrative) Sheet http://ir.ozopsurgical.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://ir.ozopsurgical.com/role/SubsequentEvents 59 false false All Reports Book All Reports ozsc-20200630.xml ozsc-20200630.xsd ozsc-20200630_cal.xml ozsc-20200630_def.xml ozsc-20200630_lab.xml ozsc-20200630_pre.xml http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/us-gaap/2020-01-31 true true ZIP 75 0001493152-20-015837-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-20-015837-xbrl.zip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�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�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end